data_1zy3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zy3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.865 0.364 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -127.49 89.69 50.55 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.219 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.65 131.35 22.63 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.578 2.185 . . . . 0.0 111.714 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.04 152.62 21.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.13 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.0 m -83.34 116.11 22.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.337 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.723 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -69.24 -55.85 9.4 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.281 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.723 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 96.0 Cg_endo -92.57 146.78 2.73 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.133 1.889 . . . . 0.0 112.917 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 13.4 t70 -76.54 148.26 37.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.848 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.423 ' O ' HG22 ' A' ' 13' ' ' VAL . 3.1 m -53.43 -35.63 60.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 2.4 mtm180 -63.11 -33.34 75.24 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.116 -0.233 . . . . 0.0 110.824 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.27 -37.6 85.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.028 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.38 -40.32 81.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.67 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 9' ' ' THR . 85.1 t -62.34 -43.14 97.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.559 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.17 -38.43 91.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.13 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.85 -38.75 86.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -67.51 -50.42 58.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.3 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.2 t -61.86 -44.47 98.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.831 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 22' ' ' ARG . . . -62.93 -40.41 99.25 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.45 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.418 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 2.6 t80 -62.85 -47.39 83.58 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.56 -37.46 81.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.969 0.414 . . . . 0.0 110.447 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.707 HD12 ' HE2' ' A' ' 24' ' ' LYS . 23.4 tp -67.72 -34.07 76.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 84.7 mtm-85 -80.14 -33.73 38.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.753 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 14.3 mm100 -60.14 -23.6 64.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.707 ' HE2' HD12 ' A' ' 21' ' ' LEU . 57.3 pttt -97.08 22.78 8.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.885 0.374 . . . . 0.0 111.037 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.04 -55.29 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.327 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.7 110.91 4.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.24 112.87 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.088 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.4 t -120.86 125.86 48.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.054 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.19 -130.15 4.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.47 179.62 8.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.652 0.263 . . . . 0.0 110.302 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.69 96.66 0.81 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.869 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.46 113.21 3.05 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.899 2.399 . . . . 0.0 112.324 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.22 -108.96 1.83 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.959 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.38 106.36 9.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.95 0.405 . . . . 0.0 110.537 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.11 79.44 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.59 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.54 122.35 10.69 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.146 2.564 . . . . 0.0 112.786 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.88 166.91 10.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.578 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.7 18.06 9.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.093 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -120.87 89.08 45.19 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -89.71 -7.27 4.77 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.491 2.127 . . . . 0.0 110.812 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.64 -53.2 36.59 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.121 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -62.66 -38.04 88.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.953 0.406 . . . . 0.0 110.498 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -67.59 -40.28 84.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.271 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.65 91.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.545 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 37.6 mtt -61.67 -41.62 97.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.228 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -62.27 -50.33 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.532 ' HB1' ' HG3' ' A' ' 51' ' ' GLU . . . -61.8 -37.22 83.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.845 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.23 -32.61 49.13 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.127 0.267 . . . . 0.0 111.719 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.4 35.56 3.57 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.683 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -151.26 -33.49 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.532 ' HG3' ' HB1' ' A' ' 47' ' ' ALA . 3.8 mm-40 -60.38 -72.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.503 ' HE2' HG21 ' A' ' 59' ' ' THR . 9.2 p90 -56.47 -36.66 69.34 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.517 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.12 -42.3 99.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.684 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.55 -20.05 63.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 -105.92 1.21 26.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.208 0.528 . . . . 0.0 110.554 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.473 ' HB3' ' H ' ' A' ' 57' ' ' ARG . 2.8 t80 -98.13 -85.58 0.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.571 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 5.2 ttm105 175.05 -71.12 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.63 61.29 0.32 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.107 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.503 HG21 ' HE2' ' A' ' 52' ' ' PHE . 0.4 OUTLIER -50.51 -33.55 21.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.038 -178.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -56.06 -23.73 35.35 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.405 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.6 m -121.39 -40.38 2.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.615 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.5 -49.87 73.63 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.423 ' HB2' HG23 ' A' ' 59' ' ' THR . 10.9 tp -59.67 -34.15 72.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.11 0.481 . . . . 0.0 110.733 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -80.04 -18.45 50.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.97 -47.58 7.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.511 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.905 ' HG3' HD22 ' A' ' 67' ' ' LEU . 8.5 pt20 -65.02 -19.55 66.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.905 HD22 ' HG3' ' A' ' 66' ' ' GLN . 0.4 OUTLIER -109.84 13.84 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 0.0 110.612 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.597 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 9.0 t-160 -95.24 10.38 36.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.161 0.505 . . . . 0.0 110.705 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.6 t -78.88 -42.57 24.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.201 0.524 . . . . 0.0 110.139 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -86.48 132.41 42.92 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.002 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.84 109.21 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.063 2.509 . . . . 0.0 112.704 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.08 -146.84 21.71 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.633 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.658 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 20.1 m -151.17 -159.45 1.03 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.6 -157.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.796 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.464 ' OE1' ' HB2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -54.96 -31.04 60.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.442 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -64.43 -10.94 28.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.444 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.658 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 19.0 tpp85 -109.61 -25.59 10.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.7 0.286 . . . . 0.0 110.885 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.541 ' O ' HG11 ' A' ' 81' ' ' VAL . 19.4 m-85 -65.55 -61.05 2.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.33 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.17 -20.89 64.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.283 0.563 . . . . 0.0 110.731 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -75.63 -24.97 56.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.199 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.541 HG11 ' O ' ' A' ' 78' ' ' PHE . 1.4 p -73.93 -24.56 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.217 0.532 . . . . 0.0 110.04 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.23 -39.64 39.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.663 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -71.95 -28.52 63.5 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.007 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -54.6 -47.61 73.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.688 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.6 ' HB3' ' HD3' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -82.1 -21.8 36.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.535 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.544 ' HB2' ' HA ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -62.9 -32.61 73.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.356 0.598 . . . . 0.0 109.43 179.049 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -64.1 -24.09 67.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.42 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.46 45.32 1.09 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.512 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.64 74.79 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.553 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.09 52.09 3.69 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.342 2.695 . . . . 0.0 112.012 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -71.85 163.36 27.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.618 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.777 ' HB3' HD11 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -53.37 -39.94 64.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.392 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.455 ' HA3' ' OD1' ' B' ' 214' ' ' ASP . . . -65.22 -24.77 70.73 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.616 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.6 ' HD3' ' HB3' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -75.09 -39.92 60.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.82 -42.61 94.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.295 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.44 -46.75 89.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.356 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.491 ' HA ' HG13 ' A' ' 100' ' ' VAL . . . -60.97 -41.98 97.46 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.278 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -62.68 -41.55 99.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.126 0.488 . . . . 0.0 110.646 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -71.49 -49.21 43.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.398 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.491 HG13 ' HA ' ' A' ' 97' ' ' ALA . 9.9 p -64.13 -36.44 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -62.36 -49.73 74.38 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.939 0.4 . . . . 0.0 110.187 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.81 -47.08 78.7 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.017 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.34 87.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.87 81.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.755 0.312 . . . . 0.0 111.252 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.443 ' HG ' ' OE1' ' A' ' 75' ' ' GLN . 2.6 mm? -65.83 -40.84 92.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.02 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.438 ' O ' HG22 ' A' ' 110' ' ' VAL . 56.6 m -64.49 -46.93 80.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.549 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.89 77.7 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.069 0.461 . . . . 0.0 110.541 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.71 -46.21 66.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.194 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 m -62.95 -34.64 77.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.126 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 106' ' ' CYS . 40.0 t -63.17 -39.88 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.001 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -73.46 -28.22 61.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.228 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -85.6 9.33 16.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.757 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 54.49 48.93 19.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.569 0.7 . . . . 0.0 110.334 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.18 53.89 1.28 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.316 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -60.45 -28.32 68.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.745 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.6 t -56.49 -45.48 82.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.391 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.483 ' O ' HG22 ' A' ' 121' ' ' VAL . 37.9 tp -71.97 -41.9 67.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.386 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.18 -46.61 77.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.564 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.79 -35.65 90.37 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.036 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -69.7 -44.89 69.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 110.237 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 117' ' ' LEU . 57.6 t -61.27 -48.4 89.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.826 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.33 -41.34 98.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.579 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -59.62 -45.39 92.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.252 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -66.54 -40.99 89.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.833 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 85.7 mtp -60.16 -51.4 69.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.744 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.39 -45.26 93.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.414 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.57 81.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -61.86 -43.26 99.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.161 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.468 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 58.4 mt -64.3 -28.51 69.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.854 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -101.91 8.04 41.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.2 m -121.53 -70.19 0.8 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.412 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.4 ttt85 -85.76 -38.32 18.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.823 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 77.9 mt -95.02 11.8 30.74 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.49 -52.64 64.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.798 0.332 . . . . 0.0 111.262 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.37 -39.31 92.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.823 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 84.0 m95 -62.95 -48.78 77.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 133' ' ' LEU . 44.1 mm -61.57 -37.45 77.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.043 0.449 . . . . 0.0 109.817 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -66.5 -32.12 73.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 m -78.01 -37.62 46.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.046 0.451 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 29.8 m -81.5 -6.99 59.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.143 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.18 41.45 98.35 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.67 -100.97 1.99 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -120.78 13.6 11.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 140' ' ' SER . . . -51.79 -65.41 0.56 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.243 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.493 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 7.5 pt-20 -67.0 -23.52 65.94 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.234 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.463 ' HA ' HD12 ' A' ' 149' ' ' LEU . 59.0 t80 -61.92 -35.31 78.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.678 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -60.4 -30.63 69.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.131 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.41 -12.06 35.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' A' ' 92' ' ' TRP . 87.6 mt -80.54 -35.95 33.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.293 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.678 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 9.2 p90 -98.73 16.64 21.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.019 0.437 . . . . 0.0 111.056 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.22 -47.15 90.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.769 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 C--N 1.322 -0.588 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.221 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 37.6 mt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.863 0.363 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' B' ' 205' ' ' ILE . 1.8 pt -143.88 75.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.561 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -65.1 -33.2 75.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -61.38 -42.58 98.94 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' ILE . . . . . 0.561 HD13 HD11 ' A' ' 67' ' ' LEU . 8.4 mm -69.07 -42.56 81.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.091 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . 0.489 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -62.55 -37.94 88.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.354 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -66.33 -34.57 78.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.325 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' HIS . . . . . 0.561 ' HB3' HD12 ' A' ' 67' ' ' LEU . 6.1 t-80 -60.08 -56.55 20.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.435 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.1 pp -63.44 -33.43 75.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.811 0.339 . . . . 0.0 110.293 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.57 -59.37 4.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.791 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -63.6 -43.0 98.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.66 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.481 HG12 HE22 ' A' ' 66' ' ' GLN . 53.5 t -63.66 -43.19 98.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.709 0.29 . . . . 0.0 110.678 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.89 -44.22 80.07 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.095 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . 0.455 ' OD1' ' HA3' ' A' ' 93' ' ' GLY . 60.0 m-20 -60.13 -46.1 90.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.93 0.395 . . . . 0.0 111.315 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 12.6 p -70.02 -46.82 64.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.934 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' MET . . . . . 0.435 ' HG2' ' CD2' ' A' ' 56' ' ' PHE . 11.4 tpp -62.82 -43.73 98.01 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -60.15 -54.72 42.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.631 0.253 . . . . 0.0 110.912 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.449 -179.86 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.804 0.335 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -114.26 126.26 28.22 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.475 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.45 110.11 2.61 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.567 2.178 . . . . 0.0 112.123 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.89 117.3 11.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.8 m -66.34 121.58 15.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.234 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.584 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -82.76 -51.52 0.7 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.16 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 17.1 Cg_exo -67.8 141.5 54.44 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.068 1.845 . . . . 0.0 112.67 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.42 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 16.0 t70 -85.95 154.6 21.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.266 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.418 ' O ' HG22 ' A' ' 13' ' ' VAL . 2.8 m -54.65 -42.72 71.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.917 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.42 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -66.21 -35.05 79.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.418 0.151 . . . . 0.0 111.1 -179.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.27 -37.68 86.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.947 0.404 . . . . 0.0 110.552 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 41' ' ' LEU . 6.3 tp -68.27 -44.38 75.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.916 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 9' ' ' THR . 87.7 t -62.92 -44.81 99.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.389 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.64 71.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.831 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.22 -44.08 84.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.89 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -63.54 -47.64 80.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.131 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.8 t -59.77 -46.25 93.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.274 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 22' ' ' ARG . . . -62.75 -44.81 96.93 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.598 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.475 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 10.8 t80 -58.54 -49.6 76.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.38 . . . . 0.0 110.503 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -62.09 -36.21 81.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.6 tp -67.81 -26.67 66.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.59 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 87.1 mtm-85 -90.8 -32.43 16.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.461 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 15.7 mm100 -63.01 -27.14 69.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 0.0 111.38 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -88.61 17.91 5.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.132 0.492 . . . . 0.0 110.766 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.86 -74.8 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -127.58 101.35 6.37 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.436 HG11 HE22 ' A' ' 23' ' ' GLN . 59.1 t -62.06 121.95 11.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.809 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.2 t -143.23 139.21 30.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.768 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.59 -138.96 9.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.067 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.97 145.22 26.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.649 0.261 . . . . 0.0 110.473 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.59 103.99 2.23 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.272 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.83 128.15 14.68 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.78 2.32 . . . . 0.0 111.441 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.68 -55.99 0.2 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.257 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -125.09 24.94 7.38 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.173 0.511 . . . . 0.0 110.201 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.62 104.51 2.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.166 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.08 126.61 13.98 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.894 2.396 . . . . 0.0 111.802 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.51 154.69 20.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.346 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.38 -31.43 63.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.905 0.383 . . . . 0.0 110.65 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.3 130.26 23.63 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.135 0.493 . . . . 0.0 110.548 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -98.18 1.33 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.941 2.427 . . . . 0.0 111.081 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.443 ' HB3' HD22 ' A' ' 12' ' ' LEU . 47.2 mt -64.58 -47.22 79.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.821 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -58.85 -37.56 76.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.946 0.403 . . . . 0.0 111.417 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -80.27 -38.03 31.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.943 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.75 97.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.989 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.577 ' HE3' ' HZ ' ' A' ' 99' ' ' PHE . 25.3 ttm -61.22 -40.33 93.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.46 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -71.39 -44.39 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.517 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.554 ' HB1' ' HG3' ' A' ' 51' ' ' GLU . . . -59.07 -43.65 91.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.211 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.44 -21.11 34.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.553 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -125.51 26.11 5.52 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.013 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -146.37 -46.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.813 -0.228 . . . . 0.0 111.601 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.612 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 14.9 mm-40 -58.58 -55.36 36.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.829 0.347 . . . . 0.0 111.309 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.553 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 2.3 p90 -66.82 -28.74 68.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.121 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -71.55 -44.57 64.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.349 . . . . 0.0 110.407 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -71.99 -8.14 52.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.626 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.612 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 82.8 mtm-85 -109.6 5.05 22.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.296 0.569 . . . . 0.0 110.164 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.846 ' HD1' ' HG2' ' B' ' 216' ' ' MET . 60.8 t80 -118.85 -85.82 0.65 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.707 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 175.71 -72.2 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.512 0.673 . . . . 0.0 109.275 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.64 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -154.55 60.67 0.68 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.27 179.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.524 HG23 HD11 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -57.72 -32.04 67.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.909 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -58.16 -36.02 72.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.119 0.485 . . . . 0.0 110.372 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.91 -36.35 12.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.828 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.57 -40.25 86.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.584 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.524 HD11 HG23 ' A' ' 59' ' ' THR . 1.4 mp -63.84 -30.64 71.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.076 0.465 . . . . 0.0 110.861 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.98 -28.15 35.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.236 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.02 -49.28 65.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.849 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -67.4 -23.92 65.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.835 0.35 . . . . 0.0 110.516 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -85.01 -1.78 57.21 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.126 0.489 . . . . 0.0 110.108 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -104.22 -42.48 5.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.916 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.35 -50.46 78.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.432 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -87.25 142.46 33.5 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.816 178.319 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.432 ' HD2' HG22 ' A' ' 70' ' ' THR . 52.4 Cg_exo -53.45 106.35 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.799 2.332 . . . . 0.0 112.825 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.59 -169.84 22.72 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.738 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.8 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 61.3 m -146.8 -157.22 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.24 -167.32 0.31 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.93 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.484 ' HG3' HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -50.74 -38.83 49.96 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.447 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -57.56 -31.01 65.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.627 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.8 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 11.8 tpp85 -72.62 -29.0 63.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.946 0.403 . . . . 0.0 110.177 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.582 ' O ' HG11 ' A' ' 81' ' ' VAL . 73.8 m-85 -73.97 -46.59 43.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -34.9 76.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.275 0.56 . . . . 0.0 110.698 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -68.88 -35.62 77.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.069 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.582 HG11 ' O ' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -69.58 -25.33 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.678 0.275 . . . . 0.0 111.303 -179.131 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.26 -47.17 24.76 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.98 -30.19 70.71 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.072 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -50.67 -48.13 58.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.741 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.602 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -97.48 -6.23 34.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.1 -179.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -40.72 62.97 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -66.27 -29.52 69.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.93 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.72 -26.53 71.2 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.192 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.06 107.91 0.22 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.153 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.26 59.4 6.0 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.867 2.378 . . . . 0.0 111.673 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -70.48 176.69 3.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.439 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.672 ' HB3' HD13 ' A' ' 149' ' ' LEU . 1.9 m-90 -53.0 -57.31 10.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.57 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.79 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -70.22 -12.15 68.56 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.826 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -39.81 93.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.094 0.447 . . . . 0.0 110.049 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.7 tp -71.71 -36.54 70.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.897 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -61.95 -50.28 80.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.407 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.54 -42.62 99.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.165 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -64.44 -42.45 95.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.09 0.472 . . . . 0.0 110.929 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.577 ' HZ ' ' HE3' ' A' ' 45' ' ' MET . 33.9 t80 -68.18 -48.47 65.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.288 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.471 HG23 ' CZ ' ' A' ' 52' ' ' PHE . 9.1 p -65.4 -33.25 62.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.122 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.705 ' HE2' HD11 ' B' ' 209' ' ' LEU . 0.2 OUTLIER -61.9 -51.28 68.82 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.66 -44.96 96.77 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.783 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.46 81.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.604 0.24 . . . . 0.0 111.351 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.61 -45.77 88.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.659 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.07 -38.7 82.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.065 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.423 ' O ' HG21 ' A' ' 110' ' ' VAL . 19.7 m -65.78 -47.6 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.0 -42.07 89.21 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.984 0.421 . . . . 0.0 110.547 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 10.4 tm-20 -60.29 -39.83 88.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.949 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 114' ' ' MET . 14.1 m -74.73 -39.66 61.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.892 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 106' ' ' CYS . 50.8 t -59.03 -47.38 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.855 0.36 . . . . 0.0 110.601 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -65.17 -27.23 68.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.54 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 108' ' ' GLU . 4.3 ttpt -90.21 9.94 26.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.875 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 60.74 33.07 20.25 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.993 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.513 ' O ' HG22 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -104.51 61.84 0.72 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.955 0.407 . . . . 0.0 110.172 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -63.61 -29.83 71.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.145 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.28 -45.77 92.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.102 0.477 . . . . 0.0 110.556 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.484 HD22 ' HG3' ' A' ' 75' ' ' GLN . 15.7 tp -69.82 -39.65 76.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.468 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 114' ' ' MET . 67.0 t -59.52 -45.55 93.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.869 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.2 -41.07 99.38 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.323 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -64.5 -46.26 83.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.796 0.331 . . . . 0.0 110.725 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 117' ' ' LEU . 99.8 t -64.25 -46.03 94.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.764 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -45.05 96.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 110.681 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.21 -45.62 92.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.622 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -63.09 -43.49 98.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.113 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 95.1 mtp -57.85 -50.02 74.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.893 0.378 . . . . 0.0 110.655 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.77 -41.23 91.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.877 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.12 -46.14 91.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.578 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -59.58 -43.1 93.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.165 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.622 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 53.8 mt -63.88 -36.12 82.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -90.16 4.92 49.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 m -124.41 -77.1 0.59 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.75 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -75.07 -23.42 58.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.622 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 81.0 mt -109.88 14.32 23.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.348 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.4 -44.14 84.28 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.29 -39.42 48.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.822 0.344 . . . . 0.0 110.749 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.567 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 95.9 m95 -60.62 -50.54 73.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.27 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.75 -37.33 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 0.0 110.322 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -67.75 -36.08 79.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.742 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.7 m -71.68 -40.51 69.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.983 0.42 . . . . 0.0 110.704 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.409 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 68.9 m -78.61 -6.13 54.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.138 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.39 40.83 98.13 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.33 -111.35 3.27 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -109.36 14.93 23.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.05 -62.28 1.94 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.318 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 5.8 pt-20 -70.86 -20.15 62.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.725 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.45 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 75.5 t80 -60.6 -38.39 84.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.821 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -27.39 69.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.485 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.85 -13.83 38.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.748 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.672 HD13 ' HB3' ' A' ' 92' ' ' TRP . 56.6 mt -68.31 -35.3 77.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.918 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -110.22 20.33 17.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 0.0 110.223 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -75.64 -19.79 78.86 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.817 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.8 t0 . . . . . 0 C--N 1.324 -0.519 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.66 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 121.345 0.593 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 8.2 mt -132.8 86.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.889 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -64.75 -33.79 76.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.357 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -53.21 -55.26 25.72 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 66.2 mt -65.68 -47.43 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.362 . . . . 0.0 110.956 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 85' ' ' LEU . . . -56.85 -45.3 82.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.524 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' ARG . . . . . 0.602 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 18.3 ttp-105 -62.04 -36.86 82.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' HIS . . . . . 0.405 ' O ' HG21 ' B' ' 212' ' ' VAL . 38.4 t-80 -60.9 -56.1 25.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.304 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.705 HD11 ' HE2' ' A' ' 101' ' ' PHE . 1.5 pp -65.74 -34.85 79.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.487 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -69.88 -43.01 72.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.092 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' B' ' 207' ' ' ARG . 0.7 OUTLIER -65.34 -49.06 70.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.798 -178.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' B' ' 216' ' ' MET . 26.0 m -62.99 -44.27 99.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.409 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.44 -38.62 87.04 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.394 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . 0.79 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 4.0 t0 -67.01 -50.52 61.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.835 0.35 . . . . 0.0 111.335 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 2.7 m -69.72 -49.01 57.33 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' MET . . . . . 0.846 ' HG2' ' HD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -60.18 -37.82 81.37 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.27 -34.05 61.3 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.442 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.278 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.764 0.316 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 m -87.32 113.05 52.11 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.738 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.28 132.59 19.61 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.358 2.039 . . . . 0.0 112.009 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.96 139.52 32.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.118 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.53 116.91 25.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.108 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.781 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -86.24 -60.03 0.28 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.487 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.781 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 23.1 Cg_exo -65.7 138.6 54.51 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.057 1.838 . . . . 0.0 112.122 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.14 156.93 28.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.9 m -58.11 -41.13 82.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.946 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -69.95 -27.44 64.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 110.566 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.24 75.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.467 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.43 -40.27 77.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.682 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t -63.13 -47.03 94.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.968 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.95 -38.43 82.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.031 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.94 -43.23 83.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.545 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -65.06 -48.59 73.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -62.43 -45.23 99.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.342 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.75 -41.03 99.56 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.517 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -61.84 -43.09 99.55 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 21.5 mmmt -59.93 -45.26 93.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.049 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.416 HD12 ' HE3' ' A' ' 24' ' ' LYS . 55.2 tp -65.95 -40.45 91.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.706 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 84.6 mtm-85 -73.37 -30.13 63.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.829 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -64.46 -30.17 71.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.416 ' HE3' HD12 ' A' ' 21' ' ' LEU . 10.0 pttp -92.88 -0.19 57.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.913 0.387 . . . . 0.0 110.938 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.5 -60.36 0.32 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.112 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -154.14 105.26 2.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.97 113.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.162 0.506 . . . . 0.0 110.712 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.8 t -127.79 127.34 43.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.043 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.01 -135.69 5.24 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.844 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.19 158.57 43.89 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.22 111.8 4.03 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.88 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.68 76.14 4.69 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.037 2.492 . . . . 0.0 111.99 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.22 -84.81 0.79 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.569 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -119.18 127.94 53.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.022 0.439 . . . . 0.0 110.115 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.29 91.7 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.441 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.75 110.5 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.83 2.353 . . . . 0.0 112.064 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.2 150.46 21.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.857 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.461 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -70.4 -26.27 63.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.846 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -101.51 104.8 36.51 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.421 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 74.4 Cg_endo -92.29 -3.41 3.84 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.801 2.334 . . . . 0.0 111.566 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.66 -41.33 96.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.731 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -59.62 -38.86 82.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.865 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -80.71 -37.28 30.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.94 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.69 98.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.897 0.38 . . . . 0.0 110.378 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.1 ttt -62.8 -39.65 94.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.856 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -65.96 -48.85 69.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.642 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.16 79.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.62 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.25 62.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.824 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.99 19.49 13.66 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.255 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -132.46 -47.67 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.622 0.249 . . . . 0.0 111.404 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.532 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 6.2 mm-40 -62.46 -30.54 71.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.626 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.557 ' O ' ' HB2' ' A' ' 56' ' ' PHE . 67.0 t80 -59.57 -32.34 70.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.033 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 59' ' ' THR . 4.6 tp10 -87.14 -26.74 23.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.815 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.9 m -54.27 -47.96 71.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.099 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.532 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 23.1 mtm-85 -102.02 12.4 36.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.846 0.355 . . . . 0.0 111.562 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.557 ' HB2' ' O ' ' A' ' 52' ' ' PHE . 3.2 t80 -97.77 -96.74 0.21 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 56' ' ' PHE . 42.4 ttm180 170.48 -68.43 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.738 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -154.21 79.36 1.11 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.126 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.436 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 61.6 m -57.17 -44.61 83.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.745 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -74.31 1.14 12.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.856 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.52 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . 4.8 m -124.04 -54.93 1.7 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -79.27 -57.23 3.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 66' ' ' GLN . 14.6 tp -58.78 -42.86 90.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.018 0.437 . . . . 0.0 110.904 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.51 -17.5 64.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.664 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.15 -46.73 6.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.519 0.2 . . . . 0.0 111.212 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.485 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 8.4 pt20 -64.06 -33.55 76.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.394 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 67' ' ' LEU . 2.0 mm? -82.49 -11.21 58.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.063 0.459 . . . . 0.0 110.329 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -91.46 -11.83 36.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.798 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.3 t -66.17 -41.81 90.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -74.44 127.32 87.74 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.62 105.7 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.777 2.318 . . . . 0.0 112.098 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.81 -128.09 3.29 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.146 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.708 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 2.9 m -156.78 -148.3 0.21 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.99 -156.62 0.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.486 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -51.38 -35.06 37.04 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.34 0.4 . . . . 0.0 111.914 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -55.55 -42.96 75.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.11 0.481 . . . . 0.0 110.365 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.708 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 11.1 tpp180 -68.01 -43.0 79.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.393 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.506 ' O ' HG11 ' A' ' 81' ' ' VAL . 48.3 m-85 -62.67 -37.06 84.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.985 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.2 m -65.9 -49.92 66.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.609 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -70.22 -33.78 72.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.273 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 78' ' ' PHE . 1.4 p -67.06 -31.57 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 0.0 110.498 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.9 m -77.32 -44.05 30.93 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.67 -35.98 79.52 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.613 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -53.7 -60.34 3.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.805 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.6 ' HB2' ' HB2' ' B' ' 206' ' ' ALA . 0.2 OUTLIER -78.67 -16.25 57.53 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.517 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -65.63 -34.73 78.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -90.71 11.2 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.202 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.6 25.64 5.02 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.83 83.56 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -83.86 59.24 6.11 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.759 2.306 . . . . 0.0 112.227 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.509 ' HB3' ' OD2' ' B' ' 214' ' ' ASP . 60.2 t30 -76.32 171.8 13.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.818 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.667 ' CD1' HD23 ' A' ' 149' ' ' LEU . 2.4 m0 -52.61 -49.48 64.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.767 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.76 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -65.47 -33.15 85.63 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.465 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.435 ' HD2' ' HB2' ' B' ' 210' ' ' ALA . 0.0 OUTLIER -61.96 -42.67 99.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.663 0.268 . . . . 0.0 110.597 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.3 tp -64.32 -42.49 96.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.325 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.76 -47.28 86.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.357 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.557 ' HA ' HG13 ' A' ' 100' ' ' VAL . . . -62.21 -40.43 96.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.37 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -59.59 -39.17 83.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.746 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -76.69 -48.83 17.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.193 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 97' ' ' ALA . 7.2 p -63.18 -32.04 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.526 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -60.77 -54.57 43.64 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.987 0.423 . . . . 0.0 110.46 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.03 -43.3 99.05 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.949 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.93 99.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.617 0.246 . . . . 0.0 111.185 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.21 -43.77 97.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.268 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -68.78 -39.62 80.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.8 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.4 ' O ' HG21 ' A' ' 110' ' ' VAL . 50.4 m -66.12 -46.13 78.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.309 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.5 87.38 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.94 0.4 . . . . 0.0 110.515 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -45.29 91.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.268 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.6 m -65.81 -38.43 88.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.967 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 106' ' ' CYS . 49.9 t -63.16 -41.31 92.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.045 0.45 . . . . 0.0 109.807 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -70.3 -9.56 56.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.369 0.605 . . . . 0.0 110.533 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -105.21 6.4 32.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.008 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 62.66 32.47 16.24 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.198 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.434 ' SD ' ' HB ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -106.57 64.07 0.65 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.646 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -65.56 -21.99 66.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.818 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.434 ' HB ' ' SD ' ' A' ' 114' ' ' MET . 97.4 t -58.83 -56.36 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.758 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.7 tp -66.95 -37.47 84.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.681 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.5 t -59.28 -48.48 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.44 -38.62 93.76 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.14 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -68.43 -50.45 52.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.747 0.308 . . . . 0.0 110.506 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.9 t -58.24 -44.02 87.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.107 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -45.59 86.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.245 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.82 -45.16 87.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.729 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -55.91 -44.6 78.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.999 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 89.9 mtp -67.69 -50.08 59.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.392 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.14 -47.05 93.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.262 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.98 93.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.05 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -62.11 -38.48 89.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.874 0.368 . . . . 0.0 110.612 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.8 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 35.7 mt -66.92 -20.93 65.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.282 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.54 -13.72 15.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.3 m -94.96 -64.04 1.11 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -101.81 -32.12 10.42 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.8 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 73.4 mt -90.65 13.19 16.7 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.29 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.23 -53.55 53.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 110.598 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.94 -37.23 86.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.589 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.445 ' CD1' ' HA ' ' A' ' 133' ' ' LEU . 91.3 m95 -60.21 -56.5 20.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.681 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.662 HG21 ' HA2' ' A' ' 142' ' ' GLY . 45.9 mm -60.03 -36.14 65.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.009 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -63.61 -48.23 78.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.655 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.5 m -70.74 -32.2 69.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.584 0.23 . . . . 0.0 111.616 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.4 m -82.67 -6.41 59.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.796 0.331 . . . . 0.0 111.074 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.08 41.17 95.22 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.98 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.662 ' HA2' HG21 ' A' ' 137' ' ' ILE . . . 73.44 -103.2 1.38 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -118.37 16.08 13.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.59 -51.93 65.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.938 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -83.33 -15.96 48.02 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.633 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 89.0 t80 -61.7 -44.02 97.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.78 0.324 . . . . 0.0 110.5 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -24.67 66.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.129 0.49 . . . . 0.0 110.773 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.86 25.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.375 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.667 HD23 ' CD1' ' A' ' 92' ' ' TRP . 32.4 mt -61.39 -50.55 72.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 110.871 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -90.69 9.24 30.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.638 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.21 -10.61 84.55 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.8 t70 . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.14 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 43.3 mt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.979 0.418 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 81' ' ' VAL . 0.8 OUTLIER -150.46 49.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.905 179.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' B' ' 207' ' ' ARG . 42.2 mttp -57.15 -33.71 67.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.632 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -59.78 -50.71 72.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 23.0 mt -70.35 -39.95 77.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.94 0.4 . . . . 0.0 110.026 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . 0.6 ' HB2' ' HB2' ' A' ' 85' ' ' LEU . . . -60.18 -46.09 90.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.215 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' B' ' 203' ' ' LYS . 0.4 OUTLIER -62.25 -36.81 83.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.489 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -58.75 -55.7 31.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.266 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.5 pp -68.76 -36.43 78.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 111.098 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . 0.435 ' HB2' ' HD2' ' A' ' 94' ' ' ARG . . . -63.49 -51.95 63.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.756 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -59.76 -45.5 92.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.595 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' B' ' 216' ' ' MET . 85.4 t -62.75 -55.17 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.604 0.24 . . . . 0.0 111.229 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.71 -45.63 87.99 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.182 -0.532 . . . . 0.0 114.385 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . 0.76 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 11.0 t70 -56.06 -47.29 78.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.94 0.4 . . . . 0.0 111.576 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.7 m -75.48 -41.16 56.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.257 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' B' ' 212' ' ' VAL . 5.0 tpt -54.46 -50.01 68.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.6 -34.48 74.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.865 0.364 . . . . 0.0 111.402 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . 0.51 HH21 ' HA2' ' A' ' 93' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.352 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.76 0.314 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -134.46 102.18 11.77 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.221 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.4 114.21 3.39 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.565 2.177 . . . . 0.0 112.147 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.65 118.48 16.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.504 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -83.27 108.93 16.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.351 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.607 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -83.96 -52.14 0.58 Allowed Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.021 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.607 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 23.8 Cg_exo -65.05 129.17 22.36 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.941 1.761 . . . . 0.0 112.345 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -78.76 154.36 30.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.227 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.473 ' O ' HG22 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -55.82 -38.92 70.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.215 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -69.95 -34.07 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.81 0.338 . . . . 0.0 110.645 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.23 -33.48 76.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.159 0.505 . . . . 0.0 109.878 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.2 tp -70.95 -40.53 71.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.815 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.727 ' HA ' ' HE3' ' A' ' 45' ' ' MET . 87.9 t -62.67 -45.99 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.286 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.04 -36.35 74.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.093 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.68 -51.6 66.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.458 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -63.01 -44.19 96.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.098 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -61.53 -47.59 92.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 120.846 0.355 . . . . 0.0 110.274 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.31 -36.41 92.71 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.509 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.536 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 30.2 t80 -64.65 -49.64 70.19 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 20' ' ' LYS . 25.7 mmmt -57.94 -40.28 80.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.238 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.534 HD11 HG12 ' A' ' 110' ' ' VAL . 36.1 tp -65.91 -33.12 75.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.787 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -81.83 -22.24 37.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.498 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 15.6 mm100 -61.68 -26.4 68.0 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -94.95 3.28 55.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.668 0.271 . . . . 0.0 111.394 -179.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -126.91 -60.29 0.14 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.564 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -157.03 104.36 2.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.4 t -65.76 120.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.517 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.2 t -128.79 99.3 5.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.219 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.98 -134.22 1.73 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.894 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.92 174.05 10.89 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.15 83.56 0.35 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.4 99.09 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.824 2.35 . . . . 0.0 111.96 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.64 -52.15 0.82 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.539 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -137.49 91.07 2.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.044 0.45 . . . . 0.0 110.325 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.75 105.32 0.24 Allowed Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.702 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.1 111.95 1.01 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.783 2.322 . . . . 0.0 111.821 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.38 139.96 39.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.431 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.72 -35.26 67.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.527 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.43 ' OD1' ' HB2' ' A' ' 41' ' ' LEU . 4.4 t70 -96.1 112.69 60.39 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.729 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -94.47 -1.5 2.8 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.684 2.256 . . . . 0.0 112.655 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 39' ' ' ASP . 24.9 mt -64.31 -44.64 90.97 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -62.22 -32.19 72.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.386 . . . . 0.0 110.818 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -79.79 -44.17 21.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.129 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.634 ' HB1' ' HE2' ' A' ' 146' ' ' PHE . . . -61.89 -42.96 99.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.743 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.727 ' HE3' ' HA ' ' A' ' 13' ' ' VAL . 13.8 ttt -61.57 -36.64 81.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.247 0.546 . . . . 0.0 110.202 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -73.67 -42.4 61.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.313 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.9 90.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.627 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -55.11 -25.79 33.89 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.86 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.441 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -123.76 39.85 2.09 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.227 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -162.82 -42.59 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.566 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 23.4 mm-40 -54.3 -60.33 3.48 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.441 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 11.5 p90 -57.46 -27.81 62.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.584 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.507 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 4.6 tp10 -72.9 -46.43 52.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.754 0.312 . . . . 0.0 110.947 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 m -64.95 -24.32 67.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.109 0.48 . . . . 0.0 110.738 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.566 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 9.6 mtm-85 -87.28 -25.18 24.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.202 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -97.52 -92.27 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.994 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 179.92 -64.23 0.01 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.921 0.391 . . . . 0.0 110.418 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.791 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -148.26 54.7 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.209 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.38 -30.41 71.55 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -59.74 -39.04 83.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.937 0.399 . . . . 0.0 110.287 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.414 ' OG ' ' HD3' ' A' ' 58' ' ' ARG . 1.6 m -86.59 -38.42 17.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.389 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 24.0 t70 -60.66 -41.53 95.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.0 tp -59.56 -39.86 85.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.408 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.22 -43.37 61.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.026 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.52 85.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.74 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 10.9 pt20 -66.3 -34.11 77.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 0.0 110.677 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.31 -24.87 63.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.091 0.472 . . . . 0.0 110.366 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -79.66 -13.22 59.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.554 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.4 t -76.25 -29.74 19.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.408 HG23 HG12 ' B' ' 205' ' ' ILE . 3.2 p -94.03 161.08 30.87 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.366 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.98 70.04 2.98 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.0 2.467 . . . . 0.0 112.034 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.84 -163.79 30.5 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.58 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -152.57 -132.06 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -99.69 -159.08 0.72 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.608 0.242 . . . . 0.0 110.886 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -51.32 -43.39 61.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.279 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -54.49 -44.52 72.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 0.0 111.192 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -71.76 -37.74 70.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.603 ' O ' HG11 ' A' ' 81' ' ' VAL . 15.5 m-85 -65.54 -45.95 81.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.593 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 m -69.38 -38.45 78.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.893 0.378 . . . . 0.0 110.854 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.519 ' HA ' ' OD1' ' A' ' 83' ' ' ASP . 5.9 tp60 -65.92 -32.22 73.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.682 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.603 HG11 ' O ' ' A' ' 78' ' ' PHE . 1.9 p -75.37 -11.67 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.083 0.468 . . . . 0.0 110.982 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.0 m -86.95 -45.92 10.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.195 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.519 ' OD1' ' HA ' ' A' ' 80' ' ' GLN . 5.1 p-10 -80.7 -12.59 59.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.245 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.99 -41.56 96.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.919 0.39 . . . . 0.0 110.975 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.603 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -97.73 -11.86 22.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.126 -179.435 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.489 ' HE1' ' HA ' ' A' ' 95' ' ' LEU . 18.4 t80 -68.43 -25.65 65.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.902 0.382 . . . . 0.0 110.732 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -69.18 -9.72 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.657 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.97 -8.88 71.81 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.21 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.87 134.14 3.3 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.786 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.05 69.54 7.88 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.829 2.352 . . . . 0.0 111.945 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 94' ' ' ARG . 21.5 t30 -68.87 171.86 7.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.849 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.593 ' HA ' ' HB3' ' A' ' 149' ' ' LEU . 1.9 m-90 -46.43 -71.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 1.017 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -79.43 -15.98 78.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.555 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.59 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -61.97 -45.29 94.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.489 ' HA ' ' HE1' ' A' ' 86' ' ' PHE . 37.2 tp -68.65 -37.45 79.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.558 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.412 HG13 ' HA ' ' A' ' 48' ' ' ALA . 74.7 t -62.01 -53.02 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.697 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.32 -43.82 96.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.509 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -62.19 -41.94 98.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 0.0 110.849 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.552 ' HE2' ' HG3' ' A' ' 45' ' ' MET . 10.9 t80 -71.02 -47.67 57.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.649 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.12 -31.27 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.456 ' HE2' HD21 ' B' ' 209' ' ' LEU . 0.8 OUTLIER -57.47 -54.42 47.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.895 0.378 . . . . 0.0 110.181 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.81 -43.49 96.08 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.094 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.05 95.53 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.68 -46.2 76.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.704 0.288 . . . . 0.0 111.043 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 41.4 m -64.36 -46.29 84.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.459 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.03 75.26 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.014 0.435 . . . . 0.0 110.16 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.17 -44.12 84.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.735 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.577 ' HB2' HG23 ' A' ' 118' ' ' VAL . 6.3 m -66.66 -36.5 82.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.487 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.534 HG12 HD11 ' A' ' 21' ' ' LEU . 43.4 t -63.56 -43.97 98.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.05 0.453 . . . . 0.0 110.2 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -68.49 -23.09 64.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.793 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -94.7 13.5 24.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.448 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 60.06 45.22 12.21 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.66 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.558 ' O ' HG22 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -124.79 56.8 1.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.18 0.514 . . . . 0.0 109.811 178.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.09 -29.35 68.52 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.837 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 t -56.32 -51.63 61.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.119 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.33 -35.68 76.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.805 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.577 HG23 ' HB2' ' A' ' 109' ' ' SER . 55.3 t -59.25 -45.11 93.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 0.0 110.593 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.75 -38.04 94.04 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.786 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -63.21 -48.86 76.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 110.384 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.94 -43.86 96.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.469 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -44.4 97.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.659 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.86 -47.49 84.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.485 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -62.54 -44.88 95.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.912 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.5 ttt -60.3 -52.47 65.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.548 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.45 -44.4 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.93 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.89 94.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.428 ' OH ' ' HD3' ' A' ' 132' ' ' ARG . 44.7 t80 -59.59 -38.84 82.29 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.565 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 21.3 mt -63.6 -32.46 73.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.879 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -95.89 -0.85 50.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.422 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.6 m -105.19 -64.13 1.16 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.428 ' HD3' ' OH ' ' A' ' 128' ' ' TYR . 25.1 ttt180 -102.84 -22.52 13.86 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 69.1 mt -101.37 15.12 29.84 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.517 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.1 -50.54 72.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.296 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.07 -41.03 87.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.477 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 89.8 m95 -57.91 -51.59 69.01 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.41 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.51 HG21 ' HA2' ' A' ' 142' ' ' GLY . 26.0 mm -62.73 -37.99 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.353 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -65.47 -36.15 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.916 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.3 m -73.46 -33.61 64.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.162 0.506 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.1 m -85.42 -5.2 59.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.98 42.07 96.99 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.51 ' HA2' HG21 ' A' ' 137' ' ' ILE . . . 75.93 -100.33 1.34 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -120.23 14.23 12.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.153 0.501 . . . . 0.0 109.769 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.97 93.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.245 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.512 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -77.62 -17.93 57.28 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.05 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.634 ' HE2' ' HB1' ' A' ' 44' ' ' ALA . 28.3 t80 -63.29 -32.65 74.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.902 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -38.14 68.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.001 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.3 -28.02 23.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.593 ' HB3' ' HA ' ' A' ' 92' ' ' TRP . 62.7 mt -56.02 -53.87 51.67 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.059 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -100.47 10.79 40.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.239 0.542 . . . . 0.0 110.477 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -91.82 23.16 27.41 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.052 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.597 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . 0.432 ' HB ' ' H ' ' B' ' 202' ' ' ILE . 4.9 pt . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.706 0.288 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.432 ' H ' ' HB ' ' B' ' 201' ' ' ILE . 24.0 mt -68.98 106.84 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.603 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -62.53 -32.78 73.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.979 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -51.09 -42.73 60.81 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.156 0.285 . . . . 0.0 111.519 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' B' ' 208' ' ' HIS . 21.8 mt -68.39 -42.6 84.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.86 0.362 . . . . 0.0 110.334 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -61.34 -45.86 92.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.527 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' ARG . . . . . 0.603 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 42.1 ttp85 -64.53 -35.36 80.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.819 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' HIS . . . . . 0.412 ' HB3' ' O ' ' B' ' 205' ' ' ILE . 3.8 t60 -57.37 -51.03 71.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.925 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.4 pp -74.48 -36.18 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.351 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -62.28 -47.27 85.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.025 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.29 -39.92 93.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.731 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.59 -52.22 60.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.508 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.85 -40.2 98.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.828 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . 1.017 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 1.3 t0 -64.4 -55.77 18.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.018 0.437 . . . . 0.0 111.479 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.6 m -66.57 -33.83 76.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' MET . . . . . . . . . . . . . 20.7 tpp -73.38 -48.74 31.63 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.91 -41.5 95.52 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.849 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . 0.475 ' HD3' ' HA ' ' B' ' 218' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.48 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.979 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.87 0.367 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.4 111.05 15.16 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.747 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.23 134.23 24.51 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.716 2.277 . . . . 0.0 111.485 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.29 115.17 28.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.652 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 m -70.61 120.6 16.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.194 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.598 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -88.54 -51.82 0.38 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.557 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 31.5 Cg_exo -62.58 136.72 60.12 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.078 1.852 . . . . 0.0 112.108 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.99 154.62 40.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.557 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m -63.47 -34.53 77.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.782 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -72.64 -26.8 61.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.811 0.338 . . . . 0.0 110.157 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.99 89.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.156 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.64 -44.18 96.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.556 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.3 t -63.17 -44.72 99.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.114 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.8 -37.12 85.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -68.65 -42.66 77.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.172 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -62.59 -51.61 66.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.393 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.63 -45.41 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.327 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.66 -42.78 99.81 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.778 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.638 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 1.8 t80 -63.71 -45.21 91.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -60.39 -34.82 74.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.593 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.1 tp -70.73 -25.22 62.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.26 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.4 mtm-85 -85.92 -35.56 20.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.56 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.653 ' HA ' HG22 ' A' ' 27' ' ' VAL . 10.1 mm100 -64.12 -25.59 68.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.476 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -84.43 -3.88 58.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.815 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -132.65 -88.54 0.39 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.722 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -113.56 97.52 6.5 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 23' ' ' GLN . 75.0 t -62.72 115.72 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.057 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.89 97.87 5.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.527 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.457 ' HA3' ' OH ' ' A' ' 19' ' ' TYR . . . -176.82 165.13 35.08 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.82 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.93 123.98 46.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.735 0.302 . . . . 0.0 110.432 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.31 121.09 8.05 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.609 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -89.08 106.13 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.419 2.746 . . . . 0.0 111.383 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.44 -70.11 0.9 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.015 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -120.46 64.73 0.84 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.277 0.56 . . . . 0.0 110.316 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.02 99.61 0.24 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.116 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.3 109.15 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.845 2.363 . . . . 0.0 112.183 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.72 139.08 34.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.421 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.533 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -72.45 -24.32 61.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.681 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -94.16 106.84 24.86 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.974 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 90.6 Cg_endo -95.85 -6.48 1.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.825 2.35 . . . . 0.0 111.74 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.8 mt -65.66 -50.95 63.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.878 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -64.46 -37.88 89.09 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.952 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -69.3 -41.67 76.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.67 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.09 90.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.8 ttt -63.26 -43.24 98.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.714 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -62.48 -46.41 88.59 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.41 87.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.5 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.68 -38.19 69.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.953 0.406 . . . . 0.0 111.812 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.65 27.69 12.94 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.501 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -143.11 -51.9 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.719 ' HA ' HG22 ' A' ' 54' ' ' THR . 41.3 mm-40 -64.11 -35.57 81.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.777 0.322 . . . . 0.0 110.46 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -66.75 -10.96 52.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.783 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.637 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 7.3 tp10 -107.45 -49.94 3.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.667 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.719 HG22 ' HA ' ' A' ' 51' ' ' GLU . 2.0 t -64.67 -31.48 72.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.761 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 55' ' ' ARG . 22.1 mtm180 -94.36 9.83 36.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.081 0.467 . . . . 0.0 110.39 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.946 ' HA ' ' HG2' ' B' ' 216' ' ' MET . 49.7 t80 -107.28 -82.89 0.54 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.642 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.44 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 5.1 mtm105 167.3 -65.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.765 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -153.35 72.2 0.92 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.924 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.637 ' OG1' ' HA ' ' A' ' 53' ' ' GLU . 2.5 m -62.81 -41.58 99.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.024 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.26 20.87 1.52 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.348 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.599 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . 51.9 m -153.2 -77.03 0.12 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -56.72 -44.17 81.36 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 38.4 tp -62.89 -43.49 98.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.859 0.361 . . . . 0.0 110.343 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -66.55 -34.9 78.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.597 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.29 -44.05 72.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.515 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -74.36 -25.74 59.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.867 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -83.82 -17.92 39.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.122 0.487 . . . . 0.0 110.133 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 3.2 t-80 -76.45 -14.14 60.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.39 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.88 -32.88 56.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.305 0.574 . . . . 0.0 109.545 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.58 140.28 55.39 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.881 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.14 99.29 0.16 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.865 2.377 . . . . 0.0 112.257 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.7 -149.49 15.1 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.282 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.814 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 49.0 m -158.22 -157.73 0.66 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.3 -156.92 0.1 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.019 0.438 . . . . 0.0 111.561 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.591 ' HG3' HD22 ' A' ' 117' ' ' LEU . 4.4 mm-40 -56.8 -30.11 63.38 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -66.04 -22.85 66.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.691 0.282 . . . . 0.0 111.434 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.814 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 21.4 tpp85 -85.1 -36.68 20.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.713 0.292 . . . . 0.0 110.444 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -69.9 -31.25 68.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.512 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.96 -20.48 57.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.711 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -111.48 5.37 19.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.718 0.295 . . . . 0.0 111.656 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.8 p -100.59 -14.36 7.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.384 0.611 . . . . 0.0 110.322 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.69 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -85.36 -41.52 15.4 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.535 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.36 -13.96 57.75 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.389 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' B' ' 206' ' ' ALA . 3.6 tp10 -54.96 -41.73 71.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.886 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' B' ' 206' ' ' ALA . 0.3 OUTLIER -106.42 32.76 4.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.134 0.492 . . . . 0.0 110.495 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -121.27 -36.02 3.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.528 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -62.42 -31.05 71.68 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.223 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.74 1.48 86.02 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.7 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.78 117.51 1.58 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.678 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.09 164.56 24.66 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.879 2.386 . . . . 0.0 112.037 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.429 ' HB3' ' HB2' ' A' ' 94' ' ' ARG . 24.1 t30 -148.25 169.0 21.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.618 ' HA ' HD23 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -50.04 -61.56 2.08 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.808 0.692 . . . . 0.0 112.213 -178.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.94 -4.83 84.28 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.063 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 4.2 tpp85 -65.29 -45.77 83.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.726 0.298 . . . . 0.0 110.558 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.4 tp -67.62 -37.8 83.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.135 0.493 . . . . 0.0 110.058 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.489 HG23 ' HE1' ' A' ' 146' ' ' PHE . 3.1 t -65.92 -41.36 89.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.358 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.607 ' HA ' HG13 ' A' ' 100' ' ' VAL . . . -62.21 -39.46 92.83 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.057 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.69 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 66.1 t80 -61.61 -37.08 82.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.167 0.508 . . . . 0.0 110.302 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -79.69 -46.89 16.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.345 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.607 HG13 ' HA ' ' A' ' 97' ' ' ALA . 4.4 p -61.7 -34.02 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.41 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -64.35 -50.93 65.79 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.909 0.385 . . . . 0.0 110.006 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.98 98.59 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.881 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.05 83.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.614 0.245 . . . . 0.0 111.484 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.28 79.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.656 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.456 ' HB3' ' NE2' ' A' ' 75' ' ' GLN . 3.6 mm? -62.71 -38.78 91.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.361 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.7 m -72.66 -43.53 63.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.569 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.1 -37.65 77.67 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.101 0.477 . . . . 0.0 110.424 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.64 -43.68 88.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.787 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 114' ' ' MET . 21.5 m -68.43 -43.87 76.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.251 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.0 t -59.4 -37.37 69.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.017 0.437 . . . . 0.0 110.403 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -63.61 -29.15 70.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.839 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.9 mtpt -99.04 17.14 20.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.099 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 59.8 34.76 21.94 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.546 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.457 ' HB3' ' HB3' ' A' ' 109' ' ' SER . 0.0 OUTLIER -100.47 66.6 1.26 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.953 0.406 . . . . 0.0 110.169 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.07 -28.78 67.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.943 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 22.3 t -58.39 -51.14 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.003 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.591 HD22 ' HG3' ' A' ' 75' ' ' GLN . 14.1 tp -68.34 -39.69 81.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.984 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 114' ' ' MET . 87.7 t -59.49 -43.9 91.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.86 99.25 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.745 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 70.0 mt-30 -63.21 -50.9 68.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.624 0.25 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.28 -48.12 88.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.298 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -45.81 91.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.745 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -62.02 -42.8 99.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.246 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -60.62 -46.46 90.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.806 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 88.8 mtp -59.0 -50.94 72.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.975 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.48 -41.27 87.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.936 0.398 . . . . 0.0 110.907 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.3 -51.83 61.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.574 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.41 -42.56 87.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.215 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 36.7 mt -61.8 -26.34 68.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.102 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -107.89 3.71 24.59 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.675 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.0 m -107.41 -50.56 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -122.05 -18.7 6.85 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.893 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.667 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 83.8 mt -101.69 3.9 40.14 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.631 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.64 87.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.947 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.66 -39.7 81.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.209 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.667 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 91.8 m95 -68.09 -54.43 18.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.372 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.479 HG21 ' HA2' ' A' ' 142' ' ' GLY . 42.0 mm -56.73 -37.38 52.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.301 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -59.5 -45.11 92.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.237 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.4 m -77.51 -33.29 54.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 67.0 m -74.98 -3.24 31.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.67 39.66 96.91 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.479 ' HA2' HG21 ' A' ' 137' ' ' ILE . . . 72.04 -94.17 0.61 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -120.68 17.53 11.96 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.57 -51.56 66.86 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.54 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.61 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 4.2 pt-20 -78.21 -20.97 50.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.915 0.388 . . . . 0.0 110.5 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.489 ' HE1' HG23 ' A' ' 96' ' ' VAL . 91.5 t80 -61.25 -40.96 96.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.222 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.522 ' HA ' ' CE1' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -60.33 -33.45 72.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 110.831 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.23 -34.58 42.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.549 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.618 HD23 ' HA ' ' A' ' 92' ' ' TRP . 81.3 mt -57.38 -50.34 73.3 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.05 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.522 ' CE1' ' HA ' ' A' ' 147' ' ' THR . 5.6 p90 -86.15 -6.49 58.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.089 0.471 . . . . 0.0 110.229 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.65 -25.37 60.79 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 121.169 0.509 . . . . 0.0 109.844 178.878 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . 0.556 HG23 HG13 ' B' ' 202' ' ' ILE . 52.0 mt . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.859 0.361 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.556 HG13 HG23 ' B' ' 201' ' ' ILE . 44.9 mt -144.01 111.17 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -64.73 -34.26 77.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.332 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -53.91 -48.11 70.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 38.1 mt -62.6 -48.43 88.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.677 0.275 . . . . 0.0 110.97 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . 0.489 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -62.28 -43.15 99.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.626 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -35.86 75.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.121 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.99 -55.18 35.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.864 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.3 pp -68.65 -38.03 80.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.643 0.259 . . . . 0.0 111.642 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -65.66 -51.36 60.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -59.12 -52.09 67.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.448 ' O ' ' HB2' ' B' ' 216' ' ' MET . 57.2 t -64.29 -47.85 87.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.683 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.97 -50.66 56.88 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.92 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' B' ' 210' ' ' ALA . 0.9 OUTLIER -61.33 -46.99 87.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 15.9 m -67.18 -34.98 78.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.728 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' MET . . . . . 0.946 ' HG2' ' HA ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -68.83 -46.89 67.4 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.707 -179.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.66 -34.15 77.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.996 0.427 . . . . 0.0 110.503 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.198 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.165 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.753 0.311 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.8 m -109.66 108.3 59.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.004 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.34 114.61 3.78 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.279 1.986 . . . . 0.0 111.567 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.41 130.32 42.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.528 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 m -88.13 120.7 29.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.647 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -84.4 -53.68 0.5 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.647 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 21.5 Cg_exo -66.13 125.72 14.57 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.119 1.879 . . . . 0.0 113.156 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.79 159.74 30.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.25 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -41.46 82.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.771 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 10' ' ' ARG . 0.6 OUTLIER -69.73 -32.6 71.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.713 0.292 . . . . 0.0 110.87 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.72 -40.65 92.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.34 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.8 -40.87 92.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.027 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.632 ' HA ' ' HE2' ' A' ' 45' ' ' MET . 77.0 t -64.59 -42.53 95.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.261 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.55 -42.96 89.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.512 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.26 -37.85 86.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.0 -48.08 69.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.74 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.93 -43.39 97.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.166 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.71 98.35 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.402 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.531 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 23.3 t80 -62.81 -42.83 99.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -60.01 -36.22 76.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 0.0 110.432 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.2 tp -72.69 -28.32 62.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.232 0.539 . . . . 0.0 110.216 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 73.8 mtm-85 -80.77 -26.97 36.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.892 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 16.0 mm100 -64.35 -28.26 69.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.327 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -92.37 6.64 46.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.937 0.398 . . . . 0.0 110.789 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.83 -93.92 0.46 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -119.7 108.69 14.75 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.66 113.99 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.962 0.411 . . . . 0.0 110.396 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t -124.2 99.24 6.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.369 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.98 -132.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.538 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.7 149.64 27.72 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.96 112.33 3.43 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.036 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 88.85 1.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.55 2.167 . . . . 0.0 111.877 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.72 -129.22 5.58 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -85.09 68.73 10.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.066 0.46 . . . . 0.0 110.861 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.13 103.74 0.44 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.078 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.12 116.87 3.48 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.95 2.433 . . . . 0.0 112.383 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.52 152.64 18.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.077 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.63 -31.07 32.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.215 0.531 . . . . 0.0 109.981 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -107.92 126.0 30.8 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.196 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 39' ' ' ASP . 57.6 Cg_endo -97.2 4.63 1.58 Allowed 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.074 2.516 . . . . 0.0 111.089 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.9 mt -71.15 -46.87 60.63 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.132 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -61.39 -32.91 72.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.212 0.53 . . . . 0.0 110.084 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -78.69 -38.54 39.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.569 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.498 ' HB1' ' HE2' ' A' ' 146' ' ' PHE . . . -64.24 -41.7 96.87 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.499 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.632 ' HE2' ' HA ' ' A' ' 13' ' ' VAL . 1.9 ttt -63.32 -38.36 90.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.943 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -68.24 -48.78 64.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.264 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.59 -43.71 84.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.447 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.46 -42.34 64.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.39 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.6 40.18 2.64 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.614 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -155.62 -42.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 41.5 mm-40 -58.78 -78.41 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.471 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 4.5 p90 -64.15 -21.9 66.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.703 0.287 . . . . 0.0 110.668 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 32.1 tp10 -63.55 -52.98 58.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.547 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 m -74.92 -29.56 61.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.584 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.412 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 15.9 mtm-85 -71.22 -17.2 62.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.478 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -102.96 -74.79 0.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.232 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ttm105 177.36 -69.38 0.01 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.999 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.94 58.75 0.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.917 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.696 HG23 HD11 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -57.11 -25.67 59.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.245 -178.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -53.95 -31.11 49.46 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 111.007 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.01 -29.62 5.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 18.0 t70 -69.04 -30.23 68.55 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.696 HD11 HG23 ' A' ' 59' ' ' THR . 5.5 tp -55.65 -38.07 69.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 111.218 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.93 -11.75 56.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.0 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.27 -47.08 8.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.995 0.426 . . . . 0.0 110.618 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 8.3 pt20 -66.98 -30.62 70.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.106 0.479 . . . . 0.0 110.142 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.455 HD22 ' HG3' ' A' ' 66' ' ' GLN . 1.1 mm? -96.73 14.7 24.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.211 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.73 -9.53 58.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.054 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.71 -36.07 75.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.96 129.69 35.0 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.359 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.67 117.02 3.39 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.826 2.35 . . . . 0.0 112.325 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.43 -159.04 21.99 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.159 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.0 m -143.18 -130.64 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -99.05 -153.99 0.45 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.341 0.115 . . . . 0.0 110.719 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.595 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 2.4 mm-40 -56.51 -33.16 65.75 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.422 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.448 ' HG3' ' CZ3' ' A' ' 124' ' ' TRP . 22.9 mp0 -56.58 -28.47 60.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.617 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -83.13 -9.66 59.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.043 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.51 ' O ' HG11 ' A' ' 81' ' ' VAL . 30.8 m-85 -108.59 -43.24 4.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.714 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.25 -30.17 68.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.76 0.314 . . . . 0.0 111.785 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.476 ' HB3' HD12 ' B' ' 201' ' ' ILE . 6.7 tp60 -100.95 12.13 38.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.959 0.409 . . . . 0.0 111.314 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.51 HG11 ' O ' ' A' ' 78' ' ' PHE . 2.1 p -109.27 -14.07 10.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.286 0.565 . . . . 0.0 110.288 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.631 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -81.26 -36.99 29.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.81 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -77.65 -20.28 54.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -53.81 -42.89 68.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.703 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.737 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -95.02 5.92 50.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.26 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -100.86 -36.52 9.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.423 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -52.32 -39.24 60.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.591 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.76 34.2 5.11 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.498 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.524 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . 175.94 83.34 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.837 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.469 ' HG3' ' CZ3' ' A' ' 136' ' ' TRP . 4.8 Cg_exo -79.85 53.01 4.54 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.223 2.615 . . . . 0.0 111.688 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -71.68 164.9 25.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.617 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.838 ' HD1' HD23 ' A' ' 149' ' ' LEU . 2.2 m-90 -53.89 -58.02 8.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.755 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.65 -14.13 79.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.26 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 6.7 tpp85 -66.79 -47.78 71.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.748 0.309 . . . . 0.0 110.586 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.408 HD22 ' CD1' ' A' ' 146' ' ' PHE . 26.3 tp -64.86 -36.06 83.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.741 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.7 t -62.97 -50.93 77.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.264 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.467 ' HA ' HG13 ' A' ' 100' ' ' VAL . . . -60.2 -42.49 95.22 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.458 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.631 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 52.5 t80 -62.69 -45.21 93.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.081 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -72.11 -42.53 65.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.912 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.467 HG13 ' HA ' ' A' ' 97' ' ' ALA . 3.9 p -70.46 -27.98 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.602 ' HE2' HD13 ' B' ' 209' ' ' LEU . 0.2 OUTLIER -57.53 -50.69 72.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 110.444 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.1 -43.26 97.48 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.862 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -46.77 88.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.467 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.15 -43.53 98.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.268 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.595 ' HB3' ' NE2' ' A' ' 75' ' ' GLN . 2.0 mm? -68.17 -39.34 82.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.984 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.2 m -67.2 -39.65 86.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.243 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.72 89.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.946 0.403 . . . . 0.0 110.291 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -41.24 82.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.855 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -67.55 -46.39 72.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.204 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.16 -40.3 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.894 0.378 . . . . 0.0 110.422 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -64.1 -26.8 68.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.415 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -96.03 9.87 39.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.148 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 68.73 15.88 8.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.197 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.45 ' O ' HG22 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -88.58 67.23 8.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.182 0.515 . . . . 0.0 110.481 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -71.53 -28.76 64.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.704 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -56.87 -46.61 83.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.578 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.6 tp -67.94 -43.62 78.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.923 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 114' ' ' MET . 64.0 t -56.98 -46.67 84.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.641 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.04 -35.12 82.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.726 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -77.25 -47.15 20.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.622 0.248 . . . . 0.0 110.572 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.47 -45.79 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.784 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -61.36 -44.42 97.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.677 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -63.69 -40.04 95.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.165 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.448 ' CZ3' ' HG3' ' A' ' 76' ' ' GLN . 13.1 m0 -59.93 -44.52 94.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.635 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 85.1 mtp -60.65 -51.91 67.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.175 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.68 -44.55 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.77 0.319 . . . . 0.0 111.263 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.26 -44.97 96.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -60.85 -42.88 98.7 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.626 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.487 HD23 HD11 ' A' ' 133' ' ' LEU . 68.8 mt -62.84 -31.81 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.4 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -92.46 11.4 26.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 111.629 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.0 m -122.92 -70.0 0.8 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.606 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -85.35 -33.89 21.93 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.487 HD11 HD23 ' A' ' 129' ' ' LEU . 48.0 mt -102.47 16.58 25.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.268 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.12 -48.5 79.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 110.733 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.61 -36.83 84.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.321 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.469 ' CZ3' ' HG3' ' A' ' 90' ' ' PRO . 11.3 m95 -61.02 -55.37 33.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.392 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.412 HG21 ' HA2' ' A' ' 142' ' ' GLY . 46.7 mm -59.55 -39.9 80.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.685 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -63.37 -41.64 98.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.159 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.5 m -71.54 -37.73 71.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.375 . . . . 0.0 111.173 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.608 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 65.4 m -81.19 -6.3 58.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.812 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.46 43.32 96.86 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.004 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 137' ' ' ILE . . . 78.95 -113.62 3.71 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.327 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -110.49 17.97 20.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.997 0.427 . . . . 0.0 110.379 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.66 -60.37 3.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.432 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.608 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 5.9 pt-20 -68.5 -27.49 66.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 110.643 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.617 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 73.7 t80 -61.88 -35.79 79.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.049 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.769 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 27.7 m -62.8 -24.82 67.93 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.569 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.98 -24.0 22.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.122 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.838 HD23 ' HD1' ' A' ' 92' ' ' TRP . 29.8 mt -62.58 -47.64 82.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 110.819 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.769 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 11.1 p90 -96.29 12.67 30.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.301 0.572 . . . . 0.0 110.096 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.88 -23.73 63.47 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.11 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--N 1.323 -0.551 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.882 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . 0.476 HD12 ' HB3' ' A' ' 80' ' ' GLN . 26.1 mt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.718 0.294 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 96.3 mt -143.1 114.81 2.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -61.38 -38.0 85.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.231 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -57.53 -44.38 85.06 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 111.665 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.65 -52.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.083 0.468 . . . . 0.0 110.493 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . 0.452 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -60.21 -40.72 91.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.078 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' ARG . . . . . 0.737 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 28.8 ttp-105 -63.47 -37.2 86.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.055 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -63.68 -49.64 72.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.209 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.602 HD13 ' HE2' ' A' ' 101' ' ' PHE . 1.5 pp -67.63 -37.91 83.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.738 0.304 . . . . 0.0 110.918 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -67.32 -44.47 79.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.081 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -59.67 -47.27 86.3 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 123.272 0.358 . . . . 0.0 111.008 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.38 -53.45 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.25 0.343 . . . . 0.0 111.349 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -43.55 98.14 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.149 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.52 -40.07 85.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.005 0.431 . . . . 0.0 111.751 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 51.0 m -75.34 -46.01 35.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -34.18 77.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . 34.5 t70 -75.16 -33.35 61.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.576 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.781 0.324 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 m -124.17 113.6 27.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.51 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.0 128.27 20.33 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.777 2.318 . . . . 0.0 111.834 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.83 122.4 45.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.69 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.7 m -96.85 112.47 24.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.935 0.398 . . . . 0.0 110.619 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.557 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -73.8 -50.06 5.81 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.605 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 31.3 Cg_exo -60.85 126.54 19.92 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.103 1.869 . . . . 0.0 112.256 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.42 155.29 39.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.74 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.9 -38.33 70.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.962 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -68.7 -23.92 64.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 111.006 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.66 -37.22 65.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -68.88 -38.82 79.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.771 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 82.8 t -60.96 -43.71 96.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.673 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.76 -27.4 67.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.623 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.94 -44.0 70.46 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -68.5 -45.97 70.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.41 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.49 -46.82 95.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.965 0.412 . . . . 0.0 110.162 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.06 97.31 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.435 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.67 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 6.7 t80 -60.83 -47.68 85.27 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -57.43 -39.27 75.87 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.642 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.452 HD12 ' HE3' ' A' ' 24' ' ' LYS . 24.3 tp -66.92 -32.97 74.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.449 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.3 mtm-85 -81.22 -29.38 34.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.188 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.67 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 12.8 mm100 -64.32 -26.82 68.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.63 0.252 . . . . 0.0 111.293 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.452 ' HE3' HD12 ' A' ' 21' ' ' LEU . 6.7 pttp -97.61 13.26 30.76 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.899 0.38 . . . . 0.0 111.372 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.15 -75.4 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -142.46 106.3 4.7 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.38 109.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.922 0.391 . . . . 0.0 110.796 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 37.8 m -110.31 122.93 48.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.048 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.43 -133.4 4.57 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.862 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' A' ' 32' ' ' PRO . . . -150.64 174.93 12.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.604 0.24 . . . . 0.0 110.638 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.87 99.19 1.41 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.792 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 30' ' ' ALA . 4.9 Cg_exo -76.7 89.97 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.816 2.344 . . . . 0.0 112.103 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.19 -74.53 0.95 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.471 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.92 108.23 19.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.956 0.408 . . . . 0.0 110.069 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.54 95.8 0.11 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.576 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.97 112.14 1.43 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.931 2.42 . . . . 0.0 112.109 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.29 153.16 17.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.212 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.21 -28.62 48.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.031 0.443 . . . . 0.0 110.013 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.31 110.18 59.13 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.88 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -103.91 10.72 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.557 2.838 . . . . 0.0 112.199 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 143' ' ' TRP . 59.3 mt -72.11 -45.59 60.0 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -66.09 -38.47 88.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -67.73 -39.37 84.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.259 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.6 98.45 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.253 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 46.3 mtt -62.87 -44.68 95.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.162 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.532 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 6.7 tmm_? -65.06 -43.98 90.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.143 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.72 79.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.286 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.67 89.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.058 0.456 . . . . 0.0 110.328 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.07 22.66 30.66 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.773 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 3.2 t0 -126.8 -61.06 1.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.555 0.217 . . . . 0.0 110.967 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.769 ' HA ' HG22 ' A' ' 54' ' ' THR . 76.0 mm-40 -63.0 -41.81 99.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.032 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.476 ' HA ' ' OD1' ' B' ' 217' ' ' ASP . 51.3 t80 -58.73 -29.28 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.972 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -91.24 -40.89 11.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.398 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.769 HG22 ' HA ' ' A' ' 51' ' ' GLU . 12.6 t -70.02 -32.42 70.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 51' ' ' GLU . 21.8 mtm180 -85.07 -22.19 29.05 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 110.514 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.606 ' HA ' ' HG2' ' B' ' 216' ' ' MET . 36.3 t80 -80.08 -82.47 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 56' ' ' PHE . 9.8 ttm105 165.82 -68.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 O-C-N 123.993 0.808 . . . . 0.0 109.264 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.449 ' HD3' ' OG ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -159.42 72.45 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.056 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 m -56.47 -34.77 67.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.478 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -65.24 -15.5 62.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.584 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.449 ' OG ' ' HD3' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -118.88 -53.96 2.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.733 0.302 . . . . 0.0 111.792 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.7 -68.79 0.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.176 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.547 ' HA ' ' HG2' ' A' ' 66' ' ' GLN . 9.7 tp -57.88 -42.65 85.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.564 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -61.53 -29.79 70.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.046 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.74 -44.44 10.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 8.1 pt20 -65.37 -31.79 73.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.758 0.313 . . . . 0.0 111.27 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.767 ' HG ' ' HB3' ' B' ' 209' ' ' LEU . 2.2 mm? -87.87 -4.62 58.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.959 0.409 . . . . 0.0 110.757 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 4.7 t-80 -88.0 -10.94 48.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.778 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.1 t -75.17 -33.93 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.522 0.677 . . . . 0.0 109.595 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.46 148.42 85.74 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.185 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.83 94.98 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.577 2.185 . . . . 0.0 112.213 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.43 -147.42 14.61 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.306 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.656 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 66.4 m -162.31 -159.7 0.61 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.461 0.304 . . . . 0.0 110.217 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.04 -160.7 0.25 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.679 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.812 ' HG3' HD22 ' A' ' 117' ' ' LEU . 11.8 mm-40 -58.28 -27.51 64.11 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -63.58 -25.3 68.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.842 0.353 . . . . 0.0 110.592 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.656 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 13.1 tpp85 -88.95 -34.95 16.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.071 0.462 . . . . 0.0 109.937 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -67.74 -32.65 73.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.546 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 p -81.47 7.36 12.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.83 0.348 . . . . 0.0 111.502 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -127.09 -41.31 1.79 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.157 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.511 HG23 HG22 ' B' ' 202' ' ' ILE . 9.9 p -55.56 -29.22 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.479 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -74.22 -46.15 43.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.109 0.481 . . . . 0.0 110.974 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.01 -33.74 75.19 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.207 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.44 ' HB3' ' O ' ' B' ' 202' ' ' ILE . 8.2 mm-40 -53.88 -31.77 50.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.369 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.699 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -103.37 -14.52 16.24 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.813 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -70.53 -43.27 69.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.134 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -77.28 -2.16 33.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.176 0.513 . . . . 0.0 110.741 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -106.33 16.18 41.9 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . 148.23 85.95 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -74.64 70.81 4.92 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 123.059 2.506 . . . . 0.0 112.746 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -82.61 173.15 12.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.38 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.529 ' CD1' HD23 ' A' ' 149' ' ' LEU . 35.3 m0 -51.32 -62.63 1.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.556 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.25 -18.81 75.33 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.155 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 3.5 tpp85 -63.91 -46.46 84.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.428 HD22 ' CD1' ' A' ' 146' ' ' PHE . 39.3 tp -69.66 -35.33 75.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.089 0.471 . . . . 0.0 109.817 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.6 t -63.35 -44.98 99.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.022 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.629 ' HA ' HG13 ' A' ' 100' ' ' VAL . . . -63.2 -38.8 92.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.597 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.479 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 89.1 t80 -60.92 -40.83 94.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.419 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -76.26 -47.42 23.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.43 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.629 HG13 ' HA ' ' A' ' 97' ' ' ALA . 5.5 p -65.05 -30.52 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 1.2 t80 -61.08 -54.61 42.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.849 0.357 . . . . 0.0 110.231 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.62 -40.7 96.09 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.042 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.75 95.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.557 0.217 . . . . 0.0 111.459 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.31 75.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.112 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.505 ' HB3' HE22 ' A' ' 75' ' ' GLN . 1.7 mm? -61.58 -41.36 97.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.521 ' O ' HG22 ' A' ' 110' ' ' VAL . 30.2 m -66.44 -45.9 78.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.663 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.71 86.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.02 -42.66 99.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.993 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.2 m -67.04 -37.51 84.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.327 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 106' ' ' CYS . 76.7 t -62.89 -38.61 82.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.2 0.524 . . . . 0.0 110.095 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -73.08 -12.95 61.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.801 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -106.47 13.14 28.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.365 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 56.7 48.96 15.32 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.329 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.433 ' O ' HG22 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.02 61.27 0.9 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.105 0.478 . . . . 0.0 110.509 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -60.36 -30.48 69.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.034 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.8 t -59.24 -45.18 93.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.402 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.812 HD22 ' HG3' ' A' ' 75' ' ' GLN . 48.5 tp -72.04 -41.52 67.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.667 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 114' ' ' MET . 83.1 t -60.42 -48.91 86.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.235 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.84 -40.08 96.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.239 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -66.66 -47.54 72.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.525 0.203 . . . . 0.0 110.671 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 125' ' ' MET . 64.6 t -59.46 -45.96 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.726 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.2 -45.4 93.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -63.28 -42.3 99.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -61.31 -38.34 86.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 121' ' ' VAL . 95.7 mtp -66.81 -48.67 68.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.258 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.06 -42.52 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.53 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.22 -43.67 83.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.476 ' CE1' ' HB3' ' A' ' 132' ' ' ARG . 0.2 OUTLIER -62.88 -41.84 99.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.414 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.62 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 91.3 mt -65.56 -31.39 72.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.657 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.27 -3.71 55.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.0 m -115.41 -88.93 0.57 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.476 ' HB3' ' CE1' ' A' ' 128' ' ' TYR . 64.2 ttt180 -72.47 -36.27 68.41 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.62 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 97.5 mt -89.71 14.66 11.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.727 0.298 . . . . 0.0 111.372 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.32 -55.27 29.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.844 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.97 -34.68 78.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.775 0.322 . . . . 0.0 110.87 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -59.37 -57.93 10.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.46 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 47.3 mm -61.69 -37.27 77.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.913 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -63.49 -42.0 98.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.461 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.8 m -76.71 -27.88 55.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.728 0.299 . . . . 0.0 111.279 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.431 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 70.3 m -85.04 -11.95 54.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.583 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.17 44.82 85.79 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.53 -100.84 0.85 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.59 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.518 ' HB2' HD23 ' A' ' 41' ' ' LEU . 84.2 m95 -116.78 15.15 15.36 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.65 -60.24 3.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.592 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.516 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 3.7 pt-20 -66.76 -28.23 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 110.579 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.495 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 74.0 t80 -62.07 -30.57 71.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.639 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 5.6 m -61.83 -28.34 69.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.216 0.531 . . . . 0.0 110.569 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.27 -26.64 18.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.773 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.529 HD23 ' CD1' ' A' ' 92' ' ' TRP . 24.4 mt -62.69 -53.85 48.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.15 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.639 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 1.5 p90 -84.3 17.8 2.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.951 0.405 . . . . 0.0 111.141 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.03 -31.09 62.24 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.862 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 C--N 1.328 -0.338 0 O-C-N 122.575 -0.367 . . . . 0.0 110.463 -179.694 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . 0.543 HG13 HG12 ' B' ' 202' ' ' ILE . 13.9 pt . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.543 HG12 HG13 ' B' ' 201' ' ' ILE . 44.5 mm -104.09 114.7 44.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.861 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.3 -43.84 2.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.28 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -64.1 -54.81 28.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 0.0 111.135 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' ILE . . . . . 0.54 HG21 HD11 ' A' ' 67' ' ' LEU . 94.1 mt -63.15 -40.56 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.231 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 85' ' ' LEU . . . -61.64 -47.42 85.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.905 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' ARG . . . . . 0.699 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 74.3 ttt180 -65.94 -35.07 79.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.902 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' HIS . . . . . 0.702 ' HB3' HD12 ' A' ' 67' ' ' LEU . 3.3 t-80 -58.25 -51.92 67.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.762 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.767 ' HB3' ' HG ' ' A' ' 67' ' ' LEU . 1.2 pp -74.92 -38.44 61.81 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.733 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . 0.467 ' HB2' ' HD3' ' A' ' 94' ' ' ARG . . . -68.81 -48.26 64.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -69.41 -48.66 60.36 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 43.0 t -57.18 -43.76 82.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.812 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.74 -50.62 29.28 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.088 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 25.4 t0 -57.26 -44.58 84.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.449 0.3 . . . . 0.0 111.785 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 12.8 m -68.18 -36.22 79.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.714 0.292 . . . . 0.0 111.758 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' MET . . . . . 0.606 ' HG2' ' HA ' ' A' ' 56' ' ' PHE . 23.6 ttm -74.59 -40.81 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.76 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . 0.476 ' OD1' ' HA ' ' A' ' 52' ' ' PHE . 37.8 t70 -65.53 -34.27 77.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.455 0.645 . . . . 0.0 109.417 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.693 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.87 0.366 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.7 m -127.86 106.11 20.48 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.122 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.85 122.54 9.91 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.885 2.39 . . . . 0.0 112.11 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.6 119.09 24.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.742 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.1 m -74.98 108.17 7.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.359 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.576 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -74.08 -51.93 4.57 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 25.8 Cg_exo -63.84 140.3 72.81 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.868 1.712 . . . . 0.0 113.007 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.446 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 22.2 t70 -81.4 151.83 27.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.377 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.61 -36.89 74.75 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -73.19 -37.96 66.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.879 0.371 . . . . 0.0 110.55 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 -33.4 75.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.166 0.508 . . . . 0.0 109.919 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' A' ' 41' ' ' LEU . 20.3 tp -64.32 -42.03 96.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.047 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.92 -40.17 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.963 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 -37.17 77.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.784 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.67 -37.3 86.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.346 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -67.87 -49.87 59.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.185 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.6 t -62.84 -44.73 99.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.107 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.13 -38.09 95.02 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.619 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.58 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 9.2 t80 -66.63 -43.09 85.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -61.44 -37.1 82.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.317 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.524 HD12 ' HE3' ' A' ' 24' ' ' LYS . 15.8 tp -65.63 -33.01 74.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.733 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.7 mtm-85 -79.42 -34.4 41.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.684 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 13.7 mm100 -61.19 -39.05 88.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.354 . . . . 0.0 111.181 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.524 ' HE3' HD12 ' A' ' 21' ' ' LEU . 11.6 pttp -84.77 2.57 41.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.177 0.513 . . . . 0.0 110.823 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.25 -108.33 1.07 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.44 ' HD1' ' SG ' ' A' ' 28' ' ' CYS . 17.3 t80 -101.67 105.19 16.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 23' ' ' GLN . 98.2 t -65.17 107.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.171 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.44 ' SG ' ' HD1' ' A' ' 26' ' ' TYR . 8.2 m -113.82 118.77 35.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.87 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.57 178.74 25.72 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.058 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.31 155.91 23.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.612 0.244 . . . . 0.0 110.609 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.55 106.86 3.27 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.774 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.95 109.13 1.04 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.932 2.422 . . . . 0.0 112.438 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.78 -118.27 2.57 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.876 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -85.66 66.8 9.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.274 0.559 . . . . 0.0 109.688 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.18 98.79 0.24 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.484 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.27 112.88 1.25 Allowed 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.9 2.4 . . . . 0.0 111.613 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.69 151.48 22.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.266 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.88 -34.03 51.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.927 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.65 120.47 46.18 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.002 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -102.33 16.79 0.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.602 2.868 . . . . 0.0 112.498 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.618 ' HB3' HD22 ' A' ' 12' ' ' LEU . 79.6 mt -68.76 -46.26 69.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.714 0.292 . . . . 0.0 111.494 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -70.0 -37.69 75.76 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -65.43 -39.66 92.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.379 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.21 86.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.627 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 36.5 mtt -64.93 -38.2 90.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.416 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -69.02 -30.02 68.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.753 179.272 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.82 -35.42 38.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.809 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.61 -41.82 67.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 111.024 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.89 37.41 3.44 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.056 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.07 -43.22 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 54' ' ' THR . 56.4 mm-40 -54.13 -63.99 0.97 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' A' ' 56' ' ' PHE . 1.2 p90 -64.94 -21.14 66.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.451 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.403 ' OE1' ' HA ' ' A' ' 53' ' ' GLU . 5.0 tp10 -80.93 -40.7 24.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 111.589 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 51' ' ' GLU . 4.0 t -70.62 -13.75 62.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.732 0.301 . . . . 0.0 111.385 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' B' ' 216' ' ' MET . 81.1 mtm-85 -113.93 6.79 16.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.752 0.31 . . . . 0.0 111.148 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.531 ' HB2' ' O ' ' A' ' 52' ' ' PHE . 2.1 t80 -116.16 -88.89 0.58 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.574 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.422 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 8.1 mtm105 -174.75 -83.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.174 0.511 . . . . 0.0 109.672 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.652 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -148.87 49.99 0.99 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.724 HG23 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -53.72 -28.66 35.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.985 -178.083 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -52.85 -31.06 37.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 110.99 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.92 -37.47 3.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.648 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 15.5 t70 -61.7 -39.14 90.43 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.444 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.724 ' HB2' HG23 ' A' ' 59' ' ' THR . 14.7 tp -61.83 -34.79 76.58 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.164 0.506 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.68 -32.6 41.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.315 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.54 -44.28 62.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.538 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 9.7 pt20 -65.34 -32.36 73.96 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.885 0.374 . . . . 0.0 110.64 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.71 -8.8 59.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.284 0.564 . . . . 0.0 110.109 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -12.97 46.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.02 -37.73 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.964 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -86.5 160.53 50.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.067 178.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.964 ' HD2' HG22 ' A' ' 70' ' ' THR . 10.9 Cg_endo -55.08 115.78 2.68 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.394 2.063 . . . . 0.0 112.146 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.42 -164.53 11.0 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.41 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 50.3 m -152.36 -155.28 0.6 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.87 -159.18 0.1 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.855 0.36 . . . . 0.0 111.617 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.56 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 1.9 mm-40 -50.27 -34.77 24.42 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.719 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -56.04 -36.43 67.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.356 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.441 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 22.4 tpp85 -72.7 -34.27 67.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.702 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.56 ' HD2' ' HA ' ' A' ' 75' ' ' GLN . 90.6 m-85 -69.15 -40.46 78.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.125 0.488 . . . . 0.0 110.328 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -68.54 -36.16 78.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.284 0.564 . . . . 0.0 110.172 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.823 ' HG2' HD11 ' B' ' 201' ' ' ILE . 22.5 tp60 -71.53 -42.55 67.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.941 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 78' ' ' PHE . 3.4 p -61.22 -20.72 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.039 0.447 . . . . 0.0 111.342 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -87.67 -46.63 9.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.959 0.409 . . . . 0.0 110.445 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -35.8 80.47 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.352 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.617 ' HG3' ' HG2' ' B' ' 203' ' ' LYS . 6.3 tp10 -49.42 -39.4 32.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.246 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.704 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.5 OUTLIER -105.54 3.41 29.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.813 0.34 . . . . 0.0 111.469 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.506 ' HE1' ' HA ' ' A' ' 95' ' ' LEU . 28.7 t80 -84.15 -37.48 21.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.53 -21.46 66.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.654 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.85 8.39 69.91 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.515 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.45 ' HA2' ' HD3' ' A' ' 90' ' ' PRO . . . 130.33 116.57 1.85 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.464 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.45 ' HD3' ' HA2' ' A' ' 89' ' ' GLY . 5.6 Cg_exo -75.35 65.2 6.37 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.375 2.716 . . . . 0.0 111.321 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -68.13 178.02 2.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.72 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.637 ' HE3' ' H ' ' A' ' 92' ' ' TRP . 1.4 m-90 -45.0 -72.47 0.06 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.529 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.46 68.35 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.197 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.5 tpp85 -66.65 -51.23 58.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.612 0.244 . . . . 0.0 110.62 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.506 ' HA ' ' HE1' ' A' ' 86' ' ' PHE . 25.3 tp -67.03 -36.08 81.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.966 0.412 . . . . 0.0 110.505 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.447 HG23 ' HE1' ' A' ' 146' ' ' PHE . 60.9 t -65.83 -54.33 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.821 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.722 ' HA ' HG13 ' A' ' 100' ' ' VAL . . . -61.03 -41.74 97.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.021 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -54.6 -36.56 64.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.535 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -90.86 -46.56 8.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.818 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.722 HG13 ' HA ' ' A' ' 97' ' ' ALA . 5.6 p -65.15 -37.15 79.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.441 ' HD1' ' HA ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -65.7 -45.4 82.91 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.105 -179.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.03 -45.6 95.76 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.61 98.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.215 . . . . 0.0 111.015 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.47 97.31 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.807 0.337 . . . . 0.0 111.208 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 105' ' ' LEU . 2.0 mm? -73.74 -39.69 64.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.29 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.43 ' O ' HG22 ' A' ' 110' ' ' VAL . 52.1 m -64.57 -42.18 95.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.391 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.35 -42.53 87.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.875 0.369 . . . . 0.0 110.348 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -42.65 98.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.476 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m -65.34 -37.1 86.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.545 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 106' ' ' CYS . 42.5 t -62.51 -44.85 99.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.274 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -66.01 -24.8 66.83 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.416 0.627 . . . . 0.0 110.177 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -89.54 5.24 46.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.101 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 66.98 18.57 10.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.696 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.423 ' O ' HG22 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -92.25 60.33 3.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.219 0.533 . . . . 0.0 109.584 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.78 -24.63 66.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.341 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.7 t -62.63 -47.31 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.024 0.44 . . . . 0.0 109.914 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.73 -38.96 87.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.217 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 114' ' ' MET . 87.7 t -58.23 -52.05 63.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.532 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.74 93.18 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.041 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -62.13 -53.83 49.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.709 0.29 . . . . 0.0 110.88 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.68 -44.43 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.25 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -45.46 88.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.548 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.52 -46.07 91.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.268 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -60.02 -43.51 95.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.003 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 96.8 mtp -64.31 -52.4 58.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 72.1 t -60.57 -42.56 92.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.296 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.06 -48.41 73.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.818 0.342 . . . . 0.0 110.679 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -59.7 -39.54 84.94 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.55 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.6 mt -59.17 -29.96 67.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.409 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -106.01 11.41 31.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.702 0.287 . . . . 0.0 110.966 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 78.4 m -108.29 -65.61 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.495 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -108.24 -22.03 12.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.788 0.328 . . . . 0.0 111.396 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.758 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 61.0 mt -101.15 11.97 38.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.646 0.26 . . . . 0.0 111.024 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.52 -49.0 77.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.27 -43.72 92.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.716 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.758 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 83.0 m95 -60.11 -49.43 77.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.579 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 133' ' ' LEU . 46.0 mm -63.45 -39.37 85.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.512 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.15 -49.83 72.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.923 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.3 m -63.78 -47.77 79.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.325 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 50.7 m -70.17 -16.75 63.12 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.78 41.19 50.65 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.877 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.411 ' HA2' HG21 ' A' ' 137' ' ' ILE . . . 67.89 -100.95 0.67 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.125 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -111.77 13.78 21.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.782 0.325 . . . . 0.0 110.548 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.23 -50.91 71.4 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.822 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.61 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 11.0 pt-20 -86.26 -22.37 26.87 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.587 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.447 ' HE1' HG23 ' A' ' 96' ' ' VAL . 90.0 t80 -59.38 -41.05 88.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.947 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.553 ' HA ' ' CE2' ' A' ' 150' ' ' TYR . 0.4 OUTLIER -64.81 -26.16 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.218 0.532 . . . . 0.0 111.046 -179.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.79 -26.27 24.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.948 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 84.7 mt -60.76 -60.54 3.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.893 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.553 ' CE2' ' HA ' ' A' ' 147' ' ' THR . 34.0 p90 -74.87 -10.54 59.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.984 0.421 . . . . 0.0 110.591 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.34 -19.1 77.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.559 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.2 t70 . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.057 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . 0.823 HD11 ' HG2' ' A' ' 80' ' ' GLN . 25.6 mt . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.676 0.274 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.646 HG12 HG12 ' B' ' 205' ' ' ILE . 10.0 tt -162.3 100.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.639 0.733 . . . . 0.0 110.743 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.617 ' HG2' ' HG3' ' A' ' 84' ' ' GLU . 48.5 mttm -77.63 -32.41 53.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.92 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -45.93 -61.09 1.89 Allowed 'General case' 0 C--O 1.24 0.575 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' ILE . . . . . 0.646 HG12 HG12 ' B' ' 202' ' ' ILE . 45.3 pt -69.46 -34.38 61.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.69 0.281 . . . . 0.0 111.283 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . 0.423 ' HA ' HG21 ' A' ' 81' ' ' VAL . . . -62.54 -37.51 86.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.203 0.525 . . . . 0.0 110.365 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' ARG . . . . . 0.704 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 38.0 ttp180 -62.85 -44.42 96.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.317 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -63.65 -40.09 95.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.27 -52.45 65.63 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.29 0.567 . . . . 0.0 110.507 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -68.56 -34.98 76.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.731 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -56.6 -56.03 26.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.79 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 13.0 m -63.1 -43.41 98.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.535 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.08 -42.2 98.2 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.76 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 0.6 OUTLIER -70.33 -47.62 60.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.654 0.264 . . . . 0.0 111.574 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 12.2 m -68.34 -42.74 78.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' MET . . . . . 0.49 ' HG3' ' O ' ' A' ' 55' ' ' ARG . 6.5 tpt -66.05 -48.16 71.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.01 -35.03 79.89 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.067 0.461 . . . . 0.0 110.548 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.0 m -141.19 88.52 10.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.848 0.356 . . . . 0.0 110.508 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.23 129.78 19.97 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.473 2.115 . . . . 0.0 112.074 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.09 167.66 12.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.285 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.6 m -104.88 125.7 51.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.829 0.347 . . . . 0.0 110.58 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.647 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -84.59 -53.0 0.51 Allowed Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.224 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.647 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 10.9 Cg_exo -71.09 133.95 24.18 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.91 1.74 . . . . 0.0 111.788 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.0 149.91 47.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.935 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.91 -40.91 67.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.325 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -73.59 -27.09 61.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 0.0 110.945 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.01 94.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 mp -64.17 -42.54 96.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.289 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.99 -45.89 95.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.149 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.5 80.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.565 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.0 -42.05 85.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.215 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -63.22 -46.08 88.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.31 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.18 -47.38 93.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.073 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.46 99.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.692 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.646 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 18.3 t80 -60.78 -48.89 79.73 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -60.03 -38.86 83.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.597 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 21' ' ' LEU . 8.3 tp -67.77 -25.79 65.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.074 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -89.44 -29.59 18.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 15.6 mm100 -60.87 -28.61 68.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.017 0.436 . . . . 0.0 111.347 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -88.48 16.04 7.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.582 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.87 -62.75 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.845 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -145.3 102.53 3.74 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.82 107.41 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.252 0.549 . . . . 0.0 110.885 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.8 t -110.11 127.39 54.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.996 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.83 -124.07 2.18 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.018 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.27 172.27 16.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.764 0.316 . . . . 0.0 110.653 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.09 108.64 2.87 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.1 110.24 2.58 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.936 2.424 . . . . 0.0 111.851 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.63 -104.31 2.46 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.894 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -90.15 109.72 20.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.284 0.564 . . . . 0.0 110.24 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.98 90.71 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -48.0 108.56 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.331 2.687 . . . . 0.0 112.863 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.11 141.14 38.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.68 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.67 79.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.007 0.432 . . . . 0.0 110.152 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.87 126.33 32.13 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.21 0.529 . . . . 0.0 110.436 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -96.59 1.65 1.91 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.826 2.351 . . . . 0.0 110.716 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.564 HD22 ' HB2' ' A' ' 143' ' ' TRP . 12.2 mt -67.18 -50.23 61.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.661 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -62.13 -34.11 75.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.07 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -80.84 -38.58 28.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.465 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' A' ' 146' ' ' PHE . . . -60.87 -43.97 97.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.706 0.288 . . . . 0.0 111.011 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 54.9 mtt -63.8 -38.41 90.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.032 0.444 . . . . 0.0 110.535 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 4.9 tmm_? -70.42 -42.53 71.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.224 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.38 -32.6 71.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.875 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.93 -50.52 57.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.045 0.45 . . . . 0.0 110.609 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.413 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -98.6 42.71 2.0 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.329 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 2.8 t0 -148.34 -46.48 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.586 0.231 . . . . 0.0 111.26 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.525 ' O ' HG22 ' A' ' 54' ' ' THR . 71.0 mm-40 -57.19 -55.53 33.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.801 0.334 . . . . 0.0 111.9 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.413 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 2.1 p90 -68.35 -26.48 65.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.687 0.28 . . . . 0.0 111.248 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -77.23 -42.79 35.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.172 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 51' ' ' GLU . 6.5 t -65.22 -26.02 67.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.154 0.502 . . . . 0.0 110.219 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 37.3 mtm-85 -93.2 -1.07 56.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.895 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.616 ' HD2' ' HG2' ' B' ' 216' ' ' MET . 42.9 t80 -111.87 -92.47 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.283 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.0 ttp85 175.11 -66.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.718 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.755 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -154.3 56.55 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.268 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -30.6 71.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.995 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -52.12 -38.63 58.04 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 123.455 0.472 . . . . 0.0 110.981 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.04 -41.2 6.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.258 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -59.45 -46.44 88.75 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.649 HD13 ' HA ' ' B' ' 209' ' ' LEU . 7.4 tp -62.81 -37.47 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 110.499 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.69 -30.7 63.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.295 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.04 -49.09 54.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.799 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -66.49 -31.5 72.27 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.941 0.4 . . . . 0.0 110.128 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.789 ' HG ' ' HZ ' ' A' ' 101' ' ' PHE . 0.5 OUTLIER -69.32 -22.27 63.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 178.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -83.18 -22.49 33.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.935 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.31 -49.04 34.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.599 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -72.53 141.36 82.71 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.697 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.599 ' HD2' HG22 ' A' ' 70' ' ' THR . 77.8 Cg_exo -50.92 104.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.77 2.314 . . . . 0.0 112.63 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.59 -158.77 9.87 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.954 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 7.4 m -142.84 -148.44 0.24 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.03 -158.19 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.976 0.417 . . . . 0.0 111.423 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.596 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 3.7 mm-40 -53.04 -38.13 62.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.576 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -56.82 -40.03 75.29 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.944 0.402 . . . . 0.0 110.842 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.596 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 14.0 tpp85 -64.94 -37.94 89.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.975 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.596 ' HD2' ' HA ' ' A' ' 75' ' ' GLN . 40.9 m-85 -69.16 -37.32 78.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.526 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 m -69.04 -46.7 67.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.084 0.469 . . . . 0.0 110.632 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.81 -32.62 69.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.866 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.438 HG11 ' O ' ' A' ' 78' ' ' PHE . 2.5 p -69.25 -19.17 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.164 0.507 . . . . 0.0 110.774 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.505 ' HB3' ' HA ' ' A' ' 98' ' ' PHE . 38.4 m -82.48 -43.65 16.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.117 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.89 -24.12 55.63 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.063 0.459 . . . . 0.0 109.976 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.779 ' HG3' ' HD3' ' B' ' 203' ' ' LYS . 2.9 tp10 -51.33 -48.01 62.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.44 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.538 HD23 ' HG2' ' B' ' 207' ' ' ARG . 0.1 OUTLIER -90.1 -5.77 56.17 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.924 -0.311 . . . . 0.0 111.658 -178.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.2 -27.95 57.05 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -65.47 -23.58 66.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.297 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.19 3.3 86.38 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.908 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.33 133.16 3.45 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.547 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.53 65.83 8.57 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.141 2.561 . . . . 0.0 111.618 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -70.9 169.76 14.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.277 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.491 ' HE3' ' H ' ' A' ' 92' ' ' TRP . 5.1 m-90 -52.24 -63.17 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.865 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.32 -11.28 75.72 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.182 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -67.0 -49.99 63.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.732 0.301 . . . . 0.0 110.307 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.9 tp -67.29 -33.92 76.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.266 0.555 . . . . 0.0 109.736 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.14 -54.13 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.472 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.572 ' HA ' HG13 ' A' ' 100' ' ' VAL . . . -61.91 -43.17 99.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.574 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.505 ' HA ' ' HB3' ' A' ' 82' ' ' SER . 79.3 t80 -57.91 -42.89 85.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.039 0.447 . . . . 0.0 111.53 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -75.86 -46.78 28.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.709 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.572 HG13 ' HA ' ' A' ' 97' ' ' ALA . 9.8 p -66.93 -34.0 67.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.789 ' HZ ' ' HG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -60.8 -50.31 73.95 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 110.43 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.4 -43.23 95.28 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.918 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.11 87.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.46 97.71 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.3 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.16 -43.33 71.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.044 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.427 ' O ' HG22 ' A' ' 110' ' ' VAL . 34.7 m -61.94 -44.15 97.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.416 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.58 82.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.908 0.385 . . . . 0.0 110.488 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -68.31 -40.51 81.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.164 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.435 ' HB2' HG23 ' A' ' 118' ' ' VAL . 17.2 m -63.99 -37.81 88.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.812 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 106' ' ' CYS . 99.5 t -67.65 -33.42 61.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.122 0.487 . . . . 0.0 109.764 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.08 -13.23 61.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.248 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -106.94 7.92 30.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.121 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 62.61 34.31 15.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.48 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.506 ' O ' HG22 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -106.73 62.79 0.63 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.008 0.432 . . . . 0.0 110.117 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -64.96 -27.6 68.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.678 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.9 t -59.08 -48.36 86.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.304 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 tp -70.37 -39.17 74.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.353 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 114' ' ' MET . 99.4 t -59.2 -49.51 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.837 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.56 84.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.384 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -69.02 -51.25 41.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.71 0.291 . . . . 0.0 110.664 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.84 -43.48 97.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.759 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -43.24 94.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.989 0.423 . . . . 0.0 110.099 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.28 -42.47 88.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.36 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -60.5 -41.45 94.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 93.1 mtp -59.35 -52.22 66.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.456 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.1 t -65.18 -42.31 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.586 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.02 -47.21 81.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -63.22 -40.41 97.38 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.992 0.425 . . . . 0.0 110.119 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.703 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 24.3 mt -63.08 -35.36 79.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.145 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -90.95 6.51 44.39 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.2 m -121.37 -61.52 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -101.44 -26.6 13.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.703 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 97.3 mt -98.77 10.03 42.1 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.324 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.14 -48.07 77.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.767 0.317 . . . . 0.0 111.17 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.85 -52.09 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.621 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -61.42 -50.6 72.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.475 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.557 HG21 ' HA2' ' A' ' 142' ' ' GLY . 17.5 mm -58.92 -40.2 79.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.694 0.283 . . . . 0.0 110.938 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -61.37 -43.67 98.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.962 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.4 m -69.94 -41.01 75.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.752 0.311 . . . . 0.0 111.119 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.0 m -75.09 -2.06 25.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.594 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.0 42.02 98.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.08 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.557 ' HA2' HG21 ' A' ' 137' ' ' ILE . . . 72.95 -102.12 1.19 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.393 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.564 ' HB2' HD22 ' A' ' 41' ' ' LEU . 82.0 m95 -112.49 9.33 19.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.668 0.271 . . . . 0.0 110.365 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.16 -55.88 28.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.988 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.585 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 43.8 tt0 -59.9 -39.3 84.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.124 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.501 ' HD2' ' HB1' ' A' ' 44' ' ' ALA . 48.9 t80 -57.97 -34.84 70.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.626 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.451 ' HA ' ' CE2' ' A' ' 150' ' ' TYR . 2.1 m -60.46 -37.35 80.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.04 0.448 . . . . 0.0 110.778 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.81 -27.54 30.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.505 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 26.3 mt -57.23 -52.39 65.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.261 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.451 ' CE2' ' HA ' ' A' ' 147' ' ' THR . 30.3 p90 -87.08 8.26 24.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.838 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.72 -34.91 91.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.969 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 t0 . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 120.64 0.257 . . . . 0.0 110.382 179.611 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . 0.43 ' H3 ' ' CD ' ' A' ' 84' ' ' GLU . 43.7 mt . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 120.739 0.304 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -147.22 79.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.239 0.542 . . . . 0.0 110.363 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.779 ' HD3' ' HG3' ' A' ' 84' ' ' GLU . 39.2 mmtm -58.92 -36.07 74.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.13 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -62.49 -43.52 98.62 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.155 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' ILE . . . . . 0.425 HG12 HG23 ' A' ' 70' ' ' THR . 38.7 mt -64.99 -41.68 92.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.111 0.481 . . . . 0.0 109.707 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . 0.48 ' HB2' HD21 ' A' ' 85' ' ' LEU . . . -62.45 -42.59 99.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.631 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' ARG . . . . . 0.538 ' HG2' HD23 ' A' ' 85' ' ' LEU . 15.2 mtp180 -61.35 -34.61 75.58 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.114 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -58.69 7.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.569 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.649 ' HA ' HD13 ' A' ' 63' ' ' LEU . 1.2 pp -67.72 -42.25 82.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -64.92 -47.18 78.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' B' ' 207' ' ' ARG . 6.3 tp60 -65.69 -37.91 87.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 16.5 t -58.19 -55.09 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.656 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.29 -38.45 91.56 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.468 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 2.3 t0 -63.83 -49.77 71.53 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.7 m -68.42 -40.24 81.31 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' MET . . . . . 0.616 ' HG2' ' HD2' ' A' ' 56' ' ' PHE . 5.6 tpt -64.64 -42.68 95.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.744 0.306 . . . . 0.0 111.094 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.34 -33.34 69.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.318 0.58 . . . . 0.0 110.047 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.887 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.715 0.293 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 m -133.62 117.19 14.11 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.513 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.16 144.05 99.5 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.645 2.23 . . . . 0.0 112.15 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.62 114.86 29.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.815 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -69.72 115.88 9.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.989 0.423 . . . . 0.0 110.647 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.537 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -86.32 -49.93 0.5 Allowed Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.327 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 32.7 Cg_exo -61.3 131.87 38.48 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.05 1.833 . . . . 0.0 113.042 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -75.62 149.08 38.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.378 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 m -57.22 -36.94 71.51 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -69.66 -31.38 69.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.668 0.271 . . . . 0.0 110.617 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.45 78.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.237 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 mp -69.15 -41.7 76.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.744 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.591 ' HA ' ' HE2' ' A' ' 45' ' ' MET . 64.7 t -62.64 -42.99 98.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.995 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.32 87.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.667 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.42 -46.89 81.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -61.05 -48.86 79.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.974 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.13 -46.66 95.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.51 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.71 98.95 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.794 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -61.95 -46.14 90.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.724 0.297 . . . . 0.0 110.272 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 20' ' ' LYS . 11.8 mmmt -61.65 -35.91 79.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.936 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.11 -26.24 59.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.683 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -84.26 -36.99 22.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.379 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -56.97 -35.4 69.11 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 24.18 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.932 0.396 . . . . 0.0 111.382 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.04 -54.95 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.683 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -154.52 111.83 3.39 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.93 120.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.148 0.499 . . . . 0.0 110.812 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.8 m -132.37 108.56 9.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.397 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.5 -134.87 3.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.843 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.09 146.77 26.38 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.94 114.84 4.08 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.653 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.59 83.7 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.064 2.509 . . . . 0.0 112.2 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.63 -103.65 1.24 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.234 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -103.15 105.74 16.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.046 0.45 . . . . 0.0 109.798 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.45 85.73 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.577 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -57.22 119.17 6.25 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.069 2.512 . . . . 0.0 112.252 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.49 164.19 13.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.485 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.427 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -85.45 -15.98 41.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.133 0.492 . . . . 0.0 110.294 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -105.87 102.52 39.38 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.844 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 41.0 Cg_endo -96.77 5.28 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.224 2.616 . . . . 0.0 111.57 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.0 mt -64.27 -45.95 85.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.155 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -63.78 -43.07 97.45 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.74 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -65.49 -43.54 89.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.934 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.17 -39.0 93.39 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.834 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.591 ' HE2' ' HA ' ' A' ' 13' ' ' VAL . 15.1 ttt -73.55 -34.98 65.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.091 0.472 . . . . 0.0 110.602 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -68.81 -40.87 79.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.84 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.01 5.14 52.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.739 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.54 58.31 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.189 0.518 . . . . 0.0 110.801 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -96.67 29.2 10.8 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.43 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.77 -31.2 3.21 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.358 -0.137 . . . . 0.0 111.215 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -56.99 -71.89 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.116 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.489 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 54.2 p90 -58.95 -25.76 63.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.113 0.482 . . . . 0.0 110.545 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 4.0 tp10 -66.29 -38.06 86.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.489 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -61.16 -36.9 81.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.29 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.595 ' HB2' ' HG3' ' B' ' 216' ' ' MET . 0.0 OUTLIER -86.65 -17.42 33.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.343 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.684 ' HB2' ' HG2' ' B' ' 216' ' ' MET . 41.8 t80 -97.05 -93.62 0.22 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.295 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HB3' ' H ' ' A' ' 58' ' ' ARG . 26.1 ttm105 -175.39 -81.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.416 0.627 . . . . 0.0 109.534 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.45 ' H ' ' HB3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -153.03 67.26 0.79 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.385 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -53.22 -32.89 50.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.496 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.62 -36.58 64.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 110.619 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -99.23 -32.95 10.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.093 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 10.6 t70 -63.18 -38.21 90.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.92 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.2 tp -57.27 -43.71 83.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.49 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.72 -35.99 79.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.052 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.1 -47.6 35.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.747 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 9.5 pt20 -66.23 -33.04 74.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.602 0.239 . . . . 0.0 111.118 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.87 -0.75 40.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.737 0.303 . . . . 0.0 111.006 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -94.3 -29.35 15.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.6 t -62.57 -46.8 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.56 0.695 . . . . 0.0 109.3 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.498 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -92.9 145.18 29.69 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.495 178.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.498 ' HD2' HG22 ' A' ' 70' ' ' THR . 69.0 Cg_exo -52.35 107.65 0.2 Allowed 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.708 2.272 . . . . 0.0 112.597 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.57 -166.11 28.45 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.094 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.633 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 73.2 m -157.21 -150.43 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.898 -0.177 . . . . 0.0 110.717 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.402 ' H ' ' HB3' ' A' ' 73' ' ' SER . . . -76.35 -168.19 0.92 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.676 0.275 . . . . 0.0 111.192 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.406 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -56.69 -34.15 67.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -55.42 -27.8 50.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.373 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.633 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 15.4 tpp85 -75.61 -13.04 60.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.487 ' O ' HG11 ' A' ' 81' ' ' VAL . 80.1 m-85 -104.3 -40.78 5.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -36.46 83.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 111.71 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.519 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -95.22 3.96 54.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 111.722 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.604 ' HB ' ' O ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -97.32 -23.73 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.259 0.552 . . . . 0.0 109.681 179.22 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.12 -42.45 19.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.592 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -21.64 58.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.026 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 3.4 tp10 -55.1 -41.89 72.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.193 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.751 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.3 OUTLIER -97.76 10.03 41.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.99 0.424 . . . . 0.0 110.718 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -99.17 -29.35 12.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -56.1 -45.59 79.37 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.982 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -106.07 15.46 43.71 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.294 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.1 78.35 0.15 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.734 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.89 54.22 5.03 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 123.221 2.614 . . . . 0.0 111.641 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -74.93 162.37 28.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.093 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.458 ' CD1' HD23 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -58.41 -51.64 68.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.655 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.69 -28.48 73.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.099 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.9 tpp85 -65.83 -44.69 84.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.77 -42.21 95.27 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 71.6 t -61.48 -44.84 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.948 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.493 ' HA ' HG13 ' A' ' 100' ' ' VAL . . . -62.01 -45.02 95.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.933 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.22 -40.21 93.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.152 0.501 . . . . 0.0 110.668 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -71.11 -47.05 60.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.29 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.493 HG13 ' HA ' ' A' ' 97' ' ' ALA . 6.7 p -70.23 -29.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.45 ' CZ ' HD12 ' B' ' 209' ' ' LEU . 0.5 OUTLIER -59.14 -52.01 67.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.088 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.91 -42.01 95.13 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.629 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.98 -49.78 76.07 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.35 -46.24 84.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.572 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 105' ' ' LEU . 1.6 mm? -64.12 -39.26 93.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.048 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.31 -39.73 71.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.65 91.37 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.867 0.365 . . . . 0.0 110.259 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.36 -42.82 98.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.818 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.7 m -66.11 -44.22 84.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.031 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.474 HG22 HG21 ' A' ' 118' ' ' VAL . 51.6 t -60.35 -43.01 92.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 121.171 0.51 . . . . 0.0 109.833 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -65.56 -25.08 67.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.554 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -93.6 10.86 30.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.669 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 66.58 25.52 9.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.041 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.63 75.86 1.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.005 0.431 . . . . 0.0 110.213 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -76.14 -27.24 56.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.0 t -55.0 -50.57 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.401 ' O ' HG22 ' A' ' 121' ' ' VAL . 57.3 tp -63.08 -44.25 96.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.334 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.474 HG21 HG22 ' A' ' 110' ' ' VAL . 87.3 t -57.43 -49.1 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.195 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.18 -42.03 87.26 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.555 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -69.33 -49.48 55.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.507 0.194 . . . . 0.0 110.648 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 117' ' ' LEU . 77.2 t -57.83 -46.85 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.182 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -40.34 96.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.763 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.26 -38.91 91.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 0.0 110.437 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -66.6 -42.22 87.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.131 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 87.0 mtp -63.22 -48.6 77.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.438 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.67 -42.71 89.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.551 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.14 74.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.371 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -57.74 -41.46 81.92 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.367 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 79.3 mt -63.5 -31.78 73.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.615 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.28 9.96 42.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.638 0.256 . . . . 0.0 111.372 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.4 m -119.1 -80.15 0.61 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.448 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -81.67 -35.6 29.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.865 0.364 . . . . 0.0 111.659 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.581 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 35.4 mt -91.63 5.8 48.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.814 0.34 . . . . 0.0 110.978 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.18 81.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.854 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.98 -45.66 70.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.922 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.581 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 87.9 m95 -59.28 -51.69 68.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.411 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.6 mm -61.58 -30.92 49.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.053 0.454 . . . . 0.0 111.011 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -72.3 -45.77 58.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.089 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.6 m -70.9 -30.12 66.38 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.554 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 67.5 m -89.31 1.93 55.07 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.11 41.05 96.38 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.441 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.99 -98.84 0.9 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -115.15 11.22 16.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -54.07 -51.05 65.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.778 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.644 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 3.2 pt-20 -85.65 -24.0 27.26 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.423 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -59.88 -42.22 93.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.228 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.473 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 1.2 p -72.68 -5.49 37.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.976 0.417 . . . . 0.0 111.258 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.85 -17.52 15.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.245 0.545 . . . . 0.0 110.323 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 41.3 mt -76.34 -57.14 4.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.945 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.473 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 4.8 p90 -74.59 -10.37 59.48 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.386 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.84 -22.74 78.87 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.818 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 0.0 110.271 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . 0.621 HG22 HG13 ' B' ' 202' ' ' ILE . 50.2 mt . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.419 0.152 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.621 HG13 HG22 ' B' ' 201' ' ' ILE . 29.0 mt -145.83 119.18 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.382 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -72.96 -34.58 66.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -57.4 -57.48 12.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.834 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 33.2 mm -62.28 -39.22 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.437 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' A' ' 81' ' ' VAL . . . -60.45 -46.89 88.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.997 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' ARG . . . . . 0.751 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 2.1 ttp-105 -58.91 -37.78 77.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.66 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' HIS . . . . . 0.494 ' O ' HG23 ' B' ' 212' ' ' VAL . 9.1 t-80 -58.68 -60.59 3.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.105 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.45 HD12 ' CZ ' ' A' ' 101' ' ' PHE . 0.8 OUTLIER -66.17 -41.88 89.69 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -60.75 -44.65 96.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.433 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -67.36 -35.08 78.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.371 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.494 HG23 ' O ' ' B' ' 208' ' ' HIS . 32.8 t -56.36 -54.61 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 123.084 0.24 . . . . 0.0 110.826 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.09 -44.94 43.29 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.244 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -61.39 -56.54 19.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.6 m -62.97 -34.19 77.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.352 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' MET . . . . . 0.723 ' HA ' ' HE3' ' B' ' 216' ' ' MET . 4.0 tpt -65.85 -44.74 84.58 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.433 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . 0.519 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 30.1 t70 -61.65 -33.94 74.83 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.038 0.447 . . . . 0.0 110.071 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . 0.444 ' HD2' ' HZ3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.066 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.865 0.364 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -127.49 89.69 50.55 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.219 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.65 131.35 22.63 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.578 2.185 . . . . 0.0 111.714 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.04 152.62 21.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.13 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.0 m -83.34 116.11 22.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.337 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.723 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -69.24 -55.85 9.4 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.281 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.723 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 96.0 Cg_endo -92.57 146.78 2.73 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.133 1.889 . . . . 0.0 112.917 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 13.4 t70 -76.54 148.26 37.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.848 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.423 ' O ' HG22 ' A' ' 13' ' ' VAL . 3.1 m -53.43 -35.63 60.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 2.4 mtm180 -63.11 -33.34 75.24 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.116 -0.233 . . . . 0.0 110.824 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.27 -37.6 85.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.028 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.38 -40.32 81.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.67 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 9' ' ' THR . 85.1 t -62.34 -43.14 97.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.559 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.17 -38.43 91.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.13 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.85 -38.75 86.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -67.51 -50.42 58.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.3 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.2 t -61.86 -44.47 98.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.831 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 22' ' ' ARG . . . -62.93 -40.41 99.25 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.45 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.418 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 2.6 t80 -62.85 -47.39 83.58 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.56 -37.46 81.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.969 0.414 . . . . 0.0 110.447 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.707 HD12 ' HE2' ' A' ' 24' ' ' LYS . 23.4 tp -67.72 -34.07 76.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 84.7 mtm-85 -80.14 -33.73 38.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.753 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 14.3 mm100 -60.14 -23.6 64.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.707 ' HE2' HD12 ' A' ' 21' ' ' LEU . 57.3 pttt -97.08 22.78 8.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.885 0.374 . . . . 0.0 111.037 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.04 -55.29 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.327 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.7 110.91 4.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.24 112.87 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.088 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.4 t -120.86 125.86 48.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.054 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.19 -130.15 4.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.47 179.62 8.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.652 0.263 . . . . 0.0 110.302 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.69 96.66 0.81 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.869 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.46 113.21 3.05 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.899 2.399 . . . . 0.0 112.324 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.22 -108.96 1.83 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.959 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.38 106.36 9.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.95 0.405 . . . . 0.0 110.537 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.11 79.44 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.59 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.54 122.35 10.69 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.146 2.564 . . . . 0.0 112.786 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.88 166.91 10.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.578 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.7 18.06 9.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.093 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -120.87 89.08 45.19 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -89.71 -7.27 4.77 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.491 2.127 . . . . 0.0 110.812 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.64 -53.2 36.59 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.121 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -62.66 -38.04 88.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.953 0.406 . . . . 0.0 110.498 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -67.59 -40.28 84.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.271 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.65 91.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.545 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 37.6 mtt -61.67 -41.62 97.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.228 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -62.27 -50.33 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.532 ' HB1' ' HG3' ' A' ' 51' ' ' GLU . . . -61.8 -37.22 83.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.845 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.23 -32.61 49.13 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.127 0.267 . . . . 0.0 111.719 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.4 35.56 3.57 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.683 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -151.26 -33.49 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.532 ' HG3' ' HB1' ' A' ' 47' ' ' ALA . 3.8 mm-40 -60.38 -72.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.503 ' HE2' HG21 ' A' ' 59' ' ' THR . 9.2 p90 -56.47 -36.66 69.34 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.517 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.12 -42.3 99.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.684 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.55 -20.05 63.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 -105.92 1.21 26.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.208 0.528 . . . . 0.0 110.554 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.473 ' HB3' ' H ' ' A' ' 57' ' ' ARG . 2.8 t80 -98.13 -85.58 0.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.571 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 5.2 ttm105 175.05 -71.12 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.63 61.29 0.32 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.107 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.503 HG21 ' HE2' ' A' ' 52' ' ' PHE . 0.4 OUTLIER -50.51 -33.55 21.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.038 -178.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -56.06 -23.73 35.35 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.405 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.6 m -121.39 -40.38 2.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.615 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.5 -49.87 73.63 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.423 ' HB2' HG23 ' A' ' 59' ' ' THR . 10.9 tp -59.67 -34.15 72.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.11 0.481 . . . . 0.0 110.733 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -80.04 -18.45 50.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.97 -47.58 7.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.511 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.905 ' HG3' HD22 ' A' ' 67' ' ' LEU . 8.5 pt20 -65.02 -19.55 66.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.905 HD22 ' HG3' ' A' ' 66' ' ' GLN . 0.4 OUTLIER -109.84 13.84 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 0.0 110.612 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.597 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 9.0 t-160 -95.24 10.38 36.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.161 0.505 . . . . 0.0 110.705 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.6 t -78.88 -42.57 24.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.201 0.524 . . . . 0.0 110.139 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -86.48 132.41 42.92 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.002 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.84 109.21 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.063 2.509 . . . . 0.0 112.704 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.08 -146.84 21.71 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.633 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.658 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 20.1 m -151.17 -159.45 1.03 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.6 -157.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.796 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.464 ' OE1' ' HB2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -54.96 -31.04 60.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.442 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -64.43 -10.94 28.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.444 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.658 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 19.0 tpp85 -109.61 -25.59 10.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.7 0.286 . . . . 0.0 110.885 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.541 ' O ' HG11 ' A' ' 81' ' ' VAL . 19.4 m-85 -65.55 -61.05 2.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.33 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.17 -20.89 64.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.283 0.563 . . . . 0.0 110.731 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -75.63 -24.97 56.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.199 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.541 HG11 ' O ' ' A' ' 78' ' ' PHE . 1.4 p -73.93 -24.56 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.217 0.532 . . . . 0.0 110.04 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.23 -39.64 39.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.663 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -71.95 -28.52 63.5 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.007 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -54.6 -47.61 73.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.688 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.6 ' HB3' ' HD3' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -82.1 -21.8 36.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.535 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.544 ' HB2' ' HA ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -62.9 -32.61 73.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.356 0.598 . . . . 0.0 109.43 179.049 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -64.1 -24.09 67.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.42 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.46 45.32 1.09 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.512 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.64 74.79 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.553 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.09 52.09 3.69 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.342 2.695 . . . . 0.0 112.012 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -71.85 163.36 27.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.618 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.777 ' HB3' HD11 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -53.37 -39.94 64.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.392 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.455 ' HA3' ' OD1' ' B' ' 214' ' ' ASP . . . -65.22 -24.77 70.73 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.616 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.6 ' HD3' ' HB3' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -75.09 -39.92 60.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.82 -42.61 94.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.295 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.44 -46.75 89.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.356 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.491 ' HA ' HG13 ' A' ' 100' ' ' VAL . . . -60.97 -41.98 97.46 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.278 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -62.68 -41.55 99.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.126 0.488 . . . . 0.0 110.646 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -71.49 -49.21 43.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.398 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.491 HG13 ' HA ' ' A' ' 97' ' ' ALA . 9.9 p -64.13 -36.44 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -62.36 -49.73 74.38 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.939 0.4 . . . . 0.0 110.187 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.81 -47.08 78.7 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.017 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.34 87.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.87 81.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.755 0.312 . . . . 0.0 111.252 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.443 ' HG ' ' OE1' ' A' ' 75' ' ' GLN . 2.6 mm? -65.83 -40.84 92.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.02 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.438 ' O ' HG22 ' A' ' 110' ' ' VAL . 56.6 m -64.49 -46.93 80.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.549 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.89 77.7 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.069 0.461 . . . . 0.0 110.541 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.71 -46.21 66.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.194 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 m -62.95 -34.64 77.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.126 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 106' ' ' CYS . 40.0 t -63.17 -39.88 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.001 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -73.46 -28.22 61.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.228 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -85.6 9.33 16.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.757 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 54.49 48.93 19.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.569 0.7 . . . . 0.0 110.334 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.18 53.89 1.28 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.316 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -60.45 -28.32 68.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.745 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.6 t -56.49 -45.48 82.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.391 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.483 ' O ' HG22 ' A' ' 121' ' ' VAL . 37.9 tp -71.97 -41.9 67.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.386 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.18 -46.61 77.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.564 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.79 -35.65 90.37 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.036 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -69.7 -44.89 69.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 110.237 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 117' ' ' LEU . 57.6 t -61.27 -48.4 89.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.826 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.33 -41.34 98.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.579 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -59.62 -45.39 92.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.252 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -66.54 -40.99 89.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.833 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 85.7 mtp -60.16 -51.4 69.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.744 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.39 -45.26 93.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.414 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.57 81.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -61.86 -43.26 99.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.161 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.468 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 58.4 mt -64.3 -28.51 69.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.854 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -101.91 8.04 41.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.2 m -121.53 -70.19 0.8 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.412 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.4 ttt85 -85.76 -38.32 18.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.823 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 77.9 mt -95.02 11.8 30.74 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.49 -52.64 64.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.798 0.332 . . . . 0.0 111.262 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.37 -39.31 92.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.823 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 84.0 m95 -62.95 -48.78 77.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 133' ' ' LEU . 44.1 mm -61.57 -37.45 77.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.043 0.449 . . . . 0.0 109.817 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -66.5 -32.12 73.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 m -78.01 -37.62 46.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.046 0.451 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 29.8 m -81.5 -6.99 59.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.143 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.18 41.45 98.35 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.67 -100.97 1.99 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -120.78 13.6 11.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 140' ' ' SER . . . -51.79 -65.41 0.56 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.243 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.493 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 7.5 pt-20 -67.0 -23.52 65.94 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.234 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.463 ' HA ' HD12 ' A' ' 149' ' ' LEU . 59.0 t80 -61.92 -35.31 78.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.678 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -60.4 -30.63 69.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.131 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.41 -12.06 35.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' A' ' 92' ' ' TRP . 87.6 mt -80.54 -35.95 33.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.293 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.678 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 9.2 p90 -98.73 16.64 21.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.019 0.437 . . . . 0.0 111.056 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.22 -47.15 90.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.769 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -119.05 -172.59 2.33 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -148.86 -33.99 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.094 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.467 ' HA ' ' OG ' ' B' ' 219' ' ' SER . . . -95.51 -14.21 23.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.987 0.422 . . . . 0.0 110.901 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 54.7 tp -80.62 102.16 9.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.788 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.1 130.22 3.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.74 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -129.2 38.86 3.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.069 0.461 . . . . 0.0 110.465 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -101.91 -53.89 2.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.181 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.521 HH12 ' HA ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -146.37 8.58 1.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.166 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 52.2 ttp85 -54.69 142.2 29.39 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 23.5 tp -53.02 128.51 27.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.233 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.517 ' HG3' ' HB3' ' A' ' 166' ' ' TRP . 1.3 mpt_? -89.0 104.37 16.92 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.36 168.05 20.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.874 0.369 . . . . 0.0 111.702 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 59.03 -107.17 1.09 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.336 -0.847 . . . . 0.0 113.805 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -58.4 -46.85 85.6 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.842 0.457 . . . . 0.0 111.793 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.517 ' HB3' ' HG3' ' A' ' 162' ' ' ARG . 30.3 m95 -67.46 -83.03 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.937 0.399 . . . . 0.0 111.805 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -109.27 105.26 14.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.375 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.07 -34.22 14.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.289 0.566 . . . . 0.0 110.146 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 m -108.59 146.77 13.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.632 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.717 -179.483 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 37.6 mt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.863 0.363 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' B' ' 205' ' ' ILE . 1.8 pt -143.88 75.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.561 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -65.1 -33.2 75.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -61.38 -42.58 98.94 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . 0.561 HD13 HD11 ' A' ' 67' ' ' LEU . 8.4 mm -69.07 -42.56 81.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.091 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . 0.489 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -62.55 -37.94 88.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.354 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -66.33 -34.57 78.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.325 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' HIS . . . . . 0.561 ' HB3' HD12 ' A' ' 67' ' ' LEU . 6.1 t-80 -60.08 -56.55 20.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.435 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.1 pp -63.44 -33.43 75.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.811 0.339 . . . . 0.0 110.293 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.57 -59.37 4.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.791 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -63.6 -43.0 98.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.66 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.481 HG12 HE22 ' A' ' 66' ' ' GLN . 53.5 t -63.66 -43.19 98.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.709 0.29 . . . . 0.0 110.678 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.89 -44.22 80.07 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.095 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . 0.455 ' OD1' ' HA3' ' A' ' 93' ' ' GLY . 60.0 m-20 -60.13 -46.1 90.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.93 0.395 . . . . 0.0 111.315 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 12.6 p -70.02 -46.82 64.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.934 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' MET . . . . . 0.618 ' HA ' ' HB ' ' B' ' 220' ' ' ILE . 11.4 tpp -62.82 -43.73 98.01 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' B' ' 219' ' ' SER . 11.8 t70 -60.15 -54.72 42.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.631 0.253 . . . . 0.0 110.912 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -77.07 31.6 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.449 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' SER . . . . . 0.467 ' OG ' ' HA ' ' A' ' 154' ' ' ALA . 14.5 m 67.59 92.93 0.08 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.099 0.559 . . . . 0.0 110.741 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.618 ' HB ' ' HA ' ' B' ' 216' ' ' MET . 16.6 tt . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.04 -0.981 . . . . 0.0 111.291 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.804 0.335 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -114.26 126.26 28.22 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.475 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.45 110.11 2.61 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.567 2.178 . . . . 0.0 112.123 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.89 117.3 11.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.8 m -66.34 121.58 15.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.234 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.584 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -82.76 -51.52 0.7 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.16 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 17.1 Cg_exo -67.8 141.5 54.44 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.068 1.845 . . . . 0.0 112.67 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.42 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 16.0 t70 -85.95 154.6 21.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.266 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.418 ' O ' HG22 ' A' ' 13' ' ' VAL . 2.8 m -54.65 -42.72 71.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.917 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.42 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -66.21 -35.05 79.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.418 0.151 . . . . 0.0 111.1 -179.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.27 -37.68 86.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.947 0.404 . . . . 0.0 110.552 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 41' ' ' LEU . 6.3 tp -68.27 -44.38 75.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.916 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 9' ' ' THR . 87.7 t -62.92 -44.81 99.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.389 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.64 71.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.831 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.22 -44.08 84.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.89 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -63.54 -47.64 80.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.131 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.8 t -59.77 -46.25 93.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.274 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 22' ' ' ARG . . . -62.75 -44.81 96.93 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.598 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.475 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 10.8 t80 -58.54 -49.6 76.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.38 . . . . 0.0 110.503 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -62.09 -36.21 81.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.6 tp -67.81 -26.67 66.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.59 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 87.1 mtm-85 -90.8 -32.43 16.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.461 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 15.7 mm100 -63.01 -27.14 69.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 0.0 111.38 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -88.61 17.91 5.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.132 0.492 . . . . 0.0 110.766 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.86 -74.8 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -127.58 101.35 6.37 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.436 HG11 HE22 ' A' ' 23' ' ' GLN . 59.1 t -62.06 121.95 11.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.809 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.2 t -143.23 139.21 30.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.768 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.59 -138.96 9.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.067 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.97 145.22 26.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.649 0.261 . . . . 0.0 110.473 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.59 103.99 2.23 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.272 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.83 128.15 14.68 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.78 2.32 . . . . 0.0 111.441 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.68 -55.99 0.2 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.257 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -125.09 24.94 7.38 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.173 0.511 . . . . 0.0 110.201 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.62 104.51 2.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.166 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.08 126.61 13.98 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.894 2.396 . . . . 0.0 111.802 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.51 154.69 20.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.346 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.38 -31.43 63.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.905 0.383 . . . . 0.0 110.65 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.3 130.26 23.63 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.135 0.493 . . . . 0.0 110.548 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -98.18 1.33 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.941 2.427 . . . . 0.0 111.081 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.443 ' HB3' HD22 ' A' ' 12' ' ' LEU . 47.2 mt -64.58 -47.22 79.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.821 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -58.85 -37.56 76.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.946 0.403 . . . . 0.0 111.417 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -80.27 -38.03 31.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.943 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.75 97.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.989 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.577 ' HE3' ' HZ ' ' A' ' 99' ' ' PHE . 25.3 ttm -61.22 -40.33 93.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.46 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -71.39 -44.39 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.517 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.554 ' HB1' ' HG3' ' A' ' 51' ' ' GLU . . . -59.07 -43.65 91.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.211 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.44 -21.11 34.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.553 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -125.51 26.11 5.52 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.013 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -146.37 -46.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.813 -0.228 . . . . 0.0 111.601 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.612 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 14.9 mm-40 -58.58 -55.36 36.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.829 0.347 . . . . 0.0 111.309 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.553 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 2.3 p90 -66.82 -28.74 68.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.121 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -71.55 -44.57 64.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.349 . . . . 0.0 110.407 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -71.99 -8.14 52.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.626 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.612 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 82.8 mtm-85 -109.6 5.05 22.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.296 0.569 . . . . 0.0 110.164 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.846 ' HD1' ' HG2' ' B' ' 216' ' ' MET . 60.8 t80 -118.85 -85.82 0.65 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.707 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 175.71 -72.2 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.512 0.673 . . . . 0.0 109.275 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.64 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -154.55 60.67 0.68 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.27 179.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.524 HG23 HD11 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -57.72 -32.04 67.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.909 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -58.16 -36.02 72.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.119 0.485 . . . . 0.0 110.372 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.91 -36.35 12.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.828 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.57 -40.25 86.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.584 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.524 HD11 HG23 ' A' ' 59' ' ' THR . 1.4 mp -63.84 -30.64 71.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.076 0.465 . . . . 0.0 110.861 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.98 -28.15 35.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.236 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.02 -49.28 65.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.849 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -67.4 -23.92 65.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.835 0.35 . . . . 0.0 110.516 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -85.01 -1.78 57.21 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.126 0.489 . . . . 0.0 110.108 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -104.22 -42.48 5.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.916 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.35 -50.46 78.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.432 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -87.25 142.46 33.5 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.816 178.319 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.432 ' HD2' HG22 ' A' ' 70' ' ' THR . 52.4 Cg_exo -53.45 106.35 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.799 2.332 . . . . 0.0 112.825 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.59 -169.84 22.72 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.738 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.8 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 61.3 m -146.8 -157.22 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.24 -167.32 0.31 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.93 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.484 ' HG3' HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -50.74 -38.83 49.96 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.447 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -57.56 -31.01 65.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.627 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.8 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 11.8 tpp85 -72.62 -29.0 63.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.946 0.403 . . . . 0.0 110.177 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.582 ' O ' HG11 ' A' ' 81' ' ' VAL . 73.8 m-85 -73.97 -46.59 43.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -34.9 76.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.275 0.56 . . . . 0.0 110.698 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -68.88 -35.62 77.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.069 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.582 HG11 ' O ' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -69.58 -25.33 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.678 0.275 . . . . 0.0 111.303 -179.131 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.26 -47.17 24.76 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.98 -30.19 70.71 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.072 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -50.67 -48.13 58.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.741 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.602 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -97.48 -6.23 34.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.1 -179.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -40.72 62.97 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -66.27 -29.52 69.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.93 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.72 -26.53 71.2 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.192 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.06 107.91 0.22 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.153 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.26 59.4 6.0 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.867 2.378 . . . . 0.0 111.673 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -70.48 176.69 3.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.439 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.672 ' HB3' HD13 ' A' ' 149' ' ' LEU . 1.9 m-90 -53.0 -57.31 10.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.57 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.79 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -70.22 -12.15 68.56 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.826 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -39.81 93.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.094 0.447 . . . . 0.0 110.049 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.7 tp -71.71 -36.54 70.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.897 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -61.95 -50.28 80.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.407 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.54 -42.62 99.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.165 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -64.44 -42.45 95.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.09 0.472 . . . . 0.0 110.929 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.577 ' HZ ' ' HE3' ' A' ' 45' ' ' MET . 33.9 t80 -68.18 -48.47 65.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.288 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.471 HG23 ' CZ ' ' A' ' 52' ' ' PHE . 9.1 p -65.4 -33.25 62.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.122 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.705 ' HE2' HD11 ' B' ' 209' ' ' LEU . 0.2 OUTLIER -61.9 -51.28 68.82 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.66 -44.96 96.77 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.783 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.46 81.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.604 0.24 . . . . 0.0 111.351 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.61 -45.77 88.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.659 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.07 -38.7 82.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.065 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.423 ' O ' HG21 ' A' ' 110' ' ' VAL . 19.7 m -65.78 -47.6 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.0 -42.07 89.21 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.984 0.421 . . . . 0.0 110.547 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 10.4 tm-20 -60.29 -39.83 88.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.949 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 114' ' ' MET . 14.1 m -74.73 -39.66 61.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.892 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 106' ' ' CYS . 50.8 t -59.03 -47.38 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.855 0.36 . . . . 0.0 110.601 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -65.17 -27.23 68.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.54 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 108' ' ' GLU . 4.3 ttpt -90.21 9.94 26.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.875 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 60.74 33.07 20.25 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.993 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.513 ' O ' HG22 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -104.51 61.84 0.72 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.955 0.407 . . . . 0.0 110.172 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -63.61 -29.83 71.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.145 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.28 -45.77 92.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.102 0.477 . . . . 0.0 110.556 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.484 HD22 ' HG3' ' A' ' 75' ' ' GLN . 15.7 tp -69.82 -39.65 76.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.468 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 114' ' ' MET . 67.0 t -59.52 -45.55 93.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.869 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.2 -41.07 99.38 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.323 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -64.5 -46.26 83.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.796 0.331 . . . . 0.0 110.725 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 117' ' ' LEU . 99.8 t -64.25 -46.03 94.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.764 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -45.05 96.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 110.681 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.21 -45.62 92.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.622 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -63.09 -43.49 98.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.113 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 95.1 mtp -57.85 -50.02 74.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.893 0.378 . . . . 0.0 110.655 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.77 -41.23 91.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.877 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.12 -46.14 91.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.578 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -59.58 -43.1 93.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.165 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.622 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 53.8 mt -63.88 -36.12 82.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -90.16 4.92 49.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 m -124.41 -77.1 0.59 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.75 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -75.07 -23.42 58.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.622 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 81.0 mt -109.88 14.32 23.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.348 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.4 -44.14 84.28 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.29 -39.42 48.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.822 0.344 . . . . 0.0 110.749 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.567 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 95.9 m95 -60.62 -50.54 73.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.27 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.75 -37.33 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 0.0 110.322 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -67.75 -36.08 79.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.742 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.7 m -71.68 -40.51 69.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.983 0.42 . . . . 0.0 110.704 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.409 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 68.9 m -78.61 -6.13 54.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.138 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.39 40.83 98.13 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.33 -111.35 3.27 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -109.36 14.93 23.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.05 -62.28 1.94 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.318 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 5.8 pt-20 -70.86 -20.15 62.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.725 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.45 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 75.5 t80 -60.6 -38.39 84.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.821 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -27.39 69.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.485 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.85 -13.83 38.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.748 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.672 HD13 ' HB3' ' A' ' 92' ' ' TRP . 56.6 mt -68.31 -35.3 77.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.918 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -110.22 20.33 17.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 0.0 110.223 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -75.64 -19.79 78.86 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.817 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -97.37 140.88 31.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.81 -57.79 1.38 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.232 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.43 ' HA ' ' H ' ' B' ' 220' ' ' ILE . . . -132.5 138.61 47.61 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.23 -20.34 0.78 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.254 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.86 -169.25 1.63 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -136.03 -40.14 0.68 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.756 0.312 . . . . 0.0 110.368 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -77.18 -29.27 54.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.424 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.406 ' NH1' HD11 ' B' ' 220' ' ' ILE . 26.7 mtm105 -80.81 -18.12 48.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.427 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.581 ' HG2' HG23 ' B' ' 220' ' ' ILE . 17.4 mtm180 -64.24 163.92 11.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 111.292 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.754 ' HG ' ' HA ' ' A' ' 168' ' ' SER . 4.5 mp -81.2 145.66 30.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.193 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.79 -15.61 14.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.448 0.642 . . . . 0.0 109.723 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.68 -47.13 2.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.173 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.424 ' HA2' HD21 ' A' ' 161' ' ' LEU . . . 95.47 26.6 11.77 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.955 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -78.04 -66.11 0.89 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.238 0.542 . . . . 0.0 110.144 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -165.12 -58.9 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.34 114.22 3.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.075 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.754 ' HA ' ' HG ' ' A' ' 161' ' ' LEU . 3.5 m -87.12 -37.91 16.94 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.341 0.591 . . . . 0.0 109.743 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.762 HG21 ' HE3' ' B' ' 216' ' ' MET . 18.2 m -111.74 164.42 7.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.663 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.353 -179.901 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 121.345 0.593 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 8.2 mt -132.8 86.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.889 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -64.75 -33.79 76.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.357 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -53.21 -55.26 25.72 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 66.2 mt -65.68 -47.43 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.362 . . . . 0.0 110.956 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 85' ' ' LEU . . . -56.85 -45.3 82.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.524 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' ARG . . . . . 0.602 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 18.3 ttp-105 -62.04 -36.86 82.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' HIS . . . . . 0.405 ' O ' HG21 ' B' ' 212' ' ' VAL . 38.4 t-80 -60.9 -56.1 25.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.304 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.705 HD11 ' HE2' ' A' ' 101' ' ' PHE . 1.5 pp -65.74 -34.85 79.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.487 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -69.88 -43.01 72.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.092 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' B' ' 207' ' ' ARG . 0.7 OUTLIER -65.34 -49.06 70.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.798 -178.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' B' ' 216' ' ' MET . 26.0 m -62.99 -44.27 99.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.409 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.44 -38.62 87.04 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.394 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . 0.79 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 4.0 t0 -67.01 -50.52 61.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.835 0.35 . . . . 0.0 111.335 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 2.7 m -69.72 -49.01 57.33 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' MET . . . . . 0.846 ' HG2' ' HD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -60.18 -37.82 81.37 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.27 -34.05 61.3 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.442 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER -75.22 73.33 2.33 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.278 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 7.8 m 65.93 178.13 0.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.563 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.581 HG23 ' HG2' ' A' ' 160' ' ' ARG . 7.1 tp . . . . . 0 C--N 1.316 -0.889 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.764 0.316 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 m -87.32 113.05 52.11 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.738 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.28 132.59 19.61 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.358 2.039 . . . . 0.0 112.009 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.96 139.52 32.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.118 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.53 116.91 25.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.108 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.781 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -86.24 -60.03 0.28 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.487 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.781 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 23.1 Cg_exo -65.7 138.6 54.51 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.057 1.838 . . . . 0.0 112.122 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.14 156.93 28.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.9 m -58.11 -41.13 82.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.946 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -69.95 -27.44 64.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 110.566 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.24 75.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.467 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.43 -40.27 77.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.682 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t -63.13 -47.03 94.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.968 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.95 -38.43 82.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.031 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.94 -43.23 83.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.545 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -65.06 -48.59 73.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -62.43 -45.23 99.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.342 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.75 -41.03 99.56 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.517 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -61.84 -43.09 99.55 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 21.5 mmmt -59.93 -45.26 93.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.049 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.416 HD12 ' HE3' ' A' ' 24' ' ' LYS . 55.2 tp -65.95 -40.45 91.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.706 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 84.6 mtm-85 -73.37 -30.13 63.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.829 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -64.46 -30.17 71.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.416 ' HE3' HD12 ' A' ' 21' ' ' LEU . 10.0 pttp -92.88 -0.19 57.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.913 0.387 . . . . 0.0 110.938 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.5 -60.36 0.32 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.112 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -154.14 105.26 2.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.97 113.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.162 0.506 . . . . 0.0 110.712 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.8 t -127.79 127.34 43.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.043 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.01 -135.69 5.24 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.844 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.19 158.57 43.89 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.22 111.8 4.03 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.88 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.68 76.14 4.69 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.037 2.492 . . . . 0.0 111.99 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.22 -84.81 0.79 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.569 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -119.18 127.94 53.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.022 0.439 . . . . 0.0 110.115 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.29 91.7 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.441 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.75 110.5 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.83 2.353 . . . . 0.0 112.064 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.2 150.46 21.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.857 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.461 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -70.4 -26.27 63.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.846 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -101.51 104.8 36.51 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.421 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 74.4 Cg_endo -92.29 -3.41 3.84 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.801 2.334 . . . . 0.0 111.566 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.66 -41.33 96.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.731 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -59.62 -38.86 82.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.865 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -80.71 -37.28 30.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.94 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.69 98.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.897 0.38 . . . . 0.0 110.378 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.1 ttt -62.8 -39.65 94.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.856 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -65.96 -48.85 69.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.642 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.16 79.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.62 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.25 62.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.824 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.99 19.49 13.66 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.255 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -132.46 -47.67 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.622 0.249 . . . . 0.0 111.404 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.532 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 6.2 mm-40 -62.46 -30.54 71.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.626 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.557 ' O ' ' HB2' ' A' ' 56' ' ' PHE . 67.0 t80 -59.57 -32.34 70.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.033 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 59' ' ' THR . 4.6 tp10 -87.14 -26.74 23.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.815 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.9 m -54.27 -47.96 71.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.099 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.532 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 23.1 mtm-85 -102.02 12.4 36.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.846 0.355 . . . . 0.0 111.562 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.557 ' HB2' ' O ' ' A' ' 52' ' ' PHE . 3.2 t80 -97.77 -96.74 0.21 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 56' ' ' PHE . 42.4 ttm180 170.48 -68.43 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.738 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -154.21 79.36 1.11 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.126 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.436 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 61.6 m -57.17 -44.61 83.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.745 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -74.31 1.14 12.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.856 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.52 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . 4.8 m -124.04 -54.93 1.7 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -79.27 -57.23 3.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 66' ' ' GLN . 14.6 tp -58.78 -42.86 90.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.018 0.437 . . . . 0.0 110.904 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.51 -17.5 64.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.664 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.15 -46.73 6.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.519 0.2 . . . . 0.0 111.212 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.485 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 8.4 pt20 -64.06 -33.55 76.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.394 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 67' ' ' LEU . 2.0 mm? -82.49 -11.21 58.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.063 0.459 . . . . 0.0 110.329 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -91.46 -11.83 36.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.798 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.3 t -66.17 -41.81 90.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -74.44 127.32 87.74 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.62 105.7 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.777 2.318 . . . . 0.0 112.098 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.81 -128.09 3.29 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.146 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.708 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 2.9 m -156.78 -148.3 0.21 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.99 -156.62 0.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.486 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -51.38 -35.06 37.04 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.34 0.4 . . . . 0.0 111.914 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -55.55 -42.96 75.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.11 0.481 . . . . 0.0 110.365 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.708 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 11.1 tpp180 -68.01 -43.0 79.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.393 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.506 ' O ' HG11 ' A' ' 81' ' ' VAL . 48.3 m-85 -62.67 -37.06 84.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.985 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.2 m -65.9 -49.92 66.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.609 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -70.22 -33.78 72.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.273 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 78' ' ' PHE . 1.4 p -67.06 -31.57 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 0.0 110.498 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.9 m -77.32 -44.05 30.93 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.67 -35.98 79.52 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.613 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -53.7 -60.34 3.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.805 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.6 ' HB2' ' HB2' ' B' ' 206' ' ' ALA . 0.2 OUTLIER -78.67 -16.25 57.53 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.517 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -65.63 -34.73 78.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -90.71 11.2 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.202 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.6 25.64 5.02 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.83 83.56 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -83.86 59.24 6.11 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.759 2.306 . . . . 0.0 112.227 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.509 ' HB3' ' OD2' ' B' ' 214' ' ' ASP . 60.2 t30 -76.32 171.8 13.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.818 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.667 ' CD1' HD23 ' A' ' 149' ' ' LEU . 2.4 m0 -52.61 -49.48 64.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.767 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.76 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -65.47 -33.15 85.63 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.465 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.435 ' HD2' ' HB2' ' B' ' 210' ' ' ALA . 0.0 OUTLIER -61.96 -42.67 99.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.663 0.268 . . . . 0.0 110.597 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.3 tp -64.32 -42.49 96.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.325 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.76 -47.28 86.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.357 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.557 ' HA ' HG13 ' A' ' 100' ' ' VAL . . . -62.21 -40.43 96.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.37 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -59.59 -39.17 83.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.746 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -76.69 -48.83 17.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.193 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 97' ' ' ALA . 7.2 p -63.18 -32.04 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.526 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -60.77 -54.57 43.64 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.987 0.423 . . . . 0.0 110.46 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.03 -43.3 99.05 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.949 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.93 99.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.617 0.246 . . . . 0.0 111.185 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.21 -43.77 97.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.268 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -68.78 -39.62 80.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.8 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.4 ' O ' HG21 ' A' ' 110' ' ' VAL . 50.4 m -66.12 -46.13 78.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.309 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.5 87.38 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.94 0.4 . . . . 0.0 110.515 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -45.29 91.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.268 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.6 m -65.81 -38.43 88.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.967 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 106' ' ' CYS . 49.9 t -63.16 -41.31 92.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.045 0.45 . . . . 0.0 109.807 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -70.3 -9.56 56.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.369 0.605 . . . . 0.0 110.533 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -105.21 6.4 32.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.008 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 62.66 32.47 16.24 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.198 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.434 ' SD ' ' HB ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -106.57 64.07 0.65 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.646 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -65.56 -21.99 66.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.818 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.434 ' HB ' ' SD ' ' A' ' 114' ' ' MET . 97.4 t -58.83 -56.36 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.758 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.7 tp -66.95 -37.47 84.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.681 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.5 t -59.28 -48.48 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.44 -38.62 93.76 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.14 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -68.43 -50.45 52.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.747 0.308 . . . . 0.0 110.506 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.9 t -58.24 -44.02 87.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.107 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -45.59 86.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.245 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.82 -45.16 87.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.729 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -55.91 -44.6 78.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.999 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 89.9 mtp -67.69 -50.08 59.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.392 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.14 -47.05 93.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.262 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.98 93.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.05 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -62.11 -38.48 89.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.874 0.368 . . . . 0.0 110.612 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.8 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 35.7 mt -66.92 -20.93 65.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.282 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.54 -13.72 15.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.3 m -94.96 -64.04 1.11 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -101.81 -32.12 10.42 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.8 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 73.4 mt -90.65 13.19 16.7 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.29 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.23 -53.55 53.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 110.598 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.94 -37.23 86.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.589 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.445 ' CD1' ' HA ' ' A' ' 133' ' ' LEU . 91.3 m95 -60.21 -56.5 20.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.681 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.662 HG21 ' HA2' ' A' ' 142' ' ' GLY . 45.9 mm -60.03 -36.14 65.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.009 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -63.61 -48.23 78.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.655 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.5 m -70.74 -32.2 69.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.584 0.23 . . . . 0.0 111.616 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.4 m -82.67 -6.41 59.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.796 0.331 . . . . 0.0 111.074 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.08 41.17 95.22 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.98 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.662 ' HA2' HG21 ' A' ' 137' ' ' ILE . . . 73.44 -103.2 1.38 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -118.37 16.08 13.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.59 -51.93 65.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.938 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -83.33 -15.96 48.02 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.633 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 89.0 t80 -61.7 -44.02 97.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.78 0.324 . . . . 0.0 110.5 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -24.67 66.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.129 0.49 . . . . 0.0 110.773 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.86 25.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.375 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.667 HD23 ' CD1' ' A' ' 92' ' ' TRP . 32.4 mt -61.39 -50.55 72.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 110.871 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -90.69 9.24 30.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.638 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.21 -10.61 84.55 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -136.27 159.12 42.71 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.93 93.79 1.27 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.398 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -140.0 20.64 2.46 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.565 0.221 . . . . 0.0 111.223 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.1 tt -159.21 121.88 3.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.771 0.32 . . . . 0.0 111.159 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -124.59 117.93 25.41 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -59.84 -36.87 77.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.709 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -77.21 20.02 0.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -149.14 -34.07 0.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.475 0.179 . . . . 0.0 111.404 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.432 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 17.1 mmm180 -58.28 -65.59 0.62 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.777 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 82.8 mt -98.37 -11.46 22.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.931 0.396 . . . . 0.0 111.114 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -113.26 95.23 5.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.063 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.46 -72.83 0.67 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.978 0.418 . . . . 0.0 110.16 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 177.52 -54.92 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.287 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -173.37 -29.2 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -75.31 -73.04 0.27 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -120.65 90.2 3.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.976 0.417 . . . . 0.0 110.8 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.9 m -82.43 -12.34 57.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.38 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.5 m -116.31 41.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.2 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 170' ' ' ARG . 10.2 ptp180 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.651 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 43.3 mt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.979 0.418 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 81' ' ' VAL . 0.8 OUTLIER -150.46 49.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.905 179.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' B' ' 207' ' ' ARG . 42.2 mttp -57.15 -33.71 67.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.632 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -59.78 -50.71 72.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 23.0 mt -70.35 -39.95 77.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.94 0.4 . . . . 0.0 110.026 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . 0.6 ' HB2' ' HB2' ' A' ' 85' ' ' LEU . . . -60.18 -46.09 90.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.215 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' B' ' 203' ' ' LYS . 0.4 OUTLIER -62.25 -36.81 83.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.489 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -58.75 -55.7 31.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.266 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.5 pp -68.76 -36.43 78.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 111.098 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . 0.435 ' HB2' ' HD2' ' A' ' 94' ' ' ARG . . . -63.49 -51.95 63.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.756 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -59.76 -45.5 92.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.595 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' B' ' 216' ' ' MET . 85.4 t -62.75 -55.17 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.604 0.24 . . . . 0.0 111.229 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.71 -45.63 87.99 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.182 -0.532 . . . . 0.0 114.385 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . 0.76 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 11.0 t70 -56.06 -47.29 78.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.94 0.4 . . . . 0.0 111.576 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.7 m -75.48 -41.16 56.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.257 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' B' ' 212' ' ' VAL . 5.0 tpt -54.46 -50.01 68.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.6 -34.48 74.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.865 0.364 . . . . 0.0 111.402 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . 0.51 HH21 ' HA2' ' A' ' 93' ' ' GLY . 0.1 OUTLIER -76.94 105.14 7.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.352 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 51.0 m 67.12 -177.6 0.2 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.261 0.553 . . . . 0.0 112.337 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.456 ' HB ' ' HG2' ' A' ' 55' ' ' ARG . 17.8 tt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.317 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.76 0.314 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -134.46 102.18 11.77 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.221 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.4 114.21 3.39 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.565 2.177 . . . . 0.0 112.147 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.65 118.48 16.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.504 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -83.27 108.93 16.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.351 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.607 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -83.96 -52.14 0.58 Allowed Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.021 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.607 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 23.8 Cg_exo -65.05 129.17 22.36 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.941 1.761 . . . . 0.0 112.345 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -78.76 154.36 30.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.227 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.473 ' O ' HG22 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -55.82 -38.92 70.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.215 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -69.95 -34.07 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.81 0.338 . . . . 0.0 110.645 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.23 -33.48 76.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.159 0.505 . . . . 0.0 109.878 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.2 tp -70.95 -40.53 71.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.815 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.727 ' HA ' ' HE3' ' A' ' 45' ' ' MET . 87.9 t -62.67 -45.99 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.286 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.04 -36.35 74.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.093 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.68 -51.6 66.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.458 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -63.01 -44.19 96.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.098 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -61.53 -47.59 92.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 120.846 0.355 . . . . 0.0 110.274 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.31 -36.41 92.71 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.509 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.536 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 30.2 t80 -64.65 -49.64 70.19 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 20' ' ' LYS . 25.7 mmmt -57.94 -40.28 80.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.238 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.534 HD11 HG12 ' A' ' 110' ' ' VAL . 36.1 tp -65.91 -33.12 75.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.787 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -81.83 -22.24 37.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.498 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 15.6 mm100 -61.68 -26.4 68.0 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -94.95 3.28 55.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.668 0.271 . . . . 0.0 111.394 -179.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -126.91 -60.29 0.14 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.564 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -157.03 104.36 2.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.4 t -65.76 120.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.517 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.2 t -128.79 99.3 5.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.219 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.98 -134.22 1.73 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.894 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.92 174.05 10.89 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.15 83.56 0.35 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.4 99.09 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.824 2.35 . . . . 0.0 111.96 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.64 -52.15 0.82 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.539 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -137.49 91.07 2.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.044 0.45 . . . . 0.0 110.325 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.75 105.32 0.24 Allowed Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.702 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.1 111.95 1.01 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.783 2.322 . . . . 0.0 111.821 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.38 139.96 39.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.431 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.72 -35.26 67.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.527 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.43 ' OD1' ' HB2' ' A' ' 41' ' ' LEU . 4.4 t70 -96.1 112.69 60.39 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.729 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -94.47 -1.5 2.8 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.684 2.256 . . . . 0.0 112.655 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 39' ' ' ASP . 24.9 mt -64.31 -44.64 90.97 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -62.22 -32.19 72.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.386 . . . . 0.0 110.818 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -79.79 -44.17 21.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.129 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.634 ' HB1' ' HE2' ' A' ' 146' ' ' PHE . . . -61.89 -42.96 99.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.743 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.727 ' HE3' ' HA ' ' A' ' 13' ' ' VAL . 13.8 ttt -61.57 -36.64 81.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.247 0.546 . . . . 0.0 110.202 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -73.67 -42.4 61.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.313 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.9 90.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.627 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -55.11 -25.79 33.89 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.86 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.441 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -123.76 39.85 2.09 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.227 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -162.82 -42.59 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.566 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 23.4 mm-40 -54.3 -60.33 3.48 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.441 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 11.5 p90 -57.46 -27.81 62.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.584 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.507 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 4.6 tp10 -72.9 -46.43 52.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.754 0.312 . . . . 0.0 110.947 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 m -64.95 -24.32 67.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.109 0.48 . . . . 0.0 110.738 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.566 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 9.6 mtm-85 -87.28 -25.18 24.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.202 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -97.52 -92.27 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.994 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 179.92 -64.23 0.01 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.921 0.391 . . . . 0.0 110.418 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.791 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -148.26 54.7 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.209 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.38 -30.41 71.55 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -59.74 -39.04 83.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.937 0.399 . . . . 0.0 110.287 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.414 ' OG ' ' HD3' ' A' ' 58' ' ' ARG . 1.6 m -86.59 -38.42 17.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.389 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 24.0 t70 -60.66 -41.53 95.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.0 tp -59.56 -39.86 85.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.408 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.22 -43.37 61.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.026 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.52 85.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.74 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 10.9 pt20 -66.3 -34.11 77.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 0.0 110.677 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.31 -24.87 63.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.091 0.472 . . . . 0.0 110.366 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -79.66 -13.22 59.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.554 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.4 t -76.25 -29.74 19.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.408 HG23 HG12 ' B' ' 205' ' ' ILE . 3.2 p -94.03 161.08 30.87 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.366 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.98 70.04 2.98 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.0 2.467 . . . . 0.0 112.034 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.84 -163.79 30.5 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.58 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -152.57 -132.06 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -99.69 -159.08 0.72 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.608 0.242 . . . . 0.0 110.886 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -51.32 -43.39 61.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.279 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -54.49 -44.52 72.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 0.0 111.192 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -71.76 -37.74 70.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.603 ' O ' HG11 ' A' ' 81' ' ' VAL . 15.5 m-85 -65.54 -45.95 81.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.593 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 m -69.38 -38.45 78.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.893 0.378 . . . . 0.0 110.854 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.519 ' HA ' ' OD1' ' A' ' 83' ' ' ASP . 5.9 tp60 -65.92 -32.22 73.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.682 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.603 HG11 ' O ' ' A' ' 78' ' ' PHE . 1.9 p -75.37 -11.67 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.083 0.468 . . . . 0.0 110.982 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.0 m -86.95 -45.92 10.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.195 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.519 ' OD1' ' HA ' ' A' ' 80' ' ' GLN . 5.1 p-10 -80.7 -12.59 59.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.245 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.99 -41.56 96.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.919 0.39 . . . . 0.0 110.975 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.603 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -97.73 -11.86 22.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.126 -179.435 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.489 ' HE1' ' HA ' ' A' ' 95' ' ' LEU . 18.4 t80 -68.43 -25.65 65.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.902 0.382 . . . . 0.0 110.732 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -69.18 -9.72 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.657 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.97 -8.88 71.81 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.21 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.87 134.14 3.3 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.786 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.05 69.54 7.88 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.829 2.352 . . . . 0.0 111.945 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 94' ' ' ARG . 21.5 t30 -68.87 171.86 7.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.849 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.624 ' HH2' ' HB1' ' A' ' 158' ' ' ALA . 1.9 m-90 -46.43 -71.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 1.017 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -79.43 -15.98 78.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.555 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.59 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -61.97 -45.29 94.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.489 ' HA ' ' HE1' ' A' ' 86' ' ' PHE . 37.2 tp -68.65 -37.45 79.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.558 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.412 HG13 ' HA ' ' A' ' 48' ' ' ALA . 74.7 t -62.01 -53.02 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.697 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.32 -43.82 96.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.509 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -62.19 -41.94 98.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 0.0 110.849 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.552 ' HE2' ' HG3' ' A' ' 45' ' ' MET . 10.9 t80 -71.02 -47.67 57.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.649 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.12 -31.27 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.456 ' HE2' HD21 ' B' ' 209' ' ' LEU . 0.8 OUTLIER -57.47 -54.42 47.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.895 0.378 . . . . 0.0 110.181 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.81 -43.49 96.08 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.094 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.05 95.53 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.68 -46.2 76.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.704 0.288 . . . . 0.0 111.043 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 41.4 m -64.36 -46.29 84.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.459 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.03 75.26 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.014 0.435 . . . . 0.0 110.16 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.17 -44.12 84.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.735 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.577 ' HB2' HG23 ' A' ' 118' ' ' VAL . 6.3 m -66.66 -36.5 82.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.487 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.534 HG12 HD11 ' A' ' 21' ' ' LEU . 43.4 t -63.56 -43.97 98.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.05 0.453 . . . . 0.0 110.2 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -68.49 -23.09 64.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.793 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -94.7 13.5 24.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.448 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 60.06 45.22 12.21 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.66 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.558 ' O ' HG22 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -124.79 56.8 1.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.18 0.514 . . . . 0.0 109.811 178.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.09 -29.35 68.52 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.837 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 t -56.32 -51.63 61.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.119 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.33 -35.68 76.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.805 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.577 HG23 ' HB2' ' A' ' 109' ' ' SER . 55.3 t -59.25 -45.11 93.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 0.0 110.593 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.75 -38.04 94.04 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.786 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -63.21 -48.86 76.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 110.384 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.94 -43.86 96.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.469 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -44.4 97.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.659 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.86 -47.49 84.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.485 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -62.54 -44.88 95.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.912 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.5 ttt -60.3 -52.47 65.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.548 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.45 -44.4 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.93 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.89 94.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.428 ' OH ' ' HD3' ' A' ' 132' ' ' ARG . 44.7 t80 -59.59 -38.84 82.29 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.565 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 21.3 mt -63.6 -32.46 73.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.879 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -95.89 -0.85 50.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.422 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.6 m -105.19 -64.13 1.16 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.428 ' HD3' ' OH ' ' A' ' 128' ' ' TYR . 25.1 ttt180 -102.84 -22.52 13.86 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 69.1 mt -101.37 15.12 29.84 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.517 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.1 -50.54 72.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.296 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.07 -41.03 87.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.477 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 89.8 m95 -57.91 -51.59 69.01 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.41 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.51 HG21 ' HA2' ' A' ' 142' ' ' GLY . 26.0 mm -62.73 -37.99 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.353 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -65.47 -36.15 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.916 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.3 m -73.46 -33.61 64.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.162 0.506 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.1 m -85.42 -5.2 59.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.98 42.07 96.99 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.51 ' HA2' HG21 ' A' ' 137' ' ' ILE . . . 75.93 -100.33 1.34 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -120.23 14.23 12.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.153 0.501 . . . . 0.0 109.769 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.97 93.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.245 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.512 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -77.62 -17.93 57.28 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.05 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.634 ' HE2' ' HB1' ' A' ' 44' ' ' ALA . 28.3 t80 -63.29 -32.65 74.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.902 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -38.14 68.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.001 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.3 -28.02 23.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.593 ' HB3' ' HA ' ' A' ' 92' ' ' TRP . 62.7 mt -56.02 -53.87 51.67 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.059 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -100.47 10.79 40.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.239 0.542 . . . . 0.0 110.477 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -91.82 23.16 27.41 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.052 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -152.92 -178.96 7.24 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 162.86 -36.85 0.34 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -101.66 -34.45 9.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.728 0.299 . . . . 0.0 111.181 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 18.4 tp -80.42 -28.19 37.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.072 0.463 . . . . 0.0 109.854 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -65.28 144.57 57.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.855 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -149.39 40.66 0.86 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.599 0.714 . . . . 0.0 110.651 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.624 ' HB1' ' HH2' ' A' ' 92' ' ' TRP . . . -93.17 -32.64 14.33 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.447 ' CG ' ' HZ3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -151.03 9.92 0.59 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.694 178.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.437 ' HD2' HG13 ' B' ' 220' ' ' ILE . 2.8 tmm_? -59.21 -70.33 0.16 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.65 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.435 HD12 HD11 ' B' ' 220' ' ' ILE . 14.9 tp -90.36 49.39 1.68 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.234 0.54 . . . . 0.0 109.766 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -116.09 110.86 19.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.976 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.24 158.5 17.41 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.771 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 142.47 -47.63 0.81 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -152.45 121.12 6.46 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -115.17 -33.77 5.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.884 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -114.43 -62.0 1.66 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.5 p -173.95 -63.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.285 0.564 . . . . 0.0 109.749 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.6 m -89.51 -4.01 10.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.999 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.947 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . 0.432 ' HB ' ' H ' ' B' ' 202' ' ' ILE . 4.9 pt . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.706 0.288 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.432 ' H ' ' HB ' ' B' ' 201' ' ' ILE . 24.0 mt -68.98 106.84 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.603 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -62.53 -32.78 73.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.979 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -51.09 -42.73 60.81 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.156 0.285 . . . . 0.0 111.519 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' B' ' 208' ' ' HIS . 21.8 mt -68.39 -42.6 84.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.86 0.362 . . . . 0.0 110.334 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -61.34 -45.86 92.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.527 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' ARG . . . . . 0.603 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 42.1 ttp85 -64.53 -35.36 80.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.819 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' HIS . . . . . 0.412 ' HB3' ' O ' ' B' ' 205' ' ' ILE . 3.8 t60 -57.37 -51.03 71.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.925 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.4 pp -74.48 -36.18 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.351 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -62.28 -47.27 85.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.025 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.29 -39.92 93.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.731 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.59 -52.22 60.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.508 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.85 -40.2 98.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.828 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . 1.017 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 1.3 t0 -64.4 -55.77 18.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.018 0.437 . . . . 0.0 111.479 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.6 m -66.57 -33.83 76.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' MET . . . . . . . . . . . . . 20.7 tpp -73.38 -48.74 31.63 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.91 -41.5 95.52 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.849 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . 0.475 ' HD3' ' HA ' ' B' ' 218' ' ' ARG . 0.0 OUTLIER -75.28 -21.9 58.17 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.979 179.185 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' SER . . . . . 0.411 ' OG ' ' HD2' ' A' ' 55' ' ' ARG . 57.6 m 57.85 -164.58 0.18 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.973 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.437 HG13 ' HD2' ' A' ' 160' ' ' ARG . 12.1 tt . . . . . 0 C--O 1.246 0.897 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.176 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.87 0.367 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.4 111.05 15.16 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.747 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.23 134.23 24.51 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.716 2.277 . . . . 0.0 111.485 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.29 115.17 28.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.652 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 m -70.61 120.6 16.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.194 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.598 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -88.54 -51.82 0.38 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.557 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 31.5 Cg_exo -62.58 136.72 60.12 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.078 1.852 . . . . 0.0 112.108 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.99 154.62 40.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.557 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m -63.47 -34.53 77.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.782 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -72.64 -26.8 61.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.811 0.338 . . . . 0.0 110.157 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.99 89.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.156 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.64 -44.18 96.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.556 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.3 t -63.17 -44.72 99.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.114 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.8 -37.12 85.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -68.65 -42.66 77.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.172 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -62.59 -51.61 66.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.393 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.63 -45.41 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.327 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.66 -42.78 99.81 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.778 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.638 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 1.8 t80 -63.71 -45.21 91.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -60.39 -34.82 74.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.593 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.1 tp -70.73 -25.22 62.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.26 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.4 mtm-85 -85.92 -35.56 20.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.56 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.653 ' HA ' HG22 ' A' ' 27' ' ' VAL . 10.1 mm100 -64.12 -25.59 68.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.476 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -84.43 -3.88 58.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.815 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -132.65 -88.54 0.39 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.722 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -113.56 97.52 6.5 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 23' ' ' GLN . 75.0 t -62.72 115.72 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.057 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.89 97.87 5.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.527 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.457 ' HA3' ' OH ' ' A' ' 19' ' ' TYR . . . -176.82 165.13 35.08 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.82 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.93 123.98 46.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.735 0.302 . . . . 0.0 110.432 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.31 121.09 8.05 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.609 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -89.08 106.13 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.419 2.746 . . . . 0.0 111.383 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.44 -70.11 0.9 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.015 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -120.46 64.73 0.84 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.277 0.56 . . . . 0.0 110.316 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.02 99.61 0.24 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.116 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.3 109.15 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.845 2.363 . . . . 0.0 112.183 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.72 139.08 34.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.421 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.533 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -72.45 -24.32 61.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.681 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -94.16 106.84 24.86 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.974 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 90.6 Cg_endo -95.85 -6.48 1.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.825 2.35 . . . . 0.0 111.74 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.8 mt -65.66 -50.95 63.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.878 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -64.46 -37.88 89.09 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.952 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -69.3 -41.67 76.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.67 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.09 90.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.8 ttt -63.26 -43.24 98.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.714 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -62.48 -46.41 88.59 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.41 87.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.5 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.68 -38.19 69.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.953 0.406 . . . . 0.0 111.812 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.65 27.69 12.94 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.501 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -143.11 -51.9 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.719 ' HA ' HG22 ' A' ' 54' ' ' THR . 41.3 mm-40 -64.11 -35.57 81.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.777 0.322 . . . . 0.0 110.46 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -66.75 -10.96 52.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.783 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.637 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 7.3 tp10 -107.45 -49.94 3.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.667 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.719 HG22 ' HA ' ' A' ' 51' ' ' GLU . 2.0 t -64.67 -31.48 72.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.761 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 55' ' ' ARG . 22.1 mtm180 -94.36 9.83 36.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.081 0.467 . . . . 0.0 110.39 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.946 ' HA ' ' HG2' ' B' ' 216' ' ' MET . 49.7 t80 -107.28 -82.89 0.54 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.642 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.44 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 5.1 mtm105 167.3 -65.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.765 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -153.35 72.2 0.92 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.924 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.637 ' OG1' ' HA ' ' A' ' 53' ' ' GLU . 2.5 m -62.81 -41.58 99.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.024 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.26 20.87 1.52 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.348 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.599 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . 51.9 m -153.2 -77.03 0.12 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -56.72 -44.17 81.36 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 38.4 tp -62.89 -43.49 98.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.859 0.361 . . . . 0.0 110.343 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -66.55 -34.9 78.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.597 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.29 -44.05 72.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.515 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -74.36 -25.74 59.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.867 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -83.82 -17.92 39.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.122 0.487 . . . . 0.0 110.133 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 3.2 t-80 -76.45 -14.14 60.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.39 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.88 -32.88 56.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.305 0.574 . . . . 0.0 109.545 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.58 140.28 55.39 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.881 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.14 99.29 0.16 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.865 2.377 . . . . 0.0 112.257 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.7 -149.49 15.1 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.282 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.814 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 49.0 m -158.22 -157.73 0.66 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.3 -156.92 0.1 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.019 0.438 . . . . 0.0 111.561 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.591 ' HG3' HD22 ' A' ' 117' ' ' LEU . 4.4 mm-40 -56.8 -30.11 63.38 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -66.04 -22.85 66.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.691 0.282 . . . . 0.0 111.434 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.814 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 21.4 tpp85 -85.1 -36.68 20.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.713 0.292 . . . . 0.0 110.444 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -69.9 -31.25 68.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.512 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.96 -20.48 57.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.711 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -111.48 5.37 19.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.718 0.295 . . . . 0.0 111.656 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.8 p -100.59 -14.36 7.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.384 0.611 . . . . 0.0 110.322 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.69 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -85.36 -41.52 15.4 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.535 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.36 -13.96 57.75 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.389 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' B' ' 206' ' ' ALA . 3.6 tp10 -54.96 -41.73 71.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.886 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' B' ' 206' ' ' ALA . 0.3 OUTLIER -106.42 32.76 4.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.134 0.492 . . . . 0.0 110.495 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -121.27 -36.02 3.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.528 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -62.42 -31.05 71.68 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.223 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.74 1.48 86.02 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.7 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.78 117.51 1.58 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.678 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.09 164.56 24.66 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.879 2.386 . . . . 0.0 112.037 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.429 ' HB3' ' HB2' ' A' ' 94' ' ' ARG . 24.1 t30 -148.25 169.0 21.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.618 ' HA ' HD23 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -50.04 -61.56 2.08 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.808 0.692 . . . . 0.0 112.213 -178.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.94 -4.83 84.28 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.063 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 4.2 tpp85 -65.29 -45.77 83.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.726 0.298 . . . . 0.0 110.558 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.4 tp -67.62 -37.8 83.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.135 0.493 . . . . 0.0 110.058 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.489 HG23 ' HE1' ' A' ' 146' ' ' PHE . 3.1 t -65.92 -41.36 89.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.358 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.607 ' HA ' HG13 ' A' ' 100' ' ' VAL . . . -62.21 -39.46 92.83 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.057 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.69 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 66.1 t80 -61.61 -37.08 82.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.167 0.508 . . . . 0.0 110.302 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -79.69 -46.89 16.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.345 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.607 HG13 ' HA ' ' A' ' 97' ' ' ALA . 4.4 p -61.7 -34.02 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.41 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -64.35 -50.93 65.79 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.909 0.385 . . . . 0.0 110.006 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.98 98.59 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.881 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.05 83.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.614 0.245 . . . . 0.0 111.484 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.28 79.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.656 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.456 ' HB3' ' NE2' ' A' ' 75' ' ' GLN . 3.6 mm? -62.71 -38.78 91.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.361 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.7 m -72.66 -43.53 63.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.569 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.1 -37.65 77.67 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.101 0.477 . . . . 0.0 110.424 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.64 -43.68 88.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.787 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 114' ' ' MET . 21.5 m -68.43 -43.87 76.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.251 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.0 t -59.4 -37.37 69.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.017 0.437 . . . . 0.0 110.403 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -63.61 -29.15 70.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.839 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.9 mtpt -99.04 17.14 20.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.099 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 59.8 34.76 21.94 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.546 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.457 ' HB3' ' HB3' ' A' ' 109' ' ' SER . 0.0 OUTLIER -100.47 66.6 1.26 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.953 0.406 . . . . 0.0 110.169 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.07 -28.78 67.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.943 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 22.3 t -58.39 -51.14 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.003 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.591 HD22 ' HG3' ' A' ' 75' ' ' GLN . 14.1 tp -68.34 -39.69 81.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.984 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 114' ' ' MET . 87.7 t -59.49 -43.9 91.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.86 99.25 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.745 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 70.0 mt-30 -63.21 -50.9 68.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.624 0.25 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.28 -48.12 88.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.298 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -45.81 91.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.745 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -62.02 -42.8 99.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.246 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -60.62 -46.46 90.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.806 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 88.8 mtp -59.0 -50.94 72.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.975 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.48 -41.27 87.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.936 0.398 . . . . 0.0 110.907 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.3 -51.83 61.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.574 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.41 -42.56 87.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.215 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 36.7 mt -61.8 -26.34 68.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.102 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -107.89 3.71 24.59 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.675 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.0 m -107.41 -50.56 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -122.05 -18.7 6.85 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.893 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.667 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 83.8 mt -101.69 3.9 40.14 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.631 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.64 87.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.947 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.66 -39.7 81.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.209 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.667 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 91.8 m95 -68.09 -54.43 18.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.372 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.479 HG21 ' HA2' ' A' ' 142' ' ' GLY . 42.0 mm -56.73 -37.38 52.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.301 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -59.5 -45.11 92.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.237 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.4 m -77.51 -33.29 54.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 67.0 m -74.98 -3.24 31.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.67 39.66 96.91 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.479 ' HA2' HG21 ' A' ' 137' ' ' ILE . . . 72.04 -94.17 0.61 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -120.68 17.53 11.96 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.57 -51.56 66.86 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.54 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.61 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 4.2 pt-20 -78.21 -20.97 50.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.915 0.388 . . . . 0.0 110.5 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.489 ' HE1' HG23 ' A' ' 96' ' ' VAL . 91.5 t80 -61.25 -40.96 96.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.222 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.522 ' HA ' ' CE1' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -60.33 -33.45 72.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 110.831 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.23 -34.58 42.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.549 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.618 HD23 ' HA ' ' A' ' 92' ' ' TRP . 81.3 mt -57.38 -50.34 73.3 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.05 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.522 ' CE1' ' HA ' ' A' ' 147' ' ' THR . 5.6 p90 -86.15 -6.49 58.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.089 0.471 . . . . 0.0 110.229 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.65 -25.37 60.79 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -117.2 84.63 2.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.169 0.509 . . . . 0.0 109.844 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.29 23.75 1.88 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.208 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -116.61 65.04 0.71 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.156 0.503 . . . . 0.0 110.5 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 80.1 mt -80.71 -78.55 0.17 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.734 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.602 ' HB3' HH21 ' A' ' 159' ' ' ARG . 0.3 OUTLIER -109.62 89.91 3.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.373 0.606 . . . . 0.0 110.264 179.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -110.91 16.9 21.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.719 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -94.84 -56.47 2.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.648 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.602 HH21 ' HB3' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -98.77 12.99 33.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 111.07 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.04 142.23 47.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.245 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 16.1 tp -63.34 116.51 5.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.185 0.517 . . . . 0.0 111.975 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -99.58 -38.56 8.7 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.03 177.08 8.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.079 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -127.29 168.6 19.34 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.073 -1.06 . . . . 0.0 113.417 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -111.94 140.42 46.62 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -103.08 -64.76 1.05 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.834 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -145.05 25.22 1.42 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.869 0.366 . . . . 0.0 111.828 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.5 m -96.53 159.29 15.02 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.47 62.65 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.422 0.63 . . . . 0.0 110.617 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.568 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . 0.556 HG23 HG13 ' B' ' 202' ' ' ILE . 52.0 mt . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.859 0.361 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.556 HG13 HG23 ' B' ' 201' ' ' ILE . 44.9 mt -144.01 111.17 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -64.73 -34.26 77.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.332 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -53.91 -48.11 70.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 38.1 mt -62.6 -48.43 88.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.677 0.275 . . . . 0.0 110.97 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . 0.489 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -62.28 -43.15 99.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.626 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -35.86 75.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.121 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.99 -55.18 35.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.864 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.3 pp -68.65 -38.03 80.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.643 0.259 . . . . 0.0 111.642 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -65.66 -51.36 60.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -59.12 -52.09 67.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.448 ' O ' ' HB2' ' B' ' 216' ' ' MET . 57.2 t -64.29 -47.85 87.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.683 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.97 -50.66 56.88 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.92 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' B' ' 210' ' ' ALA . 0.9 OUTLIER -61.33 -46.99 87.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 15.9 m -67.18 -34.98 78.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.728 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' MET . . . . . 0.946 ' HG2' ' HA ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -68.83 -46.89 67.4 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.707 -179.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.66 -34.15 77.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.996 0.427 . . . . 0.0 110.503 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.58 -9.84 58.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.165 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 6.3 m 63.95 59.25 1.12 Allowed 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.602 0.563 . . . . 0.0 110.85 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.826 -0.607 . . . . 0.0 110.231 179.575 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.753 0.311 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.8 m -109.66 108.3 59.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.004 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.34 114.61 3.78 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.279 1.986 . . . . 0.0 111.567 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.41 130.32 42.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.528 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 m -88.13 120.7 29.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.647 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -84.4 -53.68 0.5 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.647 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 21.5 Cg_exo -66.13 125.72 14.57 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.119 1.879 . . . . 0.0 113.156 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.79 159.74 30.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.25 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -41.46 82.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.771 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 10' ' ' ARG . 0.6 OUTLIER -69.73 -32.6 71.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.713 0.292 . . . . 0.0 110.87 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.72 -40.65 92.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.34 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.8 -40.87 92.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.027 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.632 ' HA ' ' HE2' ' A' ' 45' ' ' MET . 77.0 t -64.59 -42.53 95.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.261 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.55 -42.96 89.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.512 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.26 -37.85 86.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.0 -48.08 69.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.74 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.93 -43.39 97.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.166 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.71 98.35 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.402 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.531 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 23.3 t80 -62.81 -42.83 99.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -60.01 -36.22 76.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 0.0 110.432 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.2 tp -72.69 -28.32 62.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.232 0.539 . . . . 0.0 110.216 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 73.8 mtm-85 -80.77 -26.97 36.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.892 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 16.0 mm100 -64.35 -28.26 69.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.327 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -92.37 6.64 46.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.937 0.398 . . . . 0.0 110.789 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.83 -93.92 0.46 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -119.7 108.69 14.75 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.66 113.99 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.962 0.411 . . . . 0.0 110.396 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t -124.2 99.24 6.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.369 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.98 -132.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.538 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.7 149.64 27.72 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.96 112.33 3.43 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.036 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 88.85 1.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.55 2.167 . . . . 0.0 111.877 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.72 -129.22 5.58 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -85.09 68.73 10.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.066 0.46 . . . . 0.0 110.861 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.13 103.74 0.44 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.078 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.12 116.87 3.48 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.95 2.433 . . . . 0.0 112.383 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.52 152.64 18.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.077 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.63 -31.07 32.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.215 0.531 . . . . 0.0 109.981 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -107.92 126.0 30.8 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.196 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 39' ' ' ASP . 57.6 Cg_endo -97.2 4.63 1.58 Allowed 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.074 2.516 . . . . 0.0 111.089 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.9 mt -71.15 -46.87 60.63 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.132 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -61.39 -32.91 72.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.212 0.53 . . . . 0.0 110.084 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -78.69 -38.54 39.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.569 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.498 ' HB1' ' HE2' ' A' ' 146' ' ' PHE . . . -64.24 -41.7 96.87 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.499 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.632 ' HE2' ' HA ' ' A' ' 13' ' ' VAL . 1.9 ttt -63.32 -38.36 90.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.943 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -68.24 -48.78 64.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.264 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.59 -43.71 84.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.447 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.46 -42.34 64.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.39 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.6 40.18 2.64 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.614 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -155.62 -42.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 41.5 mm-40 -58.78 -78.41 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.471 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 4.5 p90 -64.15 -21.9 66.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.703 0.287 . . . . 0.0 110.668 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 32.1 tp10 -63.55 -52.98 58.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.547 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 m -74.92 -29.56 61.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.584 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.412 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 15.9 mtm-85 -71.22 -17.2 62.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.478 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -102.96 -74.79 0.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.232 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ttm105 177.36 -69.38 0.01 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.999 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.94 58.75 0.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.917 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.696 HG23 HD11 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -57.11 -25.67 59.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.245 -178.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -53.95 -31.11 49.46 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 111.007 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.01 -29.62 5.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 18.0 t70 -69.04 -30.23 68.55 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.696 HD11 HG23 ' A' ' 59' ' ' THR . 5.5 tp -55.65 -38.07 69.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 111.218 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.93 -11.75 56.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.0 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.27 -47.08 8.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.995 0.426 . . . . 0.0 110.618 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 8.3 pt20 -66.98 -30.62 70.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.106 0.479 . . . . 0.0 110.142 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.455 HD22 ' HG3' ' A' ' 66' ' ' GLN . 1.1 mm? -96.73 14.7 24.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.211 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.73 -9.53 58.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.054 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.71 -36.07 75.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.96 129.69 35.0 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.359 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.67 117.02 3.39 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.826 2.35 . . . . 0.0 112.325 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.43 -159.04 21.99 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.159 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.0 m -143.18 -130.64 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -99.05 -153.99 0.45 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.341 0.115 . . . . 0.0 110.719 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.595 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 2.4 mm-40 -56.51 -33.16 65.75 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.422 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.448 ' HG3' ' CZ3' ' A' ' 124' ' ' TRP . 22.9 mp0 -56.58 -28.47 60.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.617 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -83.13 -9.66 59.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.043 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.51 ' O ' HG11 ' A' ' 81' ' ' VAL . 30.8 m-85 -108.59 -43.24 4.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.714 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.25 -30.17 68.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.76 0.314 . . . . 0.0 111.785 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.476 ' HB3' HD12 ' B' ' 201' ' ' ILE . 6.7 tp60 -100.95 12.13 38.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.959 0.409 . . . . 0.0 111.314 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.51 HG11 ' O ' ' A' ' 78' ' ' PHE . 2.1 p -109.27 -14.07 10.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.286 0.565 . . . . 0.0 110.288 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.631 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -81.26 -36.99 29.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.81 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -77.65 -20.28 54.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -53.81 -42.89 68.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.703 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.737 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -95.02 5.92 50.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.26 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -100.86 -36.52 9.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.423 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -52.32 -39.24 60.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.591 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.76 34.2 5.11 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.498 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.524 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . 175.94 83.34 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.837 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.469 ' HG3' ' CZ3' ' A' ' 136' ' ' TRP . 4.8 Cg_exo -79.85 53.01 4.54 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.223 2.615 . . . . 0.0 111.688 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -71.68 164.9 25.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.617 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.838 ' HD1' HD23 ' A' ' 149' ' ' LEU . 2.2 m-90 -53.89 -58.02 8.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.755 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.65 -14.13 79.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.26 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 6.7 tpp85 -66.79 -47.78 71.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.748 0.309 . . . . 0.0 110.586 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.408 HD22 ' CD1' ' A' ' 146' ' ' PHE . 26.3 tp -64.86 -36.06 83.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.741 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.7 t -62.97 -50.93 77.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.264 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.467 ' HA ' HG13 ' A' ' 100' ' ' VAL . . . -60.2 -42.49 95.22 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.458 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.631 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 52.5 t80 -62.69 -45.21 93.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.081 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -72.11 -42.53 65.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.912 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.467 HG13 ' HA ' ' A' ' 97' ' ' ALA . 3.9 p -70.46 -27.98 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.602 ' HE2' HD13 ' B' ' 209' ' ' LEU . 0.2 OUTLIER -57.53 -50.69 72.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 110.444 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.1 -43.26 97.48 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.862 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -46.77 88.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.467 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.15 -43.53 98.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.268 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.595 ' HB3' ' NE2' ' A' ' 75' ' ' GLN . 2.0 mm? -68.17 -39.34 82.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.984 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.2 m -67.2 -39.65 86.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.243 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.72 89.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.946 0.403 . . . . 0.0 110.291 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -41.24 82.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.855 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -67.55 -46.39 72.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.204 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.16 -40.3 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.894 0.378 . . . . 0.0 110.422 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -64.1 -26.8 68.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.415 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -96.03 9.87 39.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.148 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 68.73 15.88 8.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.197 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.45 ' O ' HG22 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -88.58 67.23 8.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.182 0.515 . . . . 0.0 110.481 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -71.53 -28.76 64.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.704 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -56.87 -46.61 83.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.578 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.6 tp -67.94 -43.62 78.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.923 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 114' ' ' MET . 64.0 t -56.98 -46.67 84.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.641 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.04 -35.12 82.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.726 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -77.25 -47.15 20.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.622 0.248 . . . . 0.0 110.572 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.47 -45.79 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.784 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -61.36 -44.42 97.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.677 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -63.69 -40.04 95.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.165 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.448 ' CZ3' ' HG3' ' A' ' 76' ' ' GLN . 13.1 m0 -59.93 -44.52 94.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.635 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 85.1 mtp -60.65 -51.91 67.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.175 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.68 -44.55 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.77 0.319 . . . . 0.0 111.263 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.26 -44.97 96.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -60.85 -42.88 98.7 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.626 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.487 HD23 HD11 ' A' ' 133' ' ' LEU . 68.8 mt -62.84 -31.81 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.4 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -92.46 11.4 26.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 111.629 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.0 m -122.92 -70.0 0.8 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.606 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -85.35 -33.89 21.93 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.487 HD11 HD23 ' A' ' 129' ' ' LEU . 48.0 mt -102.47 16.58 25.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.268 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.12 -48.5 79.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 110.733 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.61 -36.83 84.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.321 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.469 ' CZ3' ' HG3' ' A' ' 90' ' ' PRO . 11.3 m95 -61.02 -55.37 33.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.392 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.412 HG21 ' HA2' ' A' ' 142' ' ' GLY . 46.7 mm -59.55 -39.9 80.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.685 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -63.37 -41.64 98.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.159 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.5 m -71.54 -37.73 71.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.375 . . . . 0.0 111.173 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.608 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 65.4 m -81.19 -6.3 58.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.812 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.46 43.32 96.86 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.004 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 137' ' ' ILE . . . 78.95 -113.62 3.71 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.327 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -110.49 17.97 20.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.997 0.427 . . . . 0.0 110.379 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.66 -60.37 3.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.432 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.608 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 5.9 pt-20 -68.5 -27.49 66.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 110.643 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.617 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 73.7 t80 -61.88 -35.79 79.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.049 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.769 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 27.7 m -62.8 -24.82 67.93 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.569 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.98 -24.0 22.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.122 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.838 HD23 ' HD1' ' A' ' 92' ' ' TRP . 29.8 mt -62.58 -47.64 82.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 110.819 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.769 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 11.1 p90 -96.29 12.67 30.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.301 0.572 . . . . 0.0 110.096 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.88 -23.73 63.47 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.11 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -117.51 173.46 6.7 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -131.61 79.92 0.35 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.947 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.1 132.09 50.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.75 0.309 . . . . 0.0 110.764 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.16 96.39 8.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.482 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.54 112.85 21.95 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -110.05 28.51 8.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.338 -178.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -104.76 -67.91 0.88 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.777 0.322 . . . . 0.0 111.285 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.569 HH22 ' HA ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -87.69 42.11 1.03 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.545 ' HD2' ' OXT' ' B' ' 220' ' ' ILE . 8.5 mtm180 -76.21 -175.64 3.25 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.847 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 72.5 mt -70.8 85.42 0.67 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.375 0.607 . . . . 0.0 111.831 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 160' ' ' ARG . 1.2 mpp_? -127.24 39.06 3.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.538 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -106.95 169.65 8.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.81 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.99 18.02 0.1 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.734 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -71.25 126.03 28.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.717 0.294 . . . . 0.0 110.646 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -150.97 -68.43 0.18 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -114.18 -125.02 0.28 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.832 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.1 -40.65 90.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.943 0.402 . . . . 0.0 110.882 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.2 m -95.63 154.26 3.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.781 0.324 . . . . 0.0 110.745 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.542 ' HB2' ' NH1' ' A' ' 170' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.894 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.226 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . 0.476 HD12 ' HB3' ' A' ' 80' ' ' GLN . 26.1 mt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.718 0.294 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 96.3 mt -143.1 114.81 2.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -61.38 -38.0 85.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.231 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -57.53 -44.38 85.06 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 111.665 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.65 -52.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.083 0.468 . . . . 0.0 110.493 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . 0.452 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -60.21 -40.72 91.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.078 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' ARG . . . . . 0.737 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 28.8 ttp-105 -63.47 -37.2 86.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.055 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -63.68 -49.64 72.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.209 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.602 HD13 ' HE2' ' A' ' 101' ' ' PHE . 1.5 pp -67.63 -37.91 83.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.738 0.304 . . . . 0.0 110.918 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -67.32 -44.47 79.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.081 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -59.67 -47.27 86.3 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 123.272 0.358 . . . . 0.0 111.008 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.38 -53.45 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.25 0.343 . . . . 0.0 111.349 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -43.55 98.14 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.149 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.52 -40.07 85.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.005 0.431 . . . . 0.0 111.751 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 51.0 m -75.34 -46.01 35.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -34.18 77.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . 34.5 t70 -75.16 -33.35 61.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.576 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.67 45.83 0.34 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 7.8 m 57.13 88.24 0.05 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.445 0.64 . . . . 0.0 111.884 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.569 ' HA ' HH22 ' A' ' 159' ' ' ARG . 15.5 tt . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.279 -0.867 . . . . 0.0 109.83 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.781 0.324 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 m -124.17 113.6 27.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.51 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.0 128.27 20.33 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.777 2.318 . . . . 0.0 111.834 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.83 122.4 45.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.69 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.7 m -96.85 112.47 24.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.935 0.398 . . . . 0.0 110.619 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.557 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -73.8 -50.06 5.81 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.605 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 31.3 Cg_exo -60.85 126.54 19.92 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.103 1.869 . . . . 0.0 112.256 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.42 155.29 39.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.74 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.9 -38.33 70.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.962 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -68.7 -23.92 64.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 111.006 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.66 -37.22 65.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -68.88 -38.82 79.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.771 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 82.8 t -60.96 -43.71 96.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.673 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.76 -27.4 67.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.623 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -69.94 -44.0 70.46 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -68.5 -45.97 70.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.41 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.49 -46.82 95.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.965 0.412 . . . . 0.0 110.162 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.06 97.31 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.435 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.67 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 6.7 t80 -60.83 -47.68 85.27 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -57.43 -39.27 75.87 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.642 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.452 HD12 ' HE3' ' A' ' 24' ' ' LYS . 24.3 tp -66.92 -32.97 74.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.449 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.3 mtm-85 -81.22 -29.38 34.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.188 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.67 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 12.8 mm100 -64.32 -26.82 68.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.63 0.252 . . . . 0.0 111.293 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.452 ' HE3' HD12 ' A' ' 21' ' ' LEU . 6.7 pttp -97.61 13.26 30.76 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.899 0.38 . . . . 0.0 111.372 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.15 -75.4 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -142.46 106.3 4.7 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.38 109.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.922 0.391 . . . . 0.0 110.796 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 37.8 m -110.31 122.93 48.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.048 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.43 -133.4 4.57 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.862 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' A' ' 32' ' ' PRO . . . -150.64 174.93 12.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.604 0.24 . . . . 0.0 110.638 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.87 99.19 1.41 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.792 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 30' ' ' ALA . 4.9 Cg_exo -76.7 89.97 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.816 2.344 . . . . 0.0 112.103 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.19 -74.53 0.95 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.471 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.92 108.23 19.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.956 0.408 . . . . 0.0 110.069 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.54 95.8 0.11 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.576 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.97 112.14 1.43 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.931 2.42 . . . . 0.0 112.109 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.29 153.16 17.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.212 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.21 -28.62 48.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.031 0.443 . . . . 0.0 110.013 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.31 110.18 59.13 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.88 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -103.91 10.72 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.557 2.838 . . . . 0.0 112.199 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 143' ' ' TRP . 59.3 mt -72.11 -45.59 60.0 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -66.09 -38.47 88.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -67.73 -39.37 84.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.259 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.6 98.45 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.253 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 46.3 mtt -62.87 -44.68 95.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.162 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.532 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 6.7 tmm_? -65.06 -43.98 90.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.143 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.72 79.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.286 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.67 89.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.058 0.456 . . . . 0.0 110.328 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.07 22.66 30.66 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.773 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 3.2 t0 -126.8 -61.06 1.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.555 0.217 . . . . 0.0 110.967 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.769 ' HA ' HG22 ' A' ' 54' ' ' THR . 76.0 mm-40 -63.0 -41.81 99.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.032 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.476 ' HA ' ' OD1' ' B' ' 217' ' ' ASP . 51.3 t80 -58.73 -29.28 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.972 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -91.24 -40.89 11.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.398 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.769 HG22 ' HA ' ' A' ' 51' ' ' GLU . 12.6 t -70.02 -32.42 70.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 51' ' ' GLU . 21.8 mtm180 -85.07 -22.19 29.05 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 110.514 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.606 ' HA ' ' HG2' ' B' ' 216' ' ' MET . 36.3 t80 -80.08 -82.47 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 56' ' ' PHE . 9.8 ttm105 165.82 -68.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 O-C-N 123.993 0.808 . . . . 0.0 109.264 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.449 ' HD3' ' OG ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -159.42 72.45 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.056 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 m -56.47 -34.77 67.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.478 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -65.24 -15.5 62.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.584 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.449 ' OG ' ' HD3' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -118.88 -53.96 2.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.733 0.302 . . . . 0.0 111.792 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.7 -68.79 0.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.176 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.547 ' HA ' ' HG2' ' A' ' 66' ' ' GLN . 9.7 tp -57.88 -42.65 85.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.564 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -61.53 -29.79 70.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.046 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.74 -44.44 10.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 8.1 pt20 -65.37 -31.79 73.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.758 0.313 . . . . 0.0 111.27 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.767 ' HG ' ' HB3' ' B' ' 209' ' ' LEU . 2.2 mm? -87.87 -4.62 58.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.959 0.409 . . . . 0.0 110.757 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 4.7 t-80 -88.0 -10.94 48.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.778 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.1 t -75.17 -33.93 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.522 0.677 . . . . 0.0 109.595 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.46 148.42 85.74 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.185 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.83 94.98 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.577 2.185 . . . . 0.0 112.213 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.43 -147.42 14.61 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.306 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.656 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 66.4 m -162.31 -159.7 0.61 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.461 0.304 . . . . 0.0 110.217 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.04 -160.7 0.25 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.679 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.812 ' HG3' HD22 ' A' ' 117' ' ' LEU . 11.8 mm-40 -58.28 -27.51 64.11 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -63.58 -25.3 68.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.842 0.353 . . . . 0.0 110.592 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.656 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 13.1 tpp85 -88.95 -34.95 16.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.071 0.462 . . . . 0.0 109.937 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -67.74 -32.65 73.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.546 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 p -81.47 7.36 12.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.83 0.348 . . . . 0.0 111.502 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -127.09 -41.31 1.79 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.157 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.511 HG23 HG22 ' B' ' 202' ' ' ILE . 9.9 p -55.56 -29.22 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.479 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -74.22 -46.15 43.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.109 0.481 . . . . 0.0 110.974 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.01 -33.74 75.19 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.207 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.44 ' HB3' ' O ' ' B' ' 202' ' ' ILE . 8.2 mm-40 -53.88 -31.77 50.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.369 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.699 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -103.37 -14.52 16.24 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.813 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -70.53 -43.27 69.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.134 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -77.28 -2.16 33.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.176 0.513 . . . . 0.0 110.741 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -106.33 16.18 41.9 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . 148.23 85.95 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -74.64 70.81 4.92 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 123.059 2.506 . . . . 0.0 112.746 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -82.61 173.15 12.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.38 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.529 ' CD1' HD23 ' A' ' 149' ' ' LEU . 35.3 m0 -51.32 -62.63 1.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.556 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.25 -18.81 75.33 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.155 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 3.5 tpp85 -63.91 -46.46 84.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.428 HD22 ' CD1' ' A' ' 146' ' ' PHE . 39.3 tp -69.66 -35.33 75.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.089 0.471 . . . . 0.0 109.817 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.6 t -63.35 -44.98 99.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.022 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.629 ' HA ' HG13 ' A' ' 100' ' ' VAL . . . -63.2 -38.8 92.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.597 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.479 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 89.1 t80 -60.92 -40.83 94.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.419 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -76.26 -47.42 23.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.43 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.629 HG13 ' HA ' ' A' ' 97' ' ' ALA . 5.5 p -65.05 -30.52 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 1.2 t80 -61.08 -54.61 42.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.849 0.357 . . . . 0.0 110.231 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.62 -40.7 96.09 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.042 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.75 95.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.557 0.217 . . . . 0.0 111.459 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.31 75.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.112 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.505 ' HB3' HE22 ' A' ' 75' ' ' GLN . 1.7 mm? -61.58 -41.36 97.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.521 ' O ' HG22 ' A' ' 110' ' ' VAL . 30.2 m -66.44 -45.9 78.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.663 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.71 86.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.02 -42.66 99.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.993 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.2 m -67.04 -37.51 84.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.327 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 106' ' ' CYS . 76.7 t -62.89 -38.61 82.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.2 0.524 . . . . 0.0 110.095 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -73.08 -12.95 61.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.801 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -106.47 13.14 28.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.365 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 56.7 48.96 15.32 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.329 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.433 ' O ' HG22 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.02 61.27 0.9 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.105 0.478 . . . . 0.0 110.509 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -60.36 -30.48 69.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.034 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.8 t -59.24 -45.18 93.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.402 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.812 HD22 ' HG3' ' A' ' 75' ' ' GLN . 48.5 tp -72.04 -41.52 67.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.667 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 114' ' ' MET . 83.1 t -60.42 -48.91 86.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.235 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.84 -40.08 96.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.239 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -66.66 -47.54 72.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.525 0.203 . . . . 0.0 110.671 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 125' ' ' MET . 64.6 t -59.46 -45.96 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.726 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.2 -45.4 93.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -63.28 -42.3 99.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -61.31 -38.34 86.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 121' ' ' VAL . 95.7 mtp -66.81 -48.67 68.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.258 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.06 -42.52 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.53 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.22 -43.67 83.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.476 ' CE1' ' HB3' ' A' ' 132' ' ' ARG . 0.2 OUTLIER -62.88 -41.84 99.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.414 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.62 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 91.3 mt -65.56 -31.39 72.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.657 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.27 -3.71 55.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.0 m -115.41 -88.93 0.57 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.476 ' HB3' ' CE1' ' A' ' 128' ' ' TYR . 64.2 ttt180 -72.47 -36.27 68.41 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.62 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 97.5 mt -89.71 14.66 11.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.727 0.298 . . . . 0.0 111.372 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.32 -55.27 29.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.844 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.97 -34.68 78.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.775 0.322 . . . . 0.0 110.87 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -59.37 -57.93 10.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.46 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 47.3 mm -61.69 -37.27 77.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.913 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -63.49 -42.0 98.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.461 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.8 m -76.71 -27.88 55.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.728 0.299 . . . . 0.0 111.279 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.431 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 70.3 m -85.04 -11.95 54.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.583 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.17 44.82 85.79 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.53 -100.84 0.85 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.59 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.518 ' HB2' HD23 ' A' ' 41' ' ' LEU . 84.2 m95 -116.78 15.15 15.36 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.65 -60.24 3.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.592 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.516 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 3.7 pt-20 -66.76 -28.23 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 110.579 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.495 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 74.0 t80 -62.07 -30.57 71.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.639 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 5.6 m -61.83 -28.34 69.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.216 0.531 . . . . 0.0 110.569 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.27 -26.64 18.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.773 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.529 HD23 ' CD1' ' A' ' 92' ' ' TRP . 24.4 mt -62.69 -53.85 48.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.15 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.639 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 1.5 p90 -84.3 17.8 2.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.951 0.405 . . . . 0.0 111.141 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.03 -31.09 62.24 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.862 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.83 168.58 17.83 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.575 -0.367 . . . . 0.0 110.463 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.95 18.57 0.4 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.121 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -122.62 -162.05 0.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.553 HD23 ' HB ' ' B' ' 220' ' ' ILE . 6.0 mp -77.4 86.35 3.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.94 0.4 . . . . 0.0 110.817 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.749 ' HB3' ' HG3' ' B' ' 218' ' ' ARG . 0.8 OUTLIER -77.0 124.48 27.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.174 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.585 ' HG2' ' HD3' ' A' ' 160' ' ' ARG . 20.7 mt-10 -120.64 18.7 11.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.227 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.555 ' HA ' ' HB3' ' A' ' 162' ' ' ARG . . . -62.65 -57.01 12.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.906 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.463 ' H ' ' HG3' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -83.09 -5.06 58.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.252 0.548 . . . . 0.0 110.408 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.585 ' HD3' ' HG2' ' A' ' 157' ' ' GLU . 8.3 ttt85 -87.64 -54.05 4.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.564 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 10.9 tp -159.19 43.06 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.239 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.555 ' HB3' ' HA ' ' A' ' 158' ' ' ALA . 0.2 OUTLIER -153.12 44.51 0.64 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.976 0.417 . . . . 0.0 111.076 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -79.92 -24.33 41.15 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.94 -152.87 39.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.163 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -101.31 142.4 32.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.763 0.316 . . . . 0.0 110.335 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -118.73 -41.84 2.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.909 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -147.8 -155.26 0.61 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.467 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -32.66 53.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.884 0.374 . . . . 0.0 110.819 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.9 m -71.08 -47.28 62.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.858 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.012 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . 0.543 HG13 HG12 ' B' ' 202' ' ' ILE . 13.9 pt . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.543 HG12 HG13 ' B' ' 201' ' ' ILE . 44.5 mm -104.09 114.7 44.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.861 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.3 -43.84 2.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.28 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -64.1 -54.81 28.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 0.0 111.135 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . 0.54 HG21 HD11 ' A' ' 67' ' ' LEU . 94.1 mt -63.15 -40.56 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.231 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 85' ' ' LEU . . . -61.64 -47.42 85.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.905 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' ARG . . . . . 0.699 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 74.3 ttt180 -65.94 -35.07 79.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.902 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' HIS . . . . . 0.702 ' HB3' HD12 ' A' ' 67' ' ' LEU . 3.3 t-80 -58.25 -51.92 67.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.762 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.767 ' HB3' ' HG ' ' A' ' 67' ' ' LEU . 1.2 pp -74.92 -38.44 61.81 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.733 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . 0.467 ' HB2' ' HD3' ' A' ' 94' ' ' ARG . . . -68.81 -48.26 64.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -69.41 -48.66 60.36 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 43.0 t -57.18 -43.76 82.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.812 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.74 -50.62 29.28 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.088 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 25.4 t0 -57.26 -44.58 84.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.449 0.3 . . . . 0.0 111.785 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 12.8 m -68.18 -36.22 79.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.714 0.292 . . . . 0.0 111.758 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' MET . . . . . 0.606 ' HG2' ' HA ' ' A' ' 56' ' ' PHE . 23.6 ttm -74.59 -40.81 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.76 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . 0.476 ' OD1' ' HA ' ' A' ' 52' ' ' PHE . 37.8 t70 -65.53 -34.27 77.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.455 0.645 . . . . 0.0 109.417 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . 0.749 ' HG3' ' HB3' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -75.16 -6.3 48.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.693 179.2 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 11.1 m 68.85 4.81 4.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.202 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.553 ' HB ' HD23 ' A' ' 155' ' ' LEU . 9.9 tp . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.61 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.87 0.366 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.7 m -127.86 106.11 20.48 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.122 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.85 122.54 9.91 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.885 2.39 . . . . 0.0 112.11 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.6 119.09 24.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.742 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.1 m -74.98 108.17 7.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.359 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.576 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -74.08 -51.93 4.57 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 25.8 Cg_exo -63.84 140.3 72.81 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.868 1.712 . . . . 0.0 113.007 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.446 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 22.2 t70 -81.4 151.83 27.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.377 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.61 -36.89 74.75 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -73.19 -37.96 66.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.879 0.371 . . . . 0.0 110.55 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 -33.4 75.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.166 0.508 . . . . 0.0 109.919 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' A' ' 41' ' ' LEU . 20.3 tp -64.32 -42.03 96.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.047 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.92 -40.17 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.963 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 -37.17 77.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.784 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.67 -37.3 86.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.346 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -67.87 -49.87 59.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.185 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.6 t -62.84 -44.73 99.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.107 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.13 -38.09 95.02 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.619 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.58 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 9.2 t80 -66.63 -43.09 85.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -61.44 -37.1 82.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.317 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.524 HD12 ' HE3' ' A' ' 24' ' ' LYS . 15.8 tp -65.63 -33.01 74.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.733 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.7 mtm-85 -79.42 -34.4 41.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.684 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 13.7 mm100 -61.19 -39.05 88.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.354 . . . . 0.0 111.181 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.524 ' HE3' HD12 ' A' ' 21' ' ' LEU . 11.6 pttp -84.77 2.57 41.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.177 0.513 . . . . 0.0 110.823 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.25 -108.33 1.07 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.44 ' HD1' ' SG ' ' A' ' 28' ' ' CYS . 17.3 t80 -101.67 105.19 16.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 23' ' ' GLN . 98.2 t -65.17 107.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.171 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.44 ' SG ' ' HD1' ' A' ' 26' ' ' TYR . 8.2 m -113.82 118.77 35.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.87 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.57 178.74 25.72 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.058 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.31 155.91 23.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.612 0.244 . . . . 0.0 110.609 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.55 106.86 3.27 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.774 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.95 109.13 1.04 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.932 2.422 . . . . 0.0 112.438 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.78 -118.27 2.57 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.876 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -85.66 66.8 9.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.274 0.559 . . . . 0.0 109.688 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.18 98.79 0.24 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.484 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.27 112.88 1.25 Allowed 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.9 2.4 . . . . 0.0 111.613 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.69 151.48 22.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.266 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.88 -34.03 51.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.927 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.65 120.47 46.18 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.002 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -102.33 16.79 0.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.602 2.868 . . . . 0.0 112.498 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.618 ' HB3' HD22 ' A' ' 12' ' ' LEU . 79.6 mt -68.76 -46.26 69.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.714 0.292 . . . . 0.0 111.494 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -70.0 -37.69 75.76 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -65.43 -39.66 92.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.379 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.21 86.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.627 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 36.5 mtt -64.93 -38.2 90.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.416 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -69.02 -30.02 68.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.753 179.272 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.82 -35.42 38.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.809 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.61 -41.82 67.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 111.024 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.89 37.41 3.44 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.056 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.07 -43.22 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 54' ' ' THR . 56.4 mm-40 -54.13 -63.99 0.97 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' A' ' 56' ' ' PHE . 1.2 p90 -64.94 -21.14 66.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.451 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.403 ' OE1' ' HA ' ' A' ' 53' ' ' GLU . 5.0 tp10 -80.93 -40.7 24.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 111.589 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 51' ' ' GLU . 4.0 t -70.62 -13.75 62.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.732 0.301 . . . . 0.0 111.385 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' B' ' 216' ' ' MET . 81.1 mtm-85 -113.93 6.79 16.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.752 0.31 . . . . 0.0 111.148 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.531 ' HB2' ' O ' ' A' ' 52' ' ' PHE . 2.1 t80 -116.16 -88.89 0.58 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.574 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.422 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 8.1 mtm105 -174.75 -83.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.174 0.511 . . . . 0.0 109.672 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.652 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -148.87 49.99 0.99 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.724 HG23 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -53.72 -28.66 35.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.985 -178.083 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -52.85 -31.06 37.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 110.99 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.92 -37.47 3.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.648 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 15.5 t70 -61.7 -39.14 90.43 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.444 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.724 ' HB2' HG23 ' A' ' 59' ' ' THR . 14.7 tp -61.83 -34.79 76.58 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.164 0.506 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.68 -32.6 41.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.315 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.54 -44.28 62.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.538 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 9.7 pt20 -65.34 -32.36 73.96 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.885 0.374 . . . . 0.0 110.64 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.71 -8.8 59.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.284 0.564 . . . . 0.0 110.109 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -12.97 46.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.02 -37.73 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.964 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -86.5 160.53 50.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.067 178.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.964 ' HD2' HG22 ' A' ' 70' ' ' THR . 10.9 Cg_endo -55.08 115.78 2.68 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.394 2.063 . . . . 0.0 112.146 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.42 -164.53 11.0 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.41 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 50.3 m -152.36 -155.28 0.6 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.87 -159.18 0.1 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.855 0.36 . . . . 0.0 111.617 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.56 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 1.9 mm-40 -50.27 -34.77 24.42 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.719 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -56.04 -36.43 67.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.356 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.441 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 22.4 tpp85 -72.7 -34.27 67.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.702 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.56 ' HD2' ' HA ' ' A' ' 75' ' ' GLN . 90.6 m-85 -69.15 -40.46 78.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.125 0.488 . . . . 0.0 110.328 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -68.54 -36.16 78.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.284 0.564 . . . . 0.0 110.172 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.823 ' HG2' HD11 ' B' ' 201' ' ' ILE . 22.5 tp60 -71.53 -42.55 67.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.941 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 78' ' ' PHE . 3.4 p -61.22 -20.72 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.039 0.447 . . . . 0.0 111.342 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -87.67 -46.63 9.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.959 0.409 . . . . 0.0 110.445 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -35.8 80.47 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.352 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.617 ' HG3' ' HG2' ' B' ' 203' ' ' LYS . 6.3 tp10 -49.42 -39.4 32.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.246 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.704 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.5 OUTLIER -105.54 3.41 29.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.813 0.34 . . . . 0.0 111.469 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.506 ' HE1' ' HA ' ' A' ' 95' ' ' LEU . 28.7 t80 -84.15 -37.48 21.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.53 -21.46 66.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.654 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.85 8.39 69.91 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.515 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.45 ' HA2' ' HD3' ' A' ' 90' ' ' PRO . . . 130.33 116.57 1.85 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.464 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.45 ' HD3' ' HA2' ' A' ' 89' ' ' GLY . 5.6 Cg_exo -75.35 65.2 6.37 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.375 2.716 . . . . 0.0 111.321 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -68.13 178.02 2.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.72 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.637 ' HE3' ' H ' ' A' ' 92' ' ' TRP . 1.4 m-90 -45.0 -72.47 0.06 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.529 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.46 68.35 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.197 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.5 tpp85 -66.65 -51.23 58.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.612 0.244 . . . . 0.0 110.62 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.506 ' HA ' ' HE1' ' A' ' 86' ' ' PHE . 25.3 tp -67.03 -36.08 81.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.966 0.412 . . . . 0.0 110.505 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.447 HG23 ' HE1' ' A' ' 146' ' ' PHE . 60.9 t -65.83 -54.33 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.821 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.722 ' HA ' HG13 ' A' ' 100' ' ' VAL . . . -61.03 -41.74 97.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.021 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -54.6 -36.56 64.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.535 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -90.86 -46.56 8.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.818 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.722 HG13 ' HA ' ' A' ' 97' ' ' ALA . 5.6 p -65.15 -37.15 79.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.441 ' HD1' ' HA ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -65.7 -45.4 82.91 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.105 -179.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.03 -45.6 95.76 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.61 98.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.215 . . . . 0.0 111.015 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.47 97.31 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.807 0.337 . . . . 0.0 111.208 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 105' ' ' LEU . 2.0 mm? -73.74 -39.69 64.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.29 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.43 ' O ' HG22 ' A' ' 110' ' ' VAL . 52.1 m -64.57 -42.18 95.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.391 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.35 -42.53 87.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.875 0.369 . . . . 0.0 110.348 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -42.65 98.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.476 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m -65.34 -37.1 86.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.545 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 106' ' ' CYS . 42.5 t -62.51 -44.85 99.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.274 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -66.01 -24.8 66.83 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.416 0.627 . . . . 0.0 110.177 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -89.54 5.24 46.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.101 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 66.98 18.57 10.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.696 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.423 ' O ' HG22 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -92.25 60.33 3.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.219 0.533 . . . . 0.0 109.584 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.78 -24.63 66.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.341 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.7 t -62.63 -47.31 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.024 0.44 . . . . 0.0 109.914 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.73 -38.96 87.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.217 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 114' ' ' MET . 87.7 t -58.23 -52.05 63.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.532 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.74 93.18 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.041 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -62.13 -53.83 49.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.709 0.29 . . . . 0.0 110.88 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.68 -44.43 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.25 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -45.46 88.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.548 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.52 -46.07 91.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.268 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -60.02 -43.51 95.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.003 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 96.8 mtp -64.31 -52.4 58.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 72.1 t -60.57 -42.56 92.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.296 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.06 -48.41 73.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.818 0.342 . . . . 0.0 110.679 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -59.7 -39.54 84.94 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.55 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.6 mt -59.17 -29.96 67.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.409 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -106.01 11.41 31.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.702 0.287 . . . . 0.0 110.966 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 78.4 m -108.29 -65.61 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.495 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -108.24 -22.03 12.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.788 0.328 . . . . 0.0 111.396 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.758 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 61.0 mt -101.15 11.97 38.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.646 0.26 . . . . 0.0 111.024 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.52 -49.0 77.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.27 -43.72 92.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.716 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.758 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 83.0 m95 -60.11 -49.43 77.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.579 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 133' ' ' LEU . 46.0 mm -63.45 -39.37 85.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.512 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.15 -49.83 72.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.923 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.3 m -63.78 -47.77 79.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.325 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 50.7 m -70.17 -16.75 63.12 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.78 41.19 50.65 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.877 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.411 ' HA2' HG21 ' A' ' 137' ' ' ILE . . . 67.89 -100.95 0.67 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.125 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -111.77 13.78 21.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.782 0.325 . . . . 0.0 110.548 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.23 -50.91 71.4 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.822 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.61 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 11.0 pt-20 -86.26 -22.37 26.87 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.587 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.447 ' HE1' HG23 ' A' ' 96' ' ' VAL . 90.0 t80 -59.38 -41.05 88.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.947 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.553 ' HA ' ' CE2' ' A' ' 150' ' ' TYR . 0.4 OUTLIER -64.81 -26.16 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.218 0.532 . . . . 0.0 111.046 -179.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.79 -26.27 24.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.948 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 84.7 mt -60.76 -60.54 3.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.893 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.553 ' CE2' ' HA ' ' A' ' 147' ' ' THR . 34.0 p90 -74.87 -10.54 59.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.984 0.421 . . . . 0.0 110.591 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.34 -19.1 77.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.559 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -123.32 -65.39 1.09 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 63.23 23.97 66.83 Favored Glycine 0 C--O 1.228 -0.251 0 CA-C-N 115.722 -0.672 . . . . 0.0 114.409 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -125.29 -41.67 2.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.455 0.627 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 33.9 mt -81.79 77.98 8.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.061 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -142.07 110.13 5.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.744 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -112.92 41.68 2.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.622 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -93.01 -50.27 5.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.659 0.266 . . . . 0.0 110.902 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.486 HH21 ' HG2' ' B' ' 218' ' ' ARG . 0.3 OUTLIER -105.55 9.5 33.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.908 0.385 . . . . 0.0 111.278 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -90.92 81.21 5.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.486 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 19.0 tp -85.03 133.62 34.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.118 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -102.69 94.63 5.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.715 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.48 176.5 5.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.591 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.56 115.58 0.63 Allowed Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -90.45 72.97 6.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.253 0.549 . . . . 0.0 109.988 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -171.26 -65.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.605 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -127.03 152.24 47.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.064 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.9 m -83.73 -8.18 59.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.011 0.434 . . . . 0.0 110.317 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.3 t -69.35 126.27 29.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.406 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.931 -0.556 . . . . 0.0 109.604 -179.849 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . 0.823 HD11 ' HG2' ' A' ' 80' ' ' GLN . 25.6 mt . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.676 0.274 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.646 HG12 HG12 ' B' ' 205' ' ' ILE . 10.0 tt -162.3 100.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.639 0.733 . . . . 0.0 110.743 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.617 ' HG2' ' HG3' ' A' ' 84' ' ' GLU . 48.5 mttm -77.63 -32.41 53.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.92 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -45.93 -61.09 1.89 Allowed 'General case' 0 C--O 1.24 0.575 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . 0.646 HG12 HG12 ' B' ' 202' ' ' ILE . 45.3 pt -69.46 -34.38 61.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.69 0.281 . . . . 0.0 111.283 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . 0.423 ' HA ' HG21 ' A' ' 81' ' ' VAL . . . -62.54 -37.51 86.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.203 0.525 . . . . 0.0 110.365 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' ARG . . . . . 0.704 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 38.0 ttp180 -62.85 -44.42 96.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.317 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -63.65 -40.09 95.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.27 -52.45 65.63 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.29 0.567 . . . . 0.0 110.507 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -68.56 -34.98 76.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.731 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -56.6 -56.03 26.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.79 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 13.0 m -63.1 -43.41 98.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.535 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.08 -42.2 98.2 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.76 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 0.6 OUTLIER -70.33 -47.62 60.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.654 0.264 . . . . 0.0 111.574 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' SER . . . . . 0.427 ' OG ' ' HD3' ' A' ' 159' ' ' ARG . 12.2 m -68.34 -42.74 78.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' MET . . . . . 0.49 ' HG3' ' O ' ' A' ' 55' ' ' ARG . 6.5 tpt -66.05 -48.16 71.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.01 -35.03 79.89 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.067 0.461 . . . . 0.0 110.548 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER -73.0 -15.59 61.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 15.3 m 70.36 -57.67 0.57 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.215 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 2.8 mt . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.554 -179.287 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.0 m -141.19 88.52 10.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.848 0.356 . . . . 0.0 110.508 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.23 129.78 19.97 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.473 2.115 . . . . 0.0 112.074 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.09 167.66 12.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.285 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.6 m -104.88 125.7 51.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.829 0.347 . . . . 0.0 110.58 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.647 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -84.59 -53.0 0.51 Allowed Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.224 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.647 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 10.9 Cg_exo -71.09 133.95 24.18 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.91 1.74 . . . . 0.0 111.788 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.0 149.91 47.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.935 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.91 -40.91 67.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.325 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -73.59 -27.09 61.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 0.0 110.945 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.01 94.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 mp -64.17 -42.54 96.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.289 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.99 -45.89 95.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.149 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.5 80.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.565 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.0 -42.05 85.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.215 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -63.22 -46.08 88.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.31 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.18 -47.38 93.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.073 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.46 99.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.692 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.646 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 18.3 t80 -60.78 -48.89 79.73 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -60.03 -38.86 83.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.597 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 21' ' ' LEU . 8.3 tp -67.77 -25.79 65.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.074 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -89.44 -29.59 18.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 15.6 mm100 -60.87 -28.61 68.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.017 0.436 . . . . 0.0 111.347 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -88.48 16.04 7.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.582 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.87 -62.75 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.845 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -145.3 102.53 3.74 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.82 107.41 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.252 0.549 . . . . 0.0 110.885 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.8 t -110.11 127.39 54.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.996 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.83 -124.07 2.18 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.018 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.27 172.27 16.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.764 0.316 . . . . 0.0 110.653 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.09 108.64 2.87 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.1 110.24 2.58 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.936 2.424 . . . . 0.0 111.851 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.63 -104.31 2.46 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.894 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -90.15 109.72 20.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.284 0.564 . . . . 0.0 110.24 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.98 90.71 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -48.0 108.56 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.331 2.687 . . . . 0.0 112.863 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.11 141.14 38.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.68 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.67 79.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.007 0.432 . . . . 0.0 110.152 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.87 126.33 32.13 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.21 0.529 . . . . 0.0 110.436 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -96.59 1.65 1.91 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.826 2.351 . . . . 0.0 110.716 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.564 HD22 ' HB2' ' A' ' 143' ' ' TRP . 12.2 mt -67.18 -50.23 61.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.661 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -62.13 -34.11 75.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.07 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -80.84 -38.58 28.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.465 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' A' ' 146' ' ' PHE . . . -60.87 -43.97 97.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.706 0.288 . . . . 0.0 111.011 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 54.9 mtt -63.8 -38.41 90.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.032 0.444 . . . . 0.0 110.535 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 4.9 tmm_? -70.42 -42.53 71.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.224 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.38 -32.6 71.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.875 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.93 -50.52 57.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.045 0.45 . . . . 0.0 110.609 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.413 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -98.6 42.71 2.0 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.329 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 2.8 t0 -148.34 -46.48 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.586 0.231 . . . . 0.0 111.26 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.525 ' O ' HG22 ' A' ' 54' ' ' THR . 71.0 mm-40 -57.19 -55.53 33.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.801 0.334 . . . . 0.0 111.9 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.413 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 2.1 p90 -68.35 -26.48 65.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.687 0.28 . . . . 0.0 111.248 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -77.23 -42.79 35.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.172 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 51' ' ' GLU . 6.5 t -65.22 -26.02 67.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.154 0.502 . . . . 0.0 110.219 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 37.3 mtm-85 -93.2 -1.07 56.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.895 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.616 ' HD2' ' HG2' ' B' ' 216' ' ' MET . 42.9 t80 -111.87 -92.47 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.283 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.0 ttp85 175.11 -66.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.718 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.755 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -154.3 56.55 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.268 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -30.6 71.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.995 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -52.12 -38.63 58.04 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 123.455 0.472 . . . . 0.0 110.981 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.04 -41.2 6.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.258 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -59.45 -46.44 88.75 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.649 HD13 ' HA ' ' B' ' 209' ' ' LEU . 7.4 tp -62.81 -37.47 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 110.499 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.69 -30.7 63.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.295 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.04 -49.09 54.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.799 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -66.49 -31.5 72.27 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.941 0.4 . . . . 0.0 110.128 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.789 ' HG ' ' HZ ' ' A' ' 101' ' ' PHE . 0.5 OUTLIER -69.32 -22.27 63.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 178.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -83.18 -22.49 33.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.935 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.31 -49.04 34.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.599 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -72.53 141.36 82.71 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.697 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.599 ' HD2' HG22 ' A' ' 70' ' ' THR . 77.8 Cg_exo -50.92 104.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.77 2.314 . . . . 0.0 112.63 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.59 -158.77 9.87 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.954 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 7.4 m -142.84 -148.44 0.24 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.03 -158.19 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.976 0.417 . . . . 0.0 111.423 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.596 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 3.7 mm-40 -53.04 -38.13 62.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.576 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -56.82 -40.03 75.29 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.944 0.402 . . . . 0.0 110.842 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.596 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 14.0 tpp85 -64.94 -37.94 89.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.975 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.596 ' HD2' ' HA ' ' A' ' 75' ' ' GLN . 40.9 m-85 -69.16 -37.32 78.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.526 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 m -69.04 -46.7 67.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.084 0.469 . . . . 0.0 110.632 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.81 -32.62 69.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.866 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.438 HG11 ' O ' ' A' ' 78' ' ' PHE . 2.5 p -69.25 -19.17 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.164 0.507 . . . . 0.0 110.774 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.505 ' HB3' ' HA ' ' A' ' 98' ' ' PHE . 38.4 m -82.48 -43.65 16.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.117 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.89 -24.12 55.63 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.063 0.459 . . . . 0.0 109.976 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.779 ' HG3' ' HD3' ' B' ' 203' ' ' LYS . 2.9 tp10 -51.33 -48.01 62.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.44 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.538 HD23 ' HG2' ' B' ' 207' ' ' ARG . 0.1 OUTLIER -90.1 -5.77 56.17 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.924 -0.311 . . . . 0.0 111.658 -178.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.2 -27.95 57.05 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -65.47 -23.58 66.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.297 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.19 3.3 86.38 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.908 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.33 133.16 3.45 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.547 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.53 65.83 8.57 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.141 2.561 . . . . 0.0 111.618 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -70.9 169.76 14.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.277 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.491 ' HE3' ' H ' ' A' ' 92' ' ' TRP . 5.1 m-90 -52.24 -63.17 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.865 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.32 -11.28 75.72 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.182 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -67.0 -49.99 63.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.732 0.301 . . . . 0.0 110.307 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.9 tp -67.29 -33.92 76.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.266 0.555 . . . . 0.0 109.736 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.14 -54.13 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.472 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.572 ' HA ' HG13 ' A' ' 100' ' ' VAL . . . -61.91 -43.17 99.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.574 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.505 ' HA ' ' HB3' ' A' ' 82' ' ' SER . 79.3 t80 -57.91 -42.89 85.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.039 0.447 . . . . 0.0 111.53 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -75.86 -46.78 28.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.709 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.572 HG13 ' HA ' ' A' ' 97' ' ' ALA . 9.8 p -66.93 -34.0 67.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.789 ' HZ ' ' HG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -60.8 -50.31 73.95 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 110.43 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.4 -43.23 95.28 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.918 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.11 87.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.46 97.71 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.3 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.16 -43.33 71.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.044 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.427 ' O ' HG22 ' A' ' 110' ' ' VAL . 34.7 m -61.94 -44.15 97.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.416 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.58 82.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.908 0.385 . . . . 0.0 110.488 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -68.31 -40.51 81.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.164 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.435 ' HB2' HG23 ' A' ' 118' ' ' VAL . 17.2 m -63.99 -37.81 88.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.812 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 106' ' ' CYS . 99.5 t -67.65 -33.42 61.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.122 0.487 . . . . 0.0 109.764 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.08 -13.23 61.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.248 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -106.94 7.92 30.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.121 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 62.61 34.31 15.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.48 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.506 ' O ' HG22 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -106.73 62.79 0.63 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.008 0.432 . . . . 0.0 110.117 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -64.96 -27.6 68.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.678 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.9 t -59.08 -48.36 86.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.304 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 tp -70.37 -39.17 74.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.353 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 114' ' ' MET . 99.4 t -59.2 -49.51 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.837 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.56 84.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.384 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -69.02 -51.25 41.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.71 0.291 . . . . 0.0 110.664 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.84 -43.48 97.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.759 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -43.24 94.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.989 0.423 . . . . 0.0 110.099 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.28 -42.47 88.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.36 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -60.5 -41.45 94.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 93.1 mtp -59.35 -52.22 66.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.456 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.1 t -65.18 -42.31 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.586 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.02 -47.21 81.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -63.22 -40.41 97.38 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.992 0.425 . . . . 0.0 110.119 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.703 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 24.3 mt -63.08 -35.36 79.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.145 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -90.95 6.51 44.39 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.2 m -121.37 -61.52 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -101.44 -26.6 13.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.703 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 97.3 mt -98.77 10.03 42.1 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.324 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.14 -48.07 77.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.767 0.317 . . . . 0.0 111.17 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.85 -52.09 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.621 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -61.42 -50.6 72.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.475 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.557 HG21 ' HA2' ' A' ' 142' ' ' GLY . 17.5 mm -58.92 -40.2 79.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.694 0.283 . . . . 0.0 110.938 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -61.37 -43.67 98.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.962 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.4 m -69.94 -41.01 75.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.752 0.311 . . . . 0.0 111.119 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.0 m -75.09 -2.06 25.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.594 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.0 42.02 98.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.08 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.557 ' HA2' HG21 ' A' ' 137' ' ' ILE . . . 72.95 -102.12 1.19 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.393 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.564 ' HB2' HD22 ' A' ' 41' ' ' LEU . 82.0 m95 -112.49 9.33 19.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.668 0.271 . . . . 0.0 110.365 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.16 -55.88 28.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.988 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.585 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 43.8 tt0 -59.9 -39.3 84.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.124 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.501 ' HD2' ' HB1' ' A' ' 44' ' ' ALA . 48.9 t80 -57.97 -34.84 70.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.626 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.451 ' HA ' ' CE2' ' A' ' 150' ' ' TYR . 2.1 m -60.46 -37.35 80.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.04 0.448 . . . . 0.0 110.778 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.81 -27.54 30.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.505 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 26.3 mt -57.23 -52.39 65.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.261 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.451 ' CE2' ' HA ' ' A' ' 147' ' ' THR . 30.3 p90 -87.08 8.26 24.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.838 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.72 -34.91 91.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.969 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -154.71 125.28 6.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.64 0.257 . . . . 0.0 110.382 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.6 30.07 2.72 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.692 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -145.85 -25.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.1 mp -102.12 -40.51 6.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.335 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.96 128.26 35.05 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.2 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.573 ' OE2' ' HB3' ' A' ' 160' ' ' ARG . 0.2 OUTLIER -117.05 31.64 6.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.762 0.315 . . . . 0.0 111.379 -179.057 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -97.46 -26.06 14.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -148.36 41.39 0.97 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.299 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.573 ' HB3' ' OE2' ' A' ' 157' ' ' GLU . 27.3 ttp180 -108.76 -81.6 0.57 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.172 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.71 ' HA ' HD13 ' B' ' 220' ' ' ILE . 22.5 mt -79.92 88.52 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.362 . . . . 0.0 111.122 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 162' ' ' ARG . 66.2 mmt-85 -122.56 -93.71 0.51 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.919 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -153.6 157.35 39.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.148 0.499 . . . . 0.0 111.632 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.57 151.94 7.42 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -60.86 -38.65 86.28 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 117.196 0.498 . . . . 0.0 111.441 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.485 ' CZ3' ' HB3' ' B' ' 211' ' ' GLN . 31.7 m-90 -95.21 1.38 54.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.981 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.532 ' HB1' HG12 ' B' ' 220' ' ' ILE . . . -69.64 113.5 6.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.772 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.9 m -104.73 -32.48 8.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.982 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.2 t -81.6 107.05 13.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.261 0.553 . . . . 0.0 110.15 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 170' ' ' ARG . 9.6 ptp180 . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.254 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . 0.43 ' H3 ' ' CD ' ' A' ' 84' ' ' GLU . 43.7 mt . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 120.739 0.304 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -147.22 79.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.239 0.542 . . . . 0.0 110.363 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.779 ' HD3' ' HG3' ' A' ' 84' ' ' GLU . 39.2 mmtm -58.92 -36.07 74.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.13 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -62.49 -43.52 98.62 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.155 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . 0.425 HG12 HG23 ' A' ' 70' ' ' THR . 38.7 mt -64.99 -41.68 92.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.111 0.481 . . . . 0.0 109.707 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . 0.48 ' HB2' HD21 ' A' ' 85' ' ' LEU . . . -62.45 -42.59 99.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.631 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' ARG . . . . . 0.538 ' HG2' HD23 ' A' ' 85' ' ' LEU . 15.2 mtp180 -61.35 -34.61 75.58 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.114 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -58.69 7.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.569 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.649 ' HA ' HD13 ' A' ' 63' ' ' LEU . 1.2 pp -67.72 -42.25 82.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -64.92 -47.18 78.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' GLN . . . . . 0.485 ' HB3' ' CZ3' ' A' ' 166' ' ' TRP . 6.3 tp60 -65.69 -37.91 87.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 16.5 t -58.19 -55.09 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.656 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.29 -38.45 91.56 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.468 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 2.3 t0 -63.83 -49.77 71.53 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.7 m -68.42 -40.24 81.31 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' MET . . . . . 0.616 ' HG2' ' HD2' ' A' ' 56' ' ' PHE . 5.6 tpt -64.64 -42.68 95.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.744 0.306 . . . . 0.0 111.094 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.34 -33.34 69.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.318 0.58 . . . . 0.0 110.047 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . 0.559 ' HG3' ' HA ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -73.51 -9.96 59.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.887 179.234 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 14.4 m 64.99 37.66 6.73 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 123.604 0.565 . . . . 0.0 111.216 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.71 HD13 ' HA ' ' A' ' 161' ' ' LEU . 11.0 tt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.148 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.715 0.293 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 m -133.62 117.19 14.11 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.513 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.16 144.05 99.5 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.645 2.23 . . . . 0.0 112.15 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.62 114.86 29.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.815 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -69.72 115.88 9.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.989 0.423 . . . . 0.0 110.647 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.537 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -86.32 -49.93 0.5 Allowed Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.327 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 32.7 Cg_exo -61.3 131.87 38.48 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.05 1.833 . . . . 0.0 113.042 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -75.62 149.08 38.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.378 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 m -57.22 -36.94 71.51 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -69.66 -31.38 69.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.668 0.271 . . . . 0.0 110.617 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.45 78.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.237 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 mp -69.15 -41.7 76.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.744 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.591 ' HA ' ' HE2' ' A' ' 45' ' ' MET . 64.7 t -62.64 -42.99 98.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.995 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.32 87.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.667 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.42 -46.89 81.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -61.05 -48.86 79.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.974 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.13 -46.66 95.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.51 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.71 98.95 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.794 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -61.95 -46.14 90.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.724 0.297 . . . . 0.0 110.272 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 20' ' ' LYS . 11.8 mmmt -61.65 -35.91 79.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.936 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.11 -26.24 59.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.683 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -84.26 -36.99 22.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.379 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -56.97 -35.4 69.11 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 24.18 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.932 0.396 . . . . 0.0 111.382 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.04 -54.95 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.683 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -154.52 111.83 3.39 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.93 120.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.148 0.499 . . . . 0.0 110.812 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.8 m -132.37 108.56 9.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.397 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.5 -134.87 3.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.843 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.09 146.77 26.38 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.94 114.84 4.08 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.653 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.59 83.7 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.064 2.509 . . . . 0.0 112.2 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.63 -103.65 1.24 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.234 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -103.15 105.74 16.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.046 0.45 . . . . 0.0 109.798 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.45 85.73 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.577 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -57.22 119.17 6.25 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.069 2.512 . . . . 0.0 112.252 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.49 164.19 13.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.485 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.427 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -85.45 -15.98 41.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.133 0.492 . . . . 0.0 110.294 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -105.87 102.52 39.38 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.844 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 41.0 Cg_endo -96.77 5.28 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.224 2.616 . . . . 0.0 111.57 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.0 mt -64.27 -45.95 85.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.155 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -63.78 -43.07 97.45 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.74 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -65.49 -43.54 89.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.934 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.17 -39.0 93.39 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.834 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.591 ' HE2' ' HA ' ' A' ' 13' ' ' VAL . 15.1 ttt -73.55 -34.98 65.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.091 0.472 . . . . 0.0 110.602 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -68.81 -40.87 79.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.84 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.01 5.14 52.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.739 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.54 58.31 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.189 0.518 . . . . 0.0 110.801 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -96.67 29.2 10.8 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.43 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.77 -31.2 3.21 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.358 -0.137 . . . . 0.0 111.215 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -56.99 -71.89 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.116 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.489 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 54.2 p90 -58.95 -25.76 63.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.113 0.482 . . . . 0.0 110.545 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 4.0 tp10 -66.29 -38.06 86.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.489 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -61.16 -36.9 81.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.29 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.595 ' HB2' ' HG3' ' B' ' 216' ' ' MET . 0.0 OUTLIER -86.65 -17.42 33.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.343 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.684 ' HB2' ' HG2' ' B' ' 216' ' ' MET . 41.8 t80 -97.05 -93.62 0.22 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.295 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HB3' ' H ' ' A' ' 58' ' ' ARG . 26.1 ttm105 -175.39 -81.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.416 0.627 . . . . 0.0 109.534 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.45 ' H ' ' HB3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -153.03 67.26 0.79 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.385 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -53.22 -32.89 50.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.496 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.62 -36.58 64.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 110.619 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -99.23 -32.95 10.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.093 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 10.6 t70 -63.18 -38.21 90.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.92 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.2 tp -57.27 -43.71 83.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.49 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.72 -35.99 79.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.052 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.1 -47.6 35.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.747 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 9.5 pt20 -66.23 -33.04 74.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.602 0.239 . . . . 0.0 111.118 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.87 -0.75 40.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.737 0.303 . . . . 0.0 111.006 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -94.3 -29.35 15.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.6 t -62.57 -46.8 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.56 0.695 . . . . 0.0 109.3 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.498 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -92.9 145.18 29.69 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.495 178.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.498 ' HD2' HG22 ' A' ' 70' ' ' THR . 69.0 Cg_exo -52.35 107.65 0.2 Allowed 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.708 2.272 . . . . 0.0 112.597 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.57 -166.11 28.45 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.094 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.633 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 73.2 m -157.21 -150.43 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.898 -0.177 . . . . 0.0 110.717 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.402 ' H ' ' HB3' ' A' ' 73' ' ' SER . . . -76.35 -168.19 0.92 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.676 0.275 . . . . 0.0 111.192 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.406 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -56.69 -34.15 67.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -55.42 -27.8 50.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.373 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.633 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 15.4 tpp85 -75.61 -13.04 60.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.487 ' O ' HG11 ' A' ' 81' ' ' VAL . 80.1 m-85 -104.3 -40.78 5.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -36.46 83.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 111.71 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.519 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -95.22 3.96 54.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 111.722 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.604 ' HB ' ' O ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -97.32 -23.73 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.259 0.552 . . . . 0.0 109.681 179.22 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.12 -42.45 19.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.592 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -21.64 58.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.026 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 3.4 tp10 -55.1 -41.89 72.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.193 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.751 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.3 OUTLIER -97.76 10.03 41.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.99 0.424 . . . . 0.0 110.718 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -99.17 -29.35 12.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -56.1 -45.59 79.37 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.982 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -106.07 15.46 43.71 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.294 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.1 78.35 0.15 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.734 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.89 54.22 5.03 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 123.221 2.614 . . . . 0.0 111.641 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -74.93 162.37 28.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.093 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.458 ' CD1' HD23 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -58.41 -51.64 68.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.655 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.69 -28.48 73.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.099 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.9 tpp85 -65.83 -44.69 84.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.77 -42.21 95.27 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 71.6 t -61.48 -44.84 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.948 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.493 ' HA ' HG13 ' A' ' 100' ' ' VAL . . . -62.01 -45.02 95.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.933 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.22 -40.21 93.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.152 0.501 . . . . 0.0 110.668 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -71.11 -47.05 60.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.29 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.493 HG13 ' HA ' ' A' ' 97' ' ' ALA . 6.7 p -70.23 -29.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.45 ' CZ ' HD12 ' B' ' 209' ' ' LEU . 0.5 OUTLIER -59.14 -52.01 67.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.088 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.91 -42.01 95.13 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.629 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.98 -49.78 76.07 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.35 -46.24 84.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.572 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 105' ' ' LEU . 1.6 mm? -64.12 -39.26 93.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.048 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.31 -39.73 71.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.65 91.37 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.867 0.365 . . . . 0.0 110.259 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.36 -42.82 98.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.818 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.7 m -66.11 -44.22 84.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.031 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.474 HG22 HG21 ' A' ' 118' ' ' VAL . 51.6 t -60.35 -43.01 92.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 121.171 0.51 . . . . 0.0 109.833 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -65.56 -25.08 67.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.554 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -93.6 10.86 30.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.669 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 66.58 25.52 9.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.041 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.63 75.86 1.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.005 0.431 . . . . 0.0 110.213 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -76.14 -27.24 56.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.0 t -55.0 -50.57 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.401 ' O ' HG22 ' A' ' 121' ' ' VAL . 57.3 tp -63.08 -44.25 96.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.334 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.474 HG21 HG22 ' A' ' 110' ' ' VAL . 87.3 t -57.43 -49.1 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.195 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.18 -42.03 87.26 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.555 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -69.33 -49.48 55.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.507 0.194 . . . . 0.0 110.648 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 117' ' ' LEU . 77.2 t -57.83 -46.85 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.182 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -40.34 96.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.763 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.26 -38.91 91.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 0.0 110.437 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -66.6 -42.22 87.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.131 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 87.0 mtp -63.22 -48.6 77.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.438 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.67 -42.71 89.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.551 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.14 74.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.371 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -57.74 -41.46 81.92 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.367 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 79.3 mt -63.5 -31.78 73.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.615 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.28 9.96 42.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.638 0.256 . . . . 0.0 111.372 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.4 m -119.1 -80.15 0.61 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.448 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -81.67 -35.6 29.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.865 0.364 . . . . 0.0 111.659 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.581 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 35.4 mt -91.63 5.8 48.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.814 0.34 . . . . 0.0 110.978 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.18 81.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.854 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.98 -45.66 70.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.922 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.581 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 87.9 m95 -59.28 -51.69 68.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.411 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.6 mm -61.58 -30.92 49.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.053 0.454 . . . . 0.0 111.011 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -72.3 -45.77 58.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.089 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.6 m -70.9 -30.12 66.38 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.554 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 67.5 m -89.31 1.93 55.07 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.11 41.05 96.38 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.441 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.99 -98.84 0.9 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -115.15 11.22 16.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -54.07 -51.05 65.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.778 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.644 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 3.2 pt-20 -85.65 -24.0 27.26 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.423 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -59.88 -42.22 93.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.228 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.473 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 1.2 p -72.68 -5.49 37.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.976 0.417 . . . . 0.0 111.258 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.85 -17.52 15.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.245 0.545 . . . . 0.0 110.323 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 41.3 mt -76.34 -57.14 4.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.945 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.473 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 4.8 p90 -74.59 -10.37 59.48 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.386 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.84 -22.74 78.87 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.818 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -121.43 80.76 1.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 0.0 110.271 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.79 31.23 8.91 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.083 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -132.79 83.11 2.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.907 0.384 . . . . 0.0 110.263 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.13 -25.61 63.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.598 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.27 132.77 8.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.202 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -122.36 44.62 2.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.905 0.383 . . . . 0.0 110.553 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -110.63 -55.75 2.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.913 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.69 -6.0 4.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.678 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 25.7 ttp85 -63.38 142.96 58.2 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.212 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.92 149.34 49.81 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -67.64 90.48 0.27 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.039 0.447 . . . . 0.0 111.221 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.456 ' OE1' ' HD3' ' A' ' 55' ' ' ARG . 9.7 mm-40 -148.77 -177.28 5.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.998 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.18 -161.46 31.57 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.201 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -136.09 122.79 21.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -164.93 172.46 12.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.901 0.381 . . . . 0.0 110.632 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.47 -13.11 60.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.031 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.0 p -76.03 176.58 7.81 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.297 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.7 t -92.78 115.89 32.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.993 0.425 . . . . 0.0 109.941 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.147 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . 0.621 HG22 HG13 ' B' ' 202' ' ' ILE . 50.2 mt . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.419 0.152 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.621 HG13 HG22 ' B' ' 201' ' ' ILE . 29.0 mt -145.83 119.18 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.382 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -72.96 -34.58 66.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -57.4 -57.48 12.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.834 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 33.2 mm -62.28 -39.22 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.437 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' A' ' 81' ' ' VAL . . . -60.45 -46.89 88.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.997 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' ARG . . . . . 0.751 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 2.1 ttp-105 -58.91 -37.78 77.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.66 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' HIS . . . . . 0.494 ' O ' HG23 ' B' ' 212' ' ' VAL . 9.1 t-80 -58.68 -60.59 3.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.105 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.45 HD12 ' CZ ' ' A' ' 101' ' ' PHE . 0.8 OUTLIER -66.17 -41.88 89.69 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -60.75 -44.65 96.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.433 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -67.36 -35.08 78.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.371 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.494 HG23 ' O ' ' B' ' 208' ' ' HIS . 32.8 t -56.36 -54.61 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 123.084 0.24 . . . . 0.0 110.826 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.09 -44.94 43.29 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.244 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -61.39 -56.54 19.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.6 m -62.97 -34.19 77.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.352 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' MET . . . . . 0.723 ' HA ' ' HE3' ' B' ' 216' ' ' MET . 4.0 tpt -65.85 -44.74 84.58 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.433 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . 0.519 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 30.1 t70 -61.65 -33.94 74.83 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.038 0.447 . . . . 0.0 110.071 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . 0.444 ' HD2' ' HZ3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -66.94 -9.06 34.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.066 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 5.5 m 67.82 -170.43 0.19 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.179 0.592 . . . . 0.0 111.755 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 1.9 pt . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.446 -179.698 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.865 0.364 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -127.49 89.69 50.55 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.219 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.65 131.35 22.63 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.578 2.185 . . . . 0.0 111.714 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.04 152.62 21.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.13 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.0 m -83.34 116.11 22.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.337 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.731 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -69.24 -55.85 9.4 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.281 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.731 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 96.0 Cg_endo -92.57 146.78 2.73 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.133 1.889 . . . . 0.0 112.917 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 13.4 t70 -76.54 148.26 37.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.848 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.1 m -53.43 -35.63 60.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 2.4 mtm180 -63.11 -33.34 75.24 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.116 -0.233 . . . . 0.0 110.824 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.27 -37.6 85.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.028 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.38 -40.32 81.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.67 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 9' ' ' THR . 85.1 t -62.34 -43.14 97.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.559 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.17 -38.43 91.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.13 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.85 -38.75 86.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -67.51 -50.42 58.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.3 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.2 t -61.86 -44.47 98.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.831 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 22' ' ' ARG . . . -62.93 -40.41 99.25 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.45 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.427 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 2.6 t80 -62.85 -47.39 83.58 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.56 -37.46 81.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.969 0.414 . . . . 0.0 110.447 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.711 HD12 ' HE2' ' A' ' 24' ' ' LYS . 23.4 tp -67.72 -34.07 76.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 84.7 mtm-85 -80.14 -33.73 38.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.753 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 14.3 mm100 -60.14 -23.6 64.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.711 ' HE2' HD12 ' A' ' 21' ' ' LEU . 57.3 pttt -97.08 22.78 8.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.885 0.374 . . . . 0.0 111.037 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.04 -55.29 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.327 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.7 110.91 4.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.24 112.87 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.088 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.4 t -120.86 125.86 48.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.054 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.19 -130.15 4.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.47 179.62 8.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.652 0.263 . . . . 0.0 110.302 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.69 96.66 0.81 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.869 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.46 113.21 3.05 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.899 2.399 . . . . 0.0 112.324 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.22 -108.96 1.83 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.959 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.38 106.36 9.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.95 0.405 . . . . 0.0 110.537 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.11 79.44 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.59 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.54 122.35 10.69 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.146 2.564 . . . . 0.0 112.786 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.88 166.91 10.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.578 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.7 18.06 9.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.093 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -120.87 89.08 45.19 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -89.71 -7.27 4.77 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.491 2.127 . . . . 0.0 110.812 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.64 -53.2 36.59 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.121 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -62.66 -38.04 88.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.953 0.406 . . . . 0.0 110.498 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -67.59 -40.28 84.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.271 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.65 91.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.545 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 37.6 mtt -61.67 -41.62 97.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.228 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -62.27 -50.33 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.586 ' HB1' ' HG3' ' A' ' 51' ' ' GLU . . . -61.8 -37.22 83.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.845 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.23 -32.61 49.13 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.127 0.267 . . . . 0.0 111.719 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.4 35.56 3.57 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.683 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -151.26 -33.49 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.586 ' HG3' ' HB1' ' A' ' 47' ' ' ALA . 3.8 mm-40 -60.38 -72.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.489 ' HE2' HG21 ' A' ' 59' ' ' THR . 9.2 p90 -56.47 -36.66 69.34 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.517 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.12 -42.3 99.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.684 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.55 -20.05 63.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 -105.92 1.21 26.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.208 0.528 . . . . 0.0 110.554 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.441 ' CG ' ' HG2' ' B' ' 216' ' ' MET . 2.8 t80 -98.13 -85.58 0.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.571 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.406 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 5.2 ttm105 175.05 -71.12 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.63 61.29 0.32 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.107 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.489 HG21 ' HE2' ' A' ' 52' ' ' PHE . 0.4 OUTLIER -50.51 -33.55 21.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.038 -178.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -56.06 -23.73 35.35 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.405 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.6 m -121.39 -40.38 2.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.615 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.5 -49.87 73.63 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.9 tp -59.67 -34.15 72.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.11 0.481 . . . . 0.0 110.733 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.612 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -80.04 -18.45 50.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.97 -47.58 7.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.511 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.925 ' HG3' HD22 ' A' ' 67' ' ' LEU . 8.5 pt20 -65.02 -19.55 66.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.925 HD22 ' HG3' ' A' ' 66' ' ' GLN . 0.4 OUTLIER -109.84 13.84 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 0.0 110.612 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.612 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 9.0 t-160 -95.24 10.38 36.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.161 0.505 . . . . 0.0 110.705 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.6 t -78.88 -42.57 24.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.201 0.524 . . . . 0.0 110.139 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -86.48 132.41 42.92 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.002 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.84 109.21 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.063 2.509 . . . . 0.0 112.704 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.08 -146.84 21.71 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.633 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.68 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 20.1 m -151.17 -159.45 1.03 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.6 -157.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.796 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.476 ' OE1' ' HB2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -54.96 -31.04 60.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.442 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 26.1 mp0 -64.43 -10.94 28.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.444 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.68 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 19.0 tpp85 -109.61 -25.59 10.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.7 0.286 . . . . 0.0 110.885 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.532 ' O ' HG12 ' A' ' 81' ' ' VAL . 19.4 m-85 -65.55 -61.05 2.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.33 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.17 -20.89 64.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.283 0.563 . . . . 0.0 110.731 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 76' ' ' GLN . 1.1 tp60 -75.63 -24.97 56.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.199 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 78' ' ' PHE . 1.4 p -73.93 -24.56 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.217 0.532 . . . . 0.0 110.04 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.23 -39.64 39.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.663 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -71.95 -28.52 63.5 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.007 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.408 ' O ' ' HE3' ' B' ' 203' ' ' LYS . 4.6 tp10 -54.6 -47.61 73.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.688 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.612 ' HB3' ' HD3' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -82.1 -21.8 36.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.535 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.557 ' HB2' ' HA ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -62.9 -32.61 73.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.356 0.598 . . . . 0.0 109.43 179.049 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -64.1 -24.09 67.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.42 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.46 45.32 1.09 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.512 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.64 74.79 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.553 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.09 52.09 3.69 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.342 2.695 . . . . 0.0 112.012 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -71.85 163.36 27.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.618 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.793 ' HB3' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -53.37 -39.94 64.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.392 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.461 ' HA3' ' OD1' ' B' ' 214' ' ' ASP . . . -65.22 -24.77 70.73 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.616 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.612 ' HD3' ' HB3' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -75.09 -39.92 60.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.82 -42.61 94.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.295 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.44 -46.75 89.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.356 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.5 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -60.97 -41.98 97.46 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.278 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -62.68 -41.55 99.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.126 0.488 . . . . 0.0 110.646 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -71.49 -49.21 43.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.398 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 97' ' ' ALA . 9.9 p -64.13 -36.44 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -62.36 -49.73 74.38 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.939 0.4 . . . . 0.0 110.187 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.81 -47.08 78.7 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.017 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.34 87.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.87 81.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.755 0.312 . . . . 0.0 111.252 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.456 ' HG ' ' OE1' ' A' ' 75' ' ' GLN . 2.6 mm? -65.83 -40.84 92.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.02 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.435 ' O ' HG23 ' A' ' 110' ' ' VAL . 56.6 m -64.49 -46.93 80.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.549 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.89 77.7 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.069 0.461 . . . . 0.0 110.541 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.71 -46.21 66.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.194 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 m -62.95 -34.64 77.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.126 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 106' ' ' CYS . 40.0 t -63.17 -39.88 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.001 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -73.46 -28.22 61.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.228 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -85.6 9.33 16.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.757 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 54.49 48.93 19.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.569 0.7 . . . . 0.0 110.334 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.18 53.89 1.28 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.316 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -60.45 -28.32 68.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.745 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.6 t -56.49 -45.48 82.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.391 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.496 ' O ' HG23 ' A' ' 121' ' ' VAL . 37.9 tp -71.97 -41.9 67.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.386 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.18 -46.61 77.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.564 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.79 -35.65 90.37 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.036 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -69.7 -44.89 69.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 110.237 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 117' ' ' LEU . 57.6 t -61.27 -48.4 89.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.826 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.33 -41.34 98.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.579 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -59.62 -45.39 92.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.252 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -66.54 -40.99 89.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.833 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 85.7 mtp -60.16 -51.4 69.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.744 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.39 -45.26 93.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.414 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.57 81.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -61.86 -43.26 99.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.161 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 58.4 mt -64.3 -28.51 69.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.854 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -101.91 8.04 41.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.2 m -121.53 -70.19 0.8 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.412 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.4 ttt85 -85.76 -38.32 18.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.833 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 77.9 mt -95.02 11.8 30.74 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.49 -52.64 64.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.798 0.332 . . . . 0.0 111.262 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.37 -39.31 92.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.833 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 84.0 m95 -62.95 -48.78 77.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 133' ' ' LEU . 44.1 mm -61.57 -37.45 77.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.043 0.449 . . . . 0.0 109.817 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -66.5 -32.12 73.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 m -78.01 -37.62 46.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.046 0.451 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 144' ' ' ALA . 29.8 m -81.5 -6.99 59.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.143 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.18 41.45 98.35 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.67 -100.97 1.99 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -120.78 13.6 11.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 140' ' ' SER . . . -51.79 -65.41 0.56 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.243 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.506 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 7.5 pt-20 -67.0 -23.52 65.94 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.234 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.476 ' HA ' HD12 ' A' ' 149' ' ' LEU . 59.0 t80 -61.92 -35.31 78.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.675 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -60.4 -30.63 69.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.131 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.41 -12.06 35.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.793 HD13 ' HB3' ' A' ' 92' ' ' TRP . 87.6 mt -80.54 -35.95 33.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.293 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.675 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 9.2 p90 -98.73 16.64 21.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.019 0.437 . . . . 0.0 111.056 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.22 -47.15 90.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.769 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 C--N 1.322 -0.588 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.221 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 37.6 mt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.863 0.363 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' B' ' 205' ' ' ILE . 1.8 pt -143.88 75.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.561 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 84' ' ' GLU . 20.1 mttp -65.1 -33.2 75.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -61.38 -42.58 98.94 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 205' ' ' ILE . . . . . 0.539 HD12 HD12 ' A' ' 67' ' ' LEU . 8.4 mm -69.07 -42.56 81.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.091 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 206' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -62.55 -37.94 88.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.354 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 207' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -66.33 -34.57 78.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.325 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 208' ' ' HIS . . . . . 0.578 ' HB3' HD11 ' A' ' 67' ' ' LEU . 6.1 t-80 -60.08 -56.55 20.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.435 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.1 pp -63.44 -33.43 75.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.811 0.339 . . . . 0.0 110.293 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.57 -59.37 4.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.791 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -63.6 -43.0 98.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.66 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.532 HG11 HE22 ' A' ' 66' ' ' GLN . 53.5 t -63.66 -43.19 98.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.709 0.29 . . . . 0.0 110.678 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.89 -44.22 80.07 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.095 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.461 ' OD1' ' HA3' ' A' ' 93' ' ' GLY . 60.0 m-20 -60.13 -46.1 90.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.93 0.395 . . . . 0.0 111.315 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 12.6 p -70.02 -46.82 64.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.934 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 216' ' ' MET . . . . . 0.441 ' HG2' ' CG ' ' A' ' 56' ' ' PHE . 11.4 tpp -62.82 -43.73 98.01 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -60.15 -54.72 42.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.631 0.253 . . . . 0.0 110.912 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.449 -179.86 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.804 0.335 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -114.26 126.26 28.22 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.475 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.45 110.11 2.61 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.567 2.178 . . . . 0.0 112.123 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.89 117.3 11.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.8 m -66.34 121.58 15.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.234 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.579 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -82.76 -51.52 0.7 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.16 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 17.1 Cg_exo -67.8 141.5 54.44 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.068 1.845 . . . . 0.0 112.67 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 16.0 t70 -85.95 154.6 21.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.266 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.8 m -54.65 -42.72 71.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.917 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.418 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -66.21 -35.05 79.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.418 0.151 . . . . 0.0 111.1 -179.184 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.27 -37.68 86.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.947 0.404 . . . . 0.0 110.552 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 41' ' ' LEU . 6.3 tp -68.27 -44.38 75.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.916 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 9' ' ' THR . 87.7 t -62.92 -44.81 99.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.389 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.64 71.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.831 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.22 -44.08 84.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.89 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -63.54 -47.64 80.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.131 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.8 t -59.77 -46.25 93.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.274 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 22' ' ' ARG . . . -62.75 -44.81 96.93 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.598 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.483 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 10.8 t80 -58.54 -49.6 76.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.38 . . . . 0.0 110.503 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -62.09 -36.21 81.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.408 HD12 ' HE2' ' A' ' 24' ' ' LYS . 7.6 tp -67.81 -26.67 66.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.59 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 87.1 mtm-85 -90.8 -32.43 16.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.461 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.531 HE22 HG13 ' A' ' 27' ' ' VAL . 15.7 mm100 -63.01 -27.14 69.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 0.0 111.38 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.408 ' HE2' HD12 ' A' ' 21' ' ' LEU . 36.8 pttt -88.61 17.91 5.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.132 0.492 . . . . 0.0 110.766 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.86 -74.8 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -127.58 101.35 6.37 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.531 HG13 HE22 ' A' ' 23' ' ' GLN . 59.1 t -62.06 121.95 11.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.809 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.2 t -143.23 139.21 30.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.768 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.59 -138.96 9.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.067 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.97 145.22 26.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.649 0.261 . . . . 0.0 110.473 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.59 103.99 2.23 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.272 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.83 128.15 14.68 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.78 2.32 . . . . 0.0 111.441 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.68 -55.99 0.2 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.257 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -125.09 24.94 7.38 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.173 0.511 . . . . 0.0 110.201 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.62 104.51 2.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.166 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.08 126.61 13.98 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.894 2.396 . . . . 0.0 111.802 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.51 154.69 20.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.346 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.38 -31.43 63.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.905 0.383 . . . . 0.0 110.65 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -104.3 130.26 23.63 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.135 0.493 . . . . 0.0 110.548 179.581 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 39' ' ' ASP . 84.7 Cg_endo -98.18 1.33 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.941 2.427 . . . . 0.0 111.081 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.455 ' HB3' HD21 ' A' ' 12' ' ' LEU . 47.2 mt -64.58 -47.22 79.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.821 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -58.85 -37.56 76.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.946 0.403 . . . . 0.0 111.417 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -80.27 -38.03 31.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.943 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.75 97.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.989 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.58 ' HE2' ' HZ ' ' A' ' 99' ' ' PHE . 25.3 ttm -61.22 -40.33 93.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.46 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -71.39 -44.39 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.517 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.55 ' HB1' ' HG3' ' A' ' 51' ' ' GLU . . . -59.07 -43.65 91.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.211 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.44 -21.11 34.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.555 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -125.51 26.11 5.52 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.013 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -146.37 -46.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.813 -0.228 . . . . 0.0 111.601 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.62 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 14.9 mm-40 -58.58 -55.36 36.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.829 0.347 . . . . 0.0 111.309 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.555 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 2.3 p90 -66.82 -28.74 68.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.121 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -71.55 -44.57 64.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.349 . . . . 0.0 110.407 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -71.99 -8.14 52.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.626 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.62 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 82.8 mtm-85 -109.6 5.05 22.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.296 0.569 . . . . 0.0 110.164 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.853 ' HD1' ' HG2' ' B' ' 216' ' ' MET . 60.8 t80 -118.85 -85.82 0.65 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.707 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 175.71 -72.2 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.512 0.673 . . . . 0.0 109.275 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.68 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -154.55 60.67 0.68 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.27 179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.57 HG22 HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -57.72 -32.04 67.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.909 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -58.16 -36.02 72.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.119 0.485 . . . . 0.0 110.372 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.91 -36.35 12.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.828 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.57 -40.25 86.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.584 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.57 HD13 HG22 ' A' ' 59' ' ' THR . 1.4 mp -63.84 -30.64 71.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.076 0.465 . . . . 0.0 110.861 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.98 -28.15 35.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.236 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.02 -49.28 65.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.849 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -67.4 -23.92 65.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.835 0.35 . . . . 0.0 110.516 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -85.01 -1.78 57.21 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.126 0.489 . . . . 0.0 110.108 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -104.22 -42.48 5.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.916 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.35 -50.46 78.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.48 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -87.25 142.46 33.5 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.816 178.319 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.48 ' HD2' HG22 ' A' ' 70' ' ' THR . 52.4 Cg_exo -53.45 106.35 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.799 2.332 . . . . 0.0 112.825 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.59 -169.84 22.72 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.738 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.823 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 61.3 m -146.8 -157.22 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.24 -167.32 0.31 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.93 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.462 ' HG3' HD21 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -50.74 -38.83 49.96 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.447 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -57.56 -31.01 65.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.627 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.823 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 11.8 tpp85 -72.62 -29.0 63.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.946 0.403 . . . . 0.0 110.177 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.591 ' O ' HG12 ' A' ' 81' ' ' VAL . 73.8 m-85 -73.97 -46.59 43.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -34.9 76.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.275 0.56 . . . . 0.0 110.698 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -68.88 -35.62 77.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.069 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -69.58 -25.33 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.678 0.275 . . . . 0.0 111.303 -179.131 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.26 -47.17 24.76 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.98 -30.19 70.71 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.072 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.404 ' HG3' ' HD3' ' B' ' 203' ' ' LYS . 3.8 tp10 -50.67 -48.13 58.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.741 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.6 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -97.48 -6.23 34.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.1 -179.503 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -40.72 62.97 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -66.27 -29.52 69.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.93 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.72 -26.53 71.2 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.192 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.06 107.91 0.22 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.153 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.26 59.4 6.0 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.867 2.378 . . . . 0.0 111.673 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -70.48 176.69 3.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.439 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.67 ' HB3' HD13 ' A' ' 149' ' ' LEU . 1.9 m-90 -53.0 -57.31 10.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.57 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.8 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -70.22 -12.15 68.56 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.826 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -39.81 93.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.094 0.447 . . . . 0.0 110.049 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.7 tp -71.71 -36.54 70.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.897 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.468 HG22 ' HE1' ' A' ' 146' ' ' PHE . 41.9 t -61.95 -50.28 80.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.407 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.54 -42.62 99.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.165 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -64.44 -42.45 95.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.09 0.472 . . . . 0.0 110.929 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.58 ' HZ ' ' HE2' ' A' ' 45' ' ' MET . 33.9 t80 -68.18 -48.47 65.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.288 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.478 HG21 ' CZ ' ' A' ' 52' ' ' PHE . 9.1 p -65.4 -33.25 62.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.122 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.739 ' HE2' HD13 ' B' ' 209' ' ' LEU . 0.2 OUTLIER -61.9 -51.28 68.82 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.02 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.66 -44.96 96.77 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.783 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.46 81.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.604 0.24 . . . . 0.0 111.351 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.61 -45.77 88.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.659 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 105' ' ' LEU . 2.8 mm? -68.07 -38.7 82.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.065 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.454 ' O ' HG23 ' A' ' 110' ' ' VAL . 19.7 m -65.78 -47.6 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.0 -42.07 89.21 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.984 0.421 . . . . 0.0 110.547 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -60.29 -39.83 88.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.949 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.491 ' HB3' ' HB3' ' A' ' 114' ' ' MET . 14.1 m -74.73 -39.66 61.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.892 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 106' ' ' CYS . 50.8 t -59.03 -47.38 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.855 0.36 . . . . 0.0 110.601 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -65.17 -27.23 68.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.54 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -90.21 9.94 26.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.875 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 60.74 33.07 20.25 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.993 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.51 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -104.51 61.84 0.72 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.955 0.407 . . . . 0.0 110.172 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -63.61 -29.83 71.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.145 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.28 -45.77 92.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.102 0.477 . . . . 0.0 110.556 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.472 ' HB2' ' SD ' ' A' ' 114' ' ' MET . 15.7 tp -69.82 -39.65 76.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.468 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 114' ' ' MET . 67.0 t -59.52 -45.55 93.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.869 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.2 -41.07 99.38 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.323 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -64.5 -46.26 83.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.796 0.331 . . . . 0.0 110.725 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 117' ' ' LEU . 99.8 t -64.25 -46.03 94.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.764 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.04 -45.05 96.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 110.681 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.21 -45.62 92.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.622 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -63.09 -43.49 98.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.113 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 95.1 mtp -57.85 -50.02 74.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.893 0.378 . . . . 0.0 110.655 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.77 -41.23 91.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.877 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.12 -46.14 91.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.578 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -59.58 -43.1 93.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.165 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.648 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 53.8 mt -63.88 -36.12 82.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -90.16 4.92 49.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 m -124.41 -77.1 0.59 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.75 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -75.07 -23.42 58.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.648 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 81.0 mt -109.88 14.32 23.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.348 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.4 -44.14 84.28 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.29 -39.42 48.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.822 0.344 . . . . 0.0 110.749 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.574 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 95.9 m95 -60.62 -50.54 73.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.27 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.75 -37.33 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 0.0 110.322 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -67.75 -36.08 79.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.742 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.7 m -71.68 -40.51 69.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.983 0.42 . . . . 0.0 110.704 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.408 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 68.9 m -78.61 -6.13 54.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.138 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.39 40.83 98.13 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.33 -111.35 3.27 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -109.36 14.93 23.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.05 -62.28 1.94 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.318 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.408 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 5.8 pt-20 -70.86 -20.15 62.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.725 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.468 ' HE1' HG22 ' A' ' 96' ' ' VAL . 75.5 t80 -60.6 -38.39 84.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.821 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -27.39 69.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.485 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.85 -13.83 38.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.748 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.67 HD13 ' HB3' ' A' ' 92' ' ' TRP . 56.6 mt -68.31 -35.3 77.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.918 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -110.22 20.33 17.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 0.0 110.223 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -75.64 -19.79 78.86 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.817 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.8 t0 . . . . . 0 C--N 1.324 -0.519 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.66 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 121.345 0.593 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 8.2 mt -132.8 86.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.889 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.404 ' HD3' ' HG3' ' A' ' 84' ' ' GLU . 64.9 mmtt -64.75 -33.79 76.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.357 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -53.21 -55.26 25.72 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 66.2 mt -65.68 -47.43 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.362 . . . . 0.0 110.956 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 206' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 85' ' ' LEU . . . -56.85 -45.3 82.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.524 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 207' ' ' ARG . . . . . 0.6 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 18.3 ttp-105 -62.04 -36.86 82.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 208' ' ' HIS . . . . . 0.41 ' O ' HG22 ' B' ' 212' ' ' VAL . 38.4 t-80 -60.9 -56.1 25.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.304 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.739 HD13 ' HE2' ' A' ' 101' ' ' PHE . 1.5 pp -65.74 -34.85 79.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.487 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 210' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -69.88 -43.01 72.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.092 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 211' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' B' ' 207' ' ' ARG . 0.7 OUTLIER -65.34 -49.06 70.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.798 -178.764 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' B' ' 216' ' ' MET . 26.0 m -62.99 -44.27 99.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.409 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.44 -38.62 87.04 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.394 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.8 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 4.0 t0 -67.01 -50.52 61.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.835 0.35 . . . . 0.0 111.335 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 2.7 m -69.72 -49.01 57.33 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 216' ' ' MET . . . . . 0.853 ' HG2' ' HD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -60.18 -37.82 81.37 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.043 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.27 -34.05 61.3 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.442 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 218' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.278 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.764 0.316 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 m -87.32 113.05 52.11 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.738 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.28 132.59 19.61 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.358 2.039 . . . . 0.0 112.009 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.96 139.52 32.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.118 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.53 116.91 25.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.108 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.77 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -86.24 -60.03 0.28 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.487 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 23.1 Cg_exo -65.7 138.6 54.51 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.057 1.838 . . . . 0.0 112.122 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.14 156.93 28.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.9 m -58.11 -41.13 82.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.946 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -69.95 -27.44 64.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 110.566 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.24 75.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.467 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.43 -40.27 77.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.682 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t -63.13 -47.03 94.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.968 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.95 -38.43 82.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.031 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.94 -43.23 83.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.545 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -65.06 -48.59 73.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -62.43 -45.23 99.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.342 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.75 -41.03 99.56 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.517 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -61.84 -43.09 99.55 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 21.5 mmmt -59.93 -45.26 93.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.049 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.445 HD12 ' HE3' ' A' ' 24' ' ' LYS . 55.2 tp -65.95 -40.45 91.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.706 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 84.6 mtm-85 -73.37 -30.13 63.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.829 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -64.46 -30.17 71.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HE3' HD12 ' A' ' 21' ' ' LEU . 10.0 pttp -92.88 -0.19 57.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.913 0.387 . . . . 0.0 110.938 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.5 -60.36 0.32 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.112 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -154.14 105.26 2.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.97 113.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.162 0.506 . . . . 0.0 110.712 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.8 t -127.79 127.34 43.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.043 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.01 -135.69 5.24 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.844 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.19 158.57 43.89 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.22 111.8 4.03 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.88 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.68 76.14 4.69 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.037 2.492 . . . . 0.0 111.99 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.22 -84.81 0.79 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.569 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -119.18 127.94 53.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.022 0.439 . . . . 0.0 110.115 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.29 91.7 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.441 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.75 110.5 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.83 2.353 . . . . 0.0 112.064 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.2 150.46 21.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.857 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.469 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -70.4 -26.27 63.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.846 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -101.51 104.8 36.51 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.421 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 74.4 Cg_endo -92.29 -3.41 3.84 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.801 2.334 . . . . 0.0 111.566 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.66 -41.33 96.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.731 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -59.62 -38.86 82.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.865 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -80.71 -37.28 30.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.94 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.69 98.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.897 0.38 . . . . 0.0 110.378 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.1 ttt -62.8 -39.65 94.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.856 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -65.96 -48.85 69.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.642 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.16 79.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.62 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.25 62.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.824 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.99 19.49 13.66 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.255 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -132.46 -47.67 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.622 0.249 . . . . 0.0 111.404 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.53 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 6.2 mm-40 -62.46 -30.54 71.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.626 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.574 ' O ' ' HB2' ' A' ' 56' ' ' PHE . 67.0 t80 -59.57 -32.34 70.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.033 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 59' ' ' THR . 4.6 tp10 -87.14 -26.74 23.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.815 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.9 m -54.27 -47.96 71.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.099 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.53 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 23.1 mtm-85 -102.02 12.4 36.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.846 0.355 . . . . 0.0 111.562 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.574 ' HB2' ' O ' ' A' ' 52' ' ' PHE . 3.2 t80 -97.77 -96.74 0.21 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 56' ' ' PHE . 42.4 ttm180 170.48 -68.43 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.8 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -154.21 79.36 1.11 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.126 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.458 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 61.6 m -57.17 -44.61 83.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.745 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -74.31 1.14 12.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.856 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . 4.8 m -124.04 -54.93 1.7 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -79.27 -57.23 3.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 66' ' ' GLN . 14.6 tp -58.78 -42.86 90.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.018 0.437 . . . . 0.0 110.904 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.51 -17.5 64.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.664 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.15 -46.73 6.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.519 0.2 . . . . 0.0 111.212 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.509 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 8.4 pt20 -64.06 -33.55 76.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.394 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.476 HD13 ' HA ' ' A' ' 67' ' ' LEU . 2.0 mm? -82.49 -11.21 58.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.063 0.459 . . . . 0.0 110.329 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -91.46 -11.83 36.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.798 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.3 t -66.17 -41.81 90.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -74.44 127.32 87.74 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.62 105.7 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.777 2.318 . . . . 0.0 112.098 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.81 -128.09 3.29 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.146 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.706 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 2.9 m -156.78 -148.3 0.21 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.99 -156.62 0.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.504 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -51.38 -35.06 37.04 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.34 0.4 . . . . 0.0 111.914 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -55.55 -42.96 75.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.11 0.481 . . . . 0.0 110.365 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.706 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 11.1 tpp180 -68.01 -43.0 79.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.393 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.507 ' O ' HG12 ' A' ' 81' ' ' VAL . 48.3 m-85 -62.67 -37.06 84.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.985 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.2 m -65.9 -49.92 66.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.609 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -70.22 -33.78 72.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.273 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.528 ' HA ' HD13 ' B' ' 202' ' ' ILE . 1.4 p -67.06 -31.57 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 0.0 110.498 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.9 m -77.32 -44.05 30.93 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.67 -35.98 79.52 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.613 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -53.7 -60.34 3.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.805 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.629 ' HB2' ' HB1' ' B' ' 206' ' ' ALA . 0.2 OUTLIER -78.67 -16.25 57.53 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.517 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -65.63 -34.73 78.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -90.71 11.2 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.202 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.6 25.64 5.02 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.83 83.56 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -83.86 59.24 6.11 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.759 2.306 . . . . 0.0 112.227 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.514 ' HB3' ' OD2' ' B' ' 214' ' ' ASP . 60.2 t30 -76.32 171.8 13.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.818 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.688 ' CD1' HD22 ' A' ' 149' ' ' LEU . 2.4 m0 -52.61 -49.48 64.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.767 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.765 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -65.47 -33.15 85.63 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.465 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -42.67 99.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.663 0.268 . . . . 0.0 110.597 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.404 HD23 ' HD1' ' A' ' 146' ' ' PHE . 29.3 tp -64.32 -42.49 96.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.325 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.76 -47.28 86.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.357 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.644 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -62.21 -40.43 96.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.37 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -59.59 -39.17 83.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.746 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -76.69 -48.83 17.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.193 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 97' ' ' ALA . 7.2 p -63.18 -32.04 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.526 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -60.77 -54.57 43.64 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.987 0.423 . . . . 0.0 110.46 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.03 -43.3 99.05 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.949 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.93 99.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.617 0.246 . . . . 0.0 111.185 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.21 -43.77 97.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.268 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 105' ' ' LEU . 2.1 mm? -68.78 -39.62 80.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.8 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.417 ' O ' HG23 ' A' ' 110' ' ' VAL . 50.4 m -66.12 -46.13 78.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.309 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.5 87.38 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.94 0.4 . . . . 0.0 110.515 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -45.29 91.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.268 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.6 m -65.81 -38.43 88.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.967 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 106' ' ' CYS . 49.9 t -63.16 -41.31 92.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.045 0.45 . . . . 0.0 109.807 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -70.3 -9.56 56.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.369 0.605 . . . . 0.0 110.533 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -105.21 6.4 32.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.008 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 62.66 32.47 16.24 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.198 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.444 ' SD ' ' HB ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -106.57 64.07 0.65 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.646 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -65.56 -21.99 66.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.818 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.444 ' HB ' ' SD ' ' A' ' 114' ' ' MET . 97.4 t -58.83 -56.36 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.758 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 121' ' ' VAL . 28.7 tp -66.95 -37.47 84.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.681 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.5 t -59.28 -48.48 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.44 -38.62 93.76 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.14 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -68.43 -50.45 52.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.747 0.308 . . . . 0.0 110.506 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 117' ' ' LEU . 71.9 t -58.24 -44.02 87.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.107 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -45.59 86.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.245 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.82 -45.16 87.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.729 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -55.91 -44.6 78.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.999 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 89.9 mtp -67.69 -50.08 59.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.392 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.14 -47.05 93.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.262 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.98 93.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.05 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -62.11 -38.48 89.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.874 0.368 . . . . 0.0 110.612 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.829 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 35.7 mt -66.92 -20.93 65.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.282 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.54 -13.72 15.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.3 m -94.96 -64.04 1.11 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -101.81 -32.12 10.42 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.829 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 73.4 mt -90.65 13.19 16.7 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.29 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.23 -53.55 53.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 110.598 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.94 -37.23 86.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.589 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.456 ' CD1' ' HA ' ' A' ' 133' ' ' LEU . 91.3 m95 -60.21 -56.5 20.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.681 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.659 HG23 ' HA2' ' A' ' 142' ' ' GLY . 45.9 mm -60.03 -36.14 65.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.009 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -63.61 -48.23 78.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.655 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.5 m -70.74 -32.2 69.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.584 0.23 . . . . 0.0 111.616 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.4 m -82.67 -6.41 59.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.796 0.331 . . . . 0.0 111.074 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.08 41.17 95.22 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.98 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.659 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 73.44 -103.2 1.38 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -118.37 16.08 13.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.59 -51.93 65.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.938 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -83.33 -15.96 48.02 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.625 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 89.0 t80 -61.7 -44.02 97.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.78 0.324 . . . . 0.0 110.5 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -24.67 66.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.129 0.49 . . . . 0.0 110.773 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.86 25.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.375 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.688 HD22 ' CD1' ' A' ' 92' ' ' TRP . 32.4 mt -61.39 -50.55 72.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 110.871 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -90.69 9.24 30.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.638 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.21 -10.61 84.55 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.8 t70 . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.14 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 201' ' ' ILE . . . . . 0.443 HG22 HG13 ' B' ' 202' ' ' ILE . 43.3 mt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.979 0.418 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' A' ' 81' ' ' VAL . 0.8 OUTLIER -150.46 49.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.905 179.572 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' B' ' 207' ' ' ARG . 42.2 mttp -57.15 -33.71 67.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.632 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -59.78 -50.71 72.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 23.0 mt -70.35 -39.95 77.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.94 0.4 . . . . 0.0 110.026 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 206' ' ' ALA . . . . . 0.629 ' HB1' ' HB2' ' A' ' 85' ' ' LEU . . . -60.18 -46.09 90.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.215 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 207' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' B' ' 203' ' ' LYS . 0.4 OUTLIER -62.25 -36.81 83.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.489 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -58.75 -55.7 31.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.266 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.5 pp -68.76 -36.43 78.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 111.098 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.49 -51.95 63.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.756 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -59.76 -45.5 92.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.595 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' B' ' 216' ' ' MET . 85.4 t -62.75 -55.17 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.604 0.24 . . . . 0.0 111.229 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.71 -45.63 87.99 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.182 -0.532 . . . . 0.0 114.385 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.765 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 11.0 t70 -56.06 -47.29 78.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.94 0.4 . . . . 0.0 111.576 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.7 m -75.48 -41.16 56.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.257 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 216' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' B' ' 212' ' ' VAL . 5.0 tpt -54.46 -50.01 68.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.6 -34.48 74.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.865 0.364 . . . . 0.0 111.402 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 218' ' ' ARG . . . . . 0.521 HH21 ' HA2' ' A' ' 93' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.352 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.76 0.314 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -134.46 102.18 11.77 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.221 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.4 114.21 3.39 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.565 2.177 . . . . 0.0 112.147 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.65 118.48 16.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.504 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -83.27 108.93 16.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.351 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -83.96 -52.14 0.58 Allowed Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.021 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 23.8 Cg_exo -65.05 129.17 22.36 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.941 1.761 . . . . 0.0 112.345 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -78.76 154.36 30.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.227 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -55.82 -38.92 70.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.215 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -69.95 -34.07 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.81 0.338 . . . . 0.0 110.645 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.23 -33.48 76.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.159 0.505 . . . . 0.0 109.878 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.2 tp -70.95 -40.53 71.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.815 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 9' ' ' THR . 87.9 t -62.67 -45.99 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.286 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.04 -36.35 74.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.093 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.68 -51.6 66.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.458 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -63.01 -44.19 96.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.098 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -61.53 -47.59 92.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 120.846 0.355 . . . . 0.0 110.274 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.31 -36.41 92.71 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.509 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.536 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 30.2 t80 -64.65 -49.64 70.19 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -57.94 -40.28 80.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.238 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.561 HD13 HG12 ' A' ' 110' ' ' VAL . 36.1 tp -65.91 -33.12 75.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.787 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -81.83 -22.24 37.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.498 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 15.6 mm100 -61.68 -26.4 68.0 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -94.95 3.28 55.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.668 0.271 . . . . 0.0 111.394 -179.59 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -126.91 -60.29 0.14 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.564 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -157.03 104.36 2.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.4 t -65.76 120.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.517 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.2 t -128.79 99.3 5.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.219 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.98 -134.22 1.73 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.894 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.92 174.05 10.89 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.15 83.56 0.35 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.4 99.09 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.824 2.35 . . . . 0.0 111.96 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.64 -52.15 0.82 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.539 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -137.49 91.07 2.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.044 0.45 . . . . 0.0 110.325 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.75 105.32 0.24 Allowed Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.702 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.1 111.95 1.01 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.783 2.322 . . . . 0.0 111.821 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.38 139.96 39.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.431 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.72 -35.26 67.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.527 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 41' ' ' LEU . 4.4 t70 -96.1 112.69 60.39 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.729 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -94.47 -1.5 2.8 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.684 2.256 . . . . 0.0 112.655 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.433 ' HB2' ' OD1' ' A' ' 39' ' ' ASP . 24.9 mt -64.31 -44.64 90.97 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -62.22 -32.19 72.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.386 . . . . 0.0 110.818 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -79.79 -44.17 21.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.129 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.66 ' HB1' ' HE2' ' A' ' 146' ' ' PHE . . . -61.89 -42.96 99.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.743 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.567 ' HG3' ' HE2' ' A' ' 99' ' ' PHE . 13.8 ttt -61.57 -36.64 81.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.247 0.546 . . . . 0.0 110.202 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -73.67 -42.4 61.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.313 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.9 90.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.627 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -55.11 -25.79 33.89 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.86 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.434 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -123.76 39.85 2.09 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.227 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -162.82 -42.59 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.577 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 23.4 mm-40 -54.3 -60.33 3.48 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.434 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 11.5 p90 -57.46 -27.81 62.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.584 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 4.6 tp10 -72.9 -46.43 52.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.754 0.312 . . . . 0.0 110.947 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 m -64.95 -24.32 67.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.109 0.48 . . . . 0.0 110.738 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.577 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 9.6 mtm-85 -87.28 -25.18 24.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.202 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -97.52 -92.27 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.994 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 179.92 -64.23 0.01 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.921 0.391 . . . . 0.0 110.418 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.837 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -148.26 54.7 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.209 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.38 -30.41 71.55 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -59.74 -39.04 83.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.937 0.399 . . . . 0.0 110.287 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.424 ' OG ' ' HD3' ' A' ' 58' ' ' ARG . 1.6 m -86.59 -38.42 17.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.389 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 24.0 t70 -60.66 -41.53 95.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.0 tp -59.56 -39.86 85.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.408 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.22 -43.37 61.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.026 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.52 85.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.74 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 10.9 pt20 -66.3 -34.11 77.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 0.0 110.677 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.31 -24.87 63.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.091 0.472 . . . . 0.0 110.366 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -79.66 -13.22 59.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.554 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.4 t -76.25 -29.74 19.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 p -94.03 161.08 30.87 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.366 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.98 70.04 2.98 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.0 2.467 . . . . 0.0 112.034 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.84 -163.79 30.5 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.58 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -152.57 -132.06 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -99.69 -159.08 0.72 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.608 0.242 . . . . 0.0 110.886 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -51.32 -43.39 61.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.279 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -54.49 -44.52 72.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 0.0 111.192 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -71.76 -37.74 70.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.613 ' O ' HG12 ' A' ' 81' ' ' VAL . 15.5 m-85 -65.54 -45.95 81.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.593 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 m -69.38 -38.45 78.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.893 0.378 . . . . 0.0 110.854 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HA ' ' OD1' ' A' ' 83' ' ' ASP . 5.9 tp60 -65.92 -32.22 73.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.682 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 78' ' ' PHE . 1.9 p -75.37 -11.67 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.083 0.468 . . . . 0.0 110.982 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.0 m -86.95 -45.92 10.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.195 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.53 ' OD1' ' HA ' ' A' ' 80' ' ' GLN . 5.1 p-10 -80.7 -12.59 59.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.245 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.99 -41.56 96.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.919 0.39 . . . . 0.0 110.975 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.606 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -97.73 -11.86 22.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.126 -179.435 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 95' ' ' LEU . 18.4 t80 -68.43 -25.65 65.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.902 0.382 . . . . 0.0 110.732 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -69.18 -9.72 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.657 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.97 -8.88 71.81 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.21 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.87 134.14 3.3 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.786 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.05 69.54 7.88 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.829 2.352 . . . . 0.0 111.945 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.623 ' HB3' ' HB2' ' A' ' 94' ' ' ARG . 21.5 t30 -68.87 171.86 7.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.849 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.595 ' HA ' ' HB3' ' A' ' 149' ' ' LEU . 1.9 m-90 -46.43 -71.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 1.02 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -79.43 -15.98 78.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.555 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.623 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -61.97 -45.29 94.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.494 ' HA ' ' HE1' ' A' ' 86' ' ' PHE . 37.2 tp -68.65 -37.45 79.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.558 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 48' ' ' ALA . 74.7 t -62.01 -53.02 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.697 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.424 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -60.32 -43.82 96.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.509 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -62.19 -41.94 98.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 0.0 110.849 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.567 ' HE2' ' HG3' ' A' ' 45' ' ' MET . 10.9 t80 -71.02 -47.67 57.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.649 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 97' ' ' ALA . 9.8 p -68.12 -31.27 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.464 ' HE2' HD22 ' B' ' 209' ' ' LEU . 0.8 OUTLIER -57.47 -54.42 47.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.895 0.378 . . . . 0.0 110.181 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.81 -43.49 96.08 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.094 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.05 95.53 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.68 -46.2 76.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.704 0.288 . . . . 0.0 111.043 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 41.4 m -64.36 -46.29 84.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.459 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.03 75.26 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.014 0.435 . . . . 0.0 110.16 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.17 -44.12 84.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.735 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.596 ' HB2' HG22 ' A' ' 118' ' ' VAL . 6.3 m -66.66 -36.5 82.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.487 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.561 HG12 HD13 ' A' ' 21' ' ' LEU . 43.4 t -63.56 -43.97 98.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.05 0.453 . . . . 0.0 110.2 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -68.49 -23.09 64.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.793 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -94.7 13.5 24.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.448 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 60.06 45.22 12.21 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.66 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.568 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -124.79 56.8 1.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.18 0.514 . . . . 0.0 109.811 178.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.09 -29.35 68.52 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.837 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 t -56.32 -51.63 61.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.119 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.33 -35.68 76.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.805 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 109' ' ' SER . 55.3 t -59.25 -45.11 93.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 0.0 110.593 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.75 -38.04 94.04 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.786 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -63.21 -48.86 76.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 110.384 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.94 -43.86 96.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.469 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -61.65 -44.4 97.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.659 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.86 -47.49 84.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.485 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -62.54 -44.88 95.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.912 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.5 ttt -60.3 -52.47 65.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.548 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.409 ' HA ' HD12 ' A' ' 129' ' ' LEU . 91.7 t -62.45 -44.4 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.93 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.89 94.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.445 ' OH ' ' HD3' ' A' ' 132' ' ' ARG . 44.7 t80 -59.59 -38.84 82.29 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.579 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 21.3 mt -63.6 -32.46 73.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.879 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -95.89 -0.85 50.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.422 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.6 m -105.19 -64.13 1.16 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.445 ' HD3' ' OH ' ' A' ' 128' ' ' TYR . 25.1 ttt180 -102.84 -22.52 13.86 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 69.1 mt -101.37 15.12 29.84 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.517 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.1 -50.54 72.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.296 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.07 -41.03 87.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.493 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 89.8 m95 -57.91 -51.59 69.01 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.41 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.515 HG23 ' HA2' ' A' ' 142' ' ' GLY . 26.0 mm -62.73 -37.99 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.353 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -65.47 -36.15 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.916 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.3 m -73.46 -33.61 64.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.162 0.506 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.1 m -85.42 -5.2 59.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.98 42.07 96.99 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.515 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 75.93 -100.33 1.34 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -120.23 14.23 12.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.153 0.501 . . . . 0.0 109.769 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.97 93.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.245 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.527 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -77.62 -17.93 57.28 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.05 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.66 ' HE2' ' HB1' ' A' ' 44' ' ' ALA . 28.3 t80 -63.29 -32.65 74.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.902 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -38.14 68.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.001 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.3 -28.02 23.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.595 ' HB3' ' HA ' ' A' ' 92' ' ' TRP . 62.7 mt -56.02 -53.87 51.67 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.059 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -100.47 10.79 40.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.239 0.542 . . . . 0.0 110.477 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -91.82 23.16 27.41 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.052 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.597 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 201' ' ' ILE . . . . . 0.44 ' HB ' ' H ' ' B' ' 202' ' ' ILE . 4.9 pt . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.706 0.288 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.44 ' H ' ' HB ' ' B' ' 201' ' ' ILE . 24.0 mt -68.98 106.84 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.603 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -62.53 -32.78 73.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.979 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -51.09 -42.73 60.81 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.156 0.285 . . . . 0.0 111.519 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 205' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' B' ' 208' ' ' HIS . 21.8 mt -68.39 -42.6 84.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.86 0.362 . . . . 0.0 110.334 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 206' ' ' ALA . . . . . 0.573 ' HB1' ' HB2' ' A' ' 85' ' ' LEU . . . -61.34 -45.86 92.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.527 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 207' ' ' ARG . . . . . 0.606 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 42.1 ttp85 -64.53 -35.36 80.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.819 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 208' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' B' ' 205' ' ' ILE . 3.8 t60 -57.37 -51.03 71.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.925 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.4 pp -74.48 -36.18 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.351 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 210' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -62.28 -47.27 85.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.025 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.29 -39.92 93.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.731 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.59 -52.22 60.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.508 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.85 -40.2 98.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.828 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 1.02 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 1.3 t0 -64.4 -55.77 18.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.018 0.437 . . . . 0.0 111.479 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.6 m -66.57 -33.83 76.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 216' ' ' MET . . . . . . . . . . . . . 20.7 tpp -73.38 -48.74 31.63 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.91 -41.5 95.52 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.849 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 218' ' ' ARG . . . . . 0.47 ' HD3' ' HA ' ' B' ' 218' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.48 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.979 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.87 0.367 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.4 111.05 15.16 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.747 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.23 134.23 24.51 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.716 2.277 . . . . 0.0 111.485 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.29 115.17 28.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.652 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 m -70.61 120.6 16.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.194 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.605 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -88.54 -51.82 0.38 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.557 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 31.5 Cg_exo -62.58 136.72 60.12 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.078 1.852 . . . . 0.0 112.108 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.99 154.62 40.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.557 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m -63.47 -34.53 77.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.782 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 10' ' ' ARG . 2.0 mtm180 -72.64 -26.8 61.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.811 0.338 . . . . 0.0 110.157 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.99 89.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.156 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.64 -44.18 96.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.556 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.3 t -63.17 -44.72 99.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.114 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.8 -37.12 85.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -68.65 -42.66 77.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.172 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -62.59 -51.61 66.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.393 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.63 -45.41 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.327 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.66 -42.78 99.81 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.778 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.643 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 1.8 t80 -63.71 -45.21 91.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -60.39 -34.82 74.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.593 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.1 tp -70.73 -25.22 62.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.26 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.4 mtm-85 -85.92 -35.56 20.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.56 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.672 ' HA ' HG22 ' A' ' 27' ' ' VAL . 10.1 mm100 -64.12 -25.59 68.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.476 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -84.43 -3.88 58.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.815 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -132.65 -88.54 0.39 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.722 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -113.56 97.52 6.5 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.672 HG22 ' HA ' ' A' ' 23' ' ' GLN . 75.0 t -62.72 115.72 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.057 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.89 97.87 5.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.527 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.462 ' HA3' ' OH ' ' A' ' 19' ' ' TYR . . . -176.82 165.13 35.08 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.82 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.93 123.98 46.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.735 0.302 . . . . 0.0 110.432 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.402 ' HA2' ' HD3' ' A' ' 32' ' ' PRO . . . -72.31 121.09 8.05 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.609 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.402 ' HD3' ' HA2' ' A' ' 31' ' ' GLY . 11.4 Cg_endo -89.08 106.13 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.419 2.746 . . . . 0.0 111.383 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.44 -70.11 0.9 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.015 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -120.46 64.73 0.84 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.277 0.56 . . . . 0.0 110.316 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.02 99.61 0.24 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.116 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.3 109.15 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.845 2.363 . . . . 0.0 112.183 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.72 139.08 34.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.421 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -72.45 -24.32 61.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.681 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -94.16 106.84 24.86 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.974 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 90.6 Cg_endo -95.85 -6.48 1.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.825 2.35 . . . . 0.0 111.74 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.8 mt -65.66 -50.95 63.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.878 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -64.46 -37.88 89.09 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.952 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -69.3 -41.67 76.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.67 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.09 90.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.8 ttt -63.26 -43.24 98.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.714 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -62.48 -46.41 88.59 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.41 87.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.5 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.68 -38.19 69.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.953 0.406 . . . . 0.0 111.812 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.65 27.69 12.94 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.501 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -143.11 -51.9 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.708 ' HA ' HG22 ' A' ' 54' ' ' THR . 41.3 mm-40 -64.11 -35.57 81.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.777 0.322 . . . . 0.0 110.46 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -66.75 -10.96 52.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.783 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.647 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 7.3 tp10 -107.45 -49.94 3.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.667 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.708 HG22 ' HA ' ' A' ' 51' ' ' GLU . 2.0 t -64.67 -31.48 72.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.761 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 55' ' ' ARG . 22.1 mtm180 -94.36 9.83 36.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.081 0.467 . . . . 0.0 110.39 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.959 ' HA ' ' HG2' ' B' ' 216' ' ' MET . 49.7 t80 -107.28 -82.89 0.54 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.642 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 5.1 mtm105 167.3 -65.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.808 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -153.35 72.2 0.92 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.924 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.647 ' OG1' ' HA ' ' A' ' 53' ' ' GLU . 2.5 m -62.81 -41.58 99.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.024 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.26 20.87 1.52 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.348 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.616 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . 51.9 m -153.2 -77.03 0.12 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -56.72 -44.17 81.36 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 38.4 tp -62.89 -43.49 98.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.859 0.361 . . . . 0.0 110.343 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -66.55 -34.9 78.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.597 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.29 -44.05 72.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.515 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -74.36 -25.74 59.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.867 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -83.82 -17.92 39.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.122 0.487 . . . . 0.0 110.133 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 3.2 t-80 -76.45 -14.14 60.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.39 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.88 -32.88 56.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.305 0.574 . . . . 0.0 109.545 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.58 140.28 55.39 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.881 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.14 99.29 0.16 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.865 2.377 . . . . 0.0 112.257 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.7 -149.49 15.1 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.282 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.837 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 49.0 m -158.22 -157.73 0.66 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.3 -156.92 0.1 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.019 0.438 . . . . 0.0 111.561 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.552 ' HG3' HD21 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -56.8 -30.11 63.38 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.15 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -66.04 -22.85 66.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.691 0.282 . . . . 0.0 111.434 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.837 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 21.4 tpp85 -85.1 -36.68 20.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.713 0.292 . . . . 0.0 110.444 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -69.9 -31.25 68.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.512 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.96 -20.48 57.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.711 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -111.48 5.37 19.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.718 0.295 . . . . 0.0 111.656 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.8 p -100.59 -14.36 7.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.384 0.611 . . . . 0.0 110.322 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.689 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -85.36 -41.52 15.4 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.535 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.36 -13.96 57.75 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.389 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' B' ' 206' ' ' ALA . 3.6 tp10 -54.96 -41.73 71.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.886 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.5 HD23 ' HB3' ' B' ' 206' ' ' ALA . 0.3 OUTLIER -106.42 32.76 4.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.134 0.492 . . . . 0.0 110.495 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -121.27 -36.02 3.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.528 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -62.42 -31.05 71.68 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.223 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.74 1.48 86.02 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.7 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.78 117.51 1.58 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.678 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.09 164.56 24.66 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.879 2.386 . . . . 0.0 112.037 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.459 ' HB3' ' HB2' ' A' ' 94' ' ' ARG . 24.1 t30 -148.25 169.0 21.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.627 ' HA ' HD22 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -50.04 -61.56 2.08 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.808 0.692 . . . . 0.0 112.213 -178.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.94 -4.83 84.28 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.063 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.459 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 4.2 tpp85 -65.29 -45.77 83.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.726 0.298 . . . . 0.0 110.558 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.4 tp -67.62 -37.8 83.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.135 0.493 . . . . 0.0 110.058 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.504 HG22 ' HE1' ' A' ' 146' ' ' PHE . 3.1 t -65.92 -41.36 89.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.358 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.637 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -62.21 -39.46 92.83 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.057 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.689 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 66.1 t80 -61.61 -37.08 82.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.167 0.508 . . . . 0.0 110.302 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -79.69 -46.89 16.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.345 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.637 HG12 ' HA ' ' A' ' 97' ' ' ALA . 4.4 p -61.7 -34.02 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.41 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -64.35 -50.93 65.79 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.909 0.385 . . . . 0.0 110.006 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.98 98.59 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.881 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.05 83.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.614 0.245 . . . . 0.0 111.484 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.28 79.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.656 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 105' ' ' LEU . 3.6 mm? -62.71 -38.78 91.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.361 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.7 m -72.66 -43.53 63.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.569 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.1 -37.65 77.67 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.101 0.477 . . . . 0.0 110.424 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.64 -43.68 88.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.787 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 114' ' ' MET . 21.5 m -68.43 -43.87 76.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.251 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.418 HG23 HG21 ' A' ' 118' ' ' VAL . 53.0 t -59.4 -37.37 69.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.017 0.437 . . . . 0.0 110.403 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -63.61 -29.15 70.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.839 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.9 mtpt -99.04 17.14 20.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.099 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 59.8 34.76 21.94 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.546 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.479 ' HB3' ' HB3' ' A' ' 109' ' ' SER . 0.0 OUTLIER -100.47 66.6 1.26 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.953 0.406 . . . . 0.0 110.169 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.07 -28.78 67.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.943 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.452 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 22.3 t -58.39 -51.14 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.003 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.552 HD21 ' HG3' ' A' ' 75' ' ' GLN . 14.1 tp -68.34 -39.69 81.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.984 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 114' ' ' MET . 87.7 t -59.49 -43.9 91.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.86 99.25 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.745 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 23.8 mt-30 -63.21 -50.9 68.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.624 0.25 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.28 -48.12 88.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.298 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -45.81 91.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.745 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -62.02 -42.8 99.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.246 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -60.62 -46.46 90.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.806 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 88.8 mtp -59.0 -50.94 72.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.975 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.48 -41.27 87.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.936 0.398 . . . . 0.0 110.907 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.3 -51.83 61.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.574 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.41 -42.56 87.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.215 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.666 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 36.7 mt -61.8 -26.34 68.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.102 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -107.89 3.71 24.59 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.675 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.0 m -107.41 -50.56 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -122.05 -18.7 6.85 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.893 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.678 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 83.8 mt -101.69 3.9 40.14 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.631 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.64 87.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.947 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.66 -39.7 81.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.209 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.678 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 91.8 m95 -68.09 -54.43 18.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.372 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.488 HG23 ' HA2' ' A' ' 142' ' ' GLY . 42.0 mm -56.73 -37.38 52.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.301 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -59.5 -45.11 92.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.237 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.4 m -77.51 -33.29 54.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.425 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 67.0 m -74.98 -3.24 31.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.67 39.66 96.91 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.488 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 72.04 -94.17 0.61 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -120.68 17.53 11.96 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.57 -51.56 66.86 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.54 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.622 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 4.2 pt-20 -78.21 -20.97 50.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.915 0.388 . . . . 0.0 110.5 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.504 ' HE1' HG22 ' A' ' 96' ' ' VAL . 91.5 t80 -61.25 -40.96 96.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.222 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.531 ' HA ' ' CE1' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -60.33 -33.45 72.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 110.831 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.23 -34.58 42.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.549 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.627 HD22 ' HA ' ' A' ' 92' ' ' TRP . 81.3 mt -57.38 -50.34 73.3 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.05 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.531 ' CE1' ' HA ' ' A' ' 147' ' ' THR . 5.6 p90 -86.15 -6.49 58.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.089 0.471 . . . . 0.0 110.229 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.65 -25.37 60.79 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 121.169 0.509 . . . . 0.0 109.844 178.878 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 201' ' ' ILE . . . . . 0.558 HG22 HG13 ' B' ' 202' ' ' ILE . 52.0 mt . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.859 0.361 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.558 HG13 HG22 ' B' ' 201' ' ' ILE . 44.9 mt -144.01 111.17 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -64.73 -34.26 77.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.332 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -53.91 -48.11 70.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 38.1 mt -62.6 -48.43 88.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.677 0.275 . . . . 0.0 110.97 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 206' ' ' ALA . . . . . 0.5 ' HB3' HD23 ' A' ' 85' ' ' LEU . . . -62.28 -43.15 99.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.626 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -35.86 75.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.121 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.99 -55.18 35.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.864 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.3 pp -68.65 -38.03 80.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.643 0.259 . . . . 0.0 111.642 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 210' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -65.66 -51.36 60.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -59.12 -52.09 67.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' B' ' 216' ' ' MET . 57.2 t -64.29 -47.85 87.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.683 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.97 -50.66 56.88 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.92 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' B' ' 210' ' ' ALA . 0.9 OUTLIER -61.33 -46.99 87.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.409 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 15.9 m -67.18 -34.98 78.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.728 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' MET . . . . . 0.959 ' HG2' ' HA ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -68.83 -46.89 67.4 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.707 -179.437 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.66 -34.15 77.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.996 0.427 . . . . 0.0 110.503 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.198 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.165 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.753 0.311 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.8 m -109.66 108.3 59.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.004 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.34 114.61 3.78 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.279 1.986 . . . . 0.0 111.567 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.41 130.32 42.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.528 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 m -88.13 120.7 29.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.638 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -84.4 -53.68 0.5 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 21.5 Cg_exo -66.13 125.72 14.57 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.119 1.879 . . . . 0.0 113.156 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.79 159.74 30.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.25 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -41.46 82.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.771 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 10' ' ' ARG . 0.6 OUTLIER -69.73 -32.6 71.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.713 0.292 . . . . 0.0 110.87 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.72 -40.65 92.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.34 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.8 -40.87 92.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.027 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.0 t -64.59 -42.53 95.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.261 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.55 -42.96 89.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.512 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.26 -37.85 86.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.0 -48.08 69.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.74 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.93 -43.39 97.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.166 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.71 98.35 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.402 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 23.3 t80 -62.81 -42.83 99.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -60.01 -36.22 76.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 0.0 110.432 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.2 tp -72.69 -28.32 62.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.232 0.539 . . . . 0.0 110.216 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 73.8 mtm-85 -80.77 -26.97 36.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.892 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 16.0 mm100 -64.35 -28.26 69.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.327 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -92.37 6.64 46.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.937 0.398 . . . . 0.0 110.789 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.83 -93.92 0.46 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -119.7 108.69 14.75 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.66 113.99 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.962 0.411 . . . . 0.0 110.396 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t -124.2 99.24 6.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.369 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.98 -132.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.538 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.7 149.64 27.72 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.96 112.33 3.43 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.036 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 88.85 1.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.55 2.167 . . . . 0.0 111.877 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.72 -129.22 5.58 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -85.09 68.73 10.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.066 0.46 . . . . 0.0 110.861 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.13 103.74 0.44 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.078 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.12 116.87 3.48 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.95 2.433 . . . . 0.0 112.383 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.52 152.64 18.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.077 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.63 -31.07 32.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.215 0.531 . . . . 0.0 109.981 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -107.92 126.0 30.8 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.196 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 39' ' ' ASP . 57.6 Cg_endo -97.2 4.63 1.58 Allowed 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.074 2.516 . . . . 0.0 111.089 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.9 mt -71.15 -46.87 60.63 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.132 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -61.39 -32.91 72.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.212 0.53 . . . . 0.0 110.084 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -78.69 -38.54 39.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.569 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.503 ' HB1' ' HE2' ' A' ' 146' ' ' PHE . . . -64.24 -41.7 96.87 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.499 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.9 ttt -63.32 -38.36 90.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.943 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -68.24 -48.78 64.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.264 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.59 -43.71 84.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.447 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.46 -42.34 64.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.39 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.6 40.18 2.64 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.614 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -155.62 -42.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 41.5 mm-40 -58.78 -78.41 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 4.5 p90 -64.15 -21.9 66.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.703 0.287 . . . . 0.0 110.668 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 32.1 tp10 -63.55 -52.98 58.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.547 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 m -74.92 -29.56 61.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.584 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.412 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 15.9 mtm-85 -71.22 -17.2 62.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.478 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -102.96 -74.79 0.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.232 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ttm105 177.36 -69.38 0.01 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.999 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.94 58.75 0.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.917 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.698 HG22 HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -57.11 -25.67 59.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.245 -178.581 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -53.95 -31.11 49.46 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 111.007 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.01 -29.62 5.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 18.0 t70 -69.04 -30.23 68.55 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.698 HD13 HG22 ' A' ' 59' ' ' THR . 5.5 tp -55.65 -38.07 69.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 111.218 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.93 -11.75 56.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.0 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.27 -47.08 8.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.995 0.426 . . . . 0.0 110.618 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 8.3 pt20 -66.98 -30.62 70.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.106 0.479 . . . . 0.0 110.142 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.479 HD22 ' HG3' ' A' ' 66' ' ' GLN . 1.1 mm? -96.73 14.7 24.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.211 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.73 -9.53 58.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.054 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.71 -36.07 75.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.96 129.69 35.0 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.359 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.67 117.02 3.39 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.826 2.35 . . . . 0.0 112.325 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.43 -159.04 21.99 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.159 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.0 m -143.18 -130.64 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -99.05 -153.99 0.45 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.341 0.115 . . . . 0.0 110.719 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.455 ' OE1' ' HB3' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -56.51 -33.16 65.75 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.422 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.463 ' HG3' ' CZ3' ' A' ' 124' ' ' TRP . 22.9 mp0 -56.58 -28.47 60.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.617 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -83.13 -9.66 59.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.043 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.522 ' O ' HG12 ' A' ' 81' ' ' VAL . 30.8 m-85 -108.59 -43.24 4.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.714 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.25 -30.17 68.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.76 0.314 . . . . 0.0 111.785 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.503 ' HB3' HD11 ' B' ' 201' ' ' ILE . 6.7 tp60 -100.95 12.13 38.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.959 0.409 . . . . 0.0 111.314 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 78' ' ' PHE . 2.1 p -109.27 -14.07 10.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.286 0.565 . . . . 0.0 110.288 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.627 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -81.26 -36.99 29.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.81 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -77.65 -20.28 54.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -53.81 -42.89 68.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.703 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.744 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -95.02 5.92 50.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.26 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -100.86 -36.52 9.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.423 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -52.32 -39.24 60.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.591 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.76 34.2 5.11 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.498 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.523 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . 175.94 83.34 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.837 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.47 ' HG3' ' CZ3' ' A' ' 136' ' ' TRP . 4.8 Cg_exo -79.85 53.01 4.54 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.223 2.615 . . . . 0.0 111.688 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -71.68 164.9 25.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.617 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.847 ' HD1' HD22 ' A' ' 149' ' ' LEU . 2.2 m-90 -53.89 -58.02 8.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.755 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.65 -14.13 79.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.26 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 6.7 tpp85 -66.79 -47.78 71.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.748 0.309 . . . . 0.0 110.586 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.405 HD23 ' CD1' ' A' ' 146' ' ' PHE . 26.3 tp -64.86 -36.06 83.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.741 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.7 t -62.97 -50.93 77.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.264 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -60.2 -42.49 95.22 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.458 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.627 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 52.5 t80 -62.69 -45.21 93.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.081 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -72.11 -42.53 65.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.912 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 97' ' ' ALA . 3.9 p -70.46 -27.98 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.634 ' HE2' HD13 ' B' ' 209' ' ' LEU . 0.2 OUTLIER -57.53 -50.69 72.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 110.444 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.1 -43.26 97.48 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.862 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -46.77 88.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.467 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.15 -43.53 98.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.268 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.455 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . 2.0 mm? -68.17 -39.34 82.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.984 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.2 m -67.2 -39.65 86.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.243 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.72 89.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.946 0.403 . . . . 0.0 110.291 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -41.24 82.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.855 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -67.55 -46.39 72.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.204 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.16 -40.3 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.894 0.378 . . . . 0.0 110.422 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -64.1 -26.8 68.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.415 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -96.03 9.87 39.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.148 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 68.73 15.88 8.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.197 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.459 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -88.58 67.23 8.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.182 0.515 . . . . 0.0 110.481 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -71.53 -28.76 64.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.704 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -56.87 -46.61 83.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.578 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.4 HD21 ' HG3' ' A' ' 75' ' ' GLN . 25.6 tp -67.94 -43.62 78.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.923 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 114' ' ' MET . 64.0 t -56.98 -46.67 84.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.641 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.04 -35.12 82.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.726 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -77.25 -47.15 20.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.622 0.248 . . . . 0.0 110.572 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.47 -45.79 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.784 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.404 ' HA ' ' NE2' ' A' ' 122' ' ' GLN . 1.3 tp60 -61.36 -44.42 97.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.677 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -63.69 -40.04 95.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.165 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.463 ' CZ3' ' HG3' ' A' ' 76' ' ' GLN . 13.1 m0 -59.93 -44.52 94.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.635 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 85.1 mtp -60.65 -51.91 67.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.175 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.68 -44.55 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.77 0.319 . . . . 0.0 111.263 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.26 -44.97 96.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -60.85 -42.88 98.7 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.626 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.505 HD23 HD12 ' A' ' 133' ' ' LEU . 68.8 mt -62.84 -31.81 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.4 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -92.46 11.4 26.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 111.629 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.0 m -122.92 -70.0 0.8 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.606 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -85.35 -33.89 21.93 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.505 HD12 HD23 ' A' ' 129' ' ' LEU . 48.0 mt -102.47 16.58 25.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.268 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.12 -48.5 79.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 110.733 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.61 -36.83 84.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.321 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.47 ' CZ3' ' HG3' ' A' ' 90' ' ' PRO . 11.3 m95 -61.02 -55.37 33.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.392 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.414 HG23 ' HA2' ' A' ' 142' ' ' GLY . 46.7 mm -59.55 -39.9 80.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.685 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -63.37 -41.64 98.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.159 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.5 m -71.54 -37.73 71.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.375 . . . . 0.0 111.173 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.608 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 65.4 m -81.19 -6.3 58.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.812 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.46 43.32 96.86 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.004 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.414 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 78.95 -113.62 3.71 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.327 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -110.49 17.97 20.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.997 0.427 . . . . 0.0 110.379 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.66 -60.37 3.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.432 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.608 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 5.9 pt-20 -68.5 -27.49 66.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 110.643 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.616 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 73.7 t80 -61.88 -35.79 79.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.049 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.776 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 27.7 m -62.8 -24.82 67.93 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.569 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.98 -24.0 22.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.122 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.847 HD22 ' HD1' ' A' ' 92' ' ' TRP . 29.8 mt -62.58 -47.64 82.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 110.819 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.776 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 11.1 p90 -96.29 12.67 30.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.301 0.572 . . . . 0.0 110.096 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.88 -23.73 63.47 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.11 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--N 1.323 -0.551 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.882 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 201' ' ' ILE . . . . . 0.503 HD11 ' HB3' ' A' ' 80' ' ' GLN . 26.1 mt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.718 0.294 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 96.3 mt -143.1 114.81 2.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -61.38 -38.0 85.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.231 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -57.53 -44.38 85.06 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 111.665 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.65 -52.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.083 0.468 . . . . 0.0 110.493 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 206' ' ' ALA . . . . . 0.457 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -60.21 -40.72 91.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.078 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 207' ' ' ARG . . . . . 0.744 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 28.8 ttp-105 -63.47 -37.2 86.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.055 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -63.68 -49.64 72.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.209 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.634 HD13 ' HE2' ' A' ' 101' ' ' PHE . 1.5 pp -67.63 -37.91 83.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.738 0.304 . . . . 0.0 110.918 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -67.32 -44.47 79.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.081 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -59.67 -47.27 86.3 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 123.272 0.358 . . . . 0.0 111.008 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.38 -53.45 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.25 0.343 . . . . 0.0 111.349 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -43.55 98.14 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.149 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.52 -40.07 85.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.005 0.431 . . . . 0.0 111.751 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 51.0 m -75.34 -46.01 35.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 216' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -34.18 77.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 217' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . 34.5 t70 -75.16 -33.35 61.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.576 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 218' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' B' ' 218' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.781 0.324 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 m -124.17 113.6 27.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.51 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.0 128.27 20.33 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.777 2.318 . . . . 0.0 111.834 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.83 122.4 45.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.69 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.7 m -96.85 112.47 24.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.935 0.398 . . . . 0.0 110.619 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.561 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.8 -50.06 5.81 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.605 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 31.3 Cg_exo -60.85 126.54 19.92 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.103 1.869 . . . . 0.0 112.256 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.42 155.29 39.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.74 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -55.9 -38.33 70.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.962 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -68.7 -23.92 64.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 111.006 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.66 -37.22 65.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -68.88 -38.82 79.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.771 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' THR . 82.8 t -60.96 -43.71 96.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.673 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.76 -27.4 67.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.623 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 35.7 t70 -69.94 -44.0 70.46 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -68.5 -45.97 70.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.41 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.49 -46.82 95.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.965 0.412 . . . . 0.0 110.162 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.06 97.31 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.435 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.679 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 6.7 t80 -60.83 -47.68 85.27 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 19.8 mmmt -57.43 -39.27 75.87 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.642 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.491 HD12 ' HE3' ' A' ' 24' ' ' LYS . 24.3 tp -66.92 -32.97 74.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.449 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.3 mtm-85 -81.22 -29.38 34.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.188 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.679 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 12.8 mm100 -64.32 -26.82 68.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.63 0.252 . . . . 0.0 111.293 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HE3' HD12 ' A' ' 21' ' ' LEU . 6.7 pttp -97.61 13.26 30.76 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.899 0.38 . . . . 0.0 111.372 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.15 -75.4 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -142.46 106.3 4.7 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.38 109.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.922 0.391 . . . . 0.0 110.796 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 37.8 m -110.31 122.93 48.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.048 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.43 -133.4 4.57 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.862 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.451 ' O ' ' HD3' ' A' ' 32' ' ' PRO . . . -150.64 174.93 12.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.604 0.24 . . . . 0.0 110.638 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.87 99.19 1.41 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.792 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 30' ' ' ALA . 4.9 Cg_exo -76.7 89.97 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.816 2.344 . . . . 0.0 112.103 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.19 -74.53 0.95 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.471 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.92 108.23 19.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.956 0.408 . . . . 0.0 110.069 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.54 95.8 0.11 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.576 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.97 112.14 1.43 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.931 2.42 . . . . 0.0 112.109 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.29 153.16 17.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.212 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.21 -28.62 48.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.031 0.443 . . . . 0.0 110.013 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.31 110.18 59.13 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.88 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -103.91 10.72 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.557 2.838 . . . . 0.0 112.199 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' A' ' 143' ' ' TRP . 59.3 mt -72.11 -45.59 60.0 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -66.09 -38.47 88.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -67.73 -39.37 84.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.259 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.6 98.45 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.253 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 46.3 mtt -62.87 -44.68 95.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.162 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.544 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 6.7 tmm_? -65.06 -43.98 90.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.143 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.72 79.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.286 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.67 89.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.058 0.456 . . . . 0.0 110.328 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.07 22.66 30.66 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.773 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 3.2 t0 -126.8 -61.06 1.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.555 0.217 . . . . 0.0 110.967 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.785 ' HA ' HG22 ' A' ' 54' ' ' THR . 76.0 mm-40 -63.0 -41.81 99.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.032 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.484 ' HA ' ' OD1' ' B' ' 217' ' ' ASP . 51.3 t80 -58.73 -29.28 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.972 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -91.24 -40.89 11.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.398 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.785 HG22 ' HA ' ' A' ' 51' ' ' GLU . 12.6 t -70.02 -32.42 70.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 51' ' ' GLU . 21.8 mtm180 -85.07 -22.19 29.05 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 110.514 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.6 ' HA ' ' HG2' ' B' ' 216' ' ' MET . 36.3 t80 -80.08 -82.47 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 56' ' ' PHE . 9.8 ttm105 165.82 -68.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 O-C-N 123.993 0.808 . . . . 0.0 109.264 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.462 ' HD3' ' OG ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -159.42 72.45 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.056 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 m -56.47 -34.77 67.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.478 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -65.24 -15.5 62.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.584 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.462 ' OG ' ' HD3' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -118.88 -53.96 2.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.733 0.302 . . . . 0.0 111.792 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.7 -68.79 0.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.176 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.572 ' HA ' ' HG2' ' A' ' 66' ' ' GLN . 9.7 tp -57.88 -42.65 85.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.564 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -61.53 -29.79 70.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.046 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.74 -44.44 10.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.572 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 8.1 pt20 -65.37 -31.79 73.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.758 0.313 . . . . 0.0 111.27 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.773 ' HG ' ' HB3' ' B' ' 209' ' ' LEU . 2.2 mm? -87.87 -4.62 58.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.959 0.409 . . . . 0.0 110.757 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.525 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 4.7 t-80 -88.0 -10.94 48.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.778 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.1 t -75.17 -33.93 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.522 0.677 . . . . 0.0 109.595 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -74.46 148.42 85.74 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.185 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 70' ' ' THR . 23.4 Cg_exo -63.83 94.98 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.577 2.185 . . . . 0.0 112.213 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.43 -147.42 14.61 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.306 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.682 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 66.4 m -162.31 -159.7 0.61 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.461 0.304 . . . . 0.0 110.217 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.04 -160.7 0.25 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.679 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.838 ' HG3' HD21 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -58.28 -27.51 64.11 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.833 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -63.58 -25.3 68.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.842 0.353 . . . . 0.0 110.592 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.682 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 13.1 tpp85 -88.95 -34.95 16.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.071 0.462 . . . . 0.0 109.937 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -67.74 -32.65 73.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.546 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 p -81.47 7.36 12.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.83 0.348 . . . . 0.0 111.502 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -127.09 -41.31 1.79 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.157 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.483 HG23 HG21 ' B' ' 202' ' ' ILE . 9.9 p -55.56 -29.22 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.473 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -74.22 -46.15 43.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.109 0.481 . . . . 0.0 110.974 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.01 -33.74 75.19 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.207 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' B' ' 202' ' ' ILE . 8.2 mm-40 -53.88 -31.77 50.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.369 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.702 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -103.37 -14.52 16.24 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.813 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -70.53 -43.27 69.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.134 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.427 HE22 ' HD3' ' A' ' 132' ' ' ARG . 61.0 mt-30 -77.28 -2.16 33.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.176 0.513 . . . . 0.0 110.741 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -106.33 16.18 41.9 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.475 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . 148.23 85.95 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HG3' ' HZ3' ' A' ' 136' ' ' TRP . 3.8 Cg_exo -74.64 70.81 4.92 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 123.059 2.506 . . . . 0.0 112.746 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -82.61 173.15 12.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.38 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.559 ' CD1' HD22 ' A' ' 149' ' ' LEU . 35.3 m0 -51.32 -62.63 1.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.556 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.25 -18.81 75.33 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.155 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 3.5 tpp85 -63.91 -46.46 84.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.417 HD23 ' CD1' ' A' ' 146' ' ' PHE . 39.3 tp -69.66 -35.33 75.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.089 0.471 . . . . 0.0 109.817 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 92' ' ' TRP . 84.6 t -63.35 -44.98 99.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.022 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.665 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -63.2 -38.8 92.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.597 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.473 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 89.1 t80 -60.92 -40.83 94.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.419 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -76.26 -47.42 23.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.43 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.665 HG12 ' HA ' ' A' ' 97' ' ' ALA . 5.5 p -65.05 -30.52 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.534 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 1.2 t80 -61.08 -54.61 42.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.849 0.357 . . . . 0.0 110.231 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.62 -40.7 96.09 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.042 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.75 95.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.557 0.217 . . . . 0.0 111.459 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.31 75.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.112 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 105' ' ' LEU . 1.7 mm? -61.58 -41.36 97.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.508 ' O ' HG23 ' A' ' 110' ' ' VAL . 30.2 m -66.44 -45.9 78.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.663 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.71 86.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.02 -42.66 99.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.993 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.2 m -67.04 -37.51 84.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.327 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 106' ' ' CYS . 76.7 t -62.89 -38.61 82.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.2 0.524 . . . . 0.0 110.095 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -73.08 -12.95 61.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.801 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -106.47 13.14 28.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.365 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 56.7 48.96 15.32 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.329 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.454 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.02 61.27 0.9 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.105 0.478 . . . . 0.0 110.509 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -60.36 -30.48 69.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.034 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.8 t -59.24 -45.18 93.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.402 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.838 HD21 ' HG3' ' A' ' 75' ' ' GLN . 48.5 tp -72.04 -41.52 67.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.667 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 114' ' ' MET . 83.1 t -60.42 -48.91 86.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.235 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.84 -40.08 96.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.239 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -66.66 -47.54 72.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.525 0.203 . . . . 0.0 110.671 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.42 ' O ' ' HG3' ' A' ' 125' ' ' MET . 64.6 t -59.46 -45.96 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.726 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.2 -45.4 93.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -63.28 -42.3 99.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -61.31 -38.34 86.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 121' ' ' VAL . 95.7 mtp -66.81 -48.67 68.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.258 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.06 -42.52 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.53 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.22 -43.67 83.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 132' ' ' ARG . 0.2 OUTLIER -62.88 -41.84 99.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.414 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.651 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 91.3 mt -65.56 -31.39 72.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.657 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.27 -3.71 55.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.0 m -115.41 -88.93 0.57 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.49 ' HB3' ' CE1' ' A' ' 128' ' ' TYR . 64.2 ttt180 -72.47 -36.27 68.41 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.651 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 97.5 mt -89.71 14.66 11.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.727 0.298 . . . . 0.0 111.372 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.32 -55.27 29.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.844 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.97 -34.68 78.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.775 0.322 . . . . 0.0 110.87 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.41 ' HZ3' ' HG3' ' A' ' 90' ' ' PRO . 60.9 m95 -59.37 -57.93 10.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.46 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.408 HG23 ' HA2' ' A' ' 142' ' ' GLY . 47.3 mm -61.69 -37.27 77.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.913 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -63.49 -42.0 98.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.461 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.8 m -76.71 -27.88 55.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.728 0.299 . . . . 0.0 111.279 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 70.3 m -85.04 -11.95 54.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.583 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.17 44.82 85.79 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.408 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 70.53 -100.84 0.85 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.59 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.532 ' HB2' HD22 ' A' ' 41' ' ' LEU . 84.2 m95 -116.78 15.15 15.36 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.65 -60.24 3.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.592 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.527 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 3.7 pt-20 -66.76 -28.23 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 110.579 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.504 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 74.0 t80 -62.07 -30.57 71.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.638 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 5.6 m -61.83 -28.34 69.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.216 0.531 . . . . 0.0 110.569 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.27 -26.64 18.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.773 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.559 HD22 ' CD1' ' A' ' 92' ' ' TRP . 24.4 mt -62.69 -53.85 48.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.15 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.638 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 1.5 p90 -84.3 17.8 2.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.951 0.405 . . . . 0.0 111.141 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.03 -31.09 62.24 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.862 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 C--N 1.328 -0.338 0 O-C-N 122.575 -0.367 . . . . 0.0 110.463 -179.694 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 201' ' ' ILE . . . . . 0.541 HG13 HG12 ' B' ' 202' ' ' ILE . 13.9 pt . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.541 HG12 HG13 ' B' ' 201' ' ' ILE . 44.5 mm -104.09 114.7 44.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.861 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.3 -43.84 2.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.28 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -64.1 -54.81 28.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 0.0 111.135 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 205' ' ' ILE . . . . . 0.559 HG23 HD12 ' A' ' 67' ' ' LEU . 94.1 mt -63.15 -40.56 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.231 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 206' ' ' ALA . . . . . 0.464 ' HB1' ' HB2' ' A' ' 85' ' ' LEU . . . -61.64 -47.42 85.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.905 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 207' ' ' ARG . . . . . 0.702 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 74.3 ttt180 -65.94 -35.07 79.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.902 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 208' ' ' HIS . . . . . 0.746 ' HB3' HD11 ' A' ' 67' ' ' LEU . 3.3 t-80 -58.25 -51.92 67.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.762 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.773 ' HB3' ' HG ' ' A' ' 67' ' ' LEU . 1.2 pp -74.92 -38.44 61.81 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.733 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 210' ' ' ALA . . . . . 0.456 ' HB1' ' HD3' ' A' ' 94' ' ' ARG . . . -68.81 -48.26 64.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -69.41 -48.66 60.36 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 43.0 t -57.18 -43.76 82.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.812 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.74 -50.62 29.28 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.088 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 25.4 t0 -57.26 -44.58 84.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.449 0.3 . . . . 0.0 111.785 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 12.8 m -68.18 -36.22 79.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.714 0.292 . . . . 0.0 111.758 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 216' ' ' MET . . . . . 0.6 ' HG2' ' HA ' ' A' ' 56' ' ' PHE . 23.6 ttm -74.59 -40.81 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.76 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 217' ' ' ASP . . . . . 0.484 ' OD1' ' HA ' ' A' ' 52' ' ' PHE . 37.8 t70 -65.53 -34.27 77.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.455 0.645 . . . . 0.0 109.417 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 218' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.693 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.87 0.366 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.7 m -127.86 106.11 20.48 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.122 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.85 122.54 9.91 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.885 2.39 . . . . 0.0 112.11 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.6 119.09 24.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.742 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.1 m -74.98 108.17 7.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.359 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.57 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -74.08 -51.93 4.57 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 25.8 Cg_exo -63.84 140.3 72.81 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.868 1.712 . . . . 0.0 113.007 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 22.2 t70 -81.4 151.83 27.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.377 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -58.61 -36.89 74.75 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.445 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -73.19 -37.96 66.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.879 0.371 . . . . 0.0 110.55 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 -33.4 75.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.166 0.508 . . . . 0.0 109.919 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 41' ' ' LEU . 20.3 tp -64.32 -42.03 96.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.047 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' THR . 48.7 t -69.92 -40.17 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.963 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 -37.17 77.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.784 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.67 -37.3 86.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.346 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -67.87 -49.87 59.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.185 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.6 t -62.84 -44.73 99.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.107 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.13 -38.09 95.02 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.619 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.586 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 9.2 t80 -66.63 -43.09 85.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -61.44 -37.1 82.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.317 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.618 HD12 ' HE3' ' A' ' 24' ' ' LYS . 15.8 tp -65.63 -33.01 74.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.733 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.7 mtm-85 -79.42 -34.4 41.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.684 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 13.7 mm100 -61.19 -39.05 88.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.354 . . . . 0.0 111.181 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.618 ' HE3' HD12 ' A' ' 21' ' ' LEU . 11.6 pttp -84.77 2.57 41.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.177 0.513 . . . . 0.0 110.823 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.25 -108.33 1.07 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.441 ' HD1' ' SG ' ' A' ' 28' ' ' CYS . 17.3 t80 -101.67 105.19 16.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 23' ' ' GLN . 98.2 t -65.17 107.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.171 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.441 ' SG ' ' HD1' ' A' ' 26' ' ' TYR . 8.2 m -113.82 118.77 35.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.87 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.57 178.74 25.72 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.058 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.31 155.91 23.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.612 0.244 . . . . 0.0 110.609 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.55 106.86 3.27 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.774 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.95 109.13 1.04 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.932 2.422 . . . . 0.0 112.438 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.78 -118.27 2.57 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.876 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -85.66 66.8 9.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.274 0.559 . . . . 0.0 109.688 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.18 98.79 0.24 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.484 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.27 112.88 1.25 Allowed 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.9 2.4 . . . . 0.0 111.613 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.69 151.48 22.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.266 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.88 -34.03 51.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.927 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.65 120.47 46.18 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.002 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -102.33 16.79 0.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.602 2.868 . . . . 0.0 112.498 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.64 ' HB3' HD21 ' A' ' 12' ' ' LEU . 79.6 mt -68.76 -46.26 69.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.714 0.292 . . . . 0.0 111.494 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -70.0 -37.69 75.76 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -65.43 -39.66 92.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.379 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.21 86.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.627 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 36.5 mtt -64.93 -38.2 90.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.416 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -69.02 -30.02 68.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.753 179.272 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.82 -35.42 38.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.809 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.61 -41.82 67.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 111.024 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.89 37.41 3.44 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.056 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.07 -43.22 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 54' ' ' THR . 56.4 mm-40 -54.13 -63.99 0.97 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.555 ' O ' ' HB2' ' A' ' 56' ' ' PHE . 1.2 p90 -64.94 -21.14 66.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.451 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 53' ' ' GLU . 5.0 tp10 -80.93 -40.7 24.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 111.589 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 51' ' ' GLU . 4.0 t -70.62 -13.75 62.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.732 0.301 . . . . 0.0 111.385 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.507 ' O ' ' HG3' ' B' ' 216' ' ' MET . 81.1 mtm-85 -113.93 6.79 16.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.752 0.31 . . . . 0.0 111.148 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 52' ' ' PHE . 2.1 t80 -116.16 -88.89 0.58 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.574 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 mtm105 -174.75 -83.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.174 0.511 . . . . 0.0 109.672 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.709 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -148.87 49.99 0.99 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.758 HG22 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -53.72 -28.66 35.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.985 -178.083 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -52.85 -31.06 37.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 110.99 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.92 -37.47 3.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.648 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 15.5 t70 -61.7 -39.14 90.43 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.444 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.758 ' HB2' HG22 ' A' ' 59' ' ' THR . 14.7 tp -61.83 -34.79 76.58 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.164 0.506 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.68 -32.6 41.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.315 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.54 -44.28 62.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.538 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 9.7 pt20 -65.34 -32.36 73.96 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.885 0.374 . . . . 0.0 110.64 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.71 -8.8 59.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.284 0.564 . . . . 0.0 110.109 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -12.97 46.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.02 -37.73 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.966 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -86.5 160.53 50.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.067 178.527 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.966 ' HD2' HG22 ' A' ' 70' ' ' THR . 10.9 Cg_endo -55.08 115.78 2.68 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.394 2.063 . . . . 0.0 112.146 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.42 -164.53 11.0 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.41 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 50.3 m -152.36 -155.28 0.6 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.87 -159.18 0.1 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.855 0.36 . . . . 0.0 111.617 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.59 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 1.9 mm-40 -50.27 -34.77 24.42 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.719 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -56.04 -36.43 67.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.356 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 22.4 tpp85 -72.7 -34.27 67.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.702 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.59 ' HD2' ' HA ' ' A' ' 75' ' ' GLN . 90.6 m-85 -69.15 -40.46 78.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.125 0.488 . . . . 0.0 110.328 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -68.54 -36.16 78.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.284 0.564 . . . . 0.0 110.172 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.85 ' HG2' HD12 ' B' ' 201' ' ' ILE . 22.5 tp60 -71.53 -42.55 67.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.941 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 78' ' ' PHE . 3.4 p -61.22 -20.72 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.039 0.447 . . . . 0.0 111.342 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -87.67 -46.63 9.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.959 0.409 . . . . 0.0 110.445 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -35.8 80.47 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.352 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.624 ' HG3' ' HG2' ' B' ' 203' ' ' LYS . 6.3 tp10 -49.42 -39.4 32.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.246 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.701 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.5 OUTLIER -105.54 3.41 29.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.813 0.34 . . . . 0.0 111.469 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.501 ' HE1' ' HA ' ' A' ' 95' ' ' LEU . 28.7 t80 -84.15 -37.48 21.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.53 -21.46 66.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.654 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.85 8.39 69.91 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.515 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.455 ' HA2' ' HD3' ' A' ' 90' ' ' PRO . . . 130.33 116.57 1.85 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.464 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.455 ' HD3' ' HA2' ' A' ' 89' ' ' GLY . 5.6 Cg_exo -75.35 65.2 6.37 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.375 2.716 . . . . 0.0 111.321 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -68.13 178.02 2.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.72 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.665 ' HE3' ' H ' ' A' ' 92' ' ' TRP . 1.4 m-90 -45.0 -72.47 0.06 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.529 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.46 68.35 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.197 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.5 tpp85 -66.65 -51.23 58.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.612 0.244 . . . . 0.0 110.62 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.501 ' HA ' ' HE1' ' A' ' 86' ' ' PHE . 25.3 tp -67.03 -36.08 81.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.966 0.412 . . . . 0.0 110.505 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.462 HG22 ' HE1' ' A' ' 146' ' ' PHE . 60.9 t -65.83 -54.33 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.821 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.751 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -61.03 -41.74 97.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.021 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -54.6 -36.56 64.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.535 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -90.86 -46.56 8.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.818 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 97' ' ' ALA . 5.6 p -65.15 -37.15 79.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.455 ' HD1' ' HA ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -65.7 -45.4 82.91 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.105 -179.589 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.03 -45.6 95.76 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.61 98.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.215 . . . . 0.0 111.015 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.47 97.31 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.807 0.337 . . . . 0.0 111.208 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 105' ' ' LEU . 2.0 mm? -73.74 -39.69 64.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.29 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.431 ' O ' HG23 ' A' ' 110' ' ' VAL . 52.1 m -64.57 -42.18 95.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.391 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.35 -42.53 87.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.875 0.369 . . . . 0.0 110.348 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -42.65 98.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.476 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m -65.34 -37.1 86.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.545 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 106' ' ' CYS . 42.5 t -62.51 -44.85 99.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.274 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -66.01 -24.8 66.83 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.416 0.627 . . . . 0.0 110.177 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -89.54 5.24 46.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.101 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 66.98 18.57 10.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.696 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.46 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -92.25 60.33 3.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.219 0.533 . . . . 0.0 109.584 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.78 -24.63 66.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.341 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.7 t -62.63 -47.31 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.024 0.44 . . . . 0.0 109.914 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.73 -38.96 87.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.217 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 114' ' ' MET . 87.7 t -58.23 -52.05 63.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.532 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.74 93.18 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.041 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -62.13 -53.83 49.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.709 0.29 . . . . 0.0 110.88 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.68 -44.43 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.25 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -45.46 88.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.548 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.52 -46.07 91.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.268 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -60.02 -43.51 95.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.003 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 96.8 mtp -64.31 -52.4 58.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 72.1 t -60.57 -42.56 92.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.296 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.06 -48.41 73.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.818 0.342 . . . . 0.0 110.679 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -59.7 -39.54 84.94 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.55 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.6 mt -59.17 -29.96 67.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.409 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -106.01 11.41 31.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.702 0.287 . . . . 0.0 110.966 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 78.4 m -108.29 -65.61 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.495 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -108.24 -22.03 12.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.788 0.328 . . . . 0.0 111.396 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.775 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 61.0 mt -101.15 11.97 38.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.646 0.26 . . . . 0.0 111.024 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.52 -49.0 77.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.27 -43.72 92.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.716 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.775 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 83.0 m95 -60.11 -49.43 77.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.579 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 133' ' ' LEU . 46.0 mm -63.45 -39.37 85.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.512 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.15 -49.83 72.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.923 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.3 m -63.78 -47.77 79.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.325 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 50.7 m -70.17 -16.75 63.12 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.78 41.19 50.65 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.877 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.89 -100.95 0.67 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.125 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -111.77 13.78 21.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.782 0.325 . . . . 0.0 110.548 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.23 -50.91 71.4 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.822 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.617 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 11.0 pt-20 -86.26 -22.37 26.87 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.587 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.462 ' HE1' HG22 ' A' ' 96' ' ' VAL . 90.0 t80 -59.38 -41.05 88.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.947 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.566 ' HA ' ' CE2' ' A' ' 150' ' ' TYR . 0.4 OUTLIER -64.81 -26.16 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.218 0.532 . . . . 0.0 111.046 -179.731 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.79 -26.27 24.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.948 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 84.7 mt -60.76 -60.54 3.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.893 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 147' ' ' THR . 34.0 p90 -74.87 -10.54 59.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.984 0.421 . . . . 0.0 110.591 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.34 -19.1 77.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.559 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.2 t70 . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.057 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 201' ' ' ILE . . . . . 0.85 HD12 ' HG2' ' A' ' 80' ' ' GLN . 25.6 mt . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.676 0.274 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.647 HG12 HG12 ' B' ' 205' ' ' ILE . 10.0 tt -162.3 100.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.639 0.733 . . . . 0.0 110.743 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.624 ' HG2' ' HG3' ' A' ' 84' ' ' GLU . 48.5 mttm -77.63 -32.41 53.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.92 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -45.93 -61.09 1.89 Allowed 'General case' 0 C--O 1.24 0.575 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 205' ' ' ILE . . . . . 0.647 HG12 HG12 ' B' ' 202' ' ' ILE . 45.3 pt -69.46 -34.38 61.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.69 0.281 . . . . 0.0 111.283 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 206' ' ' ALA . . . . . 0.447 ' HA ' HG22 ' A' ' 81' ' ' VAL . . . -62.54 -37.51 86.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.203 0.525 . . . . 0.0 110.365 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 207' ' ' ARG . . . . . 0.701 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 38.0 ttp180 -62.85 -44.42 96.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.317 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 208' ' ' HIS . . . . . 0.402 ' O ' HG22 ' B' ' 212' ' ' VAL . 84.5 t60 -63.65 -40.09 95.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.27 -52.45 65.63 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.29 0.567 . . . . 0.0 110.507 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 210' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -68.56 -34.98 76.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.731 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -56.6 -56.03 26.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.79 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 208' ' ' HIS . 13.0 m -63.1 -43.41 98.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.535 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.08 -42.2 98.2 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.76 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.513 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 0.6 OUTLIER -70.33 -47.62 60.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.654 0.264 . . . . 0.0 111.574 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 12.2 m -68.34 -42.74 78.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 216' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 55' ' ' ARG . 6.5 tpt -66.05 -48.16 71.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.01 -35.03 79.89 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.067 0.461 . . . . 0.0 110.548 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 218' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.0 m -141.19 88.52 10.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.848 0.356 . . . . 0.0 110.508 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.23 129.78 19.97 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.473 2.115 . . . . 0.0 112.074 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.09 167.66 12.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.285 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.6 m -104.88 125.7 51.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.829 0.347 . . . . 0.0 110.58 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.656 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -84.59 -53.0 0.51 Allowed Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.224 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 10.9 Cg_exo -71.09 133.95 24.18 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.91 1.74 . . . . 0.0 111.788 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.0 149.91 47.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.935 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.91 -40.91 67.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.325 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -73.59 -27.09 61.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 0.0 110.945 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.01 94.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 mp -64.17 -42.54 96.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.289 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.99 -45.89 95.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.149 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.5 80.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.565 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.0 -42.05 85.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.215 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -63.22 -46.08 88.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.31 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.18 -47.38 93.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.073 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.46 99.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.692 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.655 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 18.3 t80 -60.78 -48.89 79.73 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -60.03 -38.86 83.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.597 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 21' ' ' LEU . 8.3 tp -67.77 -25.79 65.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.074 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -89.44 -29.59 18.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 15.6 mm100 -60.87 -28.61 68.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.017 0.436 . . . . 0.0 111.347 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -88.48 16.04 7.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.582 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.87 -62.75 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.845 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -145.3 102.53 3.74 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.82 107.41 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.252 0.549 . . . . 0.0 110.885 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.8 t -110.11 127.39 54.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.996 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.83 -124.07 2.18 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.018 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.27 172.27 16.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.764 0.316 . . . . 0.0 110.653 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.09 108.64 2.87 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.1 110.24 2.58 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.936 2.424 . . . . 0.0 111.851 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.63 -104.31 2.46 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.894 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -90.15 109.72 20.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.284 0.564 . . . . 0.0 110.24 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.98 90.71 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -48.0 108.56 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.331 2.687 . . . . 0.0 112.863 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.11 141.14 38.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.68 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.67 79.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.007 0.432 . . . . 0.0 110.152 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.87 126.33 32.13 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.21 0.529 . . . . 0.0 110.436 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -96.59 1.65 1.91 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.826 2.351 . . . . 0.0 110.716 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.594 HD23 ' HB2' ' A' ' 143' ' ' TRP . 12.2 mt -67.18 -50.23 61.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.661 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -62.13 -34.11 75.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.07 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -80.84 -38.58 28.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.465 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HB1' ' HD2' ' A' ' 146' ' ' PHE . . . -60.87 -43.97 97.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.706 0.288 . . . . 0.0 111.011 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 54.9 mtt -63.8 -38.41 90.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.032 0.444 . . . . 0.0 110.535 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 4.9 tmm_? -70.42 -42.53 71.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.224 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.38 -32.6 71.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.875 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.93 -50.52 57.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.045 0.45 . . . . 0.0 110.609 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.421 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -98.6 42.71 2.0 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.329 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 2.8 t0 -148.34 -46.48 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.586 0.231 . . . . 0.0 111.26 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.496 ' O ' HG22 ' A' ' 54' ' ' THR . 71.0 mm-40 -57.19 -55.53 33.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.801 0.334 . . . . 0.0 111.9 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.421 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 2.1 p90 -68.35 -26.48 65.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.687 0.28 . . . . 0.0 111.248 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -77.23 -42.79 35.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.172 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 51' ' ' GLU . 6.5 t -65.22 -26.02 67.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.154 0.502 . . . . 0.0 110.219 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 37.3 mtm-85 -93.2 -1.07 56.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.895 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.601 ' HD2' ' HG2' ' B' ' 216' ' ' MET . 42.9 t80 -111.87 -92.47 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.283 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.0 ttp85 175.11 -66.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.718 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.794 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -154.3 56.55 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.268 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -30.6 71.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.995 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -52.12 -38.63 58.04 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 123.455 0.472 . . . . 0.0 110.981 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.04 -41.2 6.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.258 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -59.45 -46.44 88.75 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.629 HD11 ' HA ' ' B' ' 209' ' ' LEU . 7.4 tp -62.81 -37.47 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 110.499 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.69 -30.7 63.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.295 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.04 -49.09 54.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.799 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -66.49 -31.5 72.27 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.941 0.4 . . . . 0.0 110.128 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.797 ' HG ' ' HZ ' ' A' ' 101' ' ' PHE . 0.5 OUTLIER -69.32 -22.27 63.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 178.508 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -83.18 -22.49 33.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.935 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.31 -49.04 34.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.551 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -72.53 141.36 82.71 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.697 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.551 ' HD2' HG22 ' A' ' 70' ' ' THR . 77.8 Cg_exo -50.92 104.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.77 2.314 . . . . 0.0 112.63 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.59 -158.77 9.87 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.954 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.606 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 7.4 m -142.84 -148.44 0.24 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.03 -158.19 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.976 0.417 . . . . 0.0 111.423 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.622 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 3.7 mm-40 -53.04 -38.13 62.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.576 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -56.82 -40.03 75.29 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.944 0.402 . . . . 0.0 110.842 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.606 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 14.0 tpp85 -64.94 -37.94 89.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.975 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.622 ' HD2' ' HA ' ' A' ' 75' ' ' GLN . 40.9 m-85 -69.16 -37.32 78.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.526 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 m -69.04 -46.7 67.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.084 0.469 . . . . 0.0 110.632 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.81 -32.62 69.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.866 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 78' ' ' PHE . 2.5 p -69.25 -19.17 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.164 0.507 . . . . 0.0 110.774 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.506 ' HB3' ' HA ' ' A' ' 98' ' ' PHE . 38.4 m -82.48 -43.65 16.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.117 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.89 -24.12 55.63 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.063 0.459 . . . . 0.0 109.976 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.795 ' HG3' ' HD3' ' B' ' 203' ' ' LYS . 2.9 tp10 -51.33 -48.01 62.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.44 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.569 HD21 ' HG2' ' B' ' 207' ' ' ARG . 0.1 OUTLIER -90.1 -5.77 56.17 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.924 -0.311 . . . . 0.0 111.658 -178.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.2 -27.95 57.05 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -65.47 -23.58 66.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.297 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.19 3.3 86.38 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.908 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 90' ' ' PRO . . . 131.33 133.16 3.45 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.547 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 89' ' ' GLY . 6.3 Cg_exo -78.53 65.83 8.57 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.141 2.561 . . . . 0.0 111.618 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -70.9 169.76 14.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.277 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.529 ' HE3' ' H ' ' A' ' 92' ' ' TRP . 5.1 m-90 -52.24 -63.17 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.865 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.32 -11.28 75.72 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.182 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -67.0 -49.99 63.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.732 0.301 . . . . 0.0 110.307 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.9 tp -67.29 -33.92 76.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.266 0.555 . . . . 0.0 109.736 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.14 -54.13 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.472 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.576 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -61.91 -43.17 99.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.574 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.506 ' HA ' ' HB3' ' A' ' 82' ' ' SER . 79.3 t80 -57.91 -42.89 85.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.039 0.447 . . . . 0.0 111.53 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -75.86 -46.78 28.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.709 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 97' ' ' ALA . 9.8 p -66.93 -34.0 67.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.797 ' HZ ' ' HG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -60.8 -50.31 73.95 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 110.43 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.4 -43.23 95.28 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.918 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.11 87.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.46 97.71 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.3 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.16 -43.33 71.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.044 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.454 ' O ' HG23 ' A' ' 110' ' ' VAL . 34.7 m -61.94 -44.15 97.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.416 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.58 82.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.908 0.385 . . . . 0.0 110.488 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -68.31 -40.51 81.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.164 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.476 ' HB2' HG22 ' A' ' 118' ' ' VAL . 17.2 m -63.99 -37.81 88.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.812 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 106' ' ' CYS . 99.5 t -67.65 -33.42 61.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.122 0.487 . . . . 0.0 109.764 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.08 -13.23 61.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.248 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -106.94 7.92 30.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.121 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 62.61 34.31 15.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.48 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.541 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -106.73 62.79 0.63 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.008 0.432 . . . . 0.0 110.117 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -64.96 -27.6 68.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.678 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.9 t -59.08 -48.36 86.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.304 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 tp -70.37 -39.17 74.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.353 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 114' ' ' MET . 99.4 t -59.2 -49.51 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.837 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.56 84.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.384 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -69.02 -51.25 41.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.71 0.291 . . . . 0.0 110.664 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.84 -43.48 97.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.759 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -43.24 94.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.989 0.423 . . . . 0.0 110.099 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.28 -42.47 88.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.36 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -60.5 -41.45 94.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 93.1 mtp -59.35 -52.22 66.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.456 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.1 t -65.18 -42.31 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.586 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.02 -47.21 81.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -63.22 -40.41 97.38 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.992 0.425 . . . . 0.0 110.119 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.721 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 24.3 mt -63.08 -35.36 79.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.145 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -90.95 6.51 44.39 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.2 m -121.37 -61.52 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -101.44 -26.6 13.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.721 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 97.3 mt -98.77 10.03 42.1 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.324 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.14 -48.07 77.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.767 0.317 . . . . 0.0 111.17 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.85 -52.09 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.621 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -61.42 -50.6 72.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.475 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.574 HG23 ' HA2' ' A' ' 142' ' ' GLY . 17.5 mm -58.92 -40.2 79.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.694 0.283 . . . . 0.0 110.938 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -61.37 -43.67 98.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.962 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.4 m -69.94 -41.01 75.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.752 0.311 . . . . 0.0 111.119 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.0 m -75.09 -2.06 25.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.594 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.0 42.02 98.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.08 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.574 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 72.95 -102.12 1.19 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.393 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.594 ' HB2' HD23 ' A' ' 41' ' ' LEU . 82.0 m95 -112.49 9.33 19.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.668 0.271 . . . . 0.0 110.365 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.16 -55.88 28.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.988 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.601 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 43.8 tt0 -59.9 -39.3 84.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.124 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.44 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 48.9 t80 -57.97 -34.84 70.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.626 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.456 ' HA ' ' CE2' ' A' ' 150' ' ' TYR . 2.1 m -60.46 -37.35 80.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.04 0.448 . . . . 0.0 110.778 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.81 -27.54 30.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.505 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 26.3 mt -57.23 -52.39 65.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.261 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.456 ' CE2' ' HA ' ' A' ' 147' ' ' THR . 30.3 p90 -87.08 8.26 24.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.838 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.72 -34.91 91.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.969 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 t0 . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 120.64 0.257 . . . . 0.0 110.382 179.611 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 43.7 mt . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 120.739 0.304 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -147.22 79.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.239 0.542 . . . . 0.0 110.363 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.795 ' HD3' ' HG3' ' A' ' 84' ' ' GLU . 39.2 mmtm -58.92 -36.07 74.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.13 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -62.49 -43.52 98.62 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.155 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 38.7 mt -64.99 -41.68 92.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.111 0.481 . . . . 0.0 109.707 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 206' ' ' ALA . . . . . 0.462 ' HB3' HD23 ' A' ' 85' ' ' LEU . . . -62.45 -42.59 99.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.631 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 207' ' ' ARG . . . . . 0.569 ' HG2' HD21 ' A' ' 85' ' ' LEU . 15.2 mtp180 -61.35 -34.61 75.58 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.114 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -58.69 7.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.569 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.629 ' HA ' HD11 ' A' ' 63' ' ' LEU . 1.2 pp -67.72 -42.25 82.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 210' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -64.92 -47.18 78.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 211' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' B' ' 207' ' ' ARG . 6.3 tp60 -65.69 -37.91 87.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 16.5 t -58.19 -55.09 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.656 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.29 -38.45 91.56 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.468 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 2.3 t0 -63.83 -49.77 71.53 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.7 m -68.42 -40.24 81.31 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' MET . . . . . 0.601 ' HG2' ' HD2' ' A' ' 56' ' ' PHE . 5.6 tpt -64.64 -42.68 95.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.744 0.306 . . . . 0.0 111.094 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.34 -33.34 69.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.318 0.58 . . . . 0.0 110.047 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 218' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.887 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.715 0.293 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 m -133.62 117.19 14.11 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.513 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.16 144.05 99.5 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.645 2.23 . . . . 0.0 112.15 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.62 114.86 29.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.815 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -69.72 115.88 9.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.989 0.423 . . . . 0.0 110.647 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.548 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -86.32 -49.93 0.5 Allowed Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.327 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 32.7 Cg_exo -61.3 131.87 38.48 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.05 1.833 . . . . 0.0 113.042 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -75.62 149.08 38.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.378 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 m -57.22 -36.94 71.51 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -69.66 -31.38 69.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.668 0.271 . . . . 0.0 110.617 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.45 78.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.237 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 mp -69.15 -41.7 76.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.744 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.64 -42.99 98.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.995 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.32 87.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.667 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.42 -46.89 81.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -61.05 -48.86 79.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.974 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.13 -46.66 95.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.51 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.71 98.95 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.794 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -61.95 -46.14 90.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.724 0.297 . . . . 0.0 110.272 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 20' ' ' LYS . 11.8 mmmt -61.65 -35.91 79.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.936 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.11 -26.24 59.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.683 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -84.26 -36.99 22.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.379 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -56.97 -35.4 69.11 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 24.18 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.932 0.396 . . . . 0.0 111.382 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.04 -54.95 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.683 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -154.52 111.83 3.39 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.93 120.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.148 0.499 . . . . 0.0 110.812 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.8 m -132.37 108.56 9.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.397 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.5 -134.87 3.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.843 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.09 146.77 26.38 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.94 114.84 4.08 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.653 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.59 83.7 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.064 2.509 . . . . 0.0 112.2 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.63 -103.65 1.24 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.234 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -103.15 105.74 16.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.046 0.45 . . . . 0.0 109.798 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.45 85.73 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.577 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -57.22 119.17 6.25 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.069 2.512 . . . . 0.0 112.252 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.49 164.19 13.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.485 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.435 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -85.45 -15.98 41.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.133 0.492 . . . . 0.0 110.294 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -105.87 102.52 39.38 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.844 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 41.0 Cg_endo -96.77 5.28 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.224 2.616 . . . . 0.0 111.57 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.0 mt -64.27 -45.95 85.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.155 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -63.78 -43.07 97.45 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.74 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -65.49 -43.54 89.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.934 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.17 -39.0 93.39 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.834 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.1 ttt -73.55 -34.98 65.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.091 0.472 . . . . 0.0 110.602 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -68.81 -40.87 79.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.84 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 50' ' ' ASP . . . -95.01 5.14 52.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.739 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.54 58.31 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.189 0.518 . . . . 0.0 110.801 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -96.67 29.2 10.8 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.43 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -124.77 -31.2 3.21 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.358 -0.137 . . . . 0.0 111.215 -179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -56.99 -71.89 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.116 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.511 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 54.2 p90 -58.95 -25.76 63.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.113 0.482 . . . . 0.0 110.545 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 4.0 tp10 -66.29 -38.06 86.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.489 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -61.16 -36.9 81.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.29 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.604 ' HB2' ' HG3' ' B' ' 216' ' ' MET . 0.0 OUTLIER -86.65 -17.42 33.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.343 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.695 ' HB2' ' HG2' ' B' ' 216' ' ' MET . 41.8 t80 -97.05 -93.62 0.22 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.295 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 57' ' ' ARG . 26.1 ttm105 -175.39 -81.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.416 0.627 . . . . 0.0 109.534 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.404 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -153.03 67.26 0.79 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.385 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -53.22 -32.89 50.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.496 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.62 -36.58 64.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 110.619 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -99.23 -32.95 10.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.093 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 10.6 t70 -63.18 -38.21 90.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.92 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.2 tp -57.27 -43.71 83.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.49 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.72 -35.99 79.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.052 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.1 -47.6 35.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.747 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 9.5 pt20 -66.23 -33.04 74.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.602 0.239 . . . . 0.0 111.118 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.87 -0.75 40.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.737 0.303 . . . . 0.0 111.006 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -94.3 -29.35 15.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.6 t -62.57 -46.8 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.56 0.695 . . . . 0.0 109.3 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.582 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -92.9 145.18 29.69 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.495 178.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.582 ' HD2' HG22 ' A' ' 70' ' ' THR . 69.0 Cg_exo -52.35 107.65 0.2 Allowed 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.708 2.272 . . . . 0.0 112.597 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.57 -166.11 28.45 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.094 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.657 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 73.2 m -157.21 -150.43 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.898 -0.177 . . . . 0.0 110.717 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.35 -168.19 0.92 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.676 0.275 . . . . 0.0 111.192 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.44 HE22 HG11 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -56.69 -34.15 67.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -55.42 -27.8 50.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.373 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.657 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 15.4 tpp85 -75.61 -13.04 60.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.51 ' O ' HG12 ' A' ' 81' ' ' VAL . 80.1 m-85 -104.3 -40.78 5.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.41 HG21 HG13 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -65.99 -36.46 83.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 111.71 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -95.22 3.96 54.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 111.722 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -97.32 -23.73 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.259 0.552 . . . . 0.0 109.681 179.22 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.12 -42.45 19.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.592 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -21.64 58.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.026 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 3.4 tp10 -55.1 -41.89 72.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.193 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.749 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.3 OUTLIER -97.76 10.03 41.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.99 0.424 . . . . 0.0 110.718 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -99.17 -29.35 12.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -56.1 -45.59 79.37 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.982 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -106.07 15.46 43.71 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.294 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.1 78.35 0.15 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.734 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.89 54.22 5.03 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 123.221 2.614 . . . . 0.0 111.641 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -74.93 162.37 28.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.093 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.473 ' HZ3' ' HD2' ' B' ' 218' ' ' ARG . 0.3 OUTLIER -58.41 -51.64 68.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.655 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.69 -28.48 73.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.099 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.9 tpp85 -65.83 -44.69 84.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.77 -42.21 95.27 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 71.6 t -61.48 -44.84 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.948 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.52 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -62.01 -45.02 95.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.933 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.22 -40.21 93.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.152 0.501 . . . . 0.0 110.668 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -71.11 -47.05 60.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.29 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 97' ' ' ALA . 6.7 p -70.23 -29.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.476 ' CZ ' HD13 ' B' ' 209' ' ' LEU . 0.5 OUTLIER -59.14 -52.01 67.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.088 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.91 -42.01 95.13 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.629 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.98 -49.78 76.07 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.35 -46.24 84.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.572 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 105' ' ' LEU . 1.6 mm? -64.12 -39.26 93.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.048 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.31 -39.73 71.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.65 91.37 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.867 0.365 . . . . 0.0 110.259 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.36 -42.82 98.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.818 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.7 m -66.11 -44.22 84.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.031 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.458 HG23 HG21 ' A' ' 118' ' ' VAL . 51.6 t -60.35 -43.01 92.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 121.171 0.51 . . . . 0.0 109.833 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -65.56 -25.08 67.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.554 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -93.6 10.86 30.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.669 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 66.58 25.52 9.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.041 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.63 75.86 1.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.005 0.431 . . . . 0.0 110.213 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -76.14 -27.24 56.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.0 t -55.0 -50.57 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.424 HD21 ' HG3' ' A' ' 75' ' ' GLN . 57.3 tp -63.08 -44.25 96.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.334 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.458 HG21 HG23 ' A' ' 110' ' ' VAL . 87.3 t -57.43 -49.1 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.195 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.18 -42.03 87.26 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.555 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -69.33 -49.48 55.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.507 0.194 . . . . 0.0 110.648 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.44 HG11 HE22 ' A' ' 75' ' ' GLN . 77.2 t -57.83 -46.85 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.182 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -40.34 96.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.763 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.26 -38.91 91.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 0.0 110.437 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -66.6 -42.22 87.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.131 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 87.0 mtp -63.22 -48.6 77.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.438 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.67 -42.71 89.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.551 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.14 74.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.371 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -57.74 -41.46 81.92 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.367 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.519 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 79.3 mt -63.5 -31.78 73.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.615 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.28 9.96 42.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.638 0.256 . . . . 0.0 111.372 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.4 m -119.1 -80.15 0.61 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.448 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -81.67 -35.6 29.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.865 0.364 . . . . 0.0 111.659 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.593 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 35.4 mt -91.63 5.8 48.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.814 0.34 . . . . 0.0 110.978 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.18 81.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.854 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.98 -45.66 70.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.922 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.593 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 87.9 m95 -59.28 -51.69 68.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.411 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 133' ' ' LEU . 51.6 mm -61.58 -30.92 49.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.053 0.454 . . . . 0.0 111.011 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -72.3 -45.77 58.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.089 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.6 m -70.9 -30.12 66.38 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.554 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 67.5 m -89.31 1.93 55.07 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.11 41.05 96.38 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.441 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.99 -98.84 0.9 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -115.15 11.22 16.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -54.07 -51.05 65.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.778 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.652 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 3.2 pt-20 -85.65 -24.0 27.26 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.423 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -59.88 -42.22 93.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.228 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.473 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 1.2 p -72.68 -5.49 37.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.976 0.417 . . . . 0.0 111.258 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.85 -17.52 15.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.245 0.545 . . . . 0.0 110.323 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 41.3 mt -76.34 -57.14 4.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.945 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.473 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 4.8 p90 -74.59 -10.37 59.48 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.386 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.84 -22.74 78.87 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.818 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 0.0 110.271 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 201' ' ' ILE . . . . . 0.638 HG22 HG13 ' B' ' 202' ' ' ILE . 50.2 mt . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.419 0.152 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.638 HG13 HG22 ' B' ' 201' ' ' ILE . 29.0 mt -145.83 119.18 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.382 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -72.96 -34.58 66.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -57.4 -57.48 12.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.834 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 205' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' A' ' 70' ' ' THR . 33.2 mm -62.28 -39.22 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.437 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 206' ' ' ALA . . . . . 0.434 ' HA ' HG22 ' A' ' 81' ' ' VAL . . . -60.45 -46.89 88.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.997 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 207' ' ' ARG . . . . . 0.749 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 2.1 ttp-105 -58.91 -37.78 77.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.66 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 208' ' ' HIS . . . . . 0.508 ' O ' HG23 ' B' ' 212' ' ' VAL . 14.6 t60 -58.68 -60.59 3.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.105 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.476 HD13 ' CZ ' ' A' ' 101' ' ' PHE . 0.8 OUTLIER -66.17 -41.88 89.69 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.613 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -60.75 -44.65 96.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.433 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -67.36 -35.08 78.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.371 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 208' ' ' HIS . 32.8 t -56.36 -54.61 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 123.084 0.24 . . . . 0.0 110.826 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.09 -44.94 43.29 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.244 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -61.39 -56.54 19.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.6 m -62.97 -34.19 77.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.352 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 216' ' ' MET . . . . . 0.695 ' HG2' ' HB2' ' A' ' 56' ' ' PHE . 4.0 tpt -65.85 -44.74 84.58 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.433 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 217' ' ' ASP . . . . . 0.52 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 30.1 t70 -61.65 -33.94 74.83 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.038 0.447 . . . . 0.0 110.071 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 218' ' ' ARG . . . . . 0.473 ' HD2' ' HZ3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.066 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.865 0.364 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -127.49 89.69 50.55 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.219 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.65 131.35 22.63 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.578 2.185 . . . . 0.0 111.714 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.04 152.62 21.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.13 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.0 m -83.34 116.11 22.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.337 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.731 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -69.24 -55.85 9.4 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.281 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.731 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 96.0 Cg_endo -92.57 146.78 2.73 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.133 1.889 . . . . 0.0 112.917 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 13.4 t70 -76.54 148.26 37.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.848 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.1 m -53.43 -35.63 60.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 2.4 mtm180 -63.11 -33.34 75.24 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.116 -0.233 . . . . 0.0 110.824 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.27 -37.6 85.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.028 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.38 -40.32 81.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.67 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 9' ' ' THR . 85.1 t -62.34 -43.14 97.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.559 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.17 -38.43 91.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.13 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.85 -38.75 86.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -67.51 -50.42 58.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.3 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.2 t -61.86 -44.47 98.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.831 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 22' ' ' ARG . . . -62.93 -40.41 99.25 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.45 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.427 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 2.6 t80 -62.85 -47.39 83.58 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.56 -37.46 81.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.969 0.414 . . . . 0.0 110.447 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.711 HD12 ' HE2' ' A' ' 24' ' ' LYS . 23.4 tp -67.72 -34.07 76.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 84.7 mtm-85 -80.14 -33.73 38.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.753 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 14.3 mm100 -60.14 -23.6 64.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.711 ' HE2' HD12 ' A' ' 21' ' ' LEU . 57.3 pttt -97.08 22.78 8.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.885 0.374 . . . . 0.0 111.037 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.04 -55.29 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.327 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.7 110.91 4.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.24 112.87 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.088 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.4 t -120.86 125.86 48.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.054 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.19 -130.15 4.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.47 179.62 8.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.652 0.263 . . . . 0.0 110.302 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.69 96.66 0.81 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.869 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.46 113.21 3.05 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.899 2.399 . . . . 0.0 112.324 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.22 -108.96 1.83 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.959 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.38 106.36 9.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.95 0.405 . . . . 0.0 110.537 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.11 79.44 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.59 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.54 122.35 10.69 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.146 2.564 . . . . 0.0 112.786 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.88 166.91 10.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.578 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.7 18.06 9.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.093 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -120.87 89.08 45.19 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -89.71 -7.27 4.77 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.491 2.127 . . . . 0.0 110.812 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.64 -53.2 36.59 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.121 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -62.66 -38.04 88.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.953 0.406 . . . . 0.0 110.498 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -67.59 -40.28 84.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.271 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.65 91.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.545 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 37.6 mtt -61.67 -41.62 97.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.228 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -62.27 -50.33 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.586 ' HB1' ' HG3' ' A' ' 51' ' ' GLU . . . -61.8 -37.22 83.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.845 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.23 -32.61 49.13 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.127 0.267 . . . . 0.0 111.719 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.4 35.56 3.57 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.683 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -151.26 -33.49 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.586 ' HG3' ' HB1' ' A' ' 47' ' ' ALA . 3.8 mm-40 -60.38 -72.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.489 ' HE2' HG21 ' A' ' 59' ' ' THR . 9.2 p90 -56.47 -36.66 69.34 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.517 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.12 -42.3 99.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.684 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.55 -20.05 63.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 -105.92 1.21 26.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.208 0.528 . . . . 0.0 110.554 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.441 ' CG ' ' HG2' ' B' ' 216' ' ' MET . 2.8 t80 -98.13 -85.58 0.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.571 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.406 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 5.2 ttm105 175.05 -71.12 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.63 61.29 0.32 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.107 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.489 HG21 ' HE2' ' A' ' 52' ' ' PHE . 0.4 OUTLIER -50.51 -33.55 21.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.038 -178.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -56.06 -23.73 35.35 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.405 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.6 m -121.39 -40.38 2.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.615 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.5 -49.87 73.63 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.9 tp -59.67 -34.15 72.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.11 0.481 . . . . 0.0 110.733 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.612 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -80.04 -18.45 50.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.97 -47.58 7.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.511 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.925 ' HG3' HD22 ' A' ' 67' ' ' LEU . 8.5 pt20 -65.02 -19.55 66.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.925 HD22 ' HG3' ' A' ' 66' ' ' GLN . 0.4 OUTLIER -109.84 13.84 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 0.0 110.612 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.612 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 9.0 t-160 -95.24 10.38 36.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.161 0.505 . . . . 0.0 110.705 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.6 t -78.88 -42.57 24.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.201 0.524 . . . . 0.0 110.139 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -86.48 132.41 42.92 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.002 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.84 109.21 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.063 2.509 . . . . 0.0 112.704 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.08 -146.84 21.71 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.633 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.68 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 20.1 m -151.17 -159.45 1.03 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.6 -157.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.796 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.476 ' OE1' ' HB2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -54.96 -31.04 60.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.442 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 26.1 mp0 -64.43 -10.94 28.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.444 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.68 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 19.0 tpp85 -109.61 -25.59 10.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.7 0.286 . . . . 0.0 110.885 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.532 ' O ' HG12 ' A' ' 81' ' ' VAL . 19.4 m-85 -65.55 -61.05 2.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.33 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.17 -20.89 64.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.283 0.563 . . . . 0.0 110.731 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 76' ' ' GLN . 1.1 tp60 -75.63 -24.97 56.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.199 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 78' ' ' PHE . 1.4 p -73.93 -24.56 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.217 0.532 . . . . 0.0 110.04 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.23 -39.64 39.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.663 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -71.95 -28.52 63.5 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.007 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' O ' ' HE3' ' B' ' 203' ' ' LYS . 4.6 tp10 -54.6 -47.61 73.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.688 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.612 ' HB3' ' HD3' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -82.1 -21.8 36.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.535 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.557 ' HB2' ' HA ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -62.9 -32.61 73.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.356 0.598 . . . . 0.0 109.43 179.049 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -64.1 -24.09 67.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.42 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.46 45.32 1.09 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.512 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.64 74.79 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.553 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.09 52.09 3.69 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.342 2.695 . . . . 0.0 112.012 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -71.85 163.36 27.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.618 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.793 ' HB3' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -53.37 -39.94 64.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.392 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.461 ' HA3' ' OD1' ' B' ' 214' ' ' ASP . . . -65.22 -24.77 70.73 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.616 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.612 ' HD3' ' HB3' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -75.09 -39.92 60.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.82 -42.61 94.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.295 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.44 -46.75 89.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.356 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.5 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -60.97 -41.98 97.46 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.278 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -62.68 -41.55 99.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.126 0.488 . . . . 0.0 110.646 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -71.49 -49.21 43.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.398 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 97' ' ' ALA . 9.9 p -64.13 -36.44 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -62.36 -49.73 74.38 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.939 0.4 . . . . 0.0 110.187 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.81 -47.08 78.7 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.017 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.34 87.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.87 81.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.755 0.312 . . . . 0.0 111.252 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.456 ' HG ' ' OE1' ' A' ' 75' ' ' GLN . 2.6 mm? -65.83 -40.84 92.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.02 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.435 ' O ' HG23 ' A' ' 110' ' ' VAL . 56.6 m -64.49 -46.93 80.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.549 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.89 77.7 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.069 0.461 . . . . 0.0 110.541 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.71 -46.21 66.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.194 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 m -62.95 -34.64 77.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.126 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 106' ' ' CYS . 40.0 t -63.17 -39.88 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.001 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -73.46 -28.22 61.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.228 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -85.6 9.33 16.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.757 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 54.49 48.93 19.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.569 0.7 . . . . 0.0 110.334 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.18 53.89 1.28 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.316 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -60.45 -28.32 68.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.745 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.6 t -56.49 -45.48 82.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.391 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.496 ' O ' HG23 ' A' ' 121' ' ' VAL . 37.9 tp -71.97 -41.9 67.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.386 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.18 -46.61 77.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.564 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.79 -35.65 90.37 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.036 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -69.7 -44.89 69.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 110.237 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 117' ' ' LEU . 57.6 t -61.27 -48.4 89.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.826 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.33 -41.34 98.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.579 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -59.62 -45.39 92.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.252 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -66.54 -40.99 89.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.833 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 85.7 mtp -60.16 -51.4 69.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.744 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.39 -45.26 93.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.414 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.57 81.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -61.86 -43.26 99.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.161 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 58.4 mt -64.3 -28.51 69.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.854 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -101.91 8.04 41.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.2 m -121.53 -70.19 0.8 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.412 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.4 ttt85 -85.76 -38.32 18.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.833 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 77.9 mt -95.02 11.8 30.74 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.49 -52.64 64.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.798 0.332 . . . . 0.0 111.262 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.37 -39.31 92.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.833 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 84.0 m95 -62.95 -48.78 77.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 133' ' ' LEU . 44.1 mm -61.57 -37.45 77.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.043 0.449 . . . . 0.0 109.817 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -66.5 -32.12 73.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 m -78.01 -37.62 46.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.046 0.451 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 144' ' ' ALA . 29.8 m -81.5 -6.99 59.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.143 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.18 41.45 98.35 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.67 -100.97 1.99 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -120.78 13.6 11.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 140' ' ' SER . . . -51.79 -65.41 0.56 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.243 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.506 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 7.5 pt-20 -67.0 -23.52 65.94 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.234 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.476 ' HA ' HD12 ' A' ' 149' ' ' LEU . 59.0 t80 -61.92 -35.31 78.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.675 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -60.4 -30.63 69.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.131 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.41 -12.06 35.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.793 HD13 ' HB3' ' A' ' 92' ' ' TRP . 87.6 mt -80.54 -35.95 33.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.293 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.675 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 9.2 p90 -98.73 16.64 21.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.019 0.437 . . . . 0.0 111.056 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.22 -47.15 90.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.769 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -119.05 -172.59 2.33 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -148.86 -33.99 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.094 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.471 ' HA ' ' OG ' ' B' ' 219' ' ' SER . . . -95.51 -14.21 23.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.987 0.422 . . . . 0.0 110.901 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 54.7 tp -80.62 102.16 9.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.788 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.1 130.22 3.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.74 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -129.2 38.86 3.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.069 0.461 . . . . 0.0 110.465 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -101.91 -53.89 2.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.181 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.54 HH12 ' HA ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -146.37 8.58 1.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.166 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 52.2 ttp85 -54.69 142.2 29.39 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 23.5 tp -53.02 128.51 27.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.233 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.533 ' HG3' ' HB3' ' A' ' 166' ' ' TRP . 1.3 mpt_? -89.0 104.37 16.92 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.36 168.05 20.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.874 0.369 . . . . 0.0 111.702 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 59.03 -107.17 1.09 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.336 -0.847 . . . . 0.0 113.805 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -58.4 -46.85 85.6 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.842 0.457 . . . . 0.0 111.793 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.533 ' HB3' ' HG3' ' A' ' 162' ' ' ARG . 30.3 m95 -67.46 -83.03 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.937 0.399 . . . . 0.0 111.805 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -109.27 105.26 14.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.375 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.07 -34.22 14.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.289 0.566 . . . . 0.0 110.146 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 m -108.59 146.77 13.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.632 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.717 -179.483 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 37.6 mt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.863 0.363 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' B' ' 205' ' ' ILE . 1.8 pt -143.88 75.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.561 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 84' ' ' GLU . 20.1 mttp -65.1 -33.2 75.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -61.38 -42.58 98.94 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' ILE . . . . . 0.539 HD12 HD12 ' A' ' 67' ' ' LEU . 8.4 mm -69.07 -42.56 81.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.091 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 206' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -62.55 -37.94 88.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.354 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 207' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -66.33 -34.57 78.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.325 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' HIS . . . . . 0.578 ' HB3' HD11 ' A' ' 67' ' ' LEU . 6.1 t-80 -60.08 -56.55 20.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.435 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.1 pp -63.44 -33.43 75.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.811 0.339 . . . . 0.0 110.293 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.57 -59.37 4.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.791 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -63.6 -43.0 98.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.66 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.532 HG11 HE22 ' A' ' 66' ' ' GLN . 53.5 t -63.66 -43.19 98.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.709 0.29 . . . . 0.0 110.678 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.89 -44.22 80.07 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.095 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.461 ' OD1' ' HA3' ' A' ' 93' ' ' GLY . 60.0 m-20 -60.13 -46.1 90.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.93 0.395 . . . . 0.0 111.315 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 12.6 p -70.02 -46.82 64.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.934 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' MET . . . . . 0.63 ' HA ' ' HB ' ' B' ' 220' ' ' ILE . 11.4 tpp -62.82 -43.73 98.01 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 217' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' B' ' 219' ' ' SER . 11.8 t70 -60.15 -54.72 42.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.631 0.253 . . . . 0.0 110.912 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -77.07 31.6 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.449 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 154' ' ' ALA . 14.5 m 67.59 92.93 0.08 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.099 0.559 . . . . 0.0 110.741 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.63 ' HB ' ' HA ' ' B' ' 216' ' ' MET . 16.6 tt . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.04 -0.981 . . . . 0.0 111.291 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.804 0.335 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -114.26 126.26 28.22 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.475 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.45 110.11 2.61 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.567 2.178 . . . . 0.0 112.123 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.89 117.3 11.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.8 m -66.34 121.58 15.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.234 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.579 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -82.76 -51.52 0.7 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.16 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 17.1 Cg_exo -67.8 141.5 54.44 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.068 1.845 . . . . 0.0 112.67 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 16.0 t70 -85.95 154.6 21.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.266 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.8 m -54.65 -42.72 71.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.917 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.418 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -66.21 -35.05 79.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.418 0.151 . . . . 0.0 111.1 -179.184 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.27 -37.68 86.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.947 0.404 . . . . 0.0 110.552 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 41' ' ' LEU . 6.3 tp -68.27 -44.38 75.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.916 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 9' ' ' THR . 87.7 t -62.92 -44.81 99.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.389 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.64 71.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.831 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.22 -44.08 84.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.89 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -63.54 -47.64 80.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.131 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.8 t -59.77 -46.25 93.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.274 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 22' ' ' ARG . . . -62.75 -44.81 96.93 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.598 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.483 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 10.8 t80 -58.54 -49.6 76.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.38 . . . . 0.0 110.503 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -62.09 -36.21 81.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.408 HD12 ' HE2' ' A' ' 24' ' ' LYS . 7.6 tp -67.81 -26.67 66.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.59 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 87.1 mtm-85 -90.8 -32.43 16.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.461 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.531 HE22 HG13 ' A' ' 27' ' ' VAL . 15.7 mm100 -63.01 -27.14 69.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 0.0 111.38 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.408 ' HE2' HD12 ' A' ' 21' ' ' LEU . 36.8 pttt -88.61 17.91 5.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.132 0.492 . . . . 0.0 110.766 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.86 -74.8 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -127.58 101.35 6.37 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.531 HG13 HE22 ' A' ' 23' ' ' GLN . 59.1 t -62.06 121.95 11.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.809 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.2 t -143.23 139.21 30.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.768 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.59 -138.96 9.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.067 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.97 145.22 26.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.649 0.261 . . . . 0.0 110.473 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.59 103.99 2.23 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.272 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.83 128.15 14.68 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.78 2.32 . . . . 0.0 111.441 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.68 -55.99 0.2 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.257 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -125.09 24.94 7.38 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.173 0.511 . . . . 0.0 110.201 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.62 104.51 2.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.166 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.08 126.61 13.98 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.894 2.396 . . . . 0.0 111.802 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.51 154.69 20.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.346 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.38 -31.43 63.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.905 0.383 . . . . 0.0 110.65 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -104.3 130.26 23.63 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.135 0.493 . . . . 0.0 110.548 179.581 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 39' ' ' ASP . 84.7 Cg_endo -98.18 1.33 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.941 2.427 . . . . 0.0 111.081 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.455 ' HB3' HD21 ' A' ' 12' ' ' LEU . 47.2 mt -64.58 -47.22 79.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.821 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -58.85 -37.56 76.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.946 0.403 . . . . 0.0 111.417 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -80.27 -38.03 31.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.943 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.75 97.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.989 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.58 ' HE2' ' HZ ' ' A' ' 99' ' ' PHE . 25.3 ttm -61.22 -40.33 93.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.46 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -71.39 -44.39 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.517 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.55 ' HB1' ' HG3' ' A' ' 51' ' ' GLU . . . -59.07 -43.65 91.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.211 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.44 -21.11 34.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.555 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -125.51 26.11 5.52 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.013 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -146.37 -46.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.813 -0.228 . . . . 0.0 111.601 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.62 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 14.9 mm-40 -58.58 -55.36 36.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.829 0.347 . . . . 0.0 111.309 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.555 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 2.3 p90 -66.82 -28.74 68.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.121 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -71.55 -44.57 64.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.349 . . . . 0.0 110.407 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -71.99 -8.14 52.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.626 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.62 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 82.8 mtm-85 -109.6 5.05 22.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.296 0.569 . . . . 0.0 110.164 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.853 ' HD1' ' HG2' ' B' ' 216' ' ' MET . 60.8 t80 -118.85 -85.82 0.65 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.707 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 175.71 -72.2 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.512 0.673 . . . . 0.0 109.275 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.68 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -154.55 60.67 0.68 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.27 179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.57 HG22 HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -57.72 -32.04 67.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.909 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -58.16 -36.02 72.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.119 0.485 . . . . 0.0 110.372 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.91 -36.35 12.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.828 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.57 -40.25 86.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.584 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.57 HD13 HG22 ' A' ' 59' ' ' THR . 1.4 mp -63.84 -30.64 71.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.076 0.465 . . . . 0.0 110.861 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.98 -28.15 35.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.236 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.02 -49.28 65.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.849 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -67.4 -23.92 65.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.835 0.35 . . . . 0.0 110.516 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -85.01 -1.78 57.21 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.126 0.489 . . . . 0.0 110.108 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -104.22 -42.48 5.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.916 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.35 -50.46 78.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.48 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -87.25 142.46 33.5 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.816 178.319 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.48 ' HD2' HG22 ' A' ' 70' ' ' THR . 52.4 Cg_exo -53.45 106.35 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.799 2.332 . . . . 0.0 112.825 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.59 -169.84 22.72 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.738 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.823 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 61.3 m -146.8 -157.22 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.24 -167.32 0.31 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.93 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.462 ' HG3' HD21 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -50.74 -38.83 49.96 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.447 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -57.56 -31.01 65.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.627 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.823 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 11.8 tpp85 -72.62 -29.0 63.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.946 0.403 . . . . 0.0 110.177 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.591 ' O ' HG12 ' A' ' 81' ' ' VAL . 73.8 m-85 -73.97 -46.59 43.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -34.9 76.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.275 0.56 . . . . 0.0 110.698 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -68.88 -35.62 77.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.069 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -69.58 -25.33 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.678 0.275 . . . . 0.0 111.303 -179.131 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.26 -47.17 24.76 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.98 -30.19 70.71 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.072 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.404 ' HG3' ' HD3' ' B' ' 203' ' ' LYS . 3.8 tp10 -50.67 -48.13 58.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.741 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.6 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -97.48 -6.23 34.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.1 -179.503 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -40.72 62.97 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -66.27 -29.52 69.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.93 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.72 -26.53 71.2 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.192 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.06 107.91 0.22 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.153 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.26 59.4 6.0 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.867 2.378 . . . . 0.0 111.673 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -70.48 176.69 3.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.439 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.67 ' HB3' HD13 ' A' ' 149' ' ' LEU . 1.9 m-90 -53.0 -57.31 10.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.57 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.8 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -70.22 -12.15 68.56 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.826 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -39.81 93.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.094 0.447 . . . . 0.0 110.049 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.7 tp -71.71 -36.54 70.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.897 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.468 HG22 ' HE1' ' A' ' 146' ' ' PHE . 41.9 t -61.95 -50.28 80.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.407 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.54 -42.62 99.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.165 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -64.44 -42.45 95.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.09 0.472 . . . . 0.0 110.929 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.58 ' HZ ' ' HE2' ' A' ' 45' ' ' MET . 33.9 t80 -68.18 -48.47 65.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.288 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.478 HG21 ' CZ ' ' A' ' 52' ' ' PHE . 9.1 p -65.4 -33.25 62.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.122 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.739 ' HE2' HD13 ' B' ' 209' ' ' LEU . 0.2 OUTLIER -61.9 -51.28 68.82 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.02 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.66 -44.96 96.77 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.783 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.46 81.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.604 0.24 . . . . 0.0 111.351 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.61 -45.77 88.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.659 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 105' ' ' LEU . 2.8 mm? -68.07 -38.7 82.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.065 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.454 ' O ' HG23 ' A' ' 110' ' ' VAL . 19.7 m -65.78 -47.6 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.0 -42.07 89.21 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.984 0.421 . . . . 0.0 110.547 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -60.29 -39.83 88.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.949 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.491 ' HB3' ' HB3' ' A' ' 114' ' ' MET . 14.1 m -74.73 -39.66 61.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.892 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 106' ' ' CYS . 50.8 t -59.03 -47.38 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.855 0.36 . . . . 0.0 110.601 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -65.17 -27.23 68.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.54 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -90.21 9.94 26.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.875 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 60.74 33.07 20.25 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.993 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.51 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -104.51 61.84 0.72 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.955 0.407 . . . . 0.0 110.172 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -63.61 -29.83 71.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.145 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.28 -45.77 92.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.102 0.477 . . . . 0.0 110.556 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.472 ' HB2' ' SD ' ' A' ' 114' ' ' MET . 15.7 tp -69.82 -39.65 76.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.468 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 114' ' ' MET . 67.0 t -59.52 -45.55 93.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.869 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.2 -41.07 99.38 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.323 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -64.5 -46.26 83.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.796 0.331 . . . . 0.0 110.725 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 117' ' ' LEU . 99.8 t -64.25 -46.03 94.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.764 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.04 -45.05 96.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 110.681 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.21 -45.62 92.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.622 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -63.09 -43.49 98.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.113 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 95.1 mtp -57.85 -50.02 74.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.893 0.378 . . . . 0.0 110.655 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.77 -41.23 91.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.877 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.12 -46.14 91.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.578 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -59.58 -43.1 93.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.165 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.648 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 53.8 mt -63.88 -36.12 82.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -90.16 4.92 49.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 m -124.41 -77.1 0.59 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.75 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -75.07 -23.42 58.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.648 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 81.0 mt -109.88 14.32 23.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.348 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.4 -44.14 84.28 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.29 -39.42 48.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.822 0.344 . . . . 0.0 110.749 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.574 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 95.9 m95 -60.62 -50.54 73.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.27 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.75 -37.33 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 0.0 110.322 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -67.75 -36.08 79.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.742 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.7 m -71.68 -40.51 69.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.983 0.42 . . . . 0.0 110.704 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.408 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 68.9 m -78.61 -6.13 54.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.138 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.39 40.83 98.13 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.33 -111.35 3.27 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -109.36 14.93 23.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.05 -62.28 1.94 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.318 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.408 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 5.8 pt-20 -70.86 -20.15 62.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.725 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.468 ' HE1' HG22 ' A' ' 96' ' ' VAL . 75.5 t80 -60.6 -38.39 84.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.821 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -27.39 69.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.485 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.85 -13.83 38.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.748 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.67 HD13 ' HB3' ' A' ' 92' ' ' TRP . 56.6 mt -68.31 -35.3 77.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.918 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -110.22 20.33 17.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 0.0 110.223 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -75.64 -19.79 78.86 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.817 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -97.37 140.88 31.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.81 -57.79 1.38 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.232 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.519 ' HA ' ' H ' ' B' ' 220' ' ' ILE . . . -132.5 138.61 47.61 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.23 -20.34 0.78 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.254 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.86 -169.25 1.63 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -136.03 -40.14 0.68 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.756 0.312 . . . . 0.0 110.368 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -77.18 -29.27 54.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.424 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.418 ' NH1' HD12 ' B' ' 220' ' ' ILE . 26.7 mtm105 -80.81 -18.12 48.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.427 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.592 ' HG2' HG23 ' B' ' 220' ' ' ILE . 17.4 mtm180 -64.24 163.92 11.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 111.292 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.778 ' HG ' ' HA ' ' A' ' 168' ' ' SER . 4.5 mp -81.2 145.66 30.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.193 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.79 -15.61 14.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.448 0.642 . . . . 0.0 109.723 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.68 -47.13 2.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.173 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' A' ' 161' ' ' LEU . . . 95.47 26.6 11.77 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.955 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -78.04 -66.11 0.89 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.238 0.542 . . . . 0.0 110.144 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -165.12 -58.9 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.34 114.22 3.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.075 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.778 ' HA ' ' HG ' ' A' ' 161' ' ' LEU . 3.5 m -87.12 -37.91 16.94 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.341 0.591 . . . . 0.0 109.743 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.437 HG21 ' HE2' ' B' ' 216' ' ' MET . 18.2 m -111.74 164.42 7.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.663 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.353 -179.901 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 121.345 0.593 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 8.2 mt -132.8 86.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.889 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.404 ' HD3' ' HG3' ' A' ' 84' ' ' GLU . 64.9 mmtt -64.75 -33.79 76.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.357 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -53.21 -55.26 25.72 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 66.2 mt -65.68 -47.43 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.362 . . . . 0.0 110.956 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 206' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 85' ' ' LEU . . . -56.85 -45.3 82.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.524 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 207' ' ' ARG . . . . . 0.6 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 18.3 ttp-105 -62.04 -36.86 82.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 208' ' ' HIS . . . . . 0.41 ' O ' HG22 ' B' ' 212' ' ' VAL . 38.4 t-80 -60.9 -56.1 25.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.304 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.739 HD13 ' HE2' ' A' ' 101' ' ' PHE . 1.5 pp -65.74 -34.85 79.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.487 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 210' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -69.88 -43.01 72.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.092 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 211' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' B' ' 207' ' ' ARG . 0.7 OUTLIER -65.34 -49.06 70.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.798 -178.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' B' ' 216' ' ' MET . 26.0 m -62.99 -44.27 99.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.409 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.44 -38.62 87.04 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.394 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.8 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 4.0 t0 -67.01 -50.52 61.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.835 0.35 . . . . 0.0 111.335 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 2.7 m -69.72 -49.01 57.33 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 216' ' ' MET . . . . . 0.853 ' HG2' ' HD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -60.18 -37.82 81.37 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.043 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.27 -34.05 61.3 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.442 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 218' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER -75.22 73.33 2.33 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.278 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 7.8 m 65.93 178.13 0.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.563 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.592 HG23 ' HG2' ' A' ' 160' ' ' ARG . 7.1 tp . . . . . 0 C--N 1.316 -0.889 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.764 0.316 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 m -87.32 113.05 52.11 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.738 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.28 132.59 19.61 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.358 2.039 . . . . 0.0 112.009 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.96 139.52 32.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.118 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.53 116.91 25.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.108 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.77 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -86.24 -60.03 0.28 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.487 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 23.1 Cg_exo -65.7 138.6 54.51 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.057 1.838 . . . . 0.0 112.122 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.14 156.93 28.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.9 m -58.11 -41.13 82.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.946 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -69.95 -27.44 64.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 110.566 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.24 75.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.467 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.43 -40.27 77.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.682 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t -63.13 -47.03 94.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.968 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.95 -38.43 82.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.031 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.94 -43.23 83.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.545 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -65.06 -48.59 73.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -62.43 -45.23 99.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.342 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.75 -41.03 99.56 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.517 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -61.84 -43.09 99.55 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 21.5 mmmt -59.93 -45.26 93.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.049 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.445 HD12 ' HE3' ' A' ' 24' ' ' LYS . 55.2 tp -65.95 -40.45 91.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.706 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 84.6 mtm-85 -73.37 -30.13 63.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.829 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -64.46 -30.17 71.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HE3' HD12 ' A' ' 21' ' ' LEU . 10.0 pttp -92.88 -0.19 57.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.913 0.387 . . . . 0.0 110.938 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.5 -60.36 0.32 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.112 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -154.14 105.26 2.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.97 113.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.162 0.506 . . . . 0.0 110.712 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.8 t -127.79 127.34 43.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.043 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.01 -135.69 5.24 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.844 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.19 158.57 43.89 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.22 111.8 4.03 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.88 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.68 76.14 4.69 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.037 2.492 . . . . 0.0 111.99 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.22 -84.81 0.79 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.569 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -119.18 127.94 53.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.022 0.439 . . . . 0.0 110.115 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.29 91.7 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.441 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.75 110.5 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.83 2.353 . . . . 0.0 112.064 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.2 150.46 21.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.857 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.469 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -70.4 -26.27 63.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.846 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -101.51 104.8 36.51 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.421 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 74.4 Cg_endo -92.29 -3.41 3.84 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.801 2.334 . . . . 0.0 111.566 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.66 -41.33 96.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.731 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -59.62 -38.86 82.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.865 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -80.71 -37.28 30.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.94 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.69 98.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.897 0.38 . . . . 0.0 110.378 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.1 ttt -62.8 -39.65 94.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.856 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -65.96 -48.85 69.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.642 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.16 79.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.62 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.25 62.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.824 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.99 19.49 13.66 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.255 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -132.46 -47.67 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.622 0.249 . . . . 0.0 111.404 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.53 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 6.2 mm-40 -62.46 -30.54 71.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.626 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.574 ' O ' ' HB2' ' A' ' 56' ' ' PHE . 67.0 t80 -59.57 -32.34 70.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.033 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 59' ' ' THR . 4.6 tp10 -87.14 -26.74 23.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.815 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.9 m -54.27 -47.96 71.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.099 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.53 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 23.1 mtm-85 -102.02 12.4 36.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.846 0.355 . . . . 0.0 111.562 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.574 ' HB2' ' O ' ' A' ' 52' ' ' PHE . 3.2 t80 -97.77 -96.74 0.21 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 56' ' ' PHE . 42.4 ttm180 170.48 -68.43 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.8 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -154.21 79.36 1.11 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.126 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.458 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 61.6 m -57.17 -44.61 83.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.745 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -74.31 1.14 12.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.856 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . 4.8 m -124.04 -54.93 1.7 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -79.27 -57.23 3.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 66' ' ' GLN . 14.6 tp -58.78 -42.86 90.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.018 0.437 . . . . 0.0 110.904 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.51 -17.5 64.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.664 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.15 -46.73 6.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.519 0.2 . . . . 0.0 111.212 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.509 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 8.4 pt20 -64.06 -33.55 76.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.394 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.476 HD13 ' HA ' ' A' ' 67' ' ' LEU . 2.0 mm? -82.49 -11.21 58.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.063 0.459 . . . . 0.0 110.329 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -91.46 -11.83 36.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.798 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.3 t -66.17 -41.81 90.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -74.44 127.32 87.74 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.62 105.7 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.777 2.318 . . . . 0.0 112.098 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.81 -128.09 3.29 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.146 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.706 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 2.9 m -156.78 -148.3 0.21 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.99 -156.62 0.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.504 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -51.38 -35.06 37.04 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.34 0.4 . . . . 0.0 111.914 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -55.55 -42.96 75.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.11 0.481 . . . . 0.0 110.365 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.706 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 11.1 tpp180 -68.01 -43.0 79.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.393 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.507 ' O ' HG12 ' A' ' 81' ' ' VAL . 48.3 m-85 -62.67 -37.06 84.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.985 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.2 m -65.9 -49.92 66.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.609 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -70.22 -33.78 72.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.273 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.528 ' HA ' HD13 ' B' ' 202' ' ' ILE . 1.4 p -67.06 -31.57 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 0.0 110.498 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.9 m -77.32 -44.05 30.93 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.67 -35.98 79.52 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.613 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -53.7 -60.34 3.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.805 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.629 ' HB2' ' HB1' ' B' ' 206' ' ' ALA . 0.2 OUTLIER -78.67 -16.25 57.53 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.517 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -65.63 -34.73 78.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -90.71 11.2 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.202 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.6 25.64 5.02 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.83 83.56 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -83.86 59.24 6.11 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.759 2.306 . . . . 0.0 112.227 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.514 ' HB3' ' OD2' ' B' ' 214' ' ' ASP . 60.2 t30 -76.32 171.8 13.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.818 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.688 ' CD1' HD22 ' A' ' 149' ' ' LEU . 2.4 m0 -52.61 -49.48 64.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.767 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.765 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -65.47 -33.15 85.63 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.465 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -42.67 99.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.663 0.268 . . . . 0.0 110.597 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.404 HD23 ' HD1' ' A' ' 146' ' ' PHE . 29.3 tp -64.32 -42.49 96.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.325 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.76 -47.28 86.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.357 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.644 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -62.21 -40.43 96.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.37 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -59.59 -39.17 83.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.746 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -76.69 -48.83 17.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.193 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 97' ' ' ALA . 7.2 p -63.18 -32.04 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.526 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -60.77 -54.57 43.64 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.987 0.423 . . . . 0.0 110.46 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.03 -43.3 99.05 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.949 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.93 99.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.617 0.246 . . . . 0.0 111.185 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.21 -43.77 97.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.268 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 105' ' ' LEU . 2.1 mm? -68.78 -39.62 80.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.8 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.417 ' O ' HG23 ' A' ' 110' ' ' VAL . 50.4 m -66.12 -46.13 78.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.309 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.5 87.38 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.94 0.4 . . . . 0.0 110.515 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -45.29 91.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.268 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.6 m -65.81 -38.43 88.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.967 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 106' ' ' CYS . 49.9 t -63.16 -41.31 92.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.045 0.45 . . . . 0.0 109.807 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -70.3 -9.56 56.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.369 0.605 . . . . 0.0 110.533 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -105.21 6.4 32.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.008 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 62.66 32.47 16.24 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.198 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.444 ' SD ' ' HB ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -106.57 64.07 0.65 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.646 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -65.56 -21.99 66.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.818 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.444 ' HB ' ' SD ' ' A' ' 114' ' ' MET . 97.4 t -58.83 -56.36 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.758 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 121' ' ' VAL . 28.7 tp -66.95 -37.47 84.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.681 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.5 t -59.28 -48.48 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.44 -38.62 93.76 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.14 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -68.43 -50.45 52.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.747 0.308 . . . . 0.0 110.506 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 117' ' ' LEU . 71.9 t -58.24 -44.02 87.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.107 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -45.59 86.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.245 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.82 -45.16 87.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.729 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -55.91 -44.6 78.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.999 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 89.9 mtp -67.69 -50.08 59.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.392 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.14 -47.05 93.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.262 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.98 93.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.05 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -62.11 -38.48 89.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.874 0.368 . . . . 0.0 110.612 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.829 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 35.7 mt -66.92 -20.93 65.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.282 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.54 -13.72 15.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.3 m -94.96 -64.04 1.11 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -101.81 -32.12 10.42 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.829 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 73.4 mt -90.65 13.19 16.7 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.29 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.23 -53.55 53.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 110.598 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.94 -37.23 86.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.589 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.456 ' CD1' ' HA ' ' A' ' 133' ' ' LEU . 91.3 m95 -60.21 -56.5 20.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.681 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.659 HG23 ' HA2' ' A' ' 142' ' ' GLY . 45.9 mm -60.03 -36.14 65.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.009 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -63.61 -48.23 78.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.655 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.5 m -70.74 -32.2 69.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.584 0.23 . . . . 0.0 111.616 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.4 m -82.67 -6.41 59.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.796 0.331 . . . . 0.0 111.074 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.08 41.17 95.22 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.98 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.659 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 73.44 -103.2 1.38 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -118.37 16.08 13.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.59 -51.93 65.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.938 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -83.33 -15.96 48.02 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.625 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 89.0 t80 -61.7 -44.02 97.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.78 0.324 . . . . 0.0 110.5 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -24.67 66.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.129 0.49 . . . . 0.0 110.773 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.86 25.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.375 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.688 HD22 ' CD1' ' A' ' 92' ' ' TRP . 32.4 mt -61.39 -50.55 72.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 110.871 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -90.69 9.24 30.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.638 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.21 -10.61 84.55 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -136.27 159.12 42.71 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.93 93.79 1.27 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.398 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -140.0 20.64 2.46 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.565 0.221 . . . . 0.0 111.223 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.1 tt -159.21 121.88 3.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.771 0.32 . . . . 0.0 111.159 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -124.59 117.93 25.41 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -59.84 -36.87 77.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.709 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -77.21 20.02 0.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -149.14 -34.07 0.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.475 0.179 . . . . 0.0 111.404 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 17.1 mmm180 -58.28 -65.59 0.62 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.777 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 82.8 mt -98.37 -11.46 22.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.931 0.396 . . . . 0.0 111.114 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -113.26 95.23 5.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.063 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.46 -72.83 0.67 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.978 0.418 . . . . 0.0 110.16 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 177.52 -54.92 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.287 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -173.37 -29.2 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -75.31 -73.04 0.27 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -120.65 90.2 3.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.976 0.417 . . . . 0.0 110.8 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.9 m -82.43 -12.34 57.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.38 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.5 m -116.31 41.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.2 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 170' ' ' ARG . 10.2 ptp180 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.651 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 201' ' ' ILE . . . . . 0.443 HG22 HG13 ' B' ' 202' ' ' ILE . 43.3 mt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.979 0.418 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' A' ' 81' ' ' VAL . 0.8 OUTLIER -150.46 49.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.905 179.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' B' ' 207' ' ' ARG . 42.2 mttp -57.15 -33.71 67.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.632 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -59.78 -50.71 72.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 23.0 mt -70.35 -39.95 77.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.94 0.4 . . . . 0.0 110.026 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 206' ' ' ALA . . . . . 0.629 ' HB1' ' HB2' ' A' ' 85' ' ' LEU . . . -60.18 -46.09 90.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.215 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 207' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' B' ' 203' ' ' LYS . 0.4 OUTLIER -62.25 -36.81 83.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.489 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -58.75 -55.7 31.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.266 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.5 pp -68.76 -36.43 78.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 111.098 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.49 -51.95 63.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.756 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -59.76 -45.5 92.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.595 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' B' ' 216' ' ' MET . 85.4 t -62.75 -55.17 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.604 0.24 . . . . 0.0 111.229 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.71 -45.63 87.99 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.182 -0.532 . . . . 0.0 114.385 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.765 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 11.0 t70 -56.06 -47.29 78.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.94 0.4 . . . . 0.0 111.576 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.7 m -75.48 -41.16 56.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.257 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 216' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' B' ' 212' ' ' VAL . 5.0 tpt -54.46 -50.01 68.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.6 -34.48 74.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.865 0.364 . . . . 0.0 111.402 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 218' ' ' ARG . . . . . 0.521 HH21 ' HA2' ' A' ' 93' ' ' GLY . 0.1 OUTLIER -76.94 105.14 7.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.352 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 51.0 m 67.12 -177.6 0.2 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.261 0.553 . . . . 0.0 112.337 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.456 ' HB ' ' HG2' ' A' ' 55' ' ' ARG . 17.8 tt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.317 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.76 0.314 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -134.46 102.18 11.77 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.221 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.4 114.21 3.39 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.565 2.177 . . . . 0.0 112.147 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.65 118.48 16.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.504 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -83.27 108.93 16.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.351 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -83.96 -52.14 0.58 Allowed Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.021 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 23.8 Cg_exo -65.05 129.17 22.36 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.941 1.761 . . . . 0.0 112.345 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -78.76 154.36 30.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.227 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -55.82 -38.92 70.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.215 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -69.95 -34.07 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.81 0.338 . . . . 0.0 110.645 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.23 -33.48 76.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.159 0.505 . . . . 0.0 109.878 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.2 tp -70.95 -40.53 71.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.815 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 9' ' ' THR . 87.9 t -62.67 -45.99 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.286 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.04 -36.35 74.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.093 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.68 -51.6 66.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.458 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -63.01 -44.19 96.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.098 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -61.53 -47.59 92.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 120.846 0.355 . . . . 0.0 110.274 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.31 -36.41 92.71 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.509 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.536 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 30.2 t80 -64.65 -49.64 70.19 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -57.94 -40.28 80.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.238 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.561 HD13 HG12 ' A' ' 110' ' ' VAL . 36.1 tp -65.91 -33.12 75.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.787 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -81.83 -22.24 37.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.498 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 15.6 mm100 -61.68 -26.4 68.0 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -94.95 3.28 55.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.668 0.271 . . . . 0.0 111.394 -179.59 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -126.91 -60.29 0.14 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.564 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -157.03 104.36 2.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.4 t -65.76 120.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.517 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.2 t -128.79 99.3 5.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.219 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.98 -134.22 1.73 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.894 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.92 174.05 10.89 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.15 83.56 0.35 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.4 99.09 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.824 2.35 . . . . 0.0 111.96 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.64 -52.15 0.82 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.539 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -137.49 91.07 2.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.044 0.45 . . . . 0.0 110.325 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.75 105.32 0.24 Allowed Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.702 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.1 111.95 1.01 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.783 2.322 . . . . 0.0 111.821 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.38 139.96 39.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.431 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.72 -35.26 67.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.527 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 41' ' ' LEU . 4.4 t70 -96.1 112.69 60.39 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.729 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -94.47 -1.5 2.8 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.684 2.256 . . . . 0.0 112.655 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.433 ' HB2' ' OD1' ' A' ' 39' ' ' ASP . 24.9 mt -64.31 -44.64 90.97 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -62.22 -32.19 72.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.386 . . . . 0.0 110.818 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -79.79 -44.17 21.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.129 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.66 ' HB1' ' HE2' ' A' ' 146' ' ' PHE . . . -61.89 -42.96 99.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.743 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.567 ' HG3' ' HE2' ' A' ' 99' ' ' PHE . 13.8 ttt -61.57 -36.64 81.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.247 0.546 . . . . 0.0 110.202 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -73.67 -42.4 61.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.313 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.9 90.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.627 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -55.11 -25.79 33.89 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.86 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.434 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -123.76 39.85 2.09 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.227 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -162.82 -42.59 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.577 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 23.4 mm-40 -54.3 -60.33 3.48 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.434 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 11.5 p90 -57.46 -27.81 62.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.584 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 4.6 tp10 -72.9 -46.43 52.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.754 0.312 . . . . 0.0 110.947 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 m -64.95 -24.32 67.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.109 0.48 . . . . 0.0 110.738 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.577 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 9.6 mtm-85 -87.28 -25.18 24.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.202 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -97.52 -92.27 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.994 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 179.92 -64.23 0.01 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.921 0.391 . . . . 0.0 110.418 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.837 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -148.26 54.7 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.209 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.38 -30.41 71.55 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -59.74 -39.04 83.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.937 0.399 . . . . 0.0 110.287 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.424 ' OG ' ' HD3' ' A' ' 58' ' ' ARG . 1.6 m -86.59 -38.42 17.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.389 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 24.0 t70 -60.66 -41.53 95.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.0 tp -59.56 -39.86 85.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.408 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.22 -43.37 61.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.026 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.52 85.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.74 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 10.9 pt20 -66.3 -34.11 77.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 0.0 110.677 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.31 -24.87 63.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.091 0.472 . . . . 0.0 110.366 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -79.66 -13.22 59.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.554 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.4 t -76.25 -29.74 19.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 p -94.03 161.08 30.87 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.366 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.98 70.04 2.98 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.0 2.467 . . . . 0.0 112.034 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.84 -163.79 30.5 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.58 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -152.57 -132.06 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -99.69 -159.08 0.72 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.608 0.242 . . . . 0.0 110.886 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -51.32 -43.39 61.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.279 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -54.49 -44.52 72.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 0.0 111.192 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -71.76 -37.74 70.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.613 ' O ' HG12 ' A' ' 81' ' ' VAL . 15.5 m-85 -65.54 -45.95 81.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.593 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 m -69.38 -38.45 78.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.893 0.378 . . . . 0.0 110.854 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HA ' ' OD1' ' A' ' 83' ' ' ASP . 5.9 tp60 -65.92 -32.22 73.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.682 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 78' ' ' PHE . 1.9 p -75.37 -11.67 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.083 0.468 . . . . 0.0 110.982 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.0 m -86.95 -45.92 10.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.195 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.53 ' OD1' ' HA ' ' A' ' 80' ' ' GLN . 5.1 p-10 -80.7 -12.59 59.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.245 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.99 -41.56 96.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.919 0.39 . . . . 0.0 110.975 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.606 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -97.73 -11.86 22.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.126 -179.435 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 95' ' ' LEU . 18.4 t80 -68.43 -25.65 65.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.902 0.382 . . . . 0.0 110.732 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -69.18 -9.72 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.657 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.97 -8.88 71.81 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.21 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.87 134.14 3.3 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.786 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.05 69.54 7.88 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.829 2.352 . . . . 0.0 111.945 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.623 ' HB3' ' HB2' ' A' ' 94' ' ' ARG . 21.5 t30 -68.87 171.86 7.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.849 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.613 ' HH2' ' HB3' ' A' ' 158' ' ' ALA . 1.9 m-90 -46.43 -71.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 1.02 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -79.43 -15.98 78.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.555 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.623 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -61.97 -45.29 94.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.494 ' HA ' ' HE1' ' A' ' 86' ' ' PHE . 37.2 tp -68.65 -37.45 79.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.558 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 48' ' ' ALA . 74.7 t -62.01 -53.02 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.697 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.424 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -60.32 -43.82 96.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.509 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -62.19 -41.94 98.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 0.0 110.849 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.567 ' HE2' ' HG3' ' A' ' 45' ' ' MET . 10.9 t80 -71.02 -47.67 57.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.649 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 97' ' ' ALA . 9.8 p -68.12 -31.27 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.464 ' HE2' HD22 ' B' ' 209' ' ' LEU . 0.8 OUTLIER -57.47 -54.42 47.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.895 0.378 . . . . 0.0 110.181 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.81 -43.49 96.08 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.094 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.05 95.53 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.68 -46.2 76.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.704 0.288 . . . . 0.0 111.043 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 41.4 m -64.36 -46.29 84.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.459 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.03 75.26 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.014 0.435 . . . . 0.0 110.16 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.17 -44.12 84.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.735 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.596 ' HB2' HG22 ' A' ' 118' ' ' VAL . 6.3 m -66.66 -36.5 82.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.487 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.561 HG12 HD13 ' A' ' 21' ' ' LEU . 43.4 t -63.56 -43.97 98.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.05 0.453 . . . . 0.0 110.2 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -68.49 -23.09 64.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.793 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -94.7 13.5 24.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.448 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 60.06 45.22 12.21 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.66 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.568 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -124.79 56.8 1.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.18 0.514 . . . . 0.0 109.811 178.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.09 -29.35 68.52 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.837 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 t -56.32 -51.63 61.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.119 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.33 -35.68 76.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.805 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 109' ' ' SER . 55.3 t -59.25 -45.11 93.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 0.0 110.593 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.75 -38.04 94.04 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.786 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -63.21 -48.86 76.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 110.384 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.94 -43.86 96.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.469 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -61.65 -44.4 97.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.659 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.86 -47.49 84.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.485 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -62.54 -44.88 95.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.912 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.5 ttt -60.3 -52.47 65.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.548 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.409 ' HA ' HD12 ' A' ' 129' ' ' LEU . 91.7 t -62.45 -44.4 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.93 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.89 94.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.445 ' OH ' ' HD3' ' A' ' 132' ' ' ARG . 44.7 t80 -59.59 -38.84 82.29 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.579 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 21.3 mt -63.6 -32.46 73.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.879 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -95.89 -0.85 50.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.422 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.6 m -105.19 -64.13 1.16 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.445 ' HD3' ' OH ' ' A' ' 128' ' ' TYR . 25.1 ttt180 -102.84 -22.52 13.86 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 69.1 mt -101.37 15.12 29.84 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.517 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.1 -50.54 72.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.296 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.07 -41.03 87.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.493 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 89.8 m95 -57.91 -51.59 69.01 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.41 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.515 HG23 ' HA2' ' A' ' 142' ' ' GLY . 26.0 mm -62.73 -37.99 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.353 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -65.47 -36.15 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.916 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.3 m -73.46 -33.61 64.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.162 0.506 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.1 m -85.42 -5.2 59.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.98 42.07 96.99 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.515 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 75.93 -100.33 1.34 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -120.23 14.23 12.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.153 0.501 . . . . 0.0 109.769 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.97 93.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.245 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.527 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -77.62 -17.93 57.28 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.05 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.66 ' HE2' ' HB1' ' A' ' 44' ' ' ALA . 28.3 t80 -63.29 -32.65 74.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.902 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -38.14 68.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.001 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.3 -28.02 23.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.595 ' HB3' ' HA ' ' A' ' 92' ' ' TRP . 62.7 mt -56.02 -53.87 51.67 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.059 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -100.47 10.79 40.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.239 0.542 . . . . 0.0 110.477 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -91.82 23.16 27.41 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.052 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -152.92 -178.96 7.24 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 162.86 -36.85 0.34 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -101.66 -34.45 9.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.728 0.299 . . . . 0.0 111.181 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 18.4 tp -80.42 -28.19 37.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.072 0.463 . . . . 0.0 109.854 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -65.28 144.57 57.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.855 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -149.39 40.66 0.86 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.599 0.714 . . . . 0.0 110.651 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.613 ' HB3' ' HH2' ' A' ' 92' ' ' TRP . . . -93.17 -32.64 14.33 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.446 ' CG ' ' HZ3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -151.03 9.92 0.59 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.694 178.382 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.47 ' HD2' HG13 ' B' ' 220' ' ' ILE . 2.8 tmm_? -59.21 -70.33 0.16 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.65 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.473 HD12 HD11 ' B' ' 220' ' ' ILE . 14.9 tp -90.36 49.39 1.68 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.234 0.54 . . . . 0.0 109.766 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -116.09 110.86 19.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.976 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.24 158.5 17.41 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.771 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 142.47 -47.63 0.81 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -152.45 121.12 6.46 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -115.17 -33.77 5.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.884 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -114.43 -62.0 1.66 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.5 p -173.95 -63.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.285 0.564 . . . . 0.0 109.749 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.6 m -89.51 -4.01 10.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.999 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.947 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 201' ' ' ILE . . . . . 0.44 ' HB ' ' H ' ' B' ' 202' ' ' ILE . 4.9 pt . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.706 0.288 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.44 ' H ' ' HB ' ' B' ' 201' ' ' ILE . 24.0 mt -68.98 106.84 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.603 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -62.53 -32.78 73.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.979 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -51.09 -42.73 60.81 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.156 0.285 . . . . 0.0 111.519 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 205' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' B' ' 208' ' ' HIS . 21.8 mt -68.39 -42.6 84.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.86 0.362 . . . . 0.0 110.334 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 206' ' ' ALA . . . . . 0.573 ' HB1' ' HB2' ' A' ' 85' ' ' LEU . . . -61.34 -45.86 92.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.527 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 207' ' ' ARG . . . . . 0.606 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 42.1 ttp85 -64.53 -35.36 80.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.819 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 208' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' B' ' 205' ' ' ILE . 3.8 t60 -57.37 -51.03 71.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.925 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.4 pp -74.48 -36.18 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.351 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 210' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -62.28 -47.27 85.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.025 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.29 -39.92 93.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.731 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.59 -52.22 60.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.508 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.85 -40.2 98.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.828 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 1.02 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 1.3 t0 -64.4 -55.77 18.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.018 0.437 . . . . 0.0 111.479 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.6 m -66.57 -33.83 76.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 216' ' ' MET . . . . . . . . . . . . . 20.7 tpp -73.38 -48.74 31.63 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.91 -41.5 95.52 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.849 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 218' ' ' ARG . . . . . 0.47 ' HD3' ' HA ' ' B' ' 218' ' ' ARG . 0.0 OUTLIER -75.28 -21.9 58.17 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.979 179.185 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 219' ' ' SER . . . . . 0.427 ' OG ' ' HD2' ' A' ' 55' ' ' ARG . 57.6 m 57.85 -164.58 0.18 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.973 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 161' ' ' LEU . 12.1 tt . . . . . 0 C--O 1.246 0.897 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.176 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.87 0.367 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.4 111.05 15.16 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.747 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.23 134.23 24.51 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.716 2.277 . . . . 0.0 111.485 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.29 115.17 28.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.652 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 m -70.61 120.6 16.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.194 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.605 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -88.54 -51.82 0.38 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.557 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 31.5 Cg_exo -62.58 136.72 60.12 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.078 1.852 . . . . 0.0 112.108 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.99 154.62 40.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.557 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m -63.47 -34.53 77.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.782 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 10' ' ' ARG . 2.0 mtm180 -72.64 -26.8 61.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.811 0.338 . . . . 0.0 110.157 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.99 89.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.156 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.64 -44.18 96.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.556 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.3 t -63.17 -44.72 99.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.114 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.8 -37.12 85.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -68.65 -42.66 77.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.172 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -62.59 -51.61 66.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.393 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.63 -45.41 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.327 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.66 -42.78 99.81 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.778 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.643 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 1.8 t80 -63.71 -45.21 91.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -60.39 -34.82 74.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.593 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.1 tp -70.73 -25.22 62.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.26 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.4 mtm-85 -85.92 -35.56 20.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.56 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.672 ' HA ' HG22 ' A' ' 27' ' ' VAL . 10.1 mm100 -64.12 -25.59 68.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.476 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -84.43 -3.88 58.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.815 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -132.65 -88.54 0.39 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.722 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -113.56 97.52 6.5 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.672 HG22 ' HA ' ' A' ' 23' ' ' GLN . 75.0 t -62.72 115.72 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.057 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.89 97.87 5.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.527 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.462 ' HA3' ' OH ' ' A' ' 19' ' ' TYR . . . -176.82 165.13 35.08 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.82 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.93 123.98 46.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.735 0.302 . . . . 0.0 110.432 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.402 ' HA2' ' HD3' ' A' ' 32' ' ' PRO . . . -72.31 121.09 8.05 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.609 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.402 ' HD3' ' HA2' ' A' ' 31' ' ' GLY . 11.4 Cg_endo -89.08 106.13 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.419 2.746 . . . . 0.0 111.383 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.44 -70.11 0.9 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.015 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -120.46 64.73 0.84 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.277 0.56 . . . . 0.0 110.316 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.02 99.61 0.24 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.116 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.3 109.15 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.845 2.363 . . . . 0.0 112.183 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.72 139.08 34.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.421 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -72.45 -24.32 61.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.681 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -94.16 106.84 24.86 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.974 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 90.6 Cg_endo -95.85 -6.48 1.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.825 2.35 . . . . 0.0 111.74 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.8 mt -65.66 -50.95 63.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.878 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -64.46 -37.88 89.09 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.952 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -69.3 -41.67 76.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.67 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.09 90.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.8 ttt -63.26 -43.24 98.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.714 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -62.48 -46.41 88.59 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.41 87.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.5 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.68 -38.19 69.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.953 0.406 . . . . 0.0 111.812 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.65 27.69 12.94 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.501 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -143.11 -51.9 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.708 ' HA ' HG22 ' A' ' 54' ' ' THR . 41.3 mm-40 -64.11 -35.57 81.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.777 0.322 . . . . 0.0 110.46 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -66.75 -10.96 52.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.783 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.647 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 7.3 tp10 -107.45 -49.94 3.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.667 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.708 HG22 ' HA ' ' A' ' 51' ' ' GLU . 2.0 t -64.67 -31.48 72.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.761 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 55' ' ' ARG . 22.1 mtm180 -94.36 9.83 36.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.081 0.467 . . . . 0.0 110.39 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.959 ' HA ' ' HG2' ' B' ' 216' ' ' MET . 49.7 t80 -107.28 -82.89 0.54 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.642 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 5.1 mtm105 167.3 -65.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.808 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -153.35 72.2 0.92 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.924 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.647 ' OG1' ' HA ' ' A' ' 53' ' ' GLU . 2.5 m -62.81 -41.58 99.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.024 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.26 20.87 1.52 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.348 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.616 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . 51.9 m -153.2 -77.03 0.12 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -56.72 -44.17 81.36 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 38.4 tp -62.89 -43.49 98.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.859 0.361 . . . . 0.0 110.343 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -66.55 -34.9 78.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.597 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.29 -44.05 72.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.515 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -74.36 -25.74 59.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.867 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -83.82 -17.92 39.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.122 0.487 . . . . 0.0 110.133 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 3.2 t-80 -76.45 -14.14 60.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.39 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.88 -32.88 56.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.305 0.574 . . . . 0.0 109.545 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.58 140.28 55.39 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.881 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.14 99.29 0.16 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.865 2.377 . . . . 0.0 112.257 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.7 -149.49 15.1 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.282 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.837 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 49.0 m -158.22 -157.73 0.66 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.3 -156.92 0.1 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.019 0.438 . . . . 0.0 111.561 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.552 ' HG3' HD21 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -56.8 -30.11 63.38 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.15 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -66.04 -22.85 66.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.691 0.282 . . . . 0.0 111.434 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.837 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 21.4 tpp85 -85.1 -36.68 20.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.713 0.292 . . . . 0.0 110.444 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -69.9 -31.25 68.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.512 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.96 -20.48 57.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.711 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -111.48 5.37 19.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.718 0.295 . . . . 0.0 111.656 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.8 p -100.59 -14.36 7.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.384 0.611 . . . . 0.0 110.322 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.689 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -85.36 -41.52 15.4 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.535 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.36 -13.96 57.75 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.389 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' B' ' 206' ' ' ALA . 3.6 tp10 -54.96 -41.73 71.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.886 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.5 HD23 ' HB3' ' B' ' 206' ' ' ALA . 0.3 OUTLIER -106.42 32.76 4.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.134 0.492 . . . . 0.0 110.495 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -121.27 -36.02 3.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.528 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -62.42 -31.05 71.68 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.223 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.74 1.48 86.02 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.7 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.78 117.51 1.58 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.678 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.09 164.56 24.66 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.879 2.386 . . . . 0.0 112.037 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.459 ' HB3' ' HB2' ' A' ' 94' ' ' ARG . 24.1 t30 -148.25 169.0 21.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.627 ' HA ' HD22 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -50.04 -61.56 2.08 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.808 0.692 . . . . 0.0 112.213 -178.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.94 -4.83 84.28 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.063 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.459 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 4.2 tpp85 -65.29 -45.77 83.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.726 0.298 . . . . 0.0 110.558 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.4 tp -67.62 -37.8 83.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.135 0.493 . . . . 0.0 110.058 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.504 HG22 ' HE1' ' A' ' 146' ' ' PHE . 3.1 t -65.92 -41.36 89.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.358 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.637 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -62.21 -39.46 92.83 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.057 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.689 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 66.1 t80 -61.61 -37.08 82.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.167 0.508 . . . . 0.0 110.302 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -79.69 -46.89 16.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.345 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.637 HG12 ' HA ' ' A' ' 97' ' ' ALA . 4.4 p -61.7 -34.02 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.41 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -64.35 -50.93 65.79 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.909 0.385 . . . . 0.0 110.006 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.98 98.59 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.881 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.05 83.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.614 0.245 . . . . 0.0 111.484 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.28 79.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.656 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 105' ' ' LEU . 3.6 mm? -62.71 -38.78 91.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.361 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.7 m -72.66 -43.53 63.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.569 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.1 -37.65 77.67 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.101 0.477 . . . . 0.0 110.424 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.64 -43.68 88.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.787 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 114' ' ' MET . 21.5 m -68.43 -43.87 76.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.251 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.418 HG23 HG21 ' A' ' 118' ' ' VAL . 53.0 t -59.4 -37.37 69.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.017 0.437 . . . . 0.0 110.403 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -63.61 -29.15 70.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.839 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.9 mtpt -99.04 17.14 20.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.099 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 59.8 34.76 21.94 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.546 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.479 ' HB3' ' HB3' ' A' ' 109' ' ' SER . 0.0 OUTLIER -100.47 66.6 1.26 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.953 0.406 . . . . 0.0 110.169 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.07 -28.78 67.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.943 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.452 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 22.3 t -58.39 -51.14 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.003 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.552 HD21 ' HG3' ' A' ' 75' ' ' GLN . 14.1 tp -68.34 -39.69 81.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.984 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 114' ' ' MET . 87.7 t -59.49 -43.9 91.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.86 99.25 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.745 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 23.8 mt-30 -63.21 -50.9 68.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.624 0.25 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.28 -48.12 88.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.298 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -45.81 91.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.745 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -62.02 -42.8 99.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.246 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -60.62 -46.46 90.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.806 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 88.8 mtp -59.0 -50.94 72.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.975 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.48 -41.27 87.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.936 0.398 . . . . 0.0 110.907 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.3 -51.83 61.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.574 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.41 -42.56 87.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.215 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.666 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 36.7 mt -61.8 -26.34 68.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.102 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -107.89 3.71 24.59 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.675 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.0 m -107.41 -50.56 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -122.05 -18.7 6.85 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.893 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.678 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 83.8 mt -101.69 3.9 40.14 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.631 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.64 87.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.947 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.66 -39.7 81.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.209 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.678 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 91.8 m95 -68.09 -54.43 18.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.372 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.488 HG23 ' HA2' ' A' ' 142' ' ' GLY . 42.0 mm -56.73 -37.38 52.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.301 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -59.5 -45.11 92.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.237 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.4 m -77.51 -33.29 54.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.425 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 67.0 m -74.98 -3.24 31.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.67 39.66 96.91 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.488 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 72.04 -94.17 0.61 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -120.68 17.53 11.96 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.57 -51.56 66.86 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.54 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.622 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 4.2 pt-20 -78.21 -20.97 50.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.915 0.388 . . . . 0.0 110.5 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.504 ' HE1' HG22 ' A' ' 96' ' ' VAL . 91.5 t80 -61.25 -40.96 96.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.222 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.531 ' HA ' ' CE1' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -60.33 -33.45 72.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 110.831 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.23 -34.58 42.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.549 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.627 HD22 ' HA ' ' A' ' 92' ' ' TRP . 81.3 mt -57.38 -50.34 73.3 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.05 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.531 ' CE1' ' HA ' ' A' ' 147' ' ' THR . 5.6 p90 -86.15 -6.49 58.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.089 0.471 . . . . 0.0 110.229 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.65 -25.37 60.79 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -117.2 84.63 2.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.169 0.509 . . . . 0.0 109.844 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.29 23.75 1.88 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.208 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -116.61 65.04 0.71 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.156 0.503 . . . . 0.0 110.5 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 80.1 mt -80.71 -78.55 0.17 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.734 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.623 ' HB3' HH21 ' A' ' 159' ' ' ARG . 0.3 OUTLIER -109.62 89.91 3.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.373 0.606 . . . . 0.0 110.264 179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -110.91 16.9 21.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.719 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -94.84 -56.47 2.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.648 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.623 HH21 ' HB3' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -98.77 12.99 33.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 111.07 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.04 142.23 47.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.245 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 16.1 tp -63.34 116.51 5.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.185 0.517 . . . . 0.0 111.975 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -99.58 -38.56 8.7 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.03 177.08 8.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.079 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -127.29 168.6 19.34 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.073 -1.06 . . . . 0.0 113.417 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -111.94 140.42 46.62 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -103.08 -64.76 1.05 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.834 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -145.05 25.22 1.42 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.869 0.366 . . . . 0.0 111.828 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.5 m -96.53 159.29 15.02 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.47 62.65 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.422 0.63 . . . . 0.0 110.617 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.568 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 201' ' ' ILE . . . . . 0.558 HG22 HG13 ' B' ' 202' ' ' ILE . 52.0 mt . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.859 0.361 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.558 HG13 HG22 ' B' ' 201' ' ' ILE . 44.9 mt -144.01 111.17 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -64.73 -34.26 77.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.332 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -53.91 -48.11 70.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 38.1 mt -62.6 -48.43 88.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.677 0.275 . . . . 0.0 110.97 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 206' ' ' ALA . . . . . 0.5 ' HB3' HD23 ' A' ' 85' ' ' LEU . . . -62.28 -43.15 99.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.626 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -35.86 75.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.121 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.99 -55.18 35.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.864 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.3 pp -68.65 -38.03 80.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.643 0.259 . . . . 0.0 111.642 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 210' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -65.66 -51.36 60.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -59.12 -52.09 67.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' B' ' 216' ' ' MET . 57.2 t -64.29 -47.85 87.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.683 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.97 -50.66 56.88 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.92 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' B' ' 210' ' ' ALA . 0.9 OUTLIER -61.33 -46.99 87.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.409 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 15.9 m -67.18 -34.98 78.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.728 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 216' ' ' MET . . . . . 0.959 ' HG2' ' HA ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -68.83 -46.89 67.4 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.707 -179.437 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.66 -34.15 77.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.996 0.427 . . . . 0.0 110.503 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.58 -9.84 58.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.165 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 6.3 m 63.95 59.25 1.12 Allowed 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.602 0.563 . . . . 0.0 110.85 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.826 -0.607 . . . . 0.0 110.231 179.575 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.753 0.311 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.8 m -109.66 108.3 59.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.004 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.34 114.61 3.78 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.279 1.986 . . . . 0.0 111.567 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.41 130.32 42.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.528 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 m -88.13 120.7 29.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.638 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -84.4 -53.68 0.5 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 21.5 Cg_exo -66.13 125.72 14.57 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.119 1.879 . . . . 0.0 113.156 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.79 159.74 30.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.25 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -41.46 82.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.771 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 10' ' ' ARG . 0.6 OUTLIER -69.73 -32.6 71.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.713 0.292 . . . . 0.0 110.87 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.72 -40.65 92.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.34 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.8 -40.87 92.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.027 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.0 t -64.59 -42.53 95.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.261 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.55 -42.96 89.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.512 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.26 -37.85 86.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.0 -48.08 69.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.74 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.93 -43.39 97.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.166 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.71 98.35 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.402 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 23.3 t80 -62.81 -42.83 99.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -60.01 -36.22 76.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 0.0 110.432 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.2 tp -72.69 -28.32 62.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.232 0.539 . . . . 0.0 110.216 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 73.8 mtm-85 -80.77 -26.97 36.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.892 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 16.0 mm100 -64.35 -28.26 69.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.327 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -92.37 6.64 46.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.937 0.398 . . . . 0.0 110.789 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.83 -93.92 0.46 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -119.7 108.69 14.75 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.66 113.99 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.962 0.411 . . . . 0.0 110.396 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t -124.2 99.24 6.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.369 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.98 -132.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.538 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.7 149.64 27.72 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.96 112.33 3.43 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.036 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 88.85 1.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.55 2.167 . . . . 0.0 111.877 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.72 -129.22 5.58 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -85.09 68.73 10.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.066 0.46 . . . . 0.0 110.861 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.13 103.74 0.44 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.078 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.12 116.87 3.48 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.95 2.433 . . . . 0.0 112.383 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.52 152.64 18.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.077 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.63 -31.07 32.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.215 0.531 . . . . 0.0 109.981 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -107.92 126.0 30.8 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.196 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 39' ' ' ASP . 57.6 Cg_endo -97.2 4.63 1.58 Allowed 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.074 2.516 . . . . 0.0 111.089 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.9 mt -71.15 -46.87 60.63 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.132 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -61.39 -32.91 72.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.212 0.53 . . . . 0.0 110.084 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -78.69 -38.54 39.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.569 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.503 ' HB1' ' HE2' ' A' ' 146' ' ' PHE . . . -64.24 -41.7 96.87 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.499 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.9 ttt -63.32 -38.36 90.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.943 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -68.24 -48.78 64.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.264 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.59 -43.71 84.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.447 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.46 -42.34 64.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.39 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.6 40.18 2.64 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.614 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -155.62 -42.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 41.5 mm-40 -58.78 -78.41 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 4.5 p90 -64.15 -21.9 66.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.703 0.287 . . . . 0.0 110.668 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 32.1 tp10 -63.55 -52.98 58.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.547 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 m -74.92 -29.56 61.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.584 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.412 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 15.9 mtm-85 -71.22 -17.2 62.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.478 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -102.96 -74.79 0.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.232 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ttm105 177.36 -69.38 0.01 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.999 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.94 58.75 0.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.917 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.698 HG22 HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -57.11 -25.67 59.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.245 -178.581 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -53.95 -31.11 49.46 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 111.007 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.01 -29.62 5.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 18.0 t70 -69.04 -30.23 68.55 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.698 HD13 HG22 ' A' ' 59' ' ' THR . 5.5 tp -55.65 -38.07 69.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 111.218 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.93 -11.75 56.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.0 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.27 -47.08 8.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.995 0.426 . . . . 0.0 110.618 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 8.3 pt20 -66.98 -30.62 70.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.106 0.479 . . . . 0.0 110.142 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.479 HD22 ' HG3' ' A' ' 66' ' ' GLN . 1.1 mm? -96.73 14.7 24.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.211 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.73 -9.53 58.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.054 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.71 -36.07 75.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.96 129.69 35.0 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.359 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.67 117.02 3.39 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.826 2.35 . . . . 0.0 112.325 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.43 -159.04 21.99 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.159 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.0 m -143.18 -130.64 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -99.05 -153.99 0.45 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.341 0.115 . . . . 0.0 110.719 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.455 ' OE1' ' HB3' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -56.51 -33.16 65.75 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.422 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.463 ' HG3' ' CZ3' ' A' ' 124' ' ' TRP . 22.9 mp0 -56.58 -28.47 60.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.617 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -83.13 -9.66 59.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.043 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.522 ' O ' HG12 ' A' ' 81' ' ' VAL . 30.8 m-85 -108.59 -43.24 4.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.714 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.25 -30.17 68.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.76 0.314 . . . . 0.0 111.785 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.503 ' HB3' HD11 ' B' ' 201' ' ' ILE . 6.7 tp60 -100.95 12.13 38.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.959 0.409 . . . . 0.0 111.314 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 78' ' ' PHE . 2.1 p -109.27 -14.07 10.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.286 0.565 . . . . 0.0 110.288 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.627 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -81.26 -36.99 29.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.81 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -77.65 -20.28 54.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -53.81 -42.89 68.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.703 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.744 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -95.02 5.92 50.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.26 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -100.86 -36.52 9.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.423 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -52.32 -39.24 60.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.591 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.76 34.2 5.11 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.498 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.523 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . 175.94 83.34 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.837 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.47 ' HG3' ' CZ3' ' A' ' 136' ' ' TRP . 4.8 Cg_exo -79.85 53.01 4.54 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.223 2.615 . . . . 0.0 111.688 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -71.68 164.9 25.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.617 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.847 ' HD1' HD22 ' A' ' 149' ' ' LEU . 2.2 m-90 -53.89 -58.02 8.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.755 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.65 -14.13 79.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.26 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 6.7 tpp85 -66.79 -47.78 71.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.748 0.309 . . . . 0.0 110.586 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.405 HD23 ' CD1' ' A' ' 146' ' ' PHE . 26.3 tp -64.86 -36.06 83.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.741 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.7 t -62.97 -50.93 77.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.264 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -60.2 -42.49 95.22 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.458 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.627 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 52.5 t80 -62.69 -45.21 93.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.081 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -72.11 -42.53 65.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.912 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 97' ' ' ALA . 3.9 p -70.46 -27.98 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.634 ' HE2' HD13 ' B' ' 209' ' ' LEU . 0.2 OUTLIER -57.53 -50.69 72.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 110.444 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.1 -43.26 97.48 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.862 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -46.77 88.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.467 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.15 -43.53 98.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.268 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.455 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . 2.0 mm? -68.17 -39.34 82.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.984 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.2 m -67.2 -39.65 86.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.243 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.72 89.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.946 0.403 . . . . 0.0 110.291 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -41.24 82.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.855 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -67.55 -46.39 72.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.204 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.16 -40.3 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.894 0.378 . . . . 0.0 110.422 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -64.1 -26.8 68.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.415 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -96.03 9.87 39.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.148 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 68.73 15.88 8.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.197 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.459 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -88.58 67.23 8.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.182 0.515 . . . . 0.0 110.481 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -71.53 -28.76 64.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.704 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -56.87 -46.61 83.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.578 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.4 HD21 ' HG3' ' A' ' 75' ' ' GLN . 25.6 tp -67.94 -43.62 78.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.923 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 114' ' ' MET . 64.0 t -56.98 -46.67 84.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.641 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.04 -35.12 82.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.726 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -77.25 -47.15 20.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.622 0.248 . . . . 0.0 110.572 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.47 -45.79 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.784 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.404 ' HA ' ' NE2' ' A' ' 122' ' ' GLN . 1.3 tp60 -61.36 -44.42 97.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.677 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -63.69 -40.04 95.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.165 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.463 ' CZ3' ' HG3' ' A' ' 76' ' ' GLN . 13.1 m0 -59.93 -44.52 94.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.635 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 85.1 mtp -60.65 -51.91 67.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.175 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.68 -44.55 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.77 0.319 . . . . 0.0 111.263 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.26 -44.97 96.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -60.85 -42.88 98.7 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.626 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.505 HD23 HD12 ' A' ' 133' ' ' LEU . 68.8 mt -62.84 -31.81 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.4 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -92.46 11.4 26.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 111.629 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.0 m -122.92 -70.0 0.8 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.606 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -85.35 -33.89 21.93 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.505 HD12 HD23 ' A' ' 129' ' ' LEU . 48.0 mt -102.47 16.58 25.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.268 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.12 -48.5 79.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 110.733 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.61 -36.83 84.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.321 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.47 ' CZ3' ' HG3' ' A' ' 90' ' ' PRO . 11.3 m95 -61.02 -55.37 33.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.392 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.414 HG23 ' HA2' ' A' ' 142' ' ' GLY . 46.7 mm -59.55 -39.9 80.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.685 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -63.37 -41.64 98.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.159 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.5 m -71.54 -37.73 71.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.375 . . . . 0.0 111.173 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.608 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 65.4 m -81.19 -6.3 58.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.812 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.46 43.32 96.86 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.004 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.414 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 78.95 -113.62 3.71 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.327 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -110.49 17.97 20.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.997 0.427 . . . . 0.0 110.379 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.66 -60.37 3.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.432 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.608 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 5.9 pt-20 -68.5 -27.49 66.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 110.643 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.616 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 73.7 t80 -61.88 -35.79 79.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.049 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.776 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 27.7 m -62.8 -24.82 67.93 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.569 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.98 -24.0 22.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.122 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.847 HD22 ' HD1' ' A' ' 92' ' ' TRP . 29.8 mt -62.58 -47.64 82.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 110.819 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.776 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 11.1 p90 -96.29 12.67 30.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.301 0.572 . . . . 0.0 110.096 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.88 -23.73 63.47 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.11 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -117.51 173.46 6.7 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -131.61 79.92 0.35 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.947 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.1 132.09 50.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.75 0.309 . . . . 0.0 110.764 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.16 96.39 8.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.482 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.54 112.85 21.95 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.437 ' HA ' ' HG3' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -110.05 28.51 8.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.338 -178.488 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -104.76 -67.91 0.88 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.777 0.322 . . . . 0.0 111.285 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.596 HH22 ' HA ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -87.69 42.11 1.03 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.44 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.562 ' HD2' ' OXT' ' B' ' 220' ' ' ILE . 8.5 mtm180 -76.21 -175.64 3.25 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.847 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 72.5 mt -70.8 85.42 0.67 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.375 0.607 . . . . 0.0 111.831 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 160' ' ' ARG . 1.2 mpp_? -127.24 39.06 3.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.538 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -106.95 169.65 8.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.81 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.99 18.02 0.1 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.734 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -71.25 126.03 28.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.717 0.294 . . . . 0.0 110.646 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -150.97 -68.43 0.18 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -114.18 -125.02 0.28 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.832 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.1 -40.65 90.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.943 0.402 . . . . 0.0 110.882 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.2 m -95.63 154.26 3.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.781 0.324 . . . . 0.0 110.745 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.542 ' HB2' ' NH1' ' A' ' 170' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.894 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.226 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 201' ' ' ILE . . . . . 0.503 HD11 ' HB3' ' A' ' 80' ' ' GLN . 26.1 mt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.718 0.294 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 96.3 mt -143.1 114.81 2.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -61.38 -38.0 85.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.231 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -57.53 -44.38 85.06 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 111.665 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.65 -52.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.083 0.468 . . . . 0.0 110.493 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 206' ' ' ALA . . . . . 0.457 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -60.21 -40.72 91.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.078 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 207' ' ' ARG . . . . . 0.744 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 28.8 ttp-105 -63.47 -37.2 86.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.055 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -63.68 -49.64 72.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.209 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.634 HD13 ' HE2' ' A' ' 101' ' ' PHE . 1.5 pp -67.63 -37.91 83.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.738 0.304 . . . . 0.0 110.918 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -67.32 -44.47 79.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.081 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -59.67 -47.27 86.3 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 123.272 0.358 . . . . 0.0 111.008 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.38 -53.45 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.25 0.343 . . . . 0.0 111.349 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -43.55 98.14 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.149 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.52 -40.07 85.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.005 0.431 . . . . 0.0 111.751 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.432 ' HB3' HH11 ' A' ' 159' ' ' ARG . 51.0 m -75.34 -46.01 35.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 216' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -34.18 77.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 217' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . 34.5 t70 -75.16 -33.35 61.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.576 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 218' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' B' ' 218' ' ' ARG . 0.0 OUTLIER -75.67 45.83 0.34 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.412 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 7.8 m 57.13 88.24 0.05 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.445 0.64 . . . . 0.0 111.884 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.596 ' HA ' HH22 ' A' ' 159' ' ' ARG . 15.5 tt . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.279 -0.867 . . . . 0.0 109.83 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.781 0.324 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 m -124.17 113.6 27.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.51 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.0 128.27 20.33 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.777 2.318 . . . . 0.0 111.834 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.83 122.4 45.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.69 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.7 m -96.85 112.47 24.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.935 0.398 . . . . 0.0 110.619 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.561 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.8 -50.06 5.81 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.605 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 31.3 Cg_exo -60.85 126.54 19.92 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.103 1.869 . . . . 0.0 112.256 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.42 155.29 39.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.74 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -55.9 -38.33 70.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.962 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -68.7 -23.92 64.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 111.006 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.66 -37.22 65.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -68.88 -38.82 79.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.771 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' THR . 82.8 t -60.96 -43.71 96.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.673 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.76 -27.4 67.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.623 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 35.7 t70 -69.94 -44.0 70.46 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -68.5 -45.97 70.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.41 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.49 -46.82 95.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.965 0.412 . . . . 0.0 110.162 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.06 97.31 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.435 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.679 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 6.7 t80 -60.83 -47.68 85.27 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 19.8 mmmt -57.43 -39.27 75.87 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.642 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.491 HD12 ' HE3' ' A' ' 24' ' ' LYS . 24.3 tp -66.92 -32.97 74.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.449 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.3 mtm-85 -81.22 -29.38 34.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.188 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.679 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 12.8 mm100 -64.32 -26.82 68.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.63 0.252 . . . . 0.0 111.293 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HE3' HD12 ' A' ' 21' ' ' LEU . 6.7 pttp -97.61 13.26 30.76 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.899 0.38 . . . . 0.0 111.372 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.15 -75.4 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -142.46 106.3 4.7 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.38 109.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.922 0.391 . . . . 0.0 110.796 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 37.8 m -110.31 122.93 48.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.048 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.43 -133.4 4.57 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.862 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.451 ' O ' ' HD3' ' A' ' 32' ' ' PRO . . . -150.64 174.93 12.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.604 0.24 . . . . 0.0 110.638 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.87 99.19 1.41 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.792 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 30' ' ' ALA . 4.9 Cg_exo -76.7 89.97 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.816 2.344 . . . . 0.0 112.103 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.19 -74.53 0.95 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.471 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.92 108.23 19.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.956 0.408 . . . . 0.0 110.069 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.54 95.8 0.11 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.576 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.97 112.14 1.43 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.931 2.42 . . . . 0.0 112.109 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.29 153.16 17.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.212 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.21 -28.62 48.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.031 0.443 . . . . 0.0 110.013 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.31 110.18 59.13 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.88 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -103.91 10.72 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.557 2.838 . . . . 0.0 112.199 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' A' ' 143' ' ' TRP . 59.3 mt -72.11 -45.59 60.0 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -66.09 -38.47 88.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -67.73 -39.37 84.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.259 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.6 98.45 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.253 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 46.3 mtt -62.87 -44.68 95.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.162 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.544 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 6.7 tmm_? -65.06 -43.98 90.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.143 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.72 79.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.286 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.67 89.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.058 0.456 . . . . 0.0 110.328 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.07 22.66 30.66 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.773 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 3.2 t0 -126.8 -61.06 1.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.555 0.217 . . . . 0.0 110.967 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.785 ' HA ' HG22 ' A' ' 54' ' ' THR . 76.0 mm-40 -63.0 -41.81 99.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.032 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.484 ' HA ' ' OD1' ' B' ' 217' ' ' ASP . 51.3 t80 -58.73 -29.28 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.972 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -91.24 -40.89 11.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.398 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.785 HG22 ' HA ' ' A' ' 51' ' ' GLU . 12.6 t -70.02 -32.42 70.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 51' ' ' GLU . 21.8 mtm180 -85.07 -22.19 29.05 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 110.514 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.6 ' HA ' ' HG2' ' B' ' 216' ' ' MET . 36.3 t80 -80.08 -82.47 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 56' ' ' PHE . 9.8 ttm105 165.82 -68.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 O-C-N 123.993 0.808 . . . . 0.0 109.264 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.462 ' HD3' ' OG ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -159.42 72.45 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.056 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 m -56.47 -34.77 67.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.478 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -65.24 -15.5 62.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.584 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.462 ' OG ' ' HD3' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -118.88 -53.96 2.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.733 0.302 . . . . 0.0 111.792 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.7 -68.79 0.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.176 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.572 ' HA ' ' HG2' ' A' ' 66' ' ' GLN . 9.7 tp -57.88 -42.65 85.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.564 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -61.53 -29.79 70.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.046 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.74 -44.44 10.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.572 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 8.1 pt20 -65.37 -31.79 73.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.758 0.313 . . . . 0.0 111.27 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.773 ' HG ' ' HB3' ' B' ' 209' ' ' LEU . 2.2 mm? -87.87 -4.62 58.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.959 0.409 . . . . 0.0 110.757 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.525 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 4.7 t-80 -88.0 -10.94 48.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.778 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.1 t -75.17 -33.93 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.522 0.677 . . . . 0.0 109.595 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -74.46 148.42 85.74 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.185 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 70' ' ' THR . 23.4 Cg_exo -63.83 94.98 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.577 2.185 . . . . 0.0 112.213 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.43 -147.42 14.61 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.306 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.682 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 66.4 m -162.31 -159.7 0.61 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.461 0.304 . . . . 0.0 110.217 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.04 -160.7 0.25 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.679 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.838 ' HG3' HD21 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -58.28 -27.51 64.11 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -63.58 -25.3 68.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.842 0.353 . . . . 0.0 110.592 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.682 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 13.1 tpp85 -88.95 -34.95 16.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.071 0.462 . . . . 0.0 109.937 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -67.74 -32.65 73.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.546 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 p -81.47 7.36 12.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.83 0.348 . . . . 0.0 111.502 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -127.09 -41.31 1.79 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.157 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.483 HG23 HG21 ' B' ' 202' ' ' ILE . 9.9 p -55.56 -29.22 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.473 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -74.22 -46.15 43.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.109 0.481 . . . . 0.0 110.974 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.01 -33.74 75.19 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.207 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' B' ' 202' ' ' ILE . 8.2 mm-40 -53.88 -31.77 50.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.369 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.702 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -103.37 -14.52 16.24 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.813 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -70.53 -43.27 69.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.134 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.427 HE22 ' HD3' ' A' ' 132' ' ' ARG . 61.0 mt-30 -77.28 -2.16 33.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.176 0.513 . . . . 0.0 110.741 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -106.33 16.18 41.9 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.475 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . 148.23 85.95 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HG3' ' HZ3' ' A' ' 136' ' ' TRP . 3.8 Cg_exo -74.64 70.81 4.92 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 123.059 2.506 . . . . 0.0 112.746 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -82.61 173.15 12.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.38 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.559 ' CD1' HD22 ' A' ' 149' ' ' LEU . 35.3 m0 -51.32 -62.63 1.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.556 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.25 -18.81 75.33 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.155 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 3.5 tpp85 -63.91 -46.46 84.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.417 HD23 ' CD1' ' A' ' 146' ' ' PHE . 39.3 tp -69.66 -35.33 75.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.089 0.471 . . . . 0.0 109.817 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 92' ' ' TRP . 84.6 t -63.35 -44.98 99.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.022 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.665 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -63.2 -38.8 92.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.597 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.473 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 89.1 t80 -60.92 -40.83 94.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.419 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -76.26 -47.42 23.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.43 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.665 HG12 ' HA ' ' A' ' 97' ' ' ALA . 5.5 p -65.05 -30.52 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.534 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 1.2 t80 -61.08 -54.61 42.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.849 0.357 . . . . 0.0 110.231 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.62 -40.7 96.09 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.042 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.75 95.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.557 0.217 . . . . 0.0 111.459 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.31 75.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.112 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 105' ' ' LEU . 1.7 mm? -61.58 -41.36 97.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.508 ' O ' HG23 ' A' ' 110' ' ' VAL . 30.2 m -66.44 -45.9 78.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.663 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.71 86.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.02 -42.66 99.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.993 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.2 m -67.04 -37.51 84.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.327 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 106' ' ' CYS . 76.7 t -62.89 -38.61 82.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.2 0.524 . . . . 0.0 110.095 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -73.08 -12.95 61.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.801 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -106.47 13.14 28.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.365 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 56.7 48.96 15.32 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.329 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.454 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.02 61.27 0.9 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.105 0.478 . . . . 0.0 110.509 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -60.36 -30.48 69.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.034 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.8 t -59.24 -45.18 93.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.402 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.838 HD21 ' HG3' ' A' ' 75' ' ' GLN . 48.5 tp -72.04 -41.52 67.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.667 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 114' ' ' MET . 83.1 t -60.42 -48.91 86.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.235 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.84 -40.08 96.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.239 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -66.66 -47.54 72.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.525 0.203 . . . . 0.0 110.671 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.42 ' O ' ' HG3' ' A' ' 125' ' ' MET . 64.6 t -59.46 -45.96 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.726 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.2 -45.4 93.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -63.28 -42.3 99.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -61.31 -38.34 86.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 121' ' ' VAL . 95.7 mtp -66.81 -48.67 68.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.258 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.06 -42.52 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.53 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.22 -43.67 83.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 132' ' ' ARG . 0.2 OUTLIER -62.88 -41.84 99.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.414 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.651 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 91.3 mt -65.56 -31.39 72.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.657 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.27 -3.71 55.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.0 m -115.41 -88.93 0.57 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.49 ' HB3' ' CE1' ' A' ' 128' ' ' TYR . 64.2 ttt180 -72.47 -36.27 68.41 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.651 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 97.5 mt -89.71 14.66 11.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.727 0.298 . . . . 0.0 111.372 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.32 -55.27 29.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.844 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.97 -34.68 78.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.775 0.322 . . . . 0.0 110.87 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.41 ' HZ3' ' HG3' ' A' ' 90' ' ' PRO . 60.9 m95 -59.37 -57.93 10.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.46 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.408 HG23 ' HA2' ' A' ' 142' ' ' GLY . 47.3 mm -61.69 -37.27 77.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.913 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -63.49 -42.0 98.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.461 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.8 m -76.71 -27.88 55.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.728 0.299 . . . . 0.0 111.279 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 70.3 m -85.04 -11.95 54.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.583 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.17 44.82 85.79 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.408 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 70.53 -100.84 0.85 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.59 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.532 ' HB2' HD22 ' A' ' 41' ' ' LEU . 84.2 m95 -116.78 15.15 15.36 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.65 -60.24 3.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.592 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.527 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 3.7 pt-20 -66.76 -28.23 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 110.579 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.504 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 74.0 t80 -62.07 -30.57 71.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.638 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 5.6 m -61.83 -28.34 69.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.216 0.531 . . . . 0.0 110.569 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.27 -26.64 18.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.773 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.559 HD22 ' CD1' ' A' ' 92' ' ' TRP . 24.4 mt -62.69 -53.85 48.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.15 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.638 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 1.5 p90 -84.3 17.8 2.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.951 0.405 . . . . 0.0 111.141 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.03 -31.09 62.24 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.862 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.83 168.58 17.83 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.575 -0.367 . . . . 0.0 110.463 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.95 18.57 0.4 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.121 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -122.62 -162.05 0.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.574 HD23 ' HB ' ' B' ' 220' ' ' ILE . 6.0 mp -77.4 86.35 3.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.94 0.4 . . . . 0.0 110.817 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.763 ' HB3' ' HG3' ' B' ' 218' ' ' ARG . 0.8 OUTLIER -77.0 124.48 27.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.174 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.584 ' HG2' ' HD3' ' A' ' 160' ' ' ARG . 20.7 mt-10 -120.64 18.7 11.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.227 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.59 ' HA ' ' HB3' ' A' ' 162' ' ' ARG . . . -62.65 -57.01 12.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.906 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.431 ' HG3' ' OE2' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -83.09 -5.06 58.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.252 0.548 . . . . 0.0 110.408 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.584 ' HD3' ' HG2' ' A' ' 157' ' ' GLU . 8.3 ttt85 -87.64 -54.05 4.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.564 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 10.9 tp -159.19 43.06 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.239 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.59 ' HB3' ' HA ' ' A' ' 158' ' ' ALA . 0.2 OUTLIER -153.12 44.51 0.64 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.976 0.417 . . . . 0.0 111.076 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -79.92 -24.33 41.15 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.94 -152.87 39.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.163 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -101.31 142.4 32.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.763 0.316 . . . . 0.0 110.335 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -118.73 -41.84 2.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.909 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -147.8 -155.26 0.61 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.467 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -32.66 53.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.884 0.374 . . . . 0.0 110.819 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.9 m -71.08 -47.28 62.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.858 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.012 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 201' ' ' ILE . . . . . 0.541 HG13 HG12 ' B' ' 202' ' ' ILE . 13.9 pt . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.541 HG12 HG13 ' B' ' 201' ' ' ILE . 44.5 mm -104.09 114.7 44.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.861 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.3 -43.84 2.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.28 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -64.1 -54.81 28.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 0.0 111.135 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 205' ' ' ILE . . . . . 0.559 HG23 HD12 ' A' ' 67' ' ' LEU . 94.1 mt -63.15 -40.56 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.231 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 206' ' ' ALA . . . . . 0.464 ' HB1' ' HB2' ' A' ' 85' ' ' LEU . . . -61.64 -47.42 85.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.905 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 207' ' ' ARG . . . . . 0.702 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 74.3 ttt180 -65.94 -35.07 79.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.902 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 208' ' ' HIS . . . . . 0.746 ' HB3' HD11 ' A' ' 67' ' ' LEU . 3.3 t-80 -58.25 -51.92 67.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.762 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.773 ' HB3' ' HG ' ' A' ' 67' ' ' LEU . 1.2 pp -74.92 -38.44 61.81 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.733 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 210' ' ' ALA . . . . . 0.456 ' HB1' ' HD3' ' A' ' 94' ' ' ARG . . . -68.81 -48.26 64.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -69.41 -48.66 60.36 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 43.0 t -57.18 -43.76 82.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.812 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.74 -50.62 29.28 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.088 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 25.4 t0 -57.26 -44.58 84.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.449 0.3 . . . . 0.0 111.785 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 12.8 m -68.18 -36.22 79.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.714 0.292 . . . . 0.0 111.758 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 216' ' ' MET . . . . . 0.6 ' HG2' ' HA ' ' A' ' 56' ' ' PHE . 23.6 ttm -74.59 -40.81 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.76 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 217' ' ' ASP . . . . . 0.484 ' OD1' ' HA ' ' A' ' 52' ' ' PHE . 37.8 t70 -65.53 -34.27 77.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.455 0.645 . . . . 0.0 109.417 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' ARG . . . . . 0.763 ' HG3' ' HB3' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -75.16 -6.3 48.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.693 179.2 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 11.1 m 68.85 4.81 4.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.202 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.574 ' HB ' HD23 ' A' ' 155' ' ' LEU . 9.9 tp . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.61 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.87 0.366 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.7 m -127.86 106.11 20.48 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.122 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.85 122.54 9.91 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.885 2.39 . . . . 0.0 112.11 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.6 119.09 24.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.742 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.1 m -74.98 108.17 7.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.359 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.57 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -74.08 -51.93 4.57 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 25.8 Cg_exo -63.84 140.3 72.81 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.868 1.712 . . . . 0.0 113.007 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 22.2 t70 -81.4 151.83 27.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.377 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -58.61 -36.89 74.75 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.445 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -73.19 -37.96 66.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.879 0.371 . . . . 0.0 110.55 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 -33.4 75.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.166 0.508 . . . . 0.0 109.919 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 41' ' ' LEU . 20.3 tp -64.32 -42.03 96.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.047 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' THR . 48.7 t -69.92 -40.17 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.963 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 -37.17 77.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.784 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.67 -37.3 86.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.346 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -67.87 -49.87 59.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.185 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.6 t -62.84 -44.73 99.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.107 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.13 -38.09 95.02 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.619 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.586 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 9.2 t80 -66.63 -43.09 85.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -61.44 -37.1 82.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.317 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.618 HD12 ' HE3' ' A' ' 24' ' ' LYS . 15.8 tp -65.63 -33.01 74.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.733 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.7 mtm-85 -79.42 -34.4 41.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.684 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 13.7 mm100 -61.19 -39.05 88.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.354 . . . . 0.0 111.181 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.618 ' HE3' HD12 ' A' ' 21' ' ' LEU . 11.6 pttp -84.77 2.57 41.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.177 0.513 . . . . 0.0 110.823 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.25 -108.33 1.07 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.441 ' HD1' ' SG ' ' A' ' 28' ' ' CYS . 17.3 t80 -101.67 105.19 16.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 23' ' ' GLN . 98.2 t -65.17 107.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.171 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.441 ' SG ' ' HD1' ' A' ' 26' ' ' TYR . 8.2 m -113.82 118.77 35.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.87 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.57 178.74 25.72 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.058 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.31 155.91 23.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.612 0.244 . . . . 0.0 110.609 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.55 106.86 3.27 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.774 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.95 109.13 1.04 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.932 2.422 . . . . 0.0 112.438 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.78 -118.27 2.57 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.876 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -85.66 66.8 9.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.274 0.559 . . . . 0.0 109.688 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.18 98.79 0.24 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.484 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.27 112.88 1.25 Allowed 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.9 2.4 . . . . 0.0 111.613 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.69 151.48 22.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.266 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.88 -34.03 51.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.927 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.65 120.47 46.18 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.002 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -102.33 16.79 0.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.602 2.868 . . . . 0.0 112.498 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.64 ' HB3' HD21 ' A' ' 12' ' ' LEU . 79.6 mt -68.76 -46.26 69.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.714 0.292 . . . . 0.0 111.494 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -70.0 -37.69 75.76 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -65.43 -39.66 92.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.379 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.21 86.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.627 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 36.5 mtt -64.93 -38.2 90.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.416 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -69.02 -30.02 68.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.753 179.272 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.82 -35.42 38.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.809 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.61 -41.82 67.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 111.024 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.89 37.41 3.44 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.056 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.07 -43.22 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 54' ' ' THR . 56.4 mm-40 -54.13 -63.99 0.97 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.555 ' O ' ' HB2' ' A' ' 56' ' ' PHE . 1.2 p90 -64.94 -21.14 66.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.451 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 53' ' ' GLU . 5.0 tp10 -80.93 -40.7 24.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 111.589 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 51' ' ' GLU . 4.0 t -70.62 -13.75 62.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.732 0.301 . . . . 0.0 111.385 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.507 ' O ' ' HG3' ' B' ' 216' ' ' MET . 81.1 mtm-85 -113.93 6.79 16.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.752 0.31 . . . . 0.0 111.148 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 52' ' ' PHE . 2.1 t80 -116.16 -88.89 0.58 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.574 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 mtm105 -174.75 -83.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.174 0.511 . . . . 0.0 109.672 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.709 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -148.87 49.99 0.99 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.758 HG22 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -53.72 -28.66 35.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.985 -178.083 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -52.85 -31.06 37.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 110.99 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.92 -37.47 3.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.648 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 15.5 t70 -61.7 -39.14 90.43 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.444 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.758 ' HB2' HG22 ' A' ' 59' ' ' THR . 14.7 tp -61.83 -34.79 76.58 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.164 0.506 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.68 -32.6 41.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.315 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.54 -44.28 62.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.538 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 9.7 pt20 -65.34 -32.36 73.96 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.885 0.374 . . . . 0.0 110.64 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.71 -8.8 59.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.284 0.564 . . . . 0.0 110.109 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -12.97 46.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.02 -37.73 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.966 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -86.5 160.53 50.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.067 178.527 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.966 ' HD2' HG22 ' A' ' 70' ' ' THR . 10.9 Cg_endo -55.08 115.78 2.68 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.394 2.063 . . . . 0.0 112.146 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.42 -164.53 11.0 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.41 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 50.3 m -152.36 -155.28 0.6 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.87 -159.18 0.1 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.855 0.36 . . . . 0.0 111.617 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.59 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 1.9 mm-40 -50.27 -34.77 24.42 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.719 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -56.04 -36.43 67.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.356 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 22.4 tpp85 -72.7 -34.27 67.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.702 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.59 ' HD2' ' HA ' ' A' ' 75' ' ' GLN . 90.6 m-85 -69.15 -40.46 78.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.125 0.488 . . . . 0.0 110.328 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -68.54 -36.16 78.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.284 0.564 . . . . 0.0 110.172 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.85 ' HG2' HD12 ' B' ' 201' ' ' ILE . 22.5 tp60 -71.53 -42.55 67.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.941 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 78' ' ' PHE . 3.4 p -61.22 -20.72 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.039 0.447 . . . . 0.0 111.342 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -87.67 -46.63 9.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.959 0.409 . . . . 0.0 110.445 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -35.8 80.47 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.352 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.624 ' HG3' ' HG2' ' B' ' 203' ' ' LYS . 6.3 tp10 -49.42 -39.4 32.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.246 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.701 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.5 OUTLIER -105.54 3.41 29.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.813 0.34 . . . . 0.0 111.469 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.501 ' HE1' ' HA ' ' A' ' 95' ' ' LEU . 28.7 t80 -84.15 -37.48 21.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.53 -21.46 66.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.654 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.85 8.39 69.91 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.515 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.455 ' HA2' ' HD3' ' A' ' 90' ' ' PRO . . . 130.33 116.57 1.85 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.464 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.455 ' HD3' ' HA2' ' A' ' 89' ' ' GLY . 5.6 Cg_exo -75.35 65.2 6.37 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.375 2.716 . . . . 0.0 111.321 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -68.13 178.02 2.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.72 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.665 ' HE3' ' H ' ' A' ' 92' ' ' TRP . 1.4 m-90 -45.0 -72.47 0.06 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.529 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.46 68.35 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.197 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.5 tpp85 -66.65 -51.23 58.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.612 0.244 . . . . 0.0 110.62 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.501 ' HA ' ' HE1' ' A' ' 86' ' ' PHE . 25.3 tp -67.03 -36.08 81.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.966 0.412 . . . . 0.0 110.505 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.462 HG22 ' HE1' ' A' ' 146' ' ' PHE . 60.9 t -65.83 -54.33 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.821 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.751 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -61.03 -41.74 97.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.021 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -54.6 -36.56 64.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.535 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -90.86 -46.56 8.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.818 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 97' ' ' ALA . 5.6 p -65.15 -37.15 79.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.455 ' HD1' ' HA ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -65.7 -45.4 82.91 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.105 -179.589 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.03 -45.6 95.76 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.61 98.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.215 . . . . 0.0 111.015 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.47 97.31 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.807 0.337 . . . . 0.0 111.208 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 105' ' ' LEU . 2.0 mm? -73.74 -39.69 64.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.29 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.431 ' O ' HG23 ' A' ' 110' ' ' VAL . 52.1 m -64.57 -42.18 95.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.391 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.35 -42.53 87.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.875 0.369 . . . . 0.0 110.348 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -42.65 98.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.476 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m -65.34 -37.1 86.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.545 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 106' ' ' CYS . 42.5 t -62.51 -44.85 99.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.274 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -66.01 -24.8 66.83 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.416 0.627 . . . . 0.0 110.177 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -89.54 5.24 46.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.101 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 66.98 18.57 10.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.696 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.46 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -92.25 60.33 3.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.219 0.533 . . . . 0.0 109.584 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.78 -24.63 66.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.341 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.7 t -62.63 -47.31 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.024 0.44 . . . . 0.0 109.914 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.73 -38.96 87.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.217 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 114' ' ' MET . 87.7 t -58.23 -52.05 63.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.532 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.74 93.18 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.041 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -62.13 -53.83 49.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.709 0.29 . . . . 0.0 110.88 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.68 -44.43 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.25 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -45.46 88.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.548 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.52 -46.07 91.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.268 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -60.02 -43.51 95.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.003 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 96.8 mtp -64.31 -52.4 58.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 72.1 t -60.57 -42.56 92.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.296 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.06 -48.41 73.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.818 0.342 . . . . 0.0 110.679 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -59.7 -39.54 84.94 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.55 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.6 mt -59.17 -29.96 67.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.409 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -106.01 11.41 31.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.702 0.287 . . . . 0.0 110.966 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 78.4 m -108.29 -65.61 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.495 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -108.24 -22.03 12.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.788 0.328 . . . . 0.0 111.396 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.775 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 61.0 mt -101.15 11.97 38.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.646 0.26 . . . . 0.0 111.024 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.52 -49.0 77.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.27 -43.72 92.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.716 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.775 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 83.0 m95 -60.11 -49.43 77.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.579 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 133' ' ' LEU . 46.0 mm -63.45 -39.37 85.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.512 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.15 -49.83 72.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.923 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.3 m -63.78 -47.77 79.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.325 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 50.7 m -70.17 -16.75 63.12 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.78 41.19 50.65 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.877 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.89 -100.95 0.67 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.125 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -111.77 13.78 21.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.782 0.325 . . . . 0.0 110.548 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.23 -50.91 71.4 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.822 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.617 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 11.0 pt-20 -86.26 -22.37 26.87 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.587 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.462 ' HE1' HG22 ' A' ' 96' ' ' VAL . 90.0 t80 -59.38 -41.05 88.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.947 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.566 ' HA ' ' CE2' ' A' ' 150' ' ' TYR . 0.4 OUTLIER -64.81 -26.16 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.218 0.532 . . . . 0.0 111.046 -179.731 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.79 -26.27 24.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.948 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 84.7 mt -60.76 -60.54 3.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.893 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 147' ' ' THR . 34.0 p90 -74.87 -10.54 59.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.984 0.421 . . . . 0.0 110.591 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.34 -19.1 77.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.559 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -123.32 -65.39 1.09 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 63.23 23.97 66.83 Favored Glycine 0 C--O 1.228 -0.251 0 CA-C-N 115.722 -0.672 . . . . 0.0 114.409 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -125.29 -41.67 2.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.455 0.627 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 33.9 mt -81.79 77.98 8.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.061 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -142.07 110.13 5.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.744 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -112.92 41.68 2.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.622 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -93.01 -50.27 5.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.659 0.266 . . . . 0.0 110.902 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.512 HH21 ' HG2' ' B' ' 218' ' ' ARG . 0.3 OUTLIER -105.55 9.5 33.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.908 0.385 . . . . 0.0 111.278 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' B' ' 220' ' ' ILE . 6.3 mtm180 -90.92 81.21 5.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.486 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 19.0 tp -85.03 133.62 34.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.118 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -102.69 94.63 5.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.715 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.48 176.5 5.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.591 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.56 115.58 0.63 Allowed Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -90.45 72.97 6.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.253 0.549 . . . . 0.0 109.988 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -171.26 -65.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.605 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -127.03 152.24 47.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.064 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.9 m -83.73 -8.18 59.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.011 0.434 . . . . 0.0 110.317 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.3 t -69.35 126.27 29.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.406 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.931 -0.556 . . . . 0.0 109.604 -179.849 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 201' ' ' ILE . . . . . 0.85 HD12 ' HG2' ' A' ' 80' ' ' GLN . 25.6 mt . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.676 0.274 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.647 HG12 HG12 ' B' ' 205' ' ' ILE . 10.0 tt -162.3 100.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.639 0.733 . . . . 0.0 110.743 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.624 ' HG2' ' HG3' ' A' ' 84' ' ' GLU . 48.5 mttm -77.63 -32.41 53.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.92 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -45.93 -61.09 1.89 Allowed 'General case' 0 C--O 1.24 0.575 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 205' ' ' ILE . . . . . 0.647 HG12 HG12 ' B' ' 202' ' ' ILE . 45.3 pt -69.46 -34.38 61.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.69 0.281 . . . . 0.0 111.283 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 206' ' ' ALA . . . . . 0.447 ' HA ' HG22 ' A' ' 81' ' ' VAL . . . -62.54 -37.51 86.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.203 0.525 . . . . 0.0 110.365 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 207' ' ' ARG . . . . . 0.701 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 38.0 ttp180 -62.85 -44.42 96.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.317 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 208' ' ' HIS . . . . . 0.402 ' O ' HG22 ' B' ' 212' ' ' VAL . 84.5 t60 -63.65 -40.09 95.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.27 -52.45 65.63 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.29 0.567 . . . . 0.0 110.507 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 210' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -68.56 -34.98 76.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.731 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -56.6 -56.03 26.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.79 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 208' ' ' HIS . 13.0 m -63.1 -43.41 98.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.535 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.08 -42.2 98.2 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.76 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.513 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 0.6 OUTLIER -70.33 -47.62 60.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.654 0.264 . . . . 0.0 111.574 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.439 ' OG ' ' HD3' ' A' ' 159' ' ' ARG . 12.2 m -68.34 -42.74 78.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 55' ' ' ARG . 6.5 tpt -66.05 -48.16 71.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.01 -35.03 79.89 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.067 0.461 . . . . 0.0 110.548 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 218' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER -73.0 -15.59 61.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 15.3 m 70.36 -57.67 0.57 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.215 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.41 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 2.8 mt . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.554 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.0 m -141.19 88.52 10.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.848 0.356 . . . . 0.0 110.508 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.23 129.78 19.97 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.473 2.115 . . . . 0.0 112.074 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.09 167.66 12.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.285 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.6 m -104.88 125.7 51.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.829 0.347 . . . . 0.0 110.58 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.656 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -84.59 -53.0 0.51 Allowed Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.224 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 10.9 Cg_exo -71.09 133.95 24.18 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.91 1.74 . . . . 0.0 111.788 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.0 149.91 47.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.935 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.91 -40.91 67.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.325 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -73.59 -27.09 61.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 0.0 110.945 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.01 94.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 mp -64.17 -42.54 96.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.289 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.99 -45.89 95.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.149 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.5 80.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.565 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.0 -42.05 85.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.215 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -63.22 -46.08 88.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.31 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.18 -47.38 93.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.073 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.46 99.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.692 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.655 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 18.3 t80 -60.78 -48.89 79.73 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -60.03 -38.86 83.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.597 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 21' ' ' LEU . 8.3 tp -67.77 -25.79 65.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.074 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -89.44 -29.59 18.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 15.6 mm100 -60.87 -28.61 68.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.017 0.436 . . . . 0.0 111.347 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -88.48 16.04 7.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.582 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.87 -62.75 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.845 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -145.3 102.53 3.74 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.82 107.41 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.252 0.549 . . . . 0.0 110.885 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.8 t -110.11 127.39 54.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.996 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.83 -124.07 2.18 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.018 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.27 172.27 16.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.764 0.316 . . . . 0.0 110.653 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.09 108.64 2.87 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.1 110.24 2.58 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.936 2.424 . . . . 0.0 111.851 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.63 -104.31 2.46 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.894 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -90.15 109.72 20.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.284 0.564 . . . . 0.0 110.24 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.98 90.71 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -48.0 108.56 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.331 2.687 . . . . 0.0 112.863 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.11 141.14 38.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.68 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.67 79.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.007 0.432 . . . . 0.0 110.152 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.87 126.33 32.13 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.21 0.529 . . . . 0.0 110.436 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -96.59 1.65 1.91 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.826 2.351 . . . . 0.0 110.716 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.594 HD23 ' HB2' ' A' ' 143' ' ' TRP . 12.2 mt -67.18 -50.23 61.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.661 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -62.13 -34.11 75.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.07 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -80.84 -38.58 28.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.465 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HB1' ' HD2' ' A' ' 146' ' ' PHE . . . -60.87 -43.97 97.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.706 0.288 . . . . 0.0 111.011 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 54.9 mtt -63.8 -38.41 90.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.032 0.444 . . . . 0.0 110.535 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 4.9 tmm_? -70.42 -42.53 71.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.224 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.38 -32.6 71.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.875 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.93 -50.52 57.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.045 0.45 . . . . 0.0 110.609 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.421 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -98.6 42.71 2.0 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.329 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 2.8 t0 -148.34 -46.48 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.586 0.231 . . . . 0.0 111.26 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.496 ' O ' HG22 ' A' ' 54' ' ' THR . 71.0 mm-40 -57.19 -55.53 33.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.801 0.334 . . . . 0.0 111.9 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.421 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 2.1 p90 -68.35 -26.48 65.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.687 0.28 . . . . 0.0 111.248 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -77.23 -42.79 35.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.172 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 51' ' ' GLU . 6.5 t -65.22 -26.02 67.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.154 0.502 . . . . 0.0 110.219 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 37.3 mtm-85 -93.2 -1.07 56.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.895 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.601 ' HD2' ' HG2' ' B' ' 216' ' ' MET . 42.9 t80 -111.87 -92.47 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.283 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.0 ttp85 175.11 -66.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.718 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.794 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -154.3 56.55 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.268 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -30.6 71.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.995 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -52.12 -38.63 58.04 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 123.455 0.472 . . . . 0.0 110.981 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.04 -41.2 6.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.258 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -59.45 -46.44 88.75 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.629 HD11 ' HA ' ' B' ' 209' ' ' LEU . 7.4 tp -62.81 -37.47 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 110.499 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.69 -30.7 63.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.295 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.04 -49.09 54.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.799 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -66.49 -31.5 72.27 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.941 0.4 . . . . 0.0 110.128 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.797 ' HG ' ' HZ ' ' A' ' 101' ' ' PHE . 0.5 OUTLIER -69.32 -22.27 63.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 178.508 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -83.18 -22.49 33.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.935 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.31 -49.04 34.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.551 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -72.53 141.36 82.71 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.697 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.551 ' HD2' HG22 ' A' ' 70' ' ' THR . 77.8 Cg_exo -50.92 104.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.77 2.314 . . . . 0.0 112.63 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.59 -158.77 9.87 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.954 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.606 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 7.4 m -142.84 -148.44 0.24 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.03 -158.19 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.976 0.417 . . . . 0.0 111.423 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.622 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 3.7 mm-40 -53.04 -38.13 62.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.576 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -56.82 -40.03 75.29 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.944 0.402 . . . . 0.0 110.842 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.606 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 14.0 tpp85 -64.94 -37.94 89.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.975 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.622 ' HD2' ' HA ' ' A' ' 75' ' ' GLN . 40.9 m-85 -69.16 -37.32 78.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.526 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 m -69.04 -46.7 67.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.084 0.469 . . . . 0.0 110.632 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.81 -32.62 69.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.866 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 78' ' ' PHE . 2.5 p -69.25 -19.17 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.164 0.507 . . . . 0.0 110.774 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.506 ' HB3' ' HA ' ' A' ' 98' ' ' PHE . 38.4 m -82.48 -43.65 16.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.117 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.89 -24.12 55.63 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.063 0.459 . . . . 0.0 109.976 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.795 ' HG3' ' HD3' ' B' ' 203' ' ' LYS . 2.9 tp10 -51.33 -48.01 62.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.44 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.569 HD21 ' HG2' ' B' ' 207' ' ' ARG . 0.1 OUTLIER -90.1 -5.77 56.17 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.924 -0.311 . . . . 0.0 111.658 -178.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.2 -27.95 57.05 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -65.47 -23.58 66.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.297 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.19 3.3 86.38 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.908 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 90' ' ' PRO . . . 131.33 133.16 3.45 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.547 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 89' ' ' GLY . 6.3 Cg_exo -78.53 65.83 8.57 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.141 2.561 . . . . 0.0 111.618 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -70.9 169.76 14.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.277 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.529 ' HE3' ' H ' ' A' ' 92' ' ' TRP . 5.1 m-90 -52.24 -63.17 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.865 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.32 -11.28 75.72 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.182 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -67.0 -49.99 63.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.732 0.301 . . . . 0.0 110.307 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.9 tp -67.29 -33.92 76.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.266 0.555 . . . . 0.0 109.736 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.14 -54.13 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.472 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.576 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -61.91 -43.17 99.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.574 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.506 ' HA ' ' HB3' ' A' ' 82' ' ' SER . 79.3 t80 -57.91 -42.89 85.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.039 0.447 . . . . 0.0 111.53 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -75.86 -46.78 28.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.709 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 97' ' ' ALA . 9.8 p -66.93 -34.0 67.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.797 ' HZ ' ' HG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -60.8 -50.31 73.95 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 110.43 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.4 -43.23 95.28 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.918 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.11 87.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.46 97.71 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.3 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.16 -43.33 71.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.044 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.454 ' O ' HG23 ' A' ' 110' ' ' VAL . 34.7 m -61.94 -44.15 97.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.416 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.58 82.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.908 0.385 . . . . 0.0 110.488 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -68.31 -40.51 81.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.164 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.476 ' HB2' HG22 ' A' ' 118' ' ' VAL . 17.2 m -63.99 -37.81 88.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.812 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 106' ' ' CYS . 99.5 t -67.65 -33.42 61.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.122 0.487 . . . . 0.0 109.764 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.08 -13.23 61.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.248 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -106.94 7.92 30.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.121 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 62.61 34.31 15.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.48 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.541 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -106.73 62.79 0.63 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.008 0.432 . . . . 0.0 110.117 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -64.96 -27.6 68.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.678 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.9 t -59.08 -48.36 86.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.304 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 tp -70.37 -39.17 74.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.353 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 114' ' ' MET . 99.4 t -59.2 -49.51 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.837 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.56 84.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.384 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -69.02 -51.25 41.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.71 0.291 . . . . 0.0 110.664 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.84 -43.48 97.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.759 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -43.24 94.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.989 0.423 . . . . 0.0 110.099 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.28 -42.47 88.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.36 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -60.5 -41.45 94.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 93.1 mtp -59.35 -52.22 66.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.456 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.1 t -65.18 -42.31 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.586 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.02 -47.21 81.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -63.22 -40.41 97.38 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.992 0.425 . . . . 0.0 110.119 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.721 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 24.3 mt -63.08 -35.36 79.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.145 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -90.95 6.51 44.39 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.2 m -121.37 -61.52 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -101.44 -26.6 13.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.721 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 97.3 mt -98.77 10.03 42.1 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.324 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.14 -48.07 77.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.767 0.317 . . . . 0.0 111.17 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.85 -52.09 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.621 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -61.42 -50.6 72.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.475 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.574 HG23 ' HA2' ' A' ' 142' ' ' GLY . 17.5 mm -58.92 -40.2 79.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.694 0.283 . . . . 0.0 110.938 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -61.37 -43.67 98.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.962 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.4 m -69.94 -41.01 75.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.752 0.311 . . . . 0.0 111.119 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.0 m -75.09 -2.06 25.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.594 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.0 42.02 98.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.08 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.574 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 72.95 -102.12 1.19 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.393 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.594 ' HB2' HD23 ' A' ' 41' ' ' LEU . 82.0 m95 -112.49 9.33 19.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.668 0.271 . . . . 0.0 110.365 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.16 -55.88 28.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.988 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.601 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 43.8 tt0 -59.9 -39.3 84.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.124 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.44 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 48.9 t80 -57.97 -34.84 70.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.626 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.456 ' HA ' ' CE2' ' A' ' 150' ' ' TYR . 2.1 m -60.46 -37.35 80.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.04 0.448 . . . . 0.0 110.778 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.81 -27.54 30.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.505 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 26.3 mt -57.23 -52.39 65.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.261 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.456 ' CE2' ' HA ' ' A' ' 147' ' ' THR . 30.3 p90 -87.08 8.26 24.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.838 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.72 -34.91 91.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.969 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -154.71 125.28 6.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.64 0.257 . . . . 0.0 110.382 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.6 30.07 2.72 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.692 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -145.85 -25.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.1 mp -102.12 -40.51 6.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.335 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.96 128.26 35.05 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.2 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.58 ' OE2' ' HB3' ' A' ' 160' ' ' ARG . 0.2 OUTLIER -117.05 31.64 6.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.762 0.315 . . . . 0.0 111.379 -179.057 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -97.46 -26.06 14.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -148.36 41.39 0.97 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.299 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.59 ' HA ' ' HG3' ' B' ' 218' ' ' ARG . 27.3 ttp180 -108.76 -81.6 0.57 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.172 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.727 ' HA ' HD12 ' B' ' 220' ' ' ILE . 22.5 mt -79.92 88.52 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.362 . . . . 0.0 111.122 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.406 ' HD3' ' HA ' ' A' ' 162' ' ' ARG . 66.2 mmt-85 -122.56 -93.71 0.51 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.919 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -153.6 157.35 39.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.148 0.499 . . . . 0.0 111.632 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.57 151.94 7.42 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -60.86 -38.65 86.28 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 117.196 0.498 . . . . 0.0 111.441 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.496 ' CZ3' ' HB3' ' B' ' 211' ' ' GLN . 31.7 m-90 -95.21 1.38 54.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.981 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.49 ' HB1' HG12 ' B' ' 220' ' ' ILE . . . -69.64 113.5 6.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.772 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.9 m -104.73 -32.48 8.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.982 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.2 t -81.6 107.05 13.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.261 0.553 . . . . 0.0 110.15 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 170' ' ' ARG . 9.6 ptp180 . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.254 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 43.7 mt . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 120.739 0.304 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -147.22 79.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.239 0.542 . . . . 0.0 110.363 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.795 ' HD3' ' HG3' ' A' ' 84' ' ' GLU . 39.2 mmtm -58.92 -36.07 74.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.13 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -62.49 -43.52 98.62 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.155 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 38.7 mt -64.99 -41.68 92.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.111 0.481 . . . . 0.0 109.707 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 206' ' ' ALA . . . . . 0.462 ' HB3' HD23 ' A' ' 85' ' ' LEU . . . -62.45 -42.59 99.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.631 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 207' ' ' ARG . . . . . 0.569 ' HG2' HD21 ' A' ' 85' ' ' LEU . 15.2 mtp180 -61.35 -34.61 75.58 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.114 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -58.69 7.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.569 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.629 ' HA ' HD11 ' A' ' 63' ' ' LEU . 1.2 pp -67.72 -42.25 82.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 210' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -64.92 -47.18 78.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 211' ' ' GLN . . . . . 0.496 ' HB3' ' CZ3' ' A' ' 166' ' ' TRP . 6.3 tp60 -65.69 -37.91 87.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 16.5 t -58.19 -55.09 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.656 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.29 -38.45 91.56 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.468 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 2.3 t0 -63.83 -49.77 71.53 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.7 m -68.42 -40.24 81.31 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' MET . . . . . 0.601 ' HG2' ' HD2' ' A' ' 56' ' ' PHE . 5.6 tpt -64.64 -42.68 95.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.744 0.306 . . . . 0.0 111.094 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.34 -33.34 69.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.318 0.58 . . . . 0.0 110.047 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 218' ' ' ARG . . . . . 0.59 ' HG3' ' HA ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -73.51 -9.96 59.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.887 179.234 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 14.4 m 64.99 37.66 6.73 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 123.604 0.565 . . . . 0.0 111.216 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.727 HD12 ' HA ' ' A' ' 161' ' ' LEU . 11.0 tt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.148 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.715 0.293 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 m -133.62 117.19 14.11 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.513 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.16 144.05 99.5 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.645 2.23 . . . . 0.0 112.15 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.62 114.86 29.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.815 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -69.72 115.88 9.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.989 0.423 . . . . 0.0 110.647 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.548 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -86.32 -49.93 0.5 Allowed Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.327 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 32.7 Cg_exo -61.3 131.87 38.48 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.05 1.833 . . . . 0.0 113.042 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -75.62 149.08 38.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.378 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 m -57.22 -36.94 71.51 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -69.66 -31.38 69.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.668 0.271 . . . . 0.0 110.617 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.45 78.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.237 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 mp -69.15 -41.7 76.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.744 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.64 -42.99 98.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.995 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.32 87.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.667 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.42 -46.89 81.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -61.05 -48.86 79.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.974 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.13 -46.66 95.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.51 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.71 98.95 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.794 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -61.95 -46.14 90.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.724 0.297 . . . . 0.0 110.272 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 20' ' ' LYS . 11.8 mmmt -61.65 -35.91 79.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.936 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.11 -26.24 59.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.683 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -84.26 -36.99 22.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.379 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -56.97 -35.4 69.11 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 24.18 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.932 0.396 . . . . 0.0 111.382 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.04 -54.95 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.683 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -154.52 111.83 3.39 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.93 120.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.148 0.499 . . . . 0.0 110.812 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.8 m -132.37 108.56 9.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.397 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.5 -134.87 3.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.843 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.09 146.77 26.38 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.94 114.84 4.08 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.653 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.59 83.7 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.064 2.509 . . . . 0.0 112.2 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.63 -103.65 1.24 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.234 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -103.15 105.74 16.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.046 0.45 . . . . 0.0 109.798 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.45 85.73 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.577 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -57.22 119.17 6.25 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.069 2.512 . . . . 0.0 112.252 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.49 164.19 13.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.485 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.435 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -85.45 -15.98 41.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.133 0.492 . . . . 0.0 110.294 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -105.87 102.52 39.38 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.844 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 41.0 Cg_endo -96.77 5.28 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.224 2.616 . . . . 0.0 111.57 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.0 mt -64.27 -45.95 85.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.155 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -63.78 -43.07 97.45 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.74 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -65.49 -43.54 89.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.934 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.17 -39.0 93.39 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.834 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.1 ttt -73.55 -34.98 65.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.091 0.472 . . . . 0.0 110.602 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -68.81 -40.87 79.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.84 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 50' ' ' ASP . . . -95.01 5.14 52.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.739 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.54 58.31 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.189 0.518 . . . . 0.0 110.801 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -96.67 29.2 10.8 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.43 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -124.77 -31.2 3.21 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.358 -0.137 . . . . 0.0 111.215 -179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -56.99 -71.89 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.116 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.511 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 54.2 p90 -58.95 -25.76 63.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.113 0.482 . . . . 0.0 110.545 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 4.0 tp10 -66.29 -38.06 86.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.489 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -61.16 -36.9 81.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.29 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.604 ' HB2' ' HG3' ' B' ' 216' ' ' MET . 0.0 OUTLIER -86.65 -17.42 33.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.343 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.695 ' HB2' ' HG2' ' B' ' 216' ' ' MET . 41.8 t80 -97.05 -93.62 0.22 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.295 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 57' ' ' ARG . 26.1 ttm105 -175.39 -81.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.416 0.627 . . . . 0.0 109.534 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.404 ' HE ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -153.03 67.26 0.79 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.385 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -53.22 -32.89 50.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.496 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.62 -36.58 64.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 110.619 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -99.23 -32.95 10.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.093 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 10.6 t70 -63.18 -38.21 90.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.92 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.2 tp -57.27 -43.71 83.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.49 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.72 -35.99 79.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.052 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.1 -47.6 35.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.747 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 9.5 pt20 -66.23 -33.04 74.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.602 0.239 . . . . 0.0 111.118 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.87 -0.75 40.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.737 0.303 . . . . 0.0 111.006 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -94.3 -29.35 15.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.6 t -62.57 -46.8 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.56 0.695 . . . . 0.0 109.3 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.582 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -92.9 145.18 29.69 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.495 178.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.582 ' HD2' HG22 ' A' ' 70' ' ' THR . 69.0 Cg_exo -52.35 107.65 0.2 Allowed 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.708 2.272 . . . . 0.0 112.597 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.57 -166.11 28.45 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.094 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.657 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 73.2 m -157.21 -150.43 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.898 -0.177 . . . . 0.0 110.717 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.35 -168.19 0.92 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.676 0.275 . . . . 0.0 111.192 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.44 HE22 HG11 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -56.69 -34.15 67.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -55.42 -27.8 50.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.373 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.657 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 15.4 tpp85 -75.61 -13.04 60.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.51 ' O ' HG12 ' A' ' 81' ' ' VAL . 80.1 m-85 -104.3 -40.78 5.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.41 HG21 HG13 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -65.99 -36.46 83.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 111.71 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -95.22 3.96 54.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 111.722 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -97.32 -23.73 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.259 0.552 . . . . 0.0 109.681 179.22 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.12 -42.45 19.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.592 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -21.64 58.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.026 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 3.4 tp10 -55.1 -41.89 72.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.193 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.749 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.3 OUTLIER -97.76 10.03 41.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.99 0.424 . . . . 0.0 110.718 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -99.17 -29.35 12.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -56.1 -45.59 79.37 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.982 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -106.07 15.46 43.71 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.294 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.1 78.35 0.15 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.734 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.89 54.22 5.03 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 123.221 2.614 . . . . 0.0 111.641 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -74.93 162.37 28.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.093 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.473 ' HZ3' ' HD2' ' B' ' 218' ' ' ARG . 0.3 OUTLIER -58.41 -51.64 68.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.655 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.69 -28.48 73.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.099 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.9 tpp85 -65.83 -44.69 84.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.77 -42.21 95.27 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 71.6 t -61.48 -44.84 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.948 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.52 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -62.01 -45.02 95.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.933 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.22 -40.21 93.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.152 0.501 . . . . 0.0 110.668 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -71.11 -47.05 60.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.29 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 97' ' ' ALA . 6.7 p -70.23 -29.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.476 ' CZ ' HD13 ' B' ' 209' ' ' LEU . 0.5 OUTLIER -59.14 -52.01 67.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.088 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.91 -42.01 95.13 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.629 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.98 -49.78 76.07 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.35 -46.24 84.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.572 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 105' ' ' LEU . 1.6 mm? -64.12 -39.26 93.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.048 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.31 -39.73 71.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.65 91.37 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.867 0.365 . . . . 0.0 110.259 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.36 -42.82 98.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.818 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.7 m -66.11 -44.22 84.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.031 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.458 HG23 HG21 ' A' ' 118' ' ' VAL . 51.6 t -60.35 -43.01 92.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 121.171 0.51 . . . . 0.0 109.833 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -65.56 -25.08 67.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.554 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -93.6 10.86 30.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.669 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 66.58 25.52 9.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.041 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.63 75.86 1.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.005 0.431 . . . . 0.0 110.213 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -76.14 -27.24 56.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.0 t -55.0 -50.57 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.424 HD21 ' HG3' ' A' ' 75' ' ' GLN . 57.3 tp -63.08 -44.25 96.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.334 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.458 HG21 HG23 ' A' ' 110' ' ' VAL . 87.3 t -57.43 -49.1 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.195 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.18 -42.03 87.26 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.555 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -69.33 -49.48 55.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.507 0.194 . . . . 0.0 110.648 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.44 HG11 HE22 ' A' ' 75' ' ' GLN . 77.2 t -57.83 -46.85 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.182 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -40.34 96.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.763 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.26 -38.91 91.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 0.0 110.437 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -66.6 -42.22 87.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.131 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 87.0 mtp -63.22 -48.6 77.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.438 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.67 -42.71 89.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.551 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.14 74.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.371 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -57.74 -41.46 81.92 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.367 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.519 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 79.3 mt -63.5 -31.78 73.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.615 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.28 9.96 42.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.638 0.256 . . . . 0.0 111.372 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.4 m -119.1 -80.15 0.61 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.448 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -81.67 -35.6 29.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.865 0.364 . . . . 0.0 111.659 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.593 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 35.4 mt -91.63 5.8 48.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.814 0.34 . . . . 0.0 110.978 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.18 81.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.854 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.98 -45.66 70.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.922 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.593 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 87.9 m95 -59.28 -51.69 68.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.411 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 133' ' ' LEU . 51.6 mm -61.58 -30.92 49.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.053 0.454 . . . . 0.0 111.011 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -72.3 -45.77 58.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.089 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.6 m -70.9 -30.12 66.38 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.554 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 67.5 m -89.31 1.93 55.07 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.11 41.05 96.38 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.441 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.99 -98.84 0.9 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -115.15 11.22 16.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -54.07 -51.05 65.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.778 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.652 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 3.2 pt-20 -85.65 -24.0 27.26 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.423 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -59.88 -42.22 93.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.228 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.473 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 1.2 p -72.68 -5.49 37.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.976 0.417 . . . . 0.0 111.258 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.85 -17.52 15.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.245 0.545 . . . . 0.0 110.323 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 41.3 mt -76.34 -57.14 4.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.945 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.473 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 4.8 p90 -74.59 -10.37 59.48 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.386 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.84 -22.74 78.87 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.818 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -121.43 80.76 1.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 0.0 110.271 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.79 31.23 8.91 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.083 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -132.79 83.11 2.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.907 0.384 . . . . 0.0 110.263 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.422 ' H ' ' HG ' ' A' ' 155' ' ' LEU . 0.7 OUTLIER -70.13 -25.61 63.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.598 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.27 132.77 8.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.202 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -122.36 44.62 2.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.905 0.383 . . . . 0.0 110.553 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -110.63 -55.75 2.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.913 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.69 -6.0 4.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.678 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 160' ' ' ARG . 25.7 ttp85 -63.38 142.96 58.2 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.212 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.92 149.34 49.81 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -67.64 90.48 0.27 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.039 0.447 . . . . 0.0 111.221 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.449 ' OE1' ' HD3' ' A' ' 55' ' ' ARG . 9.7 mm-40 -148.77 -177.28 5.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.998 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.18 -161.46 31.57 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.201 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -136.09 122.79 21.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -164.93 172.46 12.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.901 0.381 . . . . 0.0 110.632 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.47 -13.11 60.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.031 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.0 p -76.03 176.58 7.81 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.297 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.7 t -92.78 115.89 32.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.993 0.425 . . . . 0.0 109.941 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.147 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 201' ' ' ILE . . . . . 0.638 HG22 HG13 ' B' ' 202' ' ' ILE . 50.2 mt . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.419 0.152 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.638 HG13 HG22 ' B' ' 201' ' ' ILE . 29.0 mt -145.83 119.18 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.382 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -72.96 -34.58 66.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -57.4 -57.48 12.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.834 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 205' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' A' ' 70' ' ' THR . 33.2 mm -62.28 -39.22 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.437 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 206' ' ' ALA . . . . . 0.434 ' HA ' HG22 ' A' ' 81' ' ' VAL . . . -60.45 -46.89 88.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.997 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 207' ' ' ARG . . . . . 0.749 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 2.1 ttp-105 -58.91 -37.78 77.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.66 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 208' ' ' HIS . . . . . 0.508 ' O ' HG23 ' B' ' 212' ' ' VAL . 14.6 t60 -58.68 -60.59 3.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.105 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.476 HD13 ' CZ ' ' A' ' 101' ' ' PHE . 0.8 OUTLIER -66.17 -41.88 89.69 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.613 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -60.75 -44.65 96.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.433 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -67.36 -35.08 78.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.371 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 208' ' ' HIS . 32.8 t -56.36 -54.61 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 123.084 0.24 . . . . 0.0 110.826 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.09 -44.94 43.29 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.244 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -61.39 -56.54 19.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.6 m -62.97 -34.19 77.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.352 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 216' ' ' MET . . . . . 0.695 ' HG2' ' HB2' ' A' ' 56' ' ' PHE . 4.0 tpt -65.85 -44.74 84.58 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.433 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 217' ' ' ASP . . . . . 0.52 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 30.1 t70 -61.65 -33.94 74.83 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.038 0.447 . . . . 0.0 110.071 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 218' ' ' ARG . . . . . 0.473 ' HD2' ' HZ3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -66.94 -9.06 34.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.066 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 5.5 m 67.82 -170.43 0.19 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.179 0.592 . . . . 0.0 111.755 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 1.9 pt . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.446 -179.698 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.865 0.364 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -127.49 89.69 50.55 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.219 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.65 131.35 22.63 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.578 2.185 . . . . 0.0 111.714 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.04 152.62 21.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.13 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.0 m -83.34 116.11 22.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.337 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.731 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -69.24 -55.85 9.4 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.281 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.731 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 96.0 Cg_endo -92.57 146.78 2.73 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.133 1.889 . . . . 0.0 112.917 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 13.4 t70 -76.54 148.26 37.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.848 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.1 m -53.43 -35.63 60.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 2.4 mtm180 -63.11 -33.34 75.24 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.116 -0.233 . . . . 0.0 110.824 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.27 -37.6 85.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.028 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.38 -40.32 81.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.67 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 9' ' ' THR . 85.1 t -62.34 -43.14 97.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.559 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.17 -38.43 91.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.13 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.85 -38.75 86.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -67.51 -50.42 58.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.3 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.2 t -61.86 -44.47 98.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.831 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 22' ' ' ARG . . . -62.93 -40.41 99.25 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.45 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.427 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 2.6 t80 -62.85 -47.39 83.58 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.56 -37.46 81.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.969 0.414 . . . . 0.0 110.447 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.711 HD12 ' HE2' ' A' ' 24' ' ' LYS . 23.4 tp -67.72 -34.07 76.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 84.7 mtm-85 -80.14 -33.73 38.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.753 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 14.3 mm100 -60.14 -23.6 64.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.711 ' HE2' HD12 ' A' ' 21' ' ' LEU . 57.3 pttt -97.08 22.78 8.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.885 0.374 . . . . 0.0 111.037 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.04 -55.29 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.327 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.7 110.91 4.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.24 112.87 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.088 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.4 t -120.86 125.86 48.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.054 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.19 -130.15 4.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.47 179.62 8.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.652 0.263 . . . . 0.0 110.302 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.69 96.66 0.81 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.869 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.46 113.21 3.05 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.899 2.399 . . . . 0.0 112.324 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.22 -108.96 1.83 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.959 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.38 106.36 9.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.95 0.405 . . . . 0.0 110.537 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.11 79.44 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.59 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.54 122.35 10.69 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.146 2.564 . . . . 0.0 112.786 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.88 166.91 10.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.578 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.7 18.06 9.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.093 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -120.87 89.08 45.19 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -89.71 -7.27 4.77 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.491 2.127 . . . . 0.0 110.812 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.64 -53.2 36.59 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.121 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -62.66 -38.04 88.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.953 0.406 . . . . 0.0 110.498 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -67.59 -40.28 84.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.271 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.65 91.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.545 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 37.6 mtt -61.67 -41.62 97.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.228 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -62.27 -50.33 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.586 ' HB1' ' HG3' ' A' ' 51' ' ' GLU . . . -61.8 -37.22 83.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.845 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.23 -32.61 49.13 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.127 0.267 . . . . 0.0 111.719 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.4 35.56 3.57 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.683 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -151.26 -33.49 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.586 ' HG3' ' HB1' ' A' ' 47' ' ' ALA . 3.8 mm-40 -60.38 -72.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.489 ' HE2' HG21 ' A' ' 59' ' ' THR . 9.2 p90 -56.47 -36.66 69.34 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.517 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.12 -42.3 99.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.684 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.55 -20.05 63.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 -105.92 1.21 26.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.208 0.528 . . . . 0.0 110.554 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.441 ' CG ' ' HG2' ' B' ' 216' ' ' MET . 2.8 t80 -98.13 -85.58 0.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.571 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.406 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 5.2 ttm105 175.05 -71.12 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.63 61.29 0.32 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.107 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.489 HG21 ' HE2' ' A' ' 52' ' ' PHE . 0.4 OUTLIER -50.51 -33.55 21.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.038 -178.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -56.06 -23.73 35.35 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.405 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.6 m -121.39 -40.38 2.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.615 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.5 -49.87 73.63 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.9 tp -59.67 -34.15 72.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.11 0.481 . . . . 0.0 110.733 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.612 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -80.04 -18.45 50.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.97 -47.58 7.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.511 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.925 ' HG3' HD22 ' A' ' 67' ' ' LEU . 8.5 pt20 -65.02 -19.55 66.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.925 HD22 ' HG3' ' A' ' 66' ' ' GLN . 0.4 OUTLIER -109.84 13.84 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 0.0 110.612 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.612 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 9.0 t-160 -95.24 10.38 36.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.161 0.505 . . . . 0.0 110.705 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.6 t -78.88 -42.57 24.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.201 0.524 . . . . 0.0 110.139 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -86.48 132.41 42.92 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.002 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.84 109.21 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.063 2.509 . . . . 0.0 112.704 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.08 -146.84 21.71 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.633 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.68 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 20.1 m -151.17 -159.45 1.03 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.6 -157.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.796 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.476 ' OE1' ' HB2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -54.96 -31.04 60.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.442 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 26.1 mp0 -64.43 -10.94 28.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.444 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.68 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 19.0 tpp85 -109.61 -25.59 10.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.7 0.286 . . . . 0.0 110.885 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.532 ' O ' HG12 ' A' ' 81' ' ' VAL . 19.4 m-85 -65.55 -61.05 2.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.33 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.17 -20.89 64.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.283 0.563 . . . . 0.0 110.731 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 76' ' ' GLN . 1.1 tp60 -75.63 -24.97 56.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.199 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 78' ' ' PHE . 1.4 p -73.93 -24.56 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.217 0.532 . . . . 0.0 110.04 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.23 -39.64 39.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.663 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -71.95 -28.52 63.5 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.007 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.408 ' O ' ' HE3' ' B' ' 203' ' ' LYS . 4.6 tp10 -54.6 -47.61 73.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.688 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.612 ' HB3' ' HD3' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -82.1 -21.8 36.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.535 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.557 ' HB2' ' HA ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -62.9 -32.61 73.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.356 0.598 . . . . 0.0 109.43 179.049 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -64.1 -24.09 67.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.42 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.46 45.32 1.09 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.512 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.64 74.79 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.553 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.09 52.09 3.69 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.342 2.695 . . . . 0.0 112.012 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -71.85 163.36 27.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.618 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.793 ' HB3' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -53.37 -39.94 64.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.392 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.461 ' HA3' ' OD1' ' B' ' 214' ' ' ASP . . . -65.22 -24.77 70.73 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.616 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.612 ' HD3' ' HB3' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -75.09 -39.92 60.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.82 -42.61 94.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.295 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.44 -46.75 89.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.356 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.5 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -60.97 -41.98 97.46 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.278 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -62.68 -41.55 99.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.126 0.488 . . . . 0.0 110.646 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -71.49 -49.21 43.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.398 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 97' ' ' ALA . 9.9 p -64.13 -36.44 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -62.36 -49.73 74.38 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.939 0.4 . . . . 0.0 110.187 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.81 -47.08 78.7 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.017 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.34 87.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.87 81.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.755 0.312 . . . . 0.0 111.252 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.456 ' HG ' ' OE1' ' A' ' 75' ' ' GLN . 2.6 mm? -65.83 -40.84 92.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.02 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.435 ' O ' HG23 ' A' ' 110' ' ' VAL . 56.6 m -64.49 -46.93 80.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.549 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.89 77.7 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.069 0.461 . . . . 0.0 110.541 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.71 -46.21 66.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.194 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 m -62.95 -34.64 77.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.126 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 106' ' ' CYS . 40.0 t -63.17 -39.88 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.001 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -73.46 -28.22 61.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.228 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -85.6 9.33 16.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.757 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 54.49 48.93 19.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.569 0.7 . . . . 0.0 110.334 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.18 53.89 1.28 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.316 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -60.45 -28.32 68.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.745 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.6 t -56.49 -45.48 82.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.391 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.496 ' O ' HG23 ' A' ' 121' ' ' VAL . 37.9 tp -71.97 -41.9 67.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.386 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.18 -46.61 77.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.564 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.79 -35.65 90.37 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.036 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -69.7 -44.89 69.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 110.237 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 117' ' ' LEU . 57.6 t -61.27 -48.4 89.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.826 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.33 -41.34 98.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.579 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -59.62 -45.39 92.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.252 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -66.54 -40.99 89.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.833 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 85.7 mtp -60.16 -51.4 69.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.744 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.39 -45.26 93.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.414 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.57 81.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -61.86 -43.26 99.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.161 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 58.4 mt -64.3 -28.51 69.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.854 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -101.91 8.04 41.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.2 m -121.53 -70.19 0.8 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.412 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.4 ttt85 -85.76 -38.32 18.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.833 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 77.9 mt -95.02 11.8 30.74 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.49 -52.64 64.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.798 0.332 . . . . 0.0 111.262 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.37 -39.31 92.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.833 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 84.0 m95 -62.95 -48.78 77.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 133' ' ' LEU . 44.1 mm -61.57 -37.45 77.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.043 0.449 . . . . 0.0 109.817 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -66.5 -32.12 73.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 m -78.01 -37.62 46.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.046 0.451 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 144' ' ' ALA . 29.8 m -81.5 -6.99 59.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.143 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.18 41.45 98.35 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.67 -100.97 1.99 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -120.78 13.6 11.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 140' ' ' SER . . . -51.79 -65.41 0.56 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.243 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.506 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 7.5 pt-20 -67.0 -23.52 65.94 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.234 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.476 ' HA ' HD12 ' A' ' 149' ' ' LEU . 59.0 t80 -61.92 -35.31 78.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.675 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -60.4 -30.63 69.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.131 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.41 -12.06 35.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.793 HD13 ' HB3' ' A' ' 92' ' ' TRP . 87.6 mt -80.54 -35.95 33.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.293 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.675 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 9.2 p90 -98.73 16.64 21.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.019 0.437 . . . . 0.0 111.056 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.22 -47.15 90.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.769 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 C--N 1.322 -0.588 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.221 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 37.6 mt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.863 0.363 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' B' ' 205' ' ' ILE . 1.8 pt -143.88 75.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.561 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 84' ' ' GLU . 20.1 mttp -65.1 -33.2 75.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -61.38 -42.58 98.94 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' ILE . . . . . 0.539 HD12 HD12 ' A' ' 67' ' ' LEU . 8.4 mm -69.07 -42.56 81.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.091 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -62.55 -37.94 88.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.354 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -66.33 -34.57 78.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.325 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' HIS . . . . . 0.578 ' HB3' HD11 ' A' ' 67' ' ' LEU . 6.1 t-80 -60.08 -56.55 20.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.435 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.1 pp -63.44 -33.43 75.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.811 0.339 . . . . 0.0 110.293 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.57 -59.37 4.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.791 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -63.6 -43.0 98.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.66 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.532 HG11 HE22 ' A' ' 66' ' ' GLN . 53.5 t -63.66 -43.19 98.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.709 0.29 . . . . 0.0 110.678 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.89 -44.22 80.07 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.095 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.461 ' OD1' ' HA3' ' A' ' 93' ' ' GLY . 60.0 m-20 -60.13 -46.1 90.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.93 0.395 . . . . 0.0 111.315 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 12.6 p -70.02 -46.82 64.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.934 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' MET . . . . . 0.441 ' HG2' ' CG ' ' A' ' 56' ' ' PHE . 11.4 tpp -62.82 -43.73 98.01 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -60.15 -54.72 42.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.631 0.253 . . . . 0.0 110.912 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.449 -179.86 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.804 0.335 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -114.26 126.26 28.22 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.475 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.45 110.11 2.61 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.567 2.178 . . . . 0.0 112.123 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.89 117.3 11.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.8 m -66.34 121.58 15.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.234 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.579 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -82.76 -51.52 0.7 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.16 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 17.1 Cg_exo -67.8 141.5 54.44 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.068 1.845 . . . . 0.0 112.67 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 16.0 t70 -85.95 154.6 21.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.266 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.8 m -54.65 -42.72 71.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.917 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.418 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -66.21 -35.05 79.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.418 0.151 . . . . 0.0 111.1 -179.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.27 -37.68 86.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.947 0.404 . . . . 0.0 110.552 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 41' ' ' LEU . 6.3 tp -68.27 -44.38 75.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.916 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 9' ' ' THR . 87.7 t -62.92 -44.81 99.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.389 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.64 71.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.831 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.22 -44.08 84.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.89 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -63.54 -47.64 80.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.131 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.8 t -59.77 -46.25 93.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.274 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 22' ' ' ARG . . . -62.75 -44.81 96.93 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.598 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.483 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 10.8 t80 -58.54 -49.6 76.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.38 . . . . 0.0 110.503 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -62.09 -36.21 81.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.408 HD12 ' HE2' ' A' ' 24' ' ' LYS . 7.6 tp -67.81 -26.67 66.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.59 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 87.1 mtm-85 -90.8 -32.43 16.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.461 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.531 HE22 HG13 ' A' ' 27' ' ' VAL . 15.7 mm100 -63.01 -27.14 69.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 0.0 111.38 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.408 ' HE2' HD12 ' A' ' 21' ' ' LEU . 36.8 pttt -88.61 17.91 5.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.132 0.492 . . . . 0.0 110.766 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.86 -74.8 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -127.58 101.35 6.37 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.531 HG13 HE22 ' A' ' 23' ' ' GLN . 59.1 t -62.06 121.95 11.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.809 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.2 t -143.23 139.21 30.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.768 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.59 -138.96 9.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.067 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.97 145.22 26.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.649 0.261 . . . . 0.0 110.473 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.59 103.99 2.23 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.272 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.83 128.15 14.68 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.78 2.32 . . . . 0.0 111.441 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.68 -55.99 0.2 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.257 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -125.09 24.94 7.38 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.173 0.511 . . . . 0.0 110.201 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.62 104.51 2.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.166 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.08 126.61 13.98 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.894 2.396 . . . . 0.0 111.802 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.51 154.69 20.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.346 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.38 -31.43 63.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.905 0.383 . . . . 0.0 110.65 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -104.3 130.26 23.63 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.135 0.493 . . . . 0.0 110.548 179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 39' ' ' ASP . 84.7 Cg_endo -98.18 1.33 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.941 2.427 . . . . 0.0 111.081 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.455 ' HB3' HD21 ' A' ' 12' ' ' LEU . 47.2 mt -64.58 -47.22 79.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.821 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -58.85 -37.56 76.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.946 0.403 . . . . 0.0 111.417 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -80.27 -38.03 31.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.943 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.75 97.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.989 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.58 ' HE2' ' HZ ' ' A' ' 99' ' ' PHE . 25.3 ttm -61.22 -40.33 93.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.46 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -71.39 -44.39 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.517 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.55 ' HB1' ' HG3' ' A' ' 51' ' ' GLU . . . -59.07 -43.65 91.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.211 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.44 -21.11 34.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.555 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -125.51 26.11 5.52 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.013 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -146.37 -46.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.813 -0.228 . . . . 0.0 111.601 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.62 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 14.9 mm-40 -58.58 -55.36 36.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.829 0.347 . . . . 0.0 111.309 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.555 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 2.3 p90 -66.82 -28.74 68.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.121 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -71.55 -44.57 64.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.349 . . . . 0.0 110.407 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -71.99 -8.14 52.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.626 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.62 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 82.8 mtm-85 -109.6 5.05 22.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.296 0.569 . . . . 0.0 110.164 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.853 ' HD1' ' HG2' ' B' ' 216' ' ' MET . 60.8 t80 -118.85 -85.82 0.65 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.707 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 175.71 -72.2 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.512 0.673 . . . . 0.0 109.275 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.68 ' HA ' ' HE ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -154.55 60.67 0.68 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.27 179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.57 HG22 HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -57.72 -32.04 67.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.909 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -58.16 -36.02 72.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.119 0.485 . . . . 0.0 110.372 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.91 -36.35 12.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.828 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.57 -40.25 86.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.584 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.57 HD13 HG22 ' A' ' 59' ' ' THR . 1.4 mp -63.84 -30.64 71.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.076 0.465 . . . . 0.0 110.861 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.98 -28.15 35.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.236 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.02 -49.28 65.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.849 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -67.4 -23.92 65.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.835 0.35 . . . . 0.0 110.516 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -85.01 -1.78 57.21 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.126 0.489 . . . . 0.0 110.108 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -104.22 -42.48 5.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.916 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.35 -50.46 78.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.48 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -87.25 142.46 33.5 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.816 178.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.48 ' HD2' HG22 ' A' ' 70' ' ' THR . 52.4 Cg_exo -53.45 106.35 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.799 2.332 . . . . 0.0 112.825 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.59 -169.84 22.72 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.738 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.823 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 61.3 m -146.8 -157.22 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.24 -167.32 0.31 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.93 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.462 ' HG3' HD21 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -50.74 -38.83 49.96 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.447 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -57.56 -31.01 65.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.627 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.823 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 11.8 tpp85 -72.62 -29.0 63.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.946 0.403 . . . . 0.0 110.177 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.591 ' O ' HG12 ' A' ' 81' ' ' VAL . 73.8 m-85 -73.97 -46.59 43.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -34.9 76.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.275 0.56 . . . . 0.0 110.698 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -68.88 -35.62 77.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.069 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -69.58 -25.33 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.678 0.275 . . . . 0.0 111.303 -179.131 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.26 -47.17 24.76 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.98 -30.19 70.71 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.072 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.404 ' HG3' ' HD3' ' B' ' 203' ' ' LYS . 3.8 tp10 -50.67 -48.13 58.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.741 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.6 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -97.48 -6.23 34.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.1 -179.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -40.72 62.97 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -66.27 -29.52 69.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.93 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.72 -26.53 71.2 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.192 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.06 107.91 0.22 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.153 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.26 59.4 6.0 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.867 2.378 . . . . 0.0 111.673 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -70.48 176.69 3.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.439 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.67 ' HB3' HD13 ' A' ' 149' ' ' LEU . 1.9 m-90 -53.0 -57.31 10.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.57 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.8 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -70.22 -12.15 68.56 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.826 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -39.81 93.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.094 0.447 . . . . 0.0 110.049 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.7 tp -71.71 -36.54 70.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.897 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.468 HG22 ' HE1' ' A' ' 146' ' ' PHE . 41.9 t -61.95 -50.28 80.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.407 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.54 -42.62 99.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.165 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -64.44 -42.45 95.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.09 0.472 . . . . 0.0 110.929 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.58 ' HZ ' ' HE2' ' A' ' 45' ' ' MET . 33.9 t80 -68.18 -48.47 65.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.288 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.478 HG21 ' CZ ' ' A' ' 52' ' ' PHE . 9.1 p -65.4 -33.25 62.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.122 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.739 ' HE2' HD13 ' B' ' 209' ' ' LEU . 0.2 OUTLIER -61.9 -51.28 68.82 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.66 -44.96 96.77 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.783 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.46 81.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.604 0.24 . . . . 0.0 111.351 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.61 -45.77 88.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.659 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.424 ' HA ' HD13 ' A' ' 105' ' ' LEU . 2.8 mm? -68.07 -38.7 82.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.065 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.454 ' O ' HG23 ' A' ' 110' ' ' VAL . 19.7 m -65.78 -47.6 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.0 -42.07 89.21 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.984 0.421 . . . . 0.0 110.547 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -60.29 -39.83 88.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.949 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.491 ' HB3' ' HB3' ' A' ' 114' ' ' MET . 14.1 m -74.73 -39.66 61.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.892 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 106' ' ' CYS . 50.8 t -59.03 -47.38 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.855 0.36 . . . . 0.0 110.601 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -65.17 -27.23 68.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.54 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -90.21 9.94 26.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.875 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 60.74 33.07 20.25 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.993 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.51 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -104.51 61.84 0.72 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.955 0.407 . . . . 0.0 110.172 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -63.61 -29.83 71.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.145 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.28 -45.77 92.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.102 0.477 . . . . 0.0 110.556 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.472 ' HB2' ' SD ' ' A' ' 114' ' ' MET . 15.7 tp -69.82 -39.65 76.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.468 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 114' ' ' MET . 67.0 t -59.52 -45.55 93.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.869 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.2 -41.07 99.38 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.323 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -64.5 -46.26 83.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.796 0.331 . . . . 0.0 110.725 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 117' ' ' LEU . 99.8 t -64.25 -46.03 94.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.764 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -45.05 96.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 110.681 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.21 -45.62 92.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.622 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -63.09 -43.49 98.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.113 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 95.1 mtp -57.85 -50.02 74.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.893 0.378 . . . . 0.0 110.655 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.77 -41.23 91.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.877 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.12 -46.14 91.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.578 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -59.58 -43.1 93.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.165 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.648 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 53.8 mt -63.88 -36.12 82.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -90.16 4.92 49.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 m -124.41 -77.1 0.59 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.75 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -75.07 -23.42 58.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.648 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 81.0 mt -109.88 14.32 23.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.348 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.4 -44.14 84.28 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.29 -39.42 48.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.822 0.344 . . . . 0.0 110.749 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.574 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 95.9 m95 -60.62 -50.54 73.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.27 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.75 -37.33 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 0.0 110.322 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -67.75 -36.08 79.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.742 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.7 m -71.68 -40.51 69.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.983 0.42 . . . . 0.0 110.704 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.408 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 68.9 m -78.61 -6.13 54.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.138 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.39 40.83 98.13 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.33 -111.35 3.27 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -109.36 14.93 23.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.05 -62.28 1.94 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.318 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.408 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 5.8 pt-20 -70.86 -20.15 62.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.725 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.468 ' HE1' HG22 ' A' ' 96' ' ' VAL . 75.5 t80 -60.6 -38.39 84.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.821 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -27.39 69.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.485 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.85 -13.83 38.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.748 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.67 HD13 ' HB3' ' A' ' 92' ' ' TRP . 56.6 mt -68.31 -35.3 77.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.918 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -110.22 20.33 17.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 0.0 110.223 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -75.64 -19.79 78.86 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.817 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.8 t0 . . . . . 0 C--N 1.324 -0.519 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.66 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 121.345 0.593 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 8.2 mt -132.8 86.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.889 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.404 ' HD3' ' HG3' ' A' ' 84' ' ' GLU . 64.9 mmtt -64.75 -33.79 76.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.357 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -53.21 -55.26 25.72 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 66.2 mt -65.68 -47.43 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.362 . . . . 0.0 110.956 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 85' ' ' LEU . . . -56.85 -45.3 82.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.524 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' ARG . . . . . 0.6 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 18.3 ttp-105 -62.04 -36.86 82.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' HIS . . . . . 0.41 ' O ' HG22 ' B' ' 212' ' ' VAL . 38.4 t-80 -60.9 -56.1 25.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.304 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.739 HD13 ' HE2' ' A' ' 101' ' ' PHE . 1.5 pp -65.74 -34.85 79.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.487 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -69.88 -43.01 72.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.092 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' B' ' 207' ' ' ARG . 0.7 OUTLIER -65.34 -49.06 70.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.798 -178.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' B' ' 216' ' ' MET . 26.0 m -62.99 -44.27 99.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.409 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.44 -38.62 87.04 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.394 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.8 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 4.0 t0 -67.01 -50.52 61.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.835 0.35 . . . . 0.0 111.335 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 2.7 m -69.72 -49.01 57.33 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' MET . . . . . 0.853 ' HG2' ' HD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -60.18 -37.82 81.37 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.27 -34.05 61.3 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.442 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.278 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.764 0.316 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 m -87.32 113.05 52.11 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.738 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.28 132.59 19.61 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.358 2.039 . . . . 0.0 112.009 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.96 139.52 32.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.118 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.53 116.91 25.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.108 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.77 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -86.24 -60.03 0.28 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.487 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 23.1 Cg_exo -65.7 138.6 54.51 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.057 1.838 . . . . 0.0 112.122 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.14 156.93 28.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.9 m -58.11 -41.13 82.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.946 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -69.95 -27.44 64.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 110.566 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.24 75.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.467 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.43 -40.27 77.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.682 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t -63.13 -47.03 94.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.968 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.95 -38.43 82.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.031 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.94 -43.23 83.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.545 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -65.06 -48.59 73.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -62.43 -45.23 99.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.342 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.75 -41.03 99.56 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.517 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -61.84 -43.09 99.55 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 21.5 mmmt -59.93 -45.26 93.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.049 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.445 HD12 ' HE3' ' A' ' 24' ' ' LYS . 55.2 tp -65.95 -40.45 91.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.706 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 84.6 mtm-85 -73.37 -30.13 63.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.829 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -64.46 -30.17 71.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HE3' HD12 ' A' ' 21' ' ' LEU . 10.0 pttp -92.88 -0.19 57.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.913 0.387 . . . . 0.0 110.938 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.5 -60.36 0.32 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.112 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -154.14 105.26 2.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.97 113.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.162 0.506 . . . . 0.0 110.712 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.8 t -127.79 127.34 43.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.043 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.01 -135.69 5.24 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.844 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.19 158.57 43.89 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.22 111.8 4.03 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.88 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.68 76.14 4.69 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.037 2.492 . . . . 0.0 111.99 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.22 -84.81 0.79 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.569 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -119.18 127.94 53.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.022 0.439 . . . . 0.0 110.115 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.29 91.7 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.441 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.75 110.5 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.83 2.353 . . . . 0.0 112.064 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.2 150.46 21.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.857 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.469 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -70.4 -26.27 63.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.846 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -101.51 104.8 36.51 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.421 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 74.4 Cg_endo -92.29 -3.41 3.84 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.801 2.334 . . . . 0.0 111.566 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.66 -41.33 96.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.731 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -59.62 -38.86 82.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.865 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -80.71 -37.28 30.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.94 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.69 98.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.897 0.38 . . . . 0.0 110.378 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.1 ttt -62.8 -39.65 94.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.856 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -65.96 -48.85 69.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.642 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.16 79.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.62 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.25 62.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.824 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.99 19.49 13.66 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.255 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -132.46 -47.67 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.622 0.249 . . . . 0.0 111.404 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.53 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 6.2 mm-40 -62.46 -30.54 71.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.626 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.574 ' O ' ' HB2' ' A' ' 56' ' ' PHE . 67.0 t80 -59.57 -32.34 70.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.033 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 59' ' ' THR . 4.6 tp10 -87.14 -26.74 23.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.815 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.9 m -54.27 -47.96 71.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.099 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.53 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 23.1 mtm-85 -102.02 12.4 36.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.846 0.355 . . . . 0.0 111.562 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.574 ' HB2' ' O ' ' A' ' 52' ' ' PHE . 3.2 t80 -97.77 -96.74 0.21 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 56' ' ' PHE . 42.4 ttm180 170.48 -68.43 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.8 ' HA ' ' HE ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -154.21 79.36 1.11 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.126 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.458 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 61.6 m -57.17 -44.61 83.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.745 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -74.31 1.14 12.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.856 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . 4.8 m -124.04 -54.93 1.7 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -79.27 -57.23 3.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 66' ' ' GLN . 14.6 tp -58.78 -42.86 90.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.018 0.437 . . . . 0.0 110.904 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.51 -17.5 64.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.664 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.15 -46.73 6.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.519 0.2 . . . . 0.0 111.212 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.509 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 8.4 pt20 -64.06 -33.55 76.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.394 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.476 ' HA ' HD13 ' A' ' 67' ' ' LEU . 2.0 mm? -82.49 -11.21 58.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.063 0.459 . . . . 0.0 110.329 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -91.46 -11.83 36.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.798 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.3 t -66.17 -41.81 90.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -74.44 127.32 87.74 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.62 105.7 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.777 2.318 . . . . 0.0 112.098 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.81 -128.09 3.29 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.146 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.706 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 2.9 m -156.78 -148.3 0.21 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.99 -156.62 0.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.504 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -51.38 -35.06 37.04 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.34 0.4 . . . . 0.0 111.914 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -55.55 -42.96 75.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.11 0.481 . . . . 0.0 110.365 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.706 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 11.1 tpp180 -68.01 -43.0 79.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.393 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.507 ' O ' HG12 ' A' ' 81' ' ' VAL . 48.3 m-85 -62.67 -37.06 84.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.985 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.2 m -65.9 -49.92 66.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.609 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -70.22 -33.78 72.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.273 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.528 ' HA ' HD13 ' B' ' 202' ' ' ILE . 1.4 p -67.06 -31.57 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 0.0 110.498 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.9 m -77.32 -44.05 30.93 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.67 -35.98 79.52 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.613 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -53.7 -60.34 3.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.805 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.629 ' HB2' ' HB1' ' B' ' 206' ' ' ALA . 0.2 OUTLIER -78.67 -16.25 57.53 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.517 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -65.63 -34.73 78.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -90.71 11.2 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.202 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.6 25.64 5.02 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.83 83.56 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -83.86 59.24 6.11 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.759 2.306 . . . . 0.0 112.227 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.514 ' HB3' ' OD2' ' B' ' 214' ' ' ASP . 60.2 t30 -76.32 171.8 13.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.818 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.688 ' CD1' HD22 ' A' ' 149' ' ' LEU . 2.4 m0 -52.61 -49.48 64.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.767 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.765 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -65.47 -33.15 85.63 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.465 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -42.67 99.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.663 0.268 . . . . 0.0 110.597 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.404 HD23 ' HD1' ' A' ' 146' ' ' PHE . 29.3 tp -64.32 -42.49 96.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.325 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.76 -47.28 86.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.357 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.644 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -62.21 -40.43 96.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.37 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -59.59 -39.17 83.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.746 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -76.69 -48.83 17.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.193 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 97' ' ' ALA . 7.2 p -63.18 -32.04 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.526 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -60.77 -54.57 43.64 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.987 0.423 . . . . 0.0 110.46 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.03 -43.3 99.05 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.949 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.93 99.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.617 0.246 . . . . 0.0 111.185 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.21 -43.77 97.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.268 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 105' ' ' LEU . 2.1 mm? -68.78 -39.62 80.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.8 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.417 ' O ' HG23 ' A' ' 110' ' ' VAL . 50.4 m -66.12 -46.13 78.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.309 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.5 87.38 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.94 0.4 . . . . 0.0 110.515 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -45.29 91.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.268 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.6 m -65.81 -38.43 88.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.967 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 106' ' ' CYS . 49.9 t -63.16 -41.31 92.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.045 0.45 . . . . 0.0 109.807 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -70.3 -9.56 56.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.369 0.605 . . . . 0.0 110.533 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -105.21 6.4 32.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.008 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 62.66 32.47 16.24 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.198 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.444 ' SD ' ' HB ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -106.57 64.07 0.65 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.646 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -65.56 -21.99 66.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.818 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.444 ' HB ' ' SD ' ' A' ' 114' ' ' MET . 97.4 t -58.83 -56.36 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.758 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 121' ' ' VAL . 28.7 tp -66.95 -37.47 84.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.681 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.5 t -59.28 -48.48 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.44 -38.62 93.76 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.14 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -68.43 -50.45 52.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.747 0.308 . . . . 0.0 110.506 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 117' ' ' LEU . 71.9 t -58.24 -44.02 87.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.107 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -45.59 86.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.245 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.82 -45.16 87.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.729 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -55.91 -44.6 78.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.999 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 89.9 mtp -67.69 -50.08 59.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.392 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.14 -47.05 93.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.262 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.98 93.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.05 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -62.11 -38.48 89.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.874 0.368 . . . . 0.0 110.612 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.829 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 35.7 mt -66.92 -20.93 65.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.282 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.54 -13.72 15.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.3 m -94.96 -64.04 1.11 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -101.81 -32.12 10.42 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.829 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 73.4 mt -90.65 13.19 16.7 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.29 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.23 -53.55 53.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 110.598 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.94 -37.23 86.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.589 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.456 ' CD1' ' HA ' ' A' ' 133' ' ' LEU . 91.3 m95 -60.21 -56.5 20.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.681 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.659 HG23 ' HA2' ' A' ' 142' ' ' GLY . 45.9 mm -60.03 -36.14 65.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.009 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -63.61 -48.23 78.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.655 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.5 m -70.74 -32.2 69.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.584 0.23 . . . . 0.0 111.616 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.4 m -82.67 -6.41 59.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.796 0.331 . . . . 0.0 111.074 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.08 41.17 95.22 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.98 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.659 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 73.44 -103.2 1.38 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -118.37 16.08 13.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.59 -51.93 65.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.938 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -83.33 -15.96 48.02 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.625 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 89.0 t80 -61.7 -44.02 97.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.78 0.324 . . . . 0.0 110.5 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -24.67 66.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.129 0.49 . . . . 0.0 110.773 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.86 25.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.375 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.688 HD22 ' CD1' ' A' ' 92' ' ' TRP . 32.4 mt -61.39 -50.55 72.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 110.871 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -90.69 9.24 30.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.638 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.21 -10.61 84.55 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.8 t70 . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.14 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . 0.443 HG22 HG13 ' B' ' 202' ' ' ILE . 43.3 mt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.979 0.418 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' A' ' 81' ' ' VAL . 0.8 OUTLIER -150.46 49.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.905 179.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' B' ' 207' ' ' ARG . 42.2 mttp -57.15 -33.71 67.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.632 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -59.78 -50.71 72.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 23.0 mt -70.35 -39.95 77.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.94 0.4 . . . . 0.0 110.026 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . 0.629 ' HB1' ' HB2' ' A' ' 85' ' ' LEU . . . -60.18 -46.09 90.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.215 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' B' ' 203' ' ' LYS . 0.4 OUTLIER -62.25 -36.81 83.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.489 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -58.75 -55.7 31.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.266 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.5 pp -68.76 -36.43 78.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 111.098 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.49 -51.95 63.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.756 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -59.76 -45.5 92.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.595 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' B' ' 216' ' ' MET . 85.4 t -62.75 -55.17 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.604 0.24 . . . . 0.0 111.229 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.71 -45.63 87.99 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.182 -0.532 . . . . 0.0 114.385 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.765 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 11.0 t70 -56.06 -47.29 78.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.94 0.4 . . . . 0.0 111.576 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.7 m -75.48 -41.16 56.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.257 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' B' ' 212' ' ' VAL . 5.0 tpt -54.46 -50.01 68.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.6 -34.48 74.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.865 0.364 . . . . 0.0 111.402 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . 0.521 HH21 ' HA2' ' A' ' 93' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.352 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.76 0.314 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -134.46 102.18 11.77 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.221 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.4 114.21 3.39 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.565 2.177 . . . . 0.0 112.147 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.65 118.48 16.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.504 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -83.27 108.93 16.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.351 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -83.96 -52.14 0.58 Allowed Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.021 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 23.8 Cg_exo -65.05 129.17 22.36 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.941 1.761 . . . . 0.0 112.345 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -78.76 154.36 30.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.227 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -55.82 -38.92 70.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.215 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -69.95 -34.07 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.81 0.338 . . . . 0.0 110.645 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.23 -33.48 76.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.159 0.505 . . . . 0.0 109.878 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.2 tp -70.95 -40.53 71.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.815 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 9' ' ' THR . 87.9 t -62.67 -45.99 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.286 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.04 -36.35 74.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.093 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.68 -51.6 66.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.458 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -63.01 -44.19 96.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.098 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -61.53 -47.59 92.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 120.846 0.355 . . . . 0.0 110.274 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.31 -36.41 92.71 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.509 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.536 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 30.2 t80 -64.65 -49.64 70.19 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -57.94 -40.28 80.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.238 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.561 HD13 HG12 ' A' ' 110' ' ' VAL . 36.1 tp -65.91 -33.12 75.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.787 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -81.83 -22.24 37.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.498 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 15.6 mm100 -61.68 -26.4 68.0 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -94.95 3.28 55.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.668 0.271 . . . . 0.0 111.394 -179.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -126.91 -60.29 0.14 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.564 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -157.03 104.36 2.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.4 t -65.76 120.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.517 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.2 t -128.79 99.3 5.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.219 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.98 -134.22 1.73 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.894 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.92 174.05 10.89 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.15 83.56 0.35 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.4 99.09 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.824 2.35 . . . . 0.0 111.96 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.64 -52.15 0.82 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.539 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -137.49 91.07 2.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.044 0.45 . . . . 0.0 110.325 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.75 105.32 0.24 Allowed Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.702 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.1 111.95 1.01 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.783 2.322 . . . . 0.0 111.821 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.38 139.96 39.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.431 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.72 -35.26 67.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.527 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 41' ' ' LEU . 4.4 t70 -96.1 112.69 60.39 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.729 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -94.47 -1.5 2.8 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.684 2.256 . . . . 0.0 112.655 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.433 ' HB2' ' OD1' ' A' ' 39' ' ' ASP . 24.9 mt -64.31 -44.64 90.97 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -62.22 -32.19 72.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.386 . . . . 0.0 110.818 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -79.79 -44.17 21.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.129 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.66 ' HB1' ' HE2' ' A' ' 146' ' ' PHE . . . -61.89 -42.96 99.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.743 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.567 ' HG3' ' HE2' ' A' ' 99' ' ' PHE . 13.8 ttt -61.57 -36.64 81.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.247 0.546 . . . . 0.0 110.202 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -73.67 -42.4 61.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.313 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.9 90.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.627 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -55.11 -25.79 33.89 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.86 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.434 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -123.76 39.85 2.09 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.227 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -162.82 -42.59 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.577 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 23.4 mm-40 -54.3 -60.33 3.48 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.434 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 11.5 p90 -57.46 -27.81 62.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.584 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 4.6 tp10 -72.9 -46.43 52.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.754 0.312 . . . . 0.0 110.947 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 m -64.95 -24.32 67.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.109 0.48 . . . . 0.0 110.738 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.577 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 9.6 mtm-85 -87.28 -25.18 24.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.202 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -97.52 -92.27 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.994 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 179.92 -64.23 0.01 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.921 0.391 . . . . 0.0 110.418 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.837 ' HA ' ' HE ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -148.26 54.7 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.209 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.38 -30.41 71.55 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -59.74 -39.04 83.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.937 0.399 . . . . 0.0 110.287 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.424 ' OG ' ' HD3' ' A' ' 58' ' ' ARG . 1.6 m -86.59 -38.42 17.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.389 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 24.0 t70 -60.66 -41.53 95.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.0 tp -59.56 -39.86 85.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.408 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.22 -43.37 61.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.026 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.52 85.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.74 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 10.9 pt20 -66.3 -34.11 77.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 0.0 110.677 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.31 -24.87 63.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.091 0.472 . . . . 0.0 110.366 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -79.66 -13.22 59.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.554 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.4 t -76.25 -29.74 19.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 p -94.03 161.08 30.87 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.366 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.98 70.04 2.98 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.0 2.467 . . . . 0.0 112.034 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.84 -163.79 30.5 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.58 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -152.57 -132.06 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -99.69 -159.08 0.72 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.608 0.242 . . . . 0.0 110.886 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -51.32 -43.39 61.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.279 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -54.49 -44.52 72.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 0.0 111.192 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -71.76 -37.74 70.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.613 ' O ' HG12 ' A' ' 81' ' ' VAL . 15.5 m-85 -65.54 -45.95 81.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.593 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 m -69.38 -38.45 78.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.893 0.378 . . . . 0.0 110.854 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HA ' ' OD1' ' A' ' 83' ' ' ASP . 5.9 tp60 -65.92 -32.22 73.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.682 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 78' ' ' PHE . 1.9 p -75.37 -11.67 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.083 0.468 . . . . 0.0 110.982 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.0 m -86.95 -45.92 10.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.195 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.53 ' OD1' ' HA ' ' A' ' 80' ' ' GLN . 5.1 p-10 -80.7 -12.59 59.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.245 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.99 -41.56 96.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.919 0.39 . . . . 0.0 110.975 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.606 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -97.73 -11.86 22.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.126 -179.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 95' ' ' LEU . 18.4 t80 -68.43 -25.65 65.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.902 0.382 . . . . 0.0 110.732 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -69.18 -9.72 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.657 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.97 -8.88 71.81 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.21 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.87 134.14 3.3 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.786 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.05 69.54 7.88 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.829 2.352 . . . . 0.0 111.945 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.623 ' HB3' ' HB2' ' A' ' 94' ' ' ARG . 21.5 t30 -68.87 171.86 7.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.849 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.595 ' HA ' ' HB3' ' A' ' 149' ' ' LEU . 1.9 m-90 -46.43 -71.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 1.02 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -79.43 -15.98 78.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.555 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.623 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -61.97 -45.29 94.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.494 ' HA ' ' HE1' ' A' ' 86' ' ' PHE . 37.2 tp -68.65 -37.45 79.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.558 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 48' ' ' ALA . 74.7 t -62.01 -53.02 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.697 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.424 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -60.32 -43.82 96.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.509 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -62.19 -41.94 98.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 0.0 110.849 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.567 ' HE2' ' HG3' ' A' ' 45' ' ' MET . 10.9 t80 -71.02 -47.67 57.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.649 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 97' ' ' ALA . 9.8 p -68.12 -31.27 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.464 ' HE2' HD22 ' B' ' 209' ' ' LEU . 0.8 OUTLIER -57.47 -54.42 47.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.895 0.378 . . . . 0.0 110.181 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.81 -43.49 96.08 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.094 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.05 95.53 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.68 -46.2 76.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.704 0.288 . . . . 0.0 111.043 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 41.4 m -64.36 -46.29 84.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.459 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.03 75.26 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.014 0.435 . . . . 0.0 110.16 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.17 -44.12 84.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.735 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.596 ' HB2' HG22 ' A' ' 118' ' ' VAL . 6.3 m -66.66 -36.5 82.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.487 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.561 HG12 HD13 ' A' ' 21' ' ' LEU . 43.4 t -63.56 -43.97 98.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.05 0.453 . . . . 0.0 110.2 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -68.49 -23.09 64.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.793 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -94.7 13.5 24.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.448 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 60.06 45.22 12.21 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.66 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.568 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -124.79 56.8 1.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.18 0.514 . . . . 0.0 109.811 178.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.09 -29.35 68.52 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.837 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 t -56.32 -51.63 61.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.119 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.33 -35.68 76.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.805 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 109' ' ' SER . 55.3 t -59.25 -45.11 93.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 0.0 110.593 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.75 -38.04 94.04 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.786 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -63.21 -48.86 76.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 110.384 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.94 -43.86 96.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.469 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -44.4 97.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.659 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.86 -47.49 84.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.485 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -62.54 -44.88 95.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.912 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.5 ttt -60.3 -52.47 65.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.548 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.409 ' HA ' HD12 ' A' ' 129' ' ' LEU . 91.7 t -62.45 -44.4 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.93 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.89 94.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.445 ' OH ' ' HD3' ' A' ' 132' ' ' ARG . 44.7 t80 -59.59 -38.84 82.29 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.579 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 21.3 mt -63.6 -32.46 73.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.879 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -95.89 -0.85 50.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.422 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.6 m -105.19 -64.13 1.16 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.445 ' HD3' ' OH ' ' A' ' 128' ' ' TYR . 25.1 ttt180 -102.84 -22.52 13.86 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 69.1 mt -101.37 15.12 29.84 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.517 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.1 -50.54 72.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.296 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.07 -41.03 87.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.493 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 89.8 m95 -57.91 -51.59 69.01 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.41 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.515 HG23 ' HA2' ' A' ' 142' ' ' GLY . 26.0 mm -62.73 -37.99 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.353 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -65.47 -36.15 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.916 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.3 m -73.46 -33.61 64.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.162 0.506 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.1 m -85.42 -5.2 59.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.98 42.07 96.99 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.515 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 75.93 -100.33 1.34 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -120.23 14.23 12.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.153 0.501 . . . . 0.0 109.769 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.97 93.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.245 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.527 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -77.62 -17.93 57.28 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.05 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.66 ' HE2' ' HB1' ' A' ' 44' ' ' ALA . 28.3 t80 -63.29 -32.65 74.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.902 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -38.14 68.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.001 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.3 -28.02 23.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.595 ' HB3' ' HA ' ' A' ' 92' ' ' TRP . 62.7 mt -56.02 -53.87 51.67 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.059 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -100.47 10.79 40.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.239 0.542 . . . . 0.0 110.477 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -91.82 23.16 27.41 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.052 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.597 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . 0.44 ' HB ' ' H ' ' B' ' 202' ' ' ILE . 4.9 pt . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.706 0.288 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.44 ' H ' ' HB ' ' B' ' 201' ' ' ILE . 24.0 mt -68.98 106.84 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.603 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -62.53 -32.78 73.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.979 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -51.09 -42.73 60.81 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.156 0.285 . . . . 0.0 111.519 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' B' ' 208' ' ' HIS . 21.8 mt -68.39 -42.6 84.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.86 0.362 . . . . 0.0 110.334 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . 0.573 ' HB1' ' HB2' ' A' ' 85' ' ' LEU . . . -61.34 -45.86 92.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.527 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' ARG . . . . . 0.606 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 42.1 ttp85 -64.53 -35.36 80.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.819 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' B' ' 205' ' ' ILE . 3.8 t60 -57.37 -51.03 71.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.925 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.4 pp -74.48 -36.18 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.351 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -62.28 -47.27 85.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.025 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.29 -39.92 93.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.731 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.59 -52.22 60.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.508 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.85 -40.2 98.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.828 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 1.02 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 1.3 t0 -64.4 -55.77 18.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.018 0.437 . . . . 0.0 111.479 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.6 m -66.57 -33.83 76.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' MET . . . . . . . . . . . . . 20.7 tpp -73.38 -48.74 31.63 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.91 -41.5 95.52 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.849 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . 0.47 ' HD3' ' HA ' ' B' ' 218' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.48 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.979 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.87 0.367 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.4 111.05 15.16 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.747 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.23 134.23 24.51 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.716 2.277 . . . . 0.0 111.485 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.29 115.17 28.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.652 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 m -70.61 120.6 16.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.194 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.605 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -88.54 -51.82 0.38 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.557 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 31.5 Cg_exo -62.58 136.72 60.12 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.078 1.852 . . . . 0.0 112.108 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.99 154.62 40.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.557 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m -63.47 -34.53 77.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.782 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 10' ' ' ARG . 2.0 mtm180 -72.64 -26.8 61.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.811 0.338 . . . . 0.0 110.157 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.99 89.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.156 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.64 -44.18 96.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.556 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.3 t -63.17 -44.72 99.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.114 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.8 -37.12 85.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -68.65 -42.66 77.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.172 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -62.59 -51.61 66.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.393 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.63 -45.41 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.327 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.66 -42.78 99.81 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.778 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.643 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 1.8 t80 -63.71 -45.21 91.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -60.39 -34.82 74.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.593 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.1 tp -70.73 -25.22 62.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.26 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.4 mtm-85 -85.92 -35.56 20.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.56 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.672 ' HA ' HG22 ' A' ' 27' ' ' VAL . 10.1 mm100 -64.12 -25.59 68.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.476 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -84.43 -3.88 58.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.815 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -132.65 -88.54 0.39 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.722 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -113.56 97.52 6.5 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.672 HG22 ' HA ' ' A' ' 23' ' ' GLN . 75.0 t -62.72 115.72 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.057 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.89 97.87 5.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.527 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.462 ' HA3' ' OH ' ' A' ' 19' ' ' TYR . . . -176.82 165.13 35.08 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.82 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.93 123.98 46.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.735 0.302 . . . . 0.0 110.432 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.402 ' HA2' ' HD3' ' A' ' 32' ' ' PRO . . . -72.31 121.09 8.05 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.609 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.402 ' HD3' ' HA2' ' A' ' 31' ' ' GLY . 11.4 Cg_endo -89.08 106.13 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.419 2.746 . . . . 0.0 111.383 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.44 -70.11 0.9 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.015 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -120.46 64.73 0.84 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.277 0.56 . . . . 0.0 110.316 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.02 99.61 0.24 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.116 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.3 109.15 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.845 2.363 . . . . 0.0 112.183 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.72 139.08 34.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.421 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -72.45 -24.32 61.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.681 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -94.16 106.84 24.86 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.974 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 90.6 Cg_endo -95.85 -6.48 1.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.825 2.35 . . . . 0.0 111.74 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.8 mt -65.66 -50.95 63.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.878 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -64.46 -37.88 89.09 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.952 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -69.3 -41.67 76.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.67 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.09 90.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.8 ttt -63.26 -43.24 98.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.714 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -62.48 -46.41 88.59 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.41 87.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.5 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.68 -38.19 69.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.953 0.406 . . . . 0.0 111.812 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.65 27.69 12.94 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.501 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -143.11 -51.9 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.708 ' HA ' HG22 ' A' ' 54' ' ' THR . 41.3 mm-40 -64.11 -35.57 81.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.777 0.322 . . . . 0.0 110.46 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -66.75 -10.96 52.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.783 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.647 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 7.3 tp10 -107.45 -49.94 3.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.667 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.708 HG22 ' HA ' ' A' ' 51' ' ' GLU . 2.0 t -64.67 -31.48 72.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.761 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 55' ' ' ARG . 22.1 mtm180 -94.36 9.83 36.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.081 0.467 . . . . 0.0 110.39 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.959 ' HA ' ' HG2' ' B' ' 216' ' ' MET . 49.7 t80 -107.28 -82.89 0.54 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.642 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 5.1 mtm105 167.3 -65.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.808 ' HA ' ' HE ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -153.35 72.2 0.92 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.924 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.647 ' OG1' ' HA ' ' A' ' 53' ' ' GLU . 2.5 m -62.81 -41.58 99.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.024 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.26 20.87 1.52 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.348 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.616 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . 51.9 m -153.2 -77.03 0.12 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -56.72 -44.17 81.36 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 38.4 tp -62.89 -43.49 98.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.859 0.361 . . . . 0.0 110.343 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -66.55 -34.9 78.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.597 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.29 -44.05 72.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.515 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -74.36 -25.74 59.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.867 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -83.82 -17.92 39.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.122 0.487 . . . . 0.0 110.133 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 3.2 t-80 -76.45 -14.14 60.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.39 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.88 -32.88 56.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.305 0.574 . . . . 0.0 109.545 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.58 140.28 55.39 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.881 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.14 99.29 0.16 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.865 2.377 . . . . 0.0 112.257 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.7 -149.49 15.1 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.282 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.837 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 49.0 m -158.22 -157.73 0.66 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.3 -156.92 0.1 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.019 0.438 . . . . 0.0 111.561 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.552 ' HG3' HD21 ' A' ' 117' ' ' LEU . 4.4 mm-40 -56.8 -30.11 63.38 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -66.04 -22.85 66.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.691 0.282 . . . . 0.0 111.434 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.837 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 21.4 tpp85 -85.1 -36.68 20.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.713 0.292 . . . . 0.0 110.444 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -69.9 -31.25 68.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.512 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.96 -20.48 57.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.711 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -111.48 5.37 19.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.718 0.295 . . . . 0.0 111.656 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.8 p -100.59 -14.36 7.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.384 0.611 . . . . 0.0 110.322 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.689 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -85.36 -41.52 15.4 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.535 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.36 -13.96 57.75 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.389 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' B' ' 206' ' ' ALA . 3.6 tp10 -54.96 -41.73 71.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.886 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.5 HD23 ' HB3' ' B' ' 206' ' ' ALA . 0.3 OUTLIER -106.42 32.76 4.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.134 0.492 . . . . 0.0 110.495 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -121.27 -36.02 3.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.528 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -62.42 -31.05 71.68 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.223 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.74 1.48 86.02 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.7 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.78 117.51 1.58 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.678 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.09 164.56 24.66 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.879 2.386 . . . . 0.0 112.037 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.459 ' HB3' ' HB2' ' A' ' 94' ' ' ARG . 24.1 t30 -148.25 169.0 21.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.627 ' HA ' HD22 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -50.04 -61.56 2.08 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.808 0.692 . . . . 0.0 112.213 -178.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.94 -4.83 84.28 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.063 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.459 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 4.2 tpp85 -65.29 -45.77 83.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.726 0.298 . . . . 0.0 110.558 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.4 tp -67.62 -37.8 83.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.135 0.493 . . . . 0.0 110.058 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.504 HG22 ' HE1' ' A' ' 146' ' ' PHE . 3.1 t -65.92 -41.36 89.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.358 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.637 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -62.21 -39.46 92.83 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.057 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.689 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 66.1 t80 -61.61 -37.08 82.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.167 0.508 . . . . 0.0 110.302 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -79.69 -46.89 16.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.345 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.637 HG12 ' HA ' ' A' ' 97' ' ' ALA . 4.4 p -61.7 -34.02 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.41 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -64.35 -50.93 65.79 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.909 0.385 . . . . 0.0 110.006 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.98 98.59 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.881 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.05 83.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.614 0.245 . . . . 0.0 111.484 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.28 79.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.656 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.464 ' HB3' ' NE2' ' A' ' 75' ' ' GLN . 3.6 mm? -62.71 -38.78 91.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.361 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.7 m -72.66 -43.53 63.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.569 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.1 -37.65 77.67 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.101 0.477 . . . . 0.0 110.424 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.64 -43.68 88.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.787 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 114' ' ' MET . 21.5 m -68.43 -43.87 76.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.251 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.418 HG23 HG21 ' A' ' 118' ' ' VAL . 53.0 t -59.4 -37.37 69.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.017 0.437 . . . . 0.0 110.403 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -63.61 -29.15 70.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.839 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.9 mtpt -99.04 17.14 20.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.099 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 59.8 34.76 21.94 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.546 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.479 ' HB3' ' HB3' ' A' ' 109' ' ' SER . 0.0 OUTLIER -100.47 66.6 1.26 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.953 0.406 . . . . 0.0 110.169 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.07 -28.78 67.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.943 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.519 HG12 HE21 ' A' ' 120' ' ' GLN . 22.3 t -58.39 -51.14 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.003 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.552 HD21 ' HG3' ' A' ' 75' ' ' GLN . 14.1 tp -68.34 -39.69 81.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.984 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 114' ' ' MET . 87.7 t -59.49 -43.9 91.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.86 99.25 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.745 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.519 HE21 HG12 ' A' ' 116' ' ' VAL . 70.0 mt-30 -63.21 -50.9 68.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.624 0.25 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.28 -48.12 88.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.298 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -45.81 91.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.745 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -62.02 -42.8 99.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.246 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -60.62 -46.46 90.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.806 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 88.8 mtp -59.0 -50.94 72.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.975 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.48 -41.27 87.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.936 0.398 . . . . 0.0 110.907 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.3 -51.83 61.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.574 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.41 -42.56 87.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.215 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.666 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 36.7 mt -61.8 -26.34 68.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.102 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -107.89 3.71 24.59 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.675 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.0 m -107.41 -50.56 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -122.05 -18.7 6.85 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.893 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.678 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 83.8 mt -101.69 3.9 40.14 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.631 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.64 87.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.947 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.66 -39.7 81.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.209 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.678 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 91.8 m95 -68.09 -54.43 18.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.372 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.488 HG23 ' HA2' ' A' ' 142' ' ' GLY . 42.0 mm -56.73 -37.38 52.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.301 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -59.5 -45.11 92.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.237 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.4 m -77.51 -33.29 54.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.425 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 67.0 m -74.98 -3.24 31.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.67 39.66 96.91 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.488 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 72.04 -94.17 0.61 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -120.68 17.53 11.96 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.57 -51.56 66.86 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.54 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.622 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 4.2 pt-20 -78.21 -20.97 50.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.915 0.388 . . . . 0.0 110.5 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.504 ' HE1' HG22 ' A' ' 96' ' ' VAL . 91.5 t80 -61.25 -40.96 96.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.222 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.531 ' HA ' ' CE1' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -60.33 -33.45 72.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 110.831 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.23 -34.58 42.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.549 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.627 HD22 ' HA ' ' A' ' 92' ' ' TRP . 81.3 mt -57.38 -50.34 73.3 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.05 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.531 ' CE1' ' HA ' ' A' ' 147' ' ' THR . 5.6 p90 -86.15 -6.49 58.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.089 0.471 . . . . 0.0 110.229 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.65 -25.37 60.79 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 121.169 0.509 . . . . 0.0 109.844 178.878 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . 0.558 HG22 HG13 ' B' ' 202' ' ' ILE . 52.0 mt . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.859 0.361 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.558 HG13 HG22 ' B' ' 201' ' ' ILE . 44.9 mt -144.01 111.17 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -64.73 -34.26 77.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.332 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -53.91 -48.11 70.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 38.1 mt -62.6 -48.43 88.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.677 0.275 . . . . 0.0 110.97 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . 0.5 ' HB3' HD23 ' A' ' 85' ' ' LEU . . . -62.28 -43.15 99.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.626 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -35.86 75.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.121 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.99 -55.18 35.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.864 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.3 pp -68.65 -38.03 80.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.643 0.259 . . . . 0.0 111.642 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -65.66 -51.36 60.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -59.12 -52.09 67.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' B' ' 216' ' ' MET . 57.2 t -64.29 -47.85 87.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.683 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.97 -50.66 56.88 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.92 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' B' ' 210' ' ' ALA . 0.9 OUTLIER -61.33 -46.99 87.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 15.9 m -67.18 -34.98 78.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.728 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' MET . . . . . 0.959 ' HG2' ' HA ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -68.83 -46.89 67.4 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.707 -179.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.66 -34.15 77.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.996 0.427 . . . . 0.0 110.503 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.198 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.165 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.753 0.311 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.8 m -109.66 108.3 59.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.004 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.34 114.61 3.78 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.279 1.986 . . . . 0.0 111.567 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.41 130.32 42.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.528 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 m -88.13 120.7 29.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.638 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -84.4 -53.68 0.5 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 21.5 Cg_exo -66.13 125.72 14.57 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.119 1.879 . . . . 0.0 113.156 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.79 159.74 30.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.25 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -41.46 82.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.771 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 10' ' ' ARG . 0.6 OUTLIER -69.73 -32.6 71.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.713 0.292 . . . . 0.0 110.87 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.72 -40.65 92.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.34 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.8 -40.87 92.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.027 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.0 t -64.59 -42.53 95.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.261 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.55 -42.96 89.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.512 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.26 -37.85 86.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.0 -48.08 69.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.74 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.93 -43.39 97.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.166 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.71 98.35 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.402 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 23.3 t80 -62.81 -42.83 99.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -60.01 -36.22 76.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 0.0 110.432 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.2 tp -72.69 -28.32 62.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.232 0.539 . . . . 0.0 110.216 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 73.8 mtm-85 -80.77 -26.97 36.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.892 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 16.0 mm100 -64.35 -28.26 69.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.327 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -92.37 6.64 46.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.937 0.398 . . . . 0.0 110.789 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.83 -93.92 0.46 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -119.7 108.69 14.75 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.66 113.99 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.962 0.411 . . . . 0.0 110.396 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t -124.2 99.24 6.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.369 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.98 -132.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.538 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.7 149.64 27.72 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.96 112.33 3.43 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.036 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 88.85 1.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.55 2.167 . . . . 0.0 111.877 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.72 -129.22 5.58 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -85.09 68.73 10.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.066 0.46 . . . . 0.0 110.861 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.13 103.74 0.44 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.078 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.12 116.87 3.48 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.95 2.433 . . . . 0.0 112.383 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.52 152.64 18.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.077 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.63 -31.07 32.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.215 0.531 . . . . 0.0 109.981 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -107.92 126.0 30.8 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.196 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 39' ' ' ASP . 57.6 Cg_endo -97.2 4.63 1.58 Allowed 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.074 2.516 . . . . 0.0 111.089 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.9 mt -71.15 -46.87 60.63 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.132 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -61.39 -32.91 72.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.212 0.53 . . . . 0.0 110.084 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -78.69 -38.54 39.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.569 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.503 ' HB1' ' HE2' ' A' ' 146' ' ' PHE . . . -64.24 -41.7 96.87 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.499 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.9 ttt -63.32 -38.36 90.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.943 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -68.24 -48.78 64.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.264 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.59 -43.71 84.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.447 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.46 -42.34 64.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.39 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.6 40.18 2.64 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.614 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -155.62 -42.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 41.5 mm-40 -58.78 -78.41 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 4.5 p90 -64.15 -21.9 66.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.703 0.287 . . . . 0.0 110.668 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 32.1 tp10 -63.55 -52.98 58.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.547 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 m -74.92 -29.56 61.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.584 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.412 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 15.9 mtm-85 -71.22 -17.2 62.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.478 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -102.96 -74.79 0.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.232 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ttm105 177.36 -69.38 0.01 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.999 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.94 58.75 0.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.917 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.698 HG22 HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -57.11 -25.67 59.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.245 -178.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -53.95 -31.11 49.46 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 111.007 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.01 -29.62 5.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 18.0 t70 -69.04 -30.23 68.55 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.698 HD13 HG22 ' A' ' 59' ' ' THR . 5.5 tp -55.65 -38.07 69.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 111.218 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.93 -11.75 56.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.0 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.27 -47.08 8.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.995 0.426 . . . . 0.0 110.618 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 8.3 pt20 -66.98 -30.62 70.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.106 0.479 . . . . 0.0 110.142 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.479 HD22 ' HG3' ' A' ' 66' ' ' GLN . 1.1 mm? -96.73 14.7 24.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.211 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.73 -9.53 58.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.054 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.71 -36.07 75.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.96 129.69 35.0 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.359 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.67 117.02 3.39 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.826 2.35 . . . . 0.0 112.325 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.43 -159.04 21.99 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.159 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.0 m -143.18 -130.64 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -99.05 -153.99 0.45 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.341 0.115 . . . . 0.0 110.719 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.605 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 2.4 mm-40 -56.51 -33.16 65.75 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.422 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.463 ' HG3' ' CZ3' ' A' ' 124' ' ' TRP . 22.9 mp0 -56.58 -28.47 60.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.617 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -83.13 -9.66 59.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.043 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.522 ' O ' HG12 ' A' ' 81' ' ' VAL . 30.8 m-85 -108.59 -43.24 4.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.714 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.25 -30.17 68.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.76 0.314 . . . . 0.0 111.785 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.503 ' HB3' HD11 ' B' ' 201' ' ' ILE . 6.7 tp60 -100.95 12.13 38.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.959 0.409 . . . . 0.0 111.314 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 78' ' ' PHE . 2.1 p -109.27 -14.07 10.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.286 0.565 . . . . 0.0 110.288 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.627 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -81.26 -36.99 29.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.81 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -77.65 -20.28 54.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -53.81 -42.89 68.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.703 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.744 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -95.02 5.92 50.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.26 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -100.86 -36.52 9.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.423 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -52.32 -39.24 60.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.591 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.76 34.2 5.11 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.498 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.523 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . 175.94 83.34 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.837 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.47 ' HG3' ' CZ3' ' A' ' 136' ' ' TRP . 4.8 Cg_exo -79.85 53.01 4.54 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.223 2.615 . . . . 0.0 111.688 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -71.68 164.9 25.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.617 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.847 ' HD1' HD22 ' A' ' 149' ' ' LEU . 2.2 m-90 -53.89 -58.02 8.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.755 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.65 -14.13 79.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.26 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 6.7 tpp85 -66.79 -47.78 71.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.748 0.309 . . . . 0.0 110.586 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.405 HD23 ' CD1' ' A' ' 146' ' ' PHE . 26.3 tp -64.86 -36.06 83.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.741 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.7 t -62.97 -50.93 77.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.264 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -60.2 -42.49 95.22 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.458 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.627 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 52.5 t80 -62.69 -45.21 93.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.081 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -72.11 -42.53 65.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.912 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 97' ' ' ALA . 3.9 p -70.46 -27.98 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.634 ' HE2' HD13 ' B' ' 209' ' ' LEU . 0.2 OUTLIER -57.53 -50.69 72.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 110.444 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.1 -43.26 97.48 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.862 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -46.77 88.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.467 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.15 -43.53 98.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.268 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.605 ' HB3' ' NE2' ' A' ' 75' ' ' GLN . 2.0 mm? -68.17 -39.34 82.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.984 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.2 m -67.2 -39.65 86.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.243 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.72 89.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.946 0.403 . . . . 0.0 110.291 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -41.24 82.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.855 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -67.55 -46.39 72.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.204 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.16 -40.3 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.894 0.378 . . . . 0.0 110.422 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -64.1 -26.8 68.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.415 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -96.03 9.87 39.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.148 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 68.73 15.88 8.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.197 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.459 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -88.58 67.23 8.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.182 0.515 . . . . 0.0 110.481 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -71.53 -28.76 64.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.704 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -56.87 -46.61 83.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.578 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.4 HD21 ' HG3' ' A' ' 75' ' ' GLN . 25.6 tp -67.94 -43.62 78.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.923 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 114' ' ' MET . 64.0 t -56.98 -46.67 84.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.641 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.04 -35.12 82.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.726 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -77.25 -47.15 20.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.622 0.248 . . . . 0.0 110.572 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.47 -45.79 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.784 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.404 ' NE2' ' HA ' ' A' ' 122' ' ' GLN . 1.3 tp60 -61.36 -44.42 97.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.677 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -63.69 -40.04 95.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.165 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.463 ' CZ3' ' HG3' ' A' ' 76' ' ' GLN . 13.1 m0 -59.93 -44.52 94.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.635 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 85.1 mtp -60.65 -51.91 67.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.175 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.68 -44.55 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.77 0.319 . . . . 0.0 111.263 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.26 -44.97 96.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -60.85 -42.88 98.7 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.626 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.505 HD23 HD12 ' A' ' 133' ' ' LEU . 68.8 mt -62.84 -31.81 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.4 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -92.46 11.4 26.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 111.629 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.0 m -122.92 -70.0 0.8 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.606 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -85.35 -33.89 21.93 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.505 HD12 HD23 ' A' ' 129' ' ' LEU . 48.0 mt -102.47 16.58 25.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.268 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.12 -48.5 79.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 110.733 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.61 -36.83 84.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.321 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.47 ' CZ3' ' HG3' ' A' ' 90' ' ' PRO . 11.3 m95 -61.02 -55.37 33.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.392 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.414 HG23 ' HA2' ' A' ' 142' ' ' GLY . 46.7 mm -59.55 -39.9 80.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.685 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -63.37 -41.64 98.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.159 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.5 m -71.54 -37.73 71.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.375 . . . . 0.0 111.173 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.608 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 65.4 m -81.19 -6.3 58.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.812 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.46 43.32 96.86 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.004 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.414 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 78.95 -113.62 3.71 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.327 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -110.49 17.97 20.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.997 0.427 . . . . 0.0 110.379 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.66 -60.37 3.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.432 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.608 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 5.9 pt-20 -68.5 -27.49 66.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 110.643 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.616 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 73.7 t80 -61.88 -35.79 79.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.049 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.776 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 27.7 m -62.8 -24.82 67.93 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.569 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.98 -24.0 22.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.122 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.847 HD22 ' HD1' ' A' ' 92' ' ' TRP . 29.8 mt -62.58 -47.64 82.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 110.819 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.776 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 11.1 p90 -96.29 12.67 30.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.301 0.572 . . . . 0.0 110.096 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.88 -23.73 63.47 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.11 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--N 1.323 -0.551 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.882 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . 0.503 HD11 ' HB3' ' A' ' 80' ' ' GLN . 26.1 mt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.718 0.294 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 96.3 mt -143.1 114.81 2.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -61.38 -38.0 85.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.231 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -57.53 -44.38 85.06 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 111.665 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.65 -52.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.083 0.468 . . . . 0.0 110.493 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . 0.457 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -60.21 -40.72 91.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.078 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' ARG . . . . . 0.744 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 28.8 ttp-105 -63.47 -37.2 86.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.055 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -63.68 -49.64 72.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.209 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.634 HD13 ' HE2' ' A' ' 101' ' ' PHE . 1.5 pp -67.63 -37.91 83.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.738 0.304 . . . . 0.0 110.918 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -67.32 -44.47 79.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.081 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -59.67 -47.27 86.3 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 123.272 0.358 . . . . 0.0 111.008 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.38 -53.45 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.25 0.343 . . . . 0.0 111.349 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -43.55 98.14 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.149 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.52 -40.07 85.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.005 0.431 . . . . 0.0 111.751 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 51.0 m -75.34 -46.01 35.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -34.18 77.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . 34.5 t70 -75.16 -33.35 61.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.576 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' B' ' 218' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.781 0.324 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 m -124.17 113.6 27.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.51 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.0 128.27 20.33 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.777 2.318 . . . . 0.0 111.834 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.83 122.4 45.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.69 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.7 m -96.85 112.47 24.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.935 0.398 . . . . 0.0 110.619 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.561 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.8 -50.06 5.81 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.605 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 31.3 Cg_exo -60.85 126.54 19.92 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.103 1.869 . . . . 0.0 112.256 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.42 155.29 39.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.74 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -55.9 -38.33 70.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.962 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -68.7 -23.92 64.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 111.006 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.66 -37.22 65.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -68.88 -38.82 79.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.771 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' THR . 82.8 t -60.96 -43.71 96.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.673 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.76 -27.4 67.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.623 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 35.7 t70 -69.94 -44.0 70.46 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -68.5 -45.97 70.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.41 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.49 -46.82 95.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.965 0.412 . . . . 0.0 110.162 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.06 97.31 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.435 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.679 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 6.7 t80 -60.83 -47.68 85.27 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 19.8 mmmt -57.43 -39.27 75.87 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.642 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.491 HD12 ' HE3' ' A' ' 24' ' ' LYS . 24.3 tp -66.92 -32.97 74.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.449 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.3 mtm-85 -81.22 -29.38 34.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.188 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.679 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 12.8 mm100 -64.32 -26.82 68.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.63 0.252 . . . . 0.0 111.293 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HE3' HD12 ' A' ' 21' ' ' LEU . 6.7 pttp -97.61 13.26 30.76 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.899 0.38 . . . . 0.0 111.372 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.15 -75.4 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -142.46 106.3 4.7 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.38 109.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.922 0.391 . . . . 0.0 110.796 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 37.8 m -110.31 122.93 48.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.048 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.43 -133.4 4.57 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.862 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.451 ' O ' ' HD3' ' A' ' 32' ' ' PRO . . . -150.64 174.93 12.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.604 0.24 . . . . 0.0 110.638 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.87 99.19 1.41 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.792 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 30' ' ' ALA . 4.9 Cg_exo -76.7 89.97 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.816 2.344 . . . . 0.0 112.103 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.19 -74.53 0.95 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.471 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.92 108.23 19.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.956 0.408 . . . . 0.0 110.069 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.54 95.8 0.11 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.576 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.97 112.14 1.43 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.931 2.42 . . . . 0.0 112.109 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.29 153.16 17.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.212 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.21 -28.62 48.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.031 0.443 . . . . 0.0 110.013 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.31 110.18 59.13 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.88 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -103.91 10.72 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.557 2.838 . . . . 0.0 112.199 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' A' ' 143' ' ' TRP . 59.3 mt -72.11 -45.59 60.0 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -66.09 -38.47 88.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -67.73 -39.37 84.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.259 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.6 98.45 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.253 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 46.3 mtt -62.87 -44.68 95.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.162 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.544 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 6.7 tmm_? -65.06 -43.98 90.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.143 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.72 79.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.286 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.67 89.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.058 0.456 . . . . 0.0 110.328 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.07 22.66 30.66 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.773 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 3.2 t0 -126.8 -61.06 1.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.555 0.217 . . . . 0.0 110.967 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.785 ' HA ' HG22 ' A' ' 54' ' ' THR . 76.0 mm-40 -63.0 -41.81 99.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.032 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.484 ' HA ' ' OD1' ' B' ' 217' ' ' ASP . 51.3 t80 -58.73 -29.28 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.972 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -91.24 -40.89 11.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.398 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.785 HG22 ' HA ' ' A' ' 51' ' ' GLU . 12.6 t -70.02 -32.42 70.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 51' ' ' GLU . 21.8 mtm180 -85.07 -22.19 29.05 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 110.514 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.6 ' HA ' ' HG2' ' B' ' 216' ' ' MET . 36.3 t80 -80.08 -82.47 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 56' ' ' PHE . 9.8 ttm105 165.82 -68.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 O-C-N 123.993 0.808 . . . . 0.0 109.264 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.462 ' HD3' ' OG ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -159.42 72.45 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.056 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 m -56.47 -34.77 67.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.478 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -65.24 -15.5 62.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.584 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.462 ' OG ' ' HD3' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -118.88 -53.96 2.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.733 0.302 . . . . 0.0 111.792 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.7 -68.79 0.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.176 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.572 ' HA ' ' HG2' ' A' ' 66' ' ' GLN . 9.7 tp -57.88 -42.65 85.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.564 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -61.53 -29.79 70.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.046 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.74 -44.44 10.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.572 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 8.1 pt20 -65.37 -31.79 73.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.758 0.313 . . . . 0.0 111.27 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.773 ' HG ' ' HB3' ' B' ' 209' ' ' LEU . 2.2 mm? -87.87 -4.62 58.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.959 0.409 . . . . 0.0 110.757 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.525 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 4.7 t-80 -88.0 -10.94 48.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.778 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.1 t -75.17 -33.93 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.522 0.677 . . . . 0.0 109.595 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -74.46 148.42 85.74 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.185 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 70' ' ' THR . 23.4 Cg_exo -63.83 94.98 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.577 2.185 . . . . 0.0 112.213 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.43 -147.42 14.61 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.306 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.682 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 66.4 m -162.31 -159.7 0.61 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.461 0.304 . . . . 0.0 110.217 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.04 -160.7 0.25 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.679 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.838 ' HG3' HD21 ' A' ' 117' ' ' LEU . 11.8 mm-40 -58.28 -27.51 64.11 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -63.58 -25.3 68.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.842 0.353 . . . . 0.0 110.592 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.682 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 13.1 tpp85 -88.95 -34.95 16.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.071 0.462 . . . . 0.0 109.937 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -67.74 -32.65 73.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.546 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 p -81.47 7.36 12.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.83 0.348 . . . . 0.0 111.502 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -127.09 -41.31 1.79 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.157 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.483 HG23 HG21 ' B' ' 202' ' ' ILE . 9.9 p -55.56 -29.22 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.473 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -74.22 -46.15 43.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.109 0.481 . . . . 0.0 110.974 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.01 -33.74 75.19 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.207 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' B' ' 202' ' ' ILE . 8.2 mm-40 -53.88 -31.77 50.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.369 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.702 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -103.37 -14.52 16.24 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.813 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -70.53 -43.27 69.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.134 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.427 HE22 ' HD3' ' A' ' 132' ' ' ARG . 61.0 mt-30 -77.28 -2.16 33.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.176 0.513 . . . . 0.0 110.741 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -106.33 16.18 41.9 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.475 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . 148.23 85.95 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HG3' ' HZ3' ' A' ' 136' ' ' TRP . 3.8 Cg_exo -74.64 70.81 4.92 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 123.059 2.506 . . . . 0.0 112.746 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -82.61 173.15 12.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.38 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.559 ' CD1' HD22 ' A' ' 149' ' ' LEU . 35.3 m0 -51.32 -62.63 1.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.556 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.25 -18.81 75.33 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.155 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 3.5 tpp85 -63.91 -46.46 84.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.417 HD23 ' CD1' ' A' ' 146' ' ' PHE . 39.3 tp -69.66 -35.33 75.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.089 0.471 . . . . 0.0 109.817 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 92' ' ' TRP . 84.6 t -63.35 -44.98 99.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.022 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.665 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -63.2 -38.8 92.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.597 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.473 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 89.1 t80 -60.92 -40.83 94.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.419 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -76.26 -47.42 23.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.43 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.665 HG12 ' HA ' ' A' ' 97' ' ' ALA . 5.5 p -65.05 -30.52 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.534 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 1.2 t80 -61.08 -54.61 42.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.849 0.357 . . . . 0.0 110.231 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.62 -40.7 96.09 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.042 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.75 95.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.557 0.217 . . . . 0.0 111.459 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.31 75.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.112 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.506 ' HB3' HE22 ' A' ' 75' ' ' GLN . 1.7 mm? -61.58 -41.36 97.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.508 ' O ' HG23 ' A' ' 110' ' ' VAL . 30.2 m -66.44 -45.9 78.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.663 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.71 86.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.02 -42.66 99.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.993 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.2 m -67.04 -37.51 84.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.327 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 106' ' ' CYS . 76.7 t -62.89 -38.61 82.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.2 0.524 . . . . 0.0 110.095 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -73.08 -12.95 61.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.801 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -106.47 13.14 28.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.365 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 56.7 48.96 15.32 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.329 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.454 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.02 61.27 0.9 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.105 0.478 . . . . 0.0 110.509 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -60.36 -30.48 69.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.034 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.8 t -59.24 -45.18 93.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.402 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.838 HD21 ' HG3' ' A' ' 75' ' ' GLN . 48.5 tp -72.04 -41.52 67.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.667 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 114' ' ' MET . 83.1 t -60.42 -48.91 86.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.235 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.84 -40.08 96.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.239 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -66.66 -47.54 72.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.525 0.203 . . . . 0.0 110.671 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.42 ' O ' ' HG3' ' A' ' 125' ' ' MET . 64.6 t -59.46 -45.96 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.726 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.2 -45.4 93.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -63.28 -42.3 99.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -61.31 -38.34 86.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 121' ' ' VAL . 95.7 mtp -66.81 -48.67 68.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.258 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.06 -42.52 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.53 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.22 -43.67 83.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 132' ' ' ARG . 0.2 OUTLIER -62.88 -41.84 99.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.414 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.651 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 91.3 mt -65.56 -31.39 72.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.657 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.27 -3.71 55.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.0 m -115.41 -88.93 0.57 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.49 ' HB3' ' CE1' ' A' ' 128' ' ' TYR . 64.2 ttt180 -72.47 -36.27 68.41 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.651 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 97.5 mt -89.71 14.66 11.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.727 0.298 . . . . 0.0 111.372 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.32 -55.27 29.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.844 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.97 -34.68 78.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.775 0.322 . . . . 0.0 110.87 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.41 ' HZ3' ' HG3' ' A' ' 90' ' ' PRO . 60.9 m95 -59.37 -57.93 10.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.46 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.408 HG23 ' HA2' ' A' ' 142' ' ' GLY . 47.3 mm -61.69 -37.27 77.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.913 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -63.49 -42.0 98.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.461 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.8 m -76.71 -27.88 55.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.728 0.299 . . . . 0.0 111.279 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 70.3 m -85.04 -11.95 54.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.583 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.17 44.82 85.79 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.408 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 70.53 -100.84 0.85 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.59 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.532 ' HB2' HD22 ' A' ' 41' ' ' LEU . 84.2 m95 -116.78 15.15 15.36 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.65 -60.24 3.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.592 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.527 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 3.7 pt-20 -66.76 -28.23 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 110.579 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.504 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 74.0 t80 -62.07 -30.57 71.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.638 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 5.6 m -61.83 -28.34 69.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.216 0.531 . . . . 0.0 110.569 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.27 -26.64 18.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.773 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.559 HD22 ' CD1' ' A' ' 92' ' ' TRP . 24.4 mt -62.69 -53.85 48.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.15 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.638 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 1.5 p90 -84.3 17.8 2.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.951 0.405 . . . . 0.0 111.141 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.03 -31.09 62.24 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.862 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 C--N 1.328 -0.338 0 O-C-N 122.575 -0.367 . . . . 0.0 110.463 -179.694 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . 0.541 HG13 HG12 ' B' ' 202' ' ' ILE . 13.9 pt . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.541 HG12 HG13 ' B' ' 201' ' ' ILE . 44.5 mm -104.09 114.7 44.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.861 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.3 -43.84 2.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.28 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -64.1 -54.81 28.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 0.0 111.135 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' ILE . . . . . 0.559 HG23 HD12 ' A' ' 67' ' ' LEU . 94.1 mt -63.15 -40.56 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.231 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . 0.464 ' HB1' ' HB2' ' A' ' 85' ' ' LEU . . . -61.64 -47.42 85.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.905 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' ARG . . . . . 0.702 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 74.3 ttt180 -65.94 -35.07 79.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.902 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' HIS . . . . . 0.746 ' HB3' HD11 ' A' ' 67' ' ' LEU . 3.3 t-80 -58.25 -51.92 67.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.762 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.773 ' HB3' ' HG ' ' A' ' 67' ' ' LEU . 1.2 pp -74.92 -38.44 61.81 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.733 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . 0.456 ' HB1' ' HD3' ' A' ' 94' ' ' ARG . . . -68.81 -48.26 64.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -69.41 -48.66 60.36 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 43.0 t -57.18 -43.76 82.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.812 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.74 -50.62 29.28 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.088 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 25.4 t0 -57.26 -44.58 84.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.449 0.3 . . . . 0.0 111.785 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 12.8 m -68.18 -36.22 79.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.714 0.292 . . . . 0.0 111.758 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' MET . . . . . 0.6 ' HG2' ' HA ' ' A' ' 56' ' ' PHE . 23.6 ttm -74.59 -40.81 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.76 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . 0.484 ' OD1' ' HA ' ' A' ' 52' ' ' PHE . 37.8 t70 -65.53 -34.27 77.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.455 0.645 . . . . 0.0 109.417 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.693 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.87 0.366 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.7 m -127.86 106.11 20.48 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.122 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.85 122.54 9.91 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.885 2.39 . . . . 0.0 112.11 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.6 119.09 24.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.742 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.1 m -74.98 108.17 7.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.359 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.57 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -74.08 -51.93 4.57 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 25.8 Cg_exo -63.84 140.3 72.81 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.868 1.712 . . . . 0.0 113.007 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 22.2 t70 -81.4 151.83 27.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.377 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -58.61 -36.89 74.75 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.445 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -73.19 -37.96 66.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.879 0.371 . . . . 0.0 110.55 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 -33.4 75.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.166 0.508 . . . . 0.0 109.919 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 41' ' ' LEU . 20.3 tp -64.32 -42.03 96.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.047 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' THR . 48.7 t -69.92 -40.17 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.963 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 -37.17 77.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.784 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.67 -37.3 86.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.346 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -67.87 -49.87 59.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.185 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.6 t -62.84 -44.73 99.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.107 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.13 -38.09 95.02 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.619 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.586 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 9.2 t80 -66.63 -43.09 85.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -61.44 -37.1 82.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.317 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.618 HD12 ' HE3' ' A' ' 24' ' ' LYS . 15.8 tp -65.63 -33.01 74.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.733 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.7 mtm-85 -79.42 -34.4 41.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.684 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 13.7 mm100 -61.19 -39.05 88.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.354 . . . . 0.0 111.181 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.618 ' HE3' HD12 ' A' ' 21' ' ' LEU . 11.6 pttp -84.77 2.57 41.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.177 0.513 . . . . 0.0 110.823 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.25 -108.33 1.07 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.441 ' HD1' ' SG ' ' A' ' 28' ' ' CYS . 17.3 t80 -101.67 105.19 16.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 23' ' ' GLN . 98.2 t -65.17 107.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.171 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.441 ' SG ' ' HD1' ' A' ' 26' ' ' TYR . 8.2 m -113.82 118.77 35.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.87 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.57 178.74 25.72 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.058 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.31 155.91 23.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.612 0.244 . . . . 0.0 110.609 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.55 106.86 3.27 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.774 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.95 109.13 1.04 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.932 2.422 . . . . 0.0 112.438 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.78 -118.27 2.57 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.876 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -85.66 66.8 9.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.274 0.559 . . . . 0.0 109.688 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.18 98.79 0.24 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.484 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.27 112.88 1.25 Allowed 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.9 2.4 . . . . 0.0 111.613 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.69 151.48 22.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.266 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.88 -34.03 51.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.927 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.65 120.47 46.18 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.002 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -102.33 16.79 0.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.602 2.868 . . . . 0.0 112.498 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.64 ' HB3' HD21 ' A' ' 12' ' ' LEU . 79.6 mt -68.76 -46.26 69.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.714 0.292 . . . . 0.0 111.494 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -70.0 -37.69 75.76 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -65.43 -39.66 92.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.379 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.21 86.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.627 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 36.5 mtt -64.93 -38.2 90.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.416 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -69.02 -30.02 68.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.753 179.272 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.82 -35.42 38.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.809 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.61 -41.82 67.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 111.024 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.89 37.41 3.44 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.056 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.07 -43.22 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 54' ' ' THR . 56.4 mm-40 -54.13 -63.99 0.97 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.555 ' O ' ' HB2' ' A' ' 56' ' ' PHE . 1.2 p90 -64.94 -21.14 66.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.451 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 53' ' ' GLU . 5.0 tp10 -80.93 -40.7 24.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 111.589 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 51' ' ' GLU . 4.0 t -70.62 -13.75 62.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.732 0.301 . . . . 0.0 111.385 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.507 ' O ' ' HG3' ' B' ' 216' ' ' MET . 81.1 mtm-85 -113.93 6.79 16.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.752 0.31 . . . . 0.0 111.148 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 52' ' ' PHE . 2.1 t80 -116.16 -88.89 0.58 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.574 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 mtm105 -174.75 -83.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.174 0.511 . . . . 0.0 109.672 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.709 ' HA ' ' HE ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -148.87 49.99 0.99 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.758 HG22 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -53.72 -28.66 35.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.985 -178.083 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -52.85 -31.06 37.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 110.99 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.92 -37.47 3.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.648 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 15.5 t70 -61.7 -39.14 90.43 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.444 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.758 ' HB2' HG22 ' A' ' 59' ' ' THR . 14.7 tp -61.83 -34.79 76.58 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.164 0.506 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.68 -32.6 41.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.315 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.54 -44.28 62.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.538 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 9.7 pt20 -65.34 -32.36 73.96 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.885 0.374 . . . . 0.0 110.64 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.71 -8.8 59.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.284 0.564 . . . . 0.0 110.109 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -12.97 46.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.02 -37.73 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.966 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -86.5 160.53 50.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.067 178.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.966 ' HD2' HG22 ' A' ' 70' ' ' THR . 10.9 Cg_endo -55.08 115.78 2.68 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.394 2.063 . . . . 0.0 112.146 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.42 -164.53 11.0 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.41 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 50.3 m -152.36 -155.28 0.6 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.87 -159.18 0.1 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.855 0.36 . . . . 0.0 111.617 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.59 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 1.9 mm-40 -50.27 -34.77 24.42 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.719 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -56.04 -36.43 67.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.356 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 22.4 tpp85 -72.7 -34.27 67.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.702 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.59 ' HD2' ' HA ' ' A' ' 75' ' ' GLN . 90.6 m-85 -69.15 -40.46 78.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.125 0.488 . . . . 0.0 110.328 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -68.54 -36.16 78.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.284 0.564 . . . . 0.0 110.172 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.85 ' HG2' HD12 ' B' ' 201' ' ' ILE . 22.5 tp60 -71.53 -42.55 67.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.941 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 78' ' ' PHE . 3.4 p -61.22 -20.72 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.039 0.447 . . . . 0.0 111.342 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -87.67 -46.63 9.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.959 0.409 . . . . 0.0 110.445 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -35.8 80.47 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.352 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.624 ' HG3' ' HG2' ' B' ' 203' ' ' LYS . 6.3 tp10 -49.42 -39.4 32.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.246 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.701 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.5 OUTLIER -105.54 3.41 29.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.813 0.34 . . . . 0.0 111.469 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.501 ' HE1' ' HA ' ' A' ' 95' ' ' LEU . 28.7 t80 -84.15 -37.48 21.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.53 -21.46 66.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.654 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.85 8.39 69.91 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.515 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.455 ' HA2' ' HD3' ' A' ' 90' ' ' PRO . . . 130.33 116.57 1.85 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.464 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.455 ' HD3' ' HA2' ' A' ' 89' ' ' GLY . 5.6 Cg_exo -75.35 65.2 6.37 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.375 2.716 . . . . 0.0 111.321 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -68.13 178.02 2.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.72 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.665 ' H ' ' HE3' ' A' ' 92' ' ' TRP . 1.4 m-90 -45.0 -72.47 0.06 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.529 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.46 68.35 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.197 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.5 tpp85 -66.65 -51.23 58.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.612 0.244 . . . . 0.0 110.62 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.501 ' HA ' ' HE1' ' A' ' 86' ' ' PHE . 25.3 tp -67.03 -36.08 81.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.966 0.412 . . . . 0.0 110.505 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.462 HG22 ' HE1' ' A' ' 146' ' ' PHE . 60.9 t -65.83 -54.33 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.821 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.751 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -61.03 -41.74 97.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.021 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -54.6 -36.56 64.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.535 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -90.86 -46.56 8.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.818 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 97' ' ' ALA . 5.6 p -65.15 -37.15 79.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.455 ' HD1' ' HA ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -65.7 -45.4 82.91 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.105 -179.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.03 -45.6 95.76 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.61 98.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.215 . . . . 0.0 111.015 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.47 97.31 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.807 0.337 . . . . 0.0 111.208 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 105' ' ' LEU . 2.0 mm? -73.74 -39.69 64.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.29 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.431 ' O ' HG23 ' A' ' 110' ' ' VAL . 52.1 m -64.57 -42.18 95.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.391 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.35 -42.53 87.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.875 0.369 . . . . 0.0 110.348 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -42.65 98.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.476 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m -65.34 -37.1 86.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.545 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 106' ' ' CYS . 42.5 t -62.51 -44.85 99.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.274 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -66.01 -24.8 66.83 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.416 0.627 . . . . 0.0 110.177 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -89.54 5.24 46.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.101 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 66.98 18.57 10.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.696 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.46 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -92.25 60.33 3.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.219 0.533 . . . . 0.0 109.584 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.78 -24.63 66.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.341 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.7 t -62.63 -47.31 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.024 0.44 . . . . 0.0 109.914 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.73 -38.96 87.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.217 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 114' ' ' MET . 87.7 t -58.23 -52.05 63.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.532 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.74 93.18 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.041 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -62.13 -53.83 49.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.709 0.29 . . . . 0.0 110.88 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.68 -44.43 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.25 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -45.46 88.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.548 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.52 -46.07 91.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.268 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -60.02 -43.51 95.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.003 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 96.8 mtp -64.31 -52.4 58.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 72.1 t -60.57 -42.56 92.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.296 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.06 -48.41 73.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.818 0.342 . . . . 0.0 110.679 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -59.7 -39.54 84.94 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.55 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.6 mt -59.17 -29.96 67.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.409 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -106.01 11.41 31.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.702 0.287 . . . . 0.0 110.966 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 78.4 m -108.29 -65.61 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.495 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -108.24 -22.03 12.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.788 0.328 . . . . 0.0 111.396 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.775 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 61.0 mt -101.15 11.97 38.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.646 0.26 . . . . 0.0 111.024 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.52 -49.0 77.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.27 -43.72 92.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.716 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.775 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 83.0 m95 -60.11 -49.43 77.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.579 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 133' ' ' LEU . 46.0 mm -63.45 -39.37 85.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.512 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.15 -49.83 72.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.923 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.3 m -63.78 -47.77 79.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.325 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 50.7 m -70.17 -16.75 63.12 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.78 41.19 50.65 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.877 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.89 -100.95 0.67 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.125 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -111.77 13.78 21.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.782 0.325 . . . . 0.0 110.548 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.23 -50.91 71.4 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.822 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.617 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 11.0 pt-20 -86.26 -22.37 26.87 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.587 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.462 ' HE1' HG22 ' A' ' 96' ' ' VAL . 90.0 t80 -59.38 -41.05 88.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.947 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.566 ' HA ' ' CE2' ' A' ' 150' ' ' TYR . 0.4 OUTLIER -64.81 -26.16 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.218 0.532 . . . . 0.0 111.046 -179.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.79 -26.27 24.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.948 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 84.7 mt -60.76 -60.54 3.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.893 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 147' ' ' THR . 34.0 p90 -74.87 -10.54 59.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.984 0.421 . . . . 0.0 110.591 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.34 -19.1 77.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.559 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.2 t70 . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.057 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . 0.85 HD12 ' HG2' ' A' ' 80' ' ' GLN . 25.6 mt . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.676 0.274 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.647 HG12 HG12 ' B' ' 205' ' ' ILE . 10.0 tt -162.3 100.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.639 0.733 . . . . 0.0 110.743 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.624 ' HG2' ' HG3' ' A' ' 84' ' ' GLU . 48.5 mttm -77.63 -32.41 53.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.92 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -45.93 -61.09 1.89 Allowed 'General case' 0 C--O 1.24 0.575 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' ILE . . . . . 0.647 HG12 HG12 ' B' ' 202' ' ' ILE . 45.3 pt -69.46 -34.38 61.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.69 0.281 . . . . 0.0 111.283 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . 0.447 ' HA ' HG22 ' A' ' 81' ' ' VAL . . . -62.54 -37.51 86.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.203 0.525 . . . . 0.0 110.365 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' ARG . . . . . 0.701 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 38.0 ttp180 -62.85 -44.42 96.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.317 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' HIS . . . . . 0.402 ' O ' HG22 ' B' ' 212' ' ' VAL . 84.5 t60 -63.65 -40.09 95.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.27 -52.45 65.63 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.29 0.567 . . . . 0.0 110.507 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -68.56 -34.98 76.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.731 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -56.6 -56.03 26.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.79 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 208' ' ' HIS . 13.0 m -63.1 -43.41 98.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.535 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.08 -42.2 98.2 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.76 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.513 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 0.6 OUTLIER -70.33 -47.62 60.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.654 0.264 . . . . 0.0 111.574 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 12.2 m -68.34 -42.74 78.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 55' ' ' ARG . 6.5 tpt -66.05 -48.16 71.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.01 -35.03 79.89 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.067 0.461 . . . . 0.0 110.548 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.0 m -141.19 88.52 10.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.848 0.356 . . . . 0.0 110.508 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.23 129.78 19.97 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.473 2.115 . . . . 0.0 112.074 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.09 167.66 12.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.285 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.6 m -104.88 125.7 51.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.829 0.347 . . . . 0.0 110.58 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.656 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -84.59 -53.0 0.51 Allowed Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.224 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 10.9 Cg_exo -71.09 133.95 24.18 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.91 1.74 . . . . 0.0 111.788 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.0 149.91 47.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.935 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.91 -40.91 67.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.325 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -73.59 -27.09 61.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 0.0 110.945 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.01 94.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 mp -64.17 -42.54 96.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.289 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.99 -45.89 95.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.149 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.5 80.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.565 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.0 -42.05 85.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.215 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -63.22 -46.08 88.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.31 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.18 -47.38 93.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.073 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.46 99.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.692 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.655 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 18.3 t80 -60.78 -48.89 79.73 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -60.03 -38.86 83.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.597 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 21' ' ' LEU . 8.3 tp -67.77 -25.79 65.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.074 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -89.44 -29.59 18.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 15.6 mm100 -60.87 -28.61 68.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.017 0.436 . . . . 0.0 111.347 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -88.48 16.04 7.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.582 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.87 -62.75 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.845 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -145.3 102.53 3.74 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.82 107.41 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.252 0.549 . . . . 0.0 110.885 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.8 t -110.11 127.39 54.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.996 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.83 -124.07 2.18 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.018 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.27 172.27 16.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.764 0.316 . . . . 0.0 110.653 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.09 108.64 2.87 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.1 110.24 2.58 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.936 2.424 . . . . 0.0 111.851 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.63 -104.31 2.46 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.894 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -90.15 109.72 20.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.284 0.564 . . . . 0.0 110.24 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.98 90.71 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -48.0 108.56 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.331 2.687 . . . . 0.0 112.863 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.11 141.14 38.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.68 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.67 79.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.007 0.432 . . . . 0.0 110.152 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.87 126.33 32.13 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.21 0.529 . . . . 0.0 110.436 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -96.59 1.65 1.91 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.826 2.351 . . . . 0.0 110.716 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.594 HD23 ' HB2' ' A' ' 143' ' ' TRP . 12.2 mt -67.18 -50.23 61.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.661 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -62.13 -34.11 75.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.07 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -80.84 -38.58 28.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.465 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HB1' ' HD2' ' A' ' 146' ' ' PHE . . . -60.87 -43.97 97.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.706 0.288 . . . . 0.0 111.011 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 54.9 mtt -63.8 -38.41 90.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.032 0.444 . . . . 0.0 110.535 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 4.9 tmm_? -70.42 -42.53 71.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.224 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.38 -32.6 71.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.875 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.93 -50.52 57.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.045 0.45 . . . . 0.0 110.609 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.421 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -98.6 42.71 2.0 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.329 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 2.8 t0 -148.34 -46.48 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.586 0.231 . . . . 0.0 111.26 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.496 ' O ' HG22 ' A' ' 54' ' ' THR . 71.0 mm-40 -57.19 -55.53 33.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.801 0.334 . . . . 0.0 111.9 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.421 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 2.1 p90 -68.35 -26.48 65.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.687 0.28 . . . . 0.0 111.248 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -77.23 -42.79 35.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.172 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 51' ' ' GLU . 6.5 t -65.22 -26.02 67.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.154 0.502 . . . . 0.0 110.219 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 37.3 mtm-85 -93.2 -1.07 56.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.895 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.601 ' HD2' ' HG2' ' B' ' 216' ' ' MET . 42.9 t80 -111.87 -92.47 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.283 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.0 ttp85 175.11 -66.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.718 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.794 ' HA ' ' HE ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -154.3 56.55 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.268 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -30.6 71.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.995 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -52.12 -38.63 58.04 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 123.455 0.472 . . . . 0.0 110.981 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.04 -41.2 6.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.258 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -59.45 -46.44 88.75 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.629 HD11 ' HA ' ' B' ' 209' ' ' LEU . 7.4 tp -62.81 -37.47 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 110.499 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.69 -30.7 63.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.295 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.04 -49.09 54.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.799 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -66.49 -31.5 72.27 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.941 0.4 . . . . 0.0 110.128 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.797 ' HG ' ' HZ ' ' A' ' 101' ' ' PHE . 0.5 OUTLIER -69.32 -22.27 63.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 178.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -83.18 -22.49 33.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.935 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.31 -49.04 34.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.551 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -72.53 141.36 82.71 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.697 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.551 ' HD2' HG22 ' A' ' 70' ' ' THR . 77.8 Cg_exo -50.92 104.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.77 2.314 . . . . 0.0 112.63 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.59 -158.77 9.87 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.954 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.606 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 7.4 m -142.84 -148.44 0.24 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.03 -158.19 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.976 0.417 . . . . 0.0 111.423 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.622 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 3.7 mm-40 -53.04 -38.13 62.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.576 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -56.82 -40.03 75.29 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.944 0.402 . . . . 0.0 110.842 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.606 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 14.0 tpp85 -64.94 -37.94 89.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.975 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.622 ' HD2' ' HA ' ' A' ' 75' ' ' GLN . 40.9 m-85 -69.16 -37.32 78.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.526 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 m -69.04 -46.7 67.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.084 0.469 . . . . 0.0 110.632 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.81 -32.62 69.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.866 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 78' ' ' PHE . 2.5 p -69.25 -19.17 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.164 0.507 . . . . 0.0 110.774 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.506 ' HB3' ' HA ' ' A' ' 98' ' ' PHE . 38.4 m -82.48 -43.65 16.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.117 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.89 -24.12 55.63 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.063 0.459 . . . . 0.0 109.976 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.795 ' HG3' ' HD3' ' B' ' 203' ' ' LYS . 2.9 tp10 -51.33 -48.01 62.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.44 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.569 HD21 ' HG2' ' B' ' 207' ' ' ARG . 0.1 OUTLIER -90.1 -5.77 56.17 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.924 -0.311 . . . . 0.0 111.658 -178.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.2 -27.95 57.05 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -65.47 -23.58 66.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.297 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.19 3.3 86.38 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.908 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 90' ' ' PRO . . . 131.33 133.16 3.45 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.547 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 89' ' ' GLY . 6.3 Cg_exo -78.53 65.83 8.57 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.141 2.561 . . . . 0.0 111.618 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -70.9 169.76 14.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.277 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.529 ' H ' ' HE3' ' A' ' 92' ' ' TRP . 5.1 m-90 -52.24 -63.17 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.865 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.32 -11.28 75.72 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.182 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -67.0 -49.99 63.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.732 0.301 . . . . 0.0 110.307 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.9 tp -67.29 -33.92 76.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.266 0.555 . . . . 0.0 109.736 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.14 -54.13 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.472 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.576 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -61.91 -43.17 99.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.574 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.506 ' HA ' ' HB3' ' A' ' 82' ' ' SER . 79.3 t80 -57.91 -42.89 85.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.039 0.447 . . . . 0.0 111.53 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -75.86 -46.78 28.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.709 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 97' ' ' ALA . 9.8 p -66.93 -34.0 67.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.797 ' HZ ' ' HG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -60.8 -50.31 73.95 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 110.43 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.4 -43.23 95.28 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.918 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.11 87.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.46 97.71 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.3 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.16 -43.33 71.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.044 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.454 ' O ' HG23 ' A' ' 110' ' ' VAL . 34.7 m -61.94 -44.15 97.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.416 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.58 82.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.908 0.385 . . . . 0.0 110.488 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -68.31 -40.51 81.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.164 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.476 ' HB2' HG22 ' A' ' 118' ' ' VAL . 17.2 m -63.99 -37.81 88.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.812 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 106' ' ' CYS . 99.5 t -67.65 -33.42 61.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.122 0.487 . . . . 0.0 109.764 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.08 -13.23 61.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.248 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -106.94 7.92 30.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.121 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 62.61 34.31 15.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.48 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.541 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -106.73 62.79 0.63 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.008 0.432 . . . . 0.0 110.117 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -64.96 -27.6 68.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.678 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.9 t -59.08 -48.36 86.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.304 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 tp -70.37 -39.17 74.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.353 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 114' ' ' MET . 99.4 t -59.2 -49.51 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.837 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.56 84.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.384 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -69.02 -51.25 41.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.71 0.291 . . . . 0.0 110.664 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.84 -43.48 97.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.759 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -43.24 94.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.989 0.423 . . . . 0.0 110.099 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.28 -42.47 88.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.36 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -60.5 -41.45 94.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 93.1 mtp -59.35 -52.22 66.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.456 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.1 t -65.18 -42.31 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.586 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.02 -47.21 81.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -63.22 -40.41 97.38 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.992 0.425 . . . . 0.0 110.119 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.721 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 24.3 mt -63.08 -35.36 79.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.145 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -90.95 6.51 44.39 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.2 m -121.37 -61.52 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -101.44 -26.6 13.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.721 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 97.3 mt -98.77 10.03 42.1 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.324 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.14 -48.07 77.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.767 0.317 . . . . 0.0 111.17 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.85 -52.09 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.621 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -61.42 -50.6 72.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.475 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.574 HG23 ' HA2' ' A' ' 142' ' ' GLY . 17.5 mm -58.92 -40.2 79.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.694 0.283 . . . . 0.0 110.938 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -61.37 -43.67 98.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.962 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.4 m -69.94 -41.01 75.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.752 0.311 . . . . 0.0 111.119 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.0 m -75.09 -2.06 25.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.594 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.0 42.02 98.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.08 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.574 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 72.95 -102.12 1.19 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.393 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.594 ' HB2' HD23 ' A' ' 41' ' ' LEU . 82.0 m95 -112.49 9.33 19.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.668 0.271 . . . . 0.0 110.365 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.16 -55.88 28.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.988 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.601 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 43.8 tt0 -59.9 -39.3 84.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.124 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.44 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 48.9 t80 -57.97 -34.84 70.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.626 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.456 ' HA ' ' CE2' ' A' ' 150' ' ' TYR . 2.1 m -60.46 -37.35 80.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.04 0.448 . . . . 0.0 110.778 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.81 -27.54 30.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.505 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 26.3 mt -57.23 -52.39 65.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.261 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.456 ' CE2' ' HA ' ' A' ' 147' ' ' THR . 30.3 p90 -87.08 8.26 24.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.838 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.72 -34.91 91.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.969 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 t0 . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 120.64 0.257 . . . . 0.0 110.382 179.611 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 43.7 mt . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 120.739 0.304 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -147.22 79.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.239 0.542 . . . . 0.0 110.363 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.795 ' HD3' ' HG3' ' A' ' 84' ' ' GLU . 39.2 mmtm -58.92 -36.07 74.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.13 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -62.49 -43.52 98.62 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.155 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 38.7 mt -64.99 -41.68 92.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.111 0.481 . . . . 0.0 109.707 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . 0.462 ' HB3' HD23 ' A' ' 85' ' ' LEU . . . -62.45 -42.59 99.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.631 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' ARG . . . . . 0.569 ' HG2' HD21 ' A' ' 85' ' ' LEU . 15.2 mtp180 -61.35 -34.61 75.58 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.114 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -58.69 7.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.569 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.629 ' HA ' HD11 ' A' ' 63' ' ' LEU . 1.2 pp -67.72 -42.25 82.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -64.92 -47.18 78.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' B' ' 207' ' ' ARG . 6.3 tp60 -65.69 -37.91 87.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 16.5 t -58.19 -55.09 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.656 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.29 -38.45 91.56 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.468 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 2.3 t0 -63.83 -49.77 71.53 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.7 m -68.42 -40.24 81.31 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' MET . . . . . 0.601 ' HG2' ' HD2' ' A' ' 56' ' ' PHE . 5.6 tpt -64.64 -42.68 95.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.744 0.306 . . . . 0.0 111.094 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.34 -33.34 69.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.318 0.58 . . . . 0.0 110.047 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.887 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.715 0.293 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 m -133.62 117.19 14.11 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.513 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.16 144.05 99.5 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.645 2.23 . . . . 0.0 112.15 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.62 114.86 29.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.815 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -69.72 115.88 9.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.989 0.423 . . . . 0.0 110.647 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.548 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -86.32 -49.93 0.5 Allowed Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.327 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 32.7 Cg_exo -61.3 131.87 38.48 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.05 1.833 . . . . 0.0 113.042 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -75.62 149.08 38.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.378 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 m -57.22 -36.94 71.51 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -69.66 -31.38 69.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.668 0.271 . . . . 0.0 110.617 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.45 78.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.237 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 mp -69.15 -41.7 76.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.744 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.64 -42.99 98.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.995 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.32 87.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.667 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.42 -46.89 81.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -61.05 -48.86 79.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.974 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.13 -46.66 95.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.51 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.71 98.95 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.794 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -61.95 -46.14 90.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.724 0.297 . . . . 0.0 110.272 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 20' ' ' LYS . 11.8 mmmt -61.65 -35.91 79.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.936 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.11 -26.24 59.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.683 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -84.26 -36.99 22.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.379 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -56.97 -35.4 69.11 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 24.18 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.932 0.396 . . . . 0.0 111.382 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.04 -54.95 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.683 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -154.52 111.83 3.39 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.93 120.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.148 0.499 . . . . 0.0 110.812 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.8 m -132.37 108.56 9.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.397 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.5 -134.87 3.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.843 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.09 146.77 26.38 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.94 114.84 4.08 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.653 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.59 83.7 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.064 2.509 . . . . 0.0 112.2 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.63 -103.65 1.24 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.234 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -103.15 105.74 16.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.046 0.45 . . . . 0.0 109.798 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.45 85.73 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.577 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -57.22 119.17 6.25 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.069 2.512 . . . . 0.0 112.252 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.49 164.19 13.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.485 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.435 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -85.45 -15.98 41.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.133 0.492 . . . . 0.0 110.294 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -105.87 102.52 39.38 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.844 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 41.0 Cg_endo -96.77 5.28 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.224 2.616 . . . . 0.0 111.57 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.0 mt -64.27 -45.95 85.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.155 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -63.78 -43.07 97.45 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.74 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -65.49 -43.54 89.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.934 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.17 -39.0 93.39 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.834 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.1 ttt -73.55 -34.98 65.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.091 0.472 . . . . 0.0 110.602 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -68.81 -40.87 79.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.84 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 50' ' ' ASP . . . -95.01 5.14 52.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.739 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.54 58.31 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.189 0.518 . . . . 0.0 110.801 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -96.67 29.2 10.8 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.43 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -124.77 -31.2 3.21 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.358 -0.137 . . . . 0.0 111.215 -179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -56.99 -71.89 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.116 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.511 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 54.2 p90 -58.95 -25.76 63.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.113 0.482 . . . . 0.0 110.545 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 4.0 tp10 -66.29 -38.06 86.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.489 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -61.16 -36.9 81.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.29 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.604 ' HB2' ' HG3' ' B' ' 216' ' ' MET . 0.0 OUTLIER -86.65 -17.42 33.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.343 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.695 ' HB2' ' HG2' ' B' ' 216' ' ' MET . 41.8 t80 -97.05 -93.62 0.22 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.295 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 57' ' ' ARG . 26.1 ttm105 -175.39 -81.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.416 0.627 . . . . 0.0 109.534 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.404 ' HA ' ' HE ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -153.03 67.26 0.79 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.385 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -53.22 -32.89 50.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.496 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.62 -36.58 64.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 110.619 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -99.23 -32.95 10.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.093 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 10.6 t70 -63.18 -38.21 90.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.92 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.2 tp -57.27 -43.71 83.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.49 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.72 -35.99 79.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.052 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.1 -47.6 35.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.747 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 9.5 pt20 -66.23 -33.04 74.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.602 0.239 . . . . 0.0 111.118 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.87 -0.75 40.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.737 0.303 . . . . 0.0 111.006 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -94.3 -29.35 15.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.6 t -62.57 -46.8 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.56 0.695 . . . . 0.0 109.3 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.582 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -92.9 145.18 29.69 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.495 178.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.582 ' HD2' HG22 ' A' ' 70' ' ' THR . 69.0 Cg_exo -52.35 107.65 0.2 Allowed 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.708 2.272 . . . . 0.0 112.597 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.57 -166.11 28.45 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.094 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.657 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 73.2 m -157.21 -150.43 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.898 -0.177 . . . . 0.0 110.717 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.35 -168.19 0.92 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.676 0.275 . . . . 0.0 111.192 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.44 HE22 HG11 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -56.69 -34.15 67.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -55.42 -27.8 50.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.373 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.657 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 15.4 tpp85 -75.61 -13.04 60.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.51 ' O ' HG12 ' A' ' 81' ' ' VAL . 80.1 m-85 -104.3 -40.78 5.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.41 HG21 HG13 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -65.99 -36.46 83.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 111.71 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -95.22 3.96 54.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 111.722 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -97.32 -23.73 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.259 0.552 . . . . 0.0 109.681 179.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.12 -42.45 19.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.592 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -21.64 58.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.026 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 3.4 tp10 -55.1 -41.89 72.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.193 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.749 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.3 OUTLIER -97.76 10.03 41.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.99 0.424 . . . . 0.0 110.718 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -99.17 -29.35 12.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -56.1 -45.59 79.37 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.982 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -106.07 15.46 43.71 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.294 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.1 78.35 0.15 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.734 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.89 54.22 5.03 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 123.221 2.614 . . . . 0.0 111.641 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -74.93 162.37 28.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.093 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.473 ' HZ3' ' HD2' ' B' ' 218' ' ' ARG . 0.3 OUTLIER -58.41 -51.64 68.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.655 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.69 -28.48 73.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.099 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.9 tpp85 -65.83 -44.69 84.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.77 -42.21 95.27 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 71.6 t -61.48 -44.84 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.948 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.52 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -62.01 -45.02 95.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.933 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.22 -40.21 93.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.152 0.501 . . . . 0.0 110.668 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -71.11 -47.05 60.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.29 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 97' ' ' ALA . 6.7 p -70.23 -29.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.476 ' CZ ' HD13 ' B' ' 209' ' ' LEU . 0.5 OUTLIER -59.14 -52.01 67.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.088 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.91 -42.01 95.13 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.629 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.98 -49.78 76.07 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.35 -46.24 84.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.572 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.472 ' HA ' HD13 ' A' ' 105' ' ' LEU . 1.6 mm? -64.12 -39.26 93.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.048 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.31 -39.73 71.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.65 91.37 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.867 0.365 . . . . 0.0 110.259 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.36 -42.82 98.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.818 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.7 m -66.11 -44.22 84.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.031 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.458 HG23 HG21 ' A' ' 118' ' ' VAL . 51.6 t -60.35 -43.01 92.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 121.171 0.51 . . . . 0.0 109.833 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -65.56 -25.08 67.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.554 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -93.6 10.86 30.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.669 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 66.58 25.52 9.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.041 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.63 75.86 1.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.005 0.431 . . . . 0.0 110.213 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -76.14 -27.24 56.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.0 t -55.0 -50.57 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.424 HD21 ' HG3' ' A' ' 75' ' ' GLN . 57.3 tp -63.08 -44.25 96.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.334 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.458 HG21 HG23 ' A' ' 110' ' ' VAL . 87.3 t -57.43 -49.1 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.195 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.18 -42.03 87.26 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.555 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -69.33 -49.48 55.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.507 0.194 . . . . 0.0 110.648 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.44 HG11 HE22 ' A' ' 75' ' ' GLN . 77.2 t -57.83 -46.85 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.182 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -40.34 96.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.763 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.26 -38.91 91.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 0.0 110.437 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -66.6 -42.22 87.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.131 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 87.0 mtp -63.22 -48.6 77.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.438 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.67 -42.71 89.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.551 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.14 74.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.371 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -57.74 -41.46 81.92 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.367 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.519 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 79.3 mt -63.5 -31.78 73.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.615 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.28 9.96 42.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.638 0.256 . . . . 0.0 111.372 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.4 m -119.1 -80.15 0.61 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.448 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -81.67 -35.6 29.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.865 0.364 . . . . 0.0 111.659 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.593 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 35.4 mt -91.63 5.8 48.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.814 0.34 . . . . 0.0 110.978 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.18 81.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.854 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.98 -45.66 70.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.922 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.593 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 87.9 m95 -59.28 -51.69 68.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.411 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 133' ' ' LEU . 51.6 mm -61.58 -30.92 49.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.053 0.454 . . . . 0.0 111.011 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -72.3 -45.77 58.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.089 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.6 m -70.9 -30.12 66.38 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.554 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 67.5 m -89.31 1.93 55.07 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.11 41.05 96.38 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.441 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.99 -98.84 0.9 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -115.15 11.22 16.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -54.07 -51.05 65.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.778 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.652 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 3.2 pt-20 -85.65 -24.0 27.26 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.423 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -59.88 -42.22 93.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.228 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.473 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 1.2 p -72.68 -5.49 37.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.976 0.417 . . . . 0.0 111.258 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.85 -17.52 15.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.245 0.545 . . . . 0.0 110.323 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 41.3 mt -76.34 -57.14 4.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.945 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.473 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 4.8 p90 -74.59 -10.37 59.48 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.386 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.84 -22.74 78.87 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.818 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 0.0 110.271 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . 0.638 HG22 HG13 ' B' ' 202' ' ' ILE . 50.2 mt . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.419 0.152 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.638 HG13 HG22 ' B' ' 201' ' ' ILE . 29.0 mt -145.83 119.18 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.382 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -72.96 -34.58 66.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -57.4 -57.48 12.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.834 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' A' ' 70' ' ' THR . 33.2 mm -62.28 -39.22 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.437 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . 0.434 ' HA ' HG22 ' A' ' 81' ' ' VAL . . . -60.45 -46.89 88.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.997 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' ARG . . . . . 0.749 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 2.1 ttp-105 -58.91 -37.78 77.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.66 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' HIS . . . . . 0.508 ' O ' HG23 ' B' ' 212' ' ' VAL . 9.1 t-80 -58.68 -60.59 3.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.105 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.476 HD13 ' CZ ' ' A' ' 101' ' ' PHE . 0.8 OUTLIER -66.17 -41.88 89.69 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -60.75 -44.65 96.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.433 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -67.36 -35.08 78.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.371 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 208' ' ' HIS . 32.8 t -56.36 -54.61 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 123.084 0.24 . . . . 0.0 110.826 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.09 -44.94 43.29 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.244 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -61.39 -56.54 19.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.6 m -62.97 -34.19 77.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.352 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' MET . . . . . 0.695 ' HG2' ' HB2' ' A' ' 56' ' ' PHE . 4.0 tpt -65.85 -44.74 84.58 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.433 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . 0.52 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 30.1 t70 -61.65 -33.94 74.83 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.038 0.447 . . . . 0.0 110.071 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . 0.473 ' HD2' ' HZ3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.066 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.865 0.364 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -127.49 89.69 50.55 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.219 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.65 131.35 22.63 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.578 2.185 . . . . 0.0 111.714 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.04 152.62 21.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.13 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.0 m -83.34 116.11 22.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.337 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.731 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -69.24 -55.85 9.4 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.281 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.731 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 96.0 Cg_endo -92.57 146.78 2.73 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.133 1.889 . . . . 0.0 112.917 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 13.4 t70 -76.54 148.26 37.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.848 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.1 m -53.43 -35.63 60.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 2.4 mtm180 -63.11 -33.34 75.24 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.116 -0.233 . . . . 0.0 110.824 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.27 -37.6 85.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.028 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.38 -40.32 81.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.67 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 9' ' ' THR . 85.1 t -62.34 -43.14 97.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.559 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.17 -38.43 91.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.13 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.85 -38.75 86.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -67.51 -50.42 58.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.3 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.2 t -61.86 -44.47 98.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.831 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 22' ' ' ARG . . . -62.93 -40.41 99.25 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.45 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.427 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 2.6 t80 -62.85 -47.39 83.58 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.56 -37.46 81.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.969 0.414 . . . . 0.0 110.447 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.711 HD12 ' HE2' ' A' ' 24' ' ' LYS . 23.4 tp -67.72 -34.07 76.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 84.7 mtm-85 -80.14 -33.73 38.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.753 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 14.3 mm100 -60.14 -23.6 64.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.711 ' HE2' HD12 ' A' ' 21' ' ' LEU . 57.3 pttt -97.08 22.78 8.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.885 0.374 . . . . 0.0 111.037 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.04 -55.29 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.327 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.7 110.91 4.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.24 112.87 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.088 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.4 t -120.86 125.86 48.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.054 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.19 -130.15 4.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.47 179.62 8.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.652 0.263 . . . . 0.0 110.302 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.69 96.66 0.81 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.869 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.46 113.21 3.05 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.899 2.399 . . . . 0.0 112.324 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.22 -108.96 1.83 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.959 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.38 106.36 9.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.95 0.405 . . . . 0.0 110.537 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.11 79.44 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.59 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.54 122.35 10.69 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.146 2.564 . . . . 0.0 112.786 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.88 166.91 10.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.578 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.7 18.06 9.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.093 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -120.87 89.08 45.19 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -89.71 -7.27 4.77 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.491 2.127 . . . . 0.0 110.812 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.64 -53.2 36.59 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.121 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -62.66 -38.04 88.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.953 0.406 . . . . 0.0 110.498 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -67.59 -40.28 84.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.271 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.65 91.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.545 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 37.6 mtt -61.67 -41.62 97.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.228 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -62.27 -50.33 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.586 ' HB1' ' HG3' ' A' ' 51' ' ' GLU . . . -61.8 -37.22 83.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.845 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.23 -32.61 49.13 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.127 0.267 . . . . 0.0 111.719 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.4 35.56 3.57 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.683 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -151.26 -33.49 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.586 ' HG3' ' HB1' ' A' ' 47' ' ' ALA . 3.8 mm-40 -60.38 -72.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.489 ' HE2' HG21 ' A' ' 59' ' ' THR . 9.2 p90 -56.47 -36.66 69.34 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.517 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.12 -42.3 99.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.684 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.55 -20.05 63.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 -105.92 1.21 26.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.208 0.528 . . . . 0.0 110.554 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.441 ' CG ' ' HG2' ' B' ' 216' ' ' MET . 2.8 t80 -98.13 -85.58 0.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.571 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.406 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 5.2 ttm105 175.05 -71.12 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.63 61.29 0.32 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.107 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.489 HG21 ' HE2' ' A' ' 52' ' ' PHE . 0.4 OUTLIER -50.51 -33.55 21.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.038 -178.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -56.06 -23.73 35.35 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.405 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.6 m -121.39 -40.38 2.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.615 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.5 -49.87 73.63 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.9 tp -59.67 -34.15 72.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.11 0.481 . . . . 0.0 110.733 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.612 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -80.04 -18.45 50.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.97 -47.58 7.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.511 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.925 ' HG3' HD22 ' A' ' 67' ' ' LEU . 8.5 pt20 -65.02 -19.55 66.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.925 HD22 ' HG3' ' A' ' 66' ' ' GLN . 0.4 OUTLIER -109.84 13.84 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 0.0 110.612 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.612 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 9.0 t-160 -95.24 10.38 36.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.161 0.505 . . . . 0.0 110.705 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.6 t -78.88 -42.57 24.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.201 0.524 . . . . 0.0 110.139 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -86.48 132.41 42.92 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.002 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.84 109.21 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.063 2.509 . . . . 0.0 112.704 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.08 -146.84 21.71 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.633 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.68 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 20.1 m -151.17 -159.45 1.03 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.6 -157.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.796 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.476 ' OE1' ' HB2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -54.96 -31.04 60.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.442 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 26.1 mp0 -64.43 -10.94 28.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.444 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.68 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 19.0 tpp85 -109.61 -25.59 10.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.7 0.286 . . . . 0.0 110.885 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.532 ' O ' HG12 ' A' ' 81' ' ' VAL . 19.4 m-85 -65.55 -61.05 2.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.33 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.17 -20.89 64.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.283 0.563 . . . . 0.0 110.731 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 76' ' ' GLN . 1.1 tp60 -75.63 -24.97 56.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.199 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 78' ' ' PHE . 1.4 p -73.93 -24.56 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.217 0.532 . . . . 0.0 110.04 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.23 -39.64 39.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.663 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -71.95 -28.52 63.5 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.007 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' O ' ' HE3' ' B' ' 203' ' ' LYS . 4.6 tp10 -54.6 -47.61 73.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.688 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.612 ' HB3' ' HD3' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -82.1 -21.8 36.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.535 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.557 ' HB2' ' HA ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -62.9 -32.61 73.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.356 0.598 . . . . 0.0 109.43 179.049 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -64.1 -24.09 67.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.42 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.46 45.32 1.09 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.512 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.64 74.79 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.553 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.09 52.09 3.69 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.342 2.695 . . . . 0.0 112.012 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -71.85 163.36 27.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.618 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.793 ' HB3' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -53.37 -39.94 64.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.392 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.461 ' HA3' ' OD1' ' B' ' 214' ' ' ASP . . . -65.22 -24.77 70.73 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.616 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.612 ' HD3' ' HB3' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -75.09 -39.92 60.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.82 -42.61 94.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.295 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.44 -46.75 89.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.356 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.5 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -60.97 -41.98 97.46 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.278 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -62.68 -41.55 99.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.126 0.488 . . . . 0.0 110.646 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -71.49 -49.21 43.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.398 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 97' ' ' ALA . 9.9 p -64.13 -36.44 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -62.36 -49.73 74.38 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.939 0.4 . . . . 0.0 110.187 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.81 -47.08 78.7 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.017 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.34 87.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.87 81.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.755 0.312 . . . . 0.0 111.252 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.456 ' HG ' ' OE1' ' A' ' 75' ' ' GLN . 2.6 mm? -65.83 -40.84 92.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.02 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.435 ' O ' HG23 ' A' ' 110' ' ' VAL . 56.6 m -64.49 -46.93 80.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.549 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.89 77.7 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.069 0.461 . . . . 0.0 110.541 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.71 -46.21 66.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.194 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 m -62.95 -34.64 77.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.126 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 106' ' ' CYS . 40.0 t -63.17 -39.88 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.001 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -73.46 -28.22 61.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.228 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -85.6 9.33 16.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.757 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 54.49 48.93 19.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.569 0.7 . . . . 0.0 110.334 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.18 53.89 1.28 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.316 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -60.45 -28.32 68.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.745 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.6 t -56.49 -45.48 82.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.391 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.496 ' O ' HG23 ' A' ' 121' ' ' VAL . 37.9 tp -71.97 -41.9 67.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.386 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.18 -46.61 77.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.564 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.79 -35.65 90.37 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.036 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -69.7 -44.89 69.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 110.237 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 117' ' ' LEU . 57.6 t -61.27 -48.4 89.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.826 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.33 -41.34 98.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.579 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -59.62 -45.39 92.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.252 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -66.54 -40.99 89.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.833 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 85.7 mtp -60.16 -51.4 69.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.744 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.39 -45.26 93.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.414 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.57 81.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -61.86 -43.26 99.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.161 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 58.4 mt -64.3 -28.51 69.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.854 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -101.91 8.04 41.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.2 m -121.53 -70.19 0.8 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.412 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.4 ttt85 -85.76 -38.32 18.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.833 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 77.9 mt -95.02 11.8 30.74 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.49 -52.64 64.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.798 0.332 . . . . 0.0 111.262 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.37 -39.31 92.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.833 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 84.0 m95 -62.95 -48.78 77.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 133' ' ' LEU . 44.1 mm -61.57 -37.45 77.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.043 0.449 . . . . 0.0 109.817 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -66.5 -32.12 73.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 m -78.01 -37.62 46.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.046 0.451 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 144' ' ' ALA . 29.8 m -81.5 -6.99 59.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.143 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.18 41.45 98.35 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.67 -100.97 1.99 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -120.78 13.6 11.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 140' ' ' SER . . . -51.79 -65.41 0.56 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.243 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.506 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 7.5 pt-20 -67.0 -23.52 65.94 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.234 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.476 ' HA ' HD12 ' A' ' 149' ' ' LEU . 59.0 t80 -61.92 -35.31 78.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.675 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -60.4 -30.63 69.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.131 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.41 -12.06 35.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.793 HD13 ' HB3' ' A' ' 92' ' ' TRP . 87.6 mt -80.54 -35.95 33.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.293 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.675 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 9.2 p90 -98.73 16.64 21.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.019 0.437 . . . . 0.0 111.056 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.22 -47.15 90.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.769 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -119.05 -172.59 2.33 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -148.86 -33.99 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.094 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.471 ' HA ' ' OG ' ' B' ' 219' ' ' SER . . . -95.51 -14.21 23.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.987 0.422 . . . . 0.0 110.901 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 54.7 tp -80.62 102.16 9.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.788 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.1 130.22 3.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.74 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -129.2 38.86 3.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.069 0.461 . . . . 0.0 110.465 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -101.91 -53.89 2.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.181 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.54 HH12 ' HA ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -146.37 8.58 1.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.166 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 52.2 ttp85 -54.69 142.2 29.39 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 23.5 tp -53.02 128.51 27.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.233 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.533 ' HG3' ' HB3' ' A' ' 166' ' ' TRP . 1.3 mpt_? -89.0 104.37 16.92 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.36 168.05 20.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.874 0.369 . . . . 0.0 111.702 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 59.03 -107.17 1.09 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.336 -0.847 . . . . 0.0 113.805 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -58.4 -46.85 85.6 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.842 0.457 . . . . 0.0 111.793 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.533 ' HB3' ' HG3' ' A' ' 162' ' ' ARG . 30.3 m95 -67.46 -83.03 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.937 0.399 . . . . 0.0 111.805 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -109.27 105.26 14.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.375 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.07 -34.22 14.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.289 0.566 . . . . 0.0 110.146 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 m -108.59 146.77 13.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.632 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.717 -179.483 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 37.6 mt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.863 0.363 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' B' ' 205' ' ' ILE . 1.8 pt -143.88 75.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.561 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 84' ' ' GLU . 20.1 mttp -65.1 -33.2 75.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -61.38 -42.58 98.94 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . 0.539 HD12 HD12 ' A' ' 67' ' ' LEU . 8.4 mm -69.07 -42.56 81.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.091 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -62.55 -37.94 88.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.354 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -66.33 -34.57 78.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.325 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' HIS . . . . . 0.578 ' HB3' HD11 ' A' ' 67' ' ' LEU . 6.1 t-80 -60.08 -56.55 20.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.435 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.1 pp -63.44 -33.43 75.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.811 0.339 . . . . 0.0 110.293 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.57 -59.37 4.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.791 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -63.6 -43.0 98.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.66 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.532 HG11 HE22 ' A' ' 66' ' ' GLN . 53.5 t -63.66 -43.19 98.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.709 0.29 . . . . 0.0 110.678 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.89 -44.22 80.07 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.095 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.461 ' OD1' ' HA3' ' A' ' 93' ' ' GLY . 60.0 m-20 -60.13 -46.1 90.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.93 0.395 . . . . 0.0 111.315 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 12.6 p -70.02 -46.82 64.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.934 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' MET . . . . . 0.63 ' HA ' ' HB ' ' B' ' 220' ' ' ILE . 11.4 tpp -62.82 -43.73 98.01 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' B' ' 219' ' ' SER . 11.8 t70 -60.15 -54.72 42.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.631 0.253 . . . . 0.0 110.912 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -77.07 31.6 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.449 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 154' ' ' ALA . 14.5 m 67.59 92.93 0.08 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.099 0.559 . . . . 0.0 110.741 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.63 ' HB ' ' HA ' ' B' ' 216' ' ' MET . 16.6 tt . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.04 -0.981 . . . . 0.0 111.291 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.804 0.335 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -114.26 126.26 28.22 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.475 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.45 110.11 2.61 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.567 2.178 . . . . 0.0 112.123 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.89 117.3 11.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.8 m -66.34 121.58 15.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.234 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.579 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -82.76 -51.52 0.7 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.16 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 17.1 Cg_exo -67.8 141.5 54.44 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.068 1.845 . . . . 0.0 112.67 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 16.0 t70 -85.95 154.6 21.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.266 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.8 m -54.65 -42.72 71.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.917 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.418 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -66.21 -35.05 79.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.418 0.151 . . . . 0.0 111.1 -179.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.27 -37.68 86.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.947 0.404 . . . . 0.0 110.552 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 41' ' ' LEU . 6.3 tp -68.27 -44.38 75.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.916 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 9' ' ' THR . 87.7 t -62.92 -44.81 99.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.389 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.64 71.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.831 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.22 -44.08 84.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.89 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -63.54 -47.64 80.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.131 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.8 t -59.77 -46.25 93.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.274 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 22' ' ' ARG . . . -62.75 -44.81 96.93 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.598 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.483 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 10.8 t80 -58.54 -49.6 76.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.38 . . . . 0.0 110.503 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -62.09 -36.21 81.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.408 HD12 ' HE2' ' A' ' 24' ' ' LYS . 7.6 tp -67.81 -26.67 66.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.59 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 87.1 mtm-85 -90.8 -32.43 16.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.461 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.531 HE22 HG13 ' A' ' 27' ' ' VAL . 15.7 mm100 -63.01 -27.14 69.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 0.0 111.38 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.408 ' HE2' HD12 ' A' ' 21' ' ' LEU . 36.8 pttt -88.61 17.91 5.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.132 0.492 . . . . 0.0 110.766 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.86 -74.8 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -127.58 101.35 6.37 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.531 HG13 HE22 ' A' ' 23' ' ' GLN . 59.1 t -62.06 121.95 11.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.809 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.2 t -143.23 139.21 30.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.768 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.59 -138.96 9.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.067 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.97 145.22 26.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.649 0.261 . . . . 0.0 110.473 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.59 103.99 2.23 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.272 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.83 128.15 14.68 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.78 2.32 . . . . 0.0 111.441 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.68 -55.99 0.2 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.257 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -125.09 24.94 7.38 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.173 0.511 . . . . 0.0 110.201 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.62 104.51 2.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.166 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.08 126.61 13.98 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.894 2.396 . . . . 0.0 111.802 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.51 154.69 20.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.346 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.38 -31.43 63.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.905 0.383 . . . . 0.0 110.65 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -104.3 130.26 23.63 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.135 0.493 . . . . 0.0 110.548 179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 39' ' ' ASP . 84.7 Cg_endo -98.18 1.33 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.941 2.427 . . . . 0.0 111.081 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.455 ' HB3' HD21 ' A' ' 12' ' ' LEU . 47.2 mt -64.58 -47.22 79.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.821 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -58.85 -37.56 76.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.946 0.403 . . . . 0.0 111.417 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -80.27 -38.03 31.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.943 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.75 97.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.989 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.58 ' HE2' ' HZ ' ' A' ' 99' ' ' PHE . 25.3 ttm -61.22 -40.33 93.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.46 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -71.39 -44.39 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.517 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.55 ' HB1' ' HG3' ' A' ' 51' ' ' GLU . . . -59.07 -43.65 91.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.211 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.44 -21.11 34.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.555 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -125.51 26.11 5.52 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.013 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -146.37 -46.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.813 -0.228 . . . . 0.0 111.601 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.62 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 14.9 mm-40 -58.58 -55.36 36.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.829 0.347 . . . . 0.0 111.309 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.555 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 2.3 p90 -66.82 -28.74 68.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.121 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -71.55 -44.57 64.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.349 . . . . 0.0 110.407 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -71.99 -8.14 52.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.626 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.62 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 82.8 mtm-85 -109.6 5.05 22.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.296 0.569 . . . . 0.0 110.164 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.853 ' HD1' ' HG2' ' B' ' 216' ' ' MET . 60.8 t80 -118.85 -85.82 0.65 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.707 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 175.71 -72.2 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.512 0.673 . . . . 0.0 109.275 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.68 ' HA ' ' HE ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -154.55 60.67 0.68 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.27 179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.57 HG22 HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -57.72 -32.04 67.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.909 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -58.16 -36.02 72.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.119 0.485 . . . . 0.0 110.372 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.91 -36.35 12.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.828 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.57 -40.25 86.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.584 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.57 HD13 HG22 ' A' ' 59' ' ' THR . 1.4 mp -63.84 -30.64 71.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.076 0.465 . . . . 0.0 110.861 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.98 -28.15 35.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.236 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.02 -49.28 65.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.849 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -67.4 -23.92 65.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.835 0.35 . . . . 0.0 110.516 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -85.01 -1.78 57.21 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.126 0.489 . . . . 0.0 110.108 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -104.22 -42.48 5.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.916 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.35 -50.46 78.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.48 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -87.25 142.46 33.5 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.816 178.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.48 ' HD2' HG22 ' A' ' 70' ' ' THR . 52.4 Cg_exo -53.45 106.35 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.799 2.332 . . . . 0.0 112.825 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.59 -169.84 22.72 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.738 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.823 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 61.3 m -146.8 -157.22 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.24 -167.32 0.31 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.93 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.462 ' HG3' HD21 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -50.74 -38.83 49.96 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.447 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -57.56 -31.01 65.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.627 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.823 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 11.8 tpp85 -72.62 -29.0 63.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.946 0.403 . . . . 0.0 110.177 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.591 ' O ' HG12 ' A' ' 81' ' ' VAL . 73.8 m-85 -73.97 -46.59 43.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -34.9 76.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.275 0.56 . . . . 0.0 110.698 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -68.88 -35.62 77.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.069 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 78' ' ' PHE . 0.8 OUTLIER -69.58 -25.33 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.678 0.275 . . . . 0.0 111.303 -179.131 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.26 -47.17 24.76 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.98 -30.19 70.71 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.072 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.404 ' HG3' ' HD3' ' B' ' 203' ' ' LYS . 3.8 tp10 -50.67 -48.13 58.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.741 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.6 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -97.48 -6.23 34.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.1 -179.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -40.72 62.97 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -66.27 -29.52 69.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.93 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.72 -26.53 71.2 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.192 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.06 107.91 0.22 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.153 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.26 59.4 6.0 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.867 2.378 . . . . 0.0 111.673 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -70.48 176.69 3.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.439 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.67 ' HB3' HD13 ' A' ' 149' ' ' LEU . 1.9 m-90 -53.0 -57.31 10.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.57 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.8 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -70.22 -12.15 68.56 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.826 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -39.81 93.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.094 0.447 . . . . 0.0 110.049 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.7 tp -71.71 -36.54 70.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.897 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.468 HG22 ' HE1' ' A' ' 146' ' ' PHE . 41.9 t -61.95 -50.28 80.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.407 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.54 -42.62 99.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.165 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -64.44 -42.45 95.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.09 0.472 . . . . 0.0 110.929 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.58 ' HZ ' ' HE2' ' A' ' 45' ' ' MET . 33.9 t80 -68.18 -48.47 65.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.288 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.478 HG21 ' CZ ' ' A' ' 52' ' ' PHE . 9.1 p -65.4 -33.25 62.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.122 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.739 ' HE2' HD13 ' B' ' 209' ' ' LEU . 0.2 OUTLIER -61.9 -51.28 68.82 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.66 -44.96 96.77 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.783 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.46 81.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.604 0.24 . . . . 0.0 111.351 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.61 -45.77 88.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.659 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.424 ' HA ' HD13 ' A' ' 105' ' ' LEU . 2.8 mm? -68.07 -38.7 82.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.065 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.454 ' O ' HG23 ' A' ' 110' ' ' VAL . 19.7 m -65.78 -47.6 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.0 -42.07 89.21 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.984 0.421 . . . . 0.0 110.547 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -60.29 -39.83 88.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.949 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.491 ' HB3' ' HB3' ' A' ' 114' ' ' MET . 14.1 m -74.73 -39.66 61.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.892 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 106' ' ' CYS . 50.8 t -59.03 -47.38 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.855 0.36 . . . . 0.0 110.601 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -65.17 -27.23 68.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.54 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -90.21 9.94 26.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.875 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 60.74 33.07 20.25 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.993 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.51 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -104.51 61.84 0.72 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.955 0.407 . . . . 0.0 110.172 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -63.61 -29.83 71.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.145 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.28 -45.77 92.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.102 0.477 . . . . 0.0 110.556 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.472 ' HB2' ' SD ' ' A' ' 114' ' ' MET . 15.7 tp -69.82 -39.65 76.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.468 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 114' ' ' MET . 67.0 t -59.52 -45.55 93.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.869 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.2 -41.07 99.38 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.323 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -64.5 -46.26 83.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.796 0.331 . . . . 0.0 110.725 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 117' ' ' LEU . 99.8 t -64.25 -46.03 94.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.764 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -45.05 96.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 110.681 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.21 -45.62 92.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.622 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -63.09 -43.49 98.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.113 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 95.1 mtp -57.85 -50.02 74.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.893 0.378 . . . . 0.0 110.655 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.77 -41.23 91.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.877 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.12 -46.14 91.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.578 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -59.58 -43.1 93.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.165 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.648 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 53.8 mt -63.88 -36.12 82.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -90.16 4.92 49.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 m -124.41 -77.1 0.59 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.75 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -75.07 -23.42 58.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.648 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 81.0 mt -109.88 14.32 23.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.348 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.4 -44.14 84.28 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.29 -39.42 48.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.822 0.344 . . . . 0.0 110.749 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.574 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 95.9 m95 -60.62 -50.54 73.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.27 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.75 -37.33 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 0.0 110.322 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -67.75 -36.08 79.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.742 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.7 m -71.68 -40.51 69.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.983 0.42 . . . . 0.0 110.704 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.408 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 68.9 m -78.61 -6.13 54.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.138 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.39 40.83 98.13 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.33 -111.35 3.27 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -109.36 14.93 23.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.05 -62.28 1.94 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.318 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.408 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 5.8 pt-20 -70.86 -20.15 62.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.725 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.468 ' HE1' HG22 ' A' ' 96' ' ' VAL . 75.5 t80 -60.6 -38.39 84.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.821 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -27.39 69.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.485 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.85 -13.83 38.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.748 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.67 HD13 ' HB3' ' A' ' 92' ' ' TRP . 56.6 mt -68.31 -35.3 77.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.918 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -110.22 20.33 17.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 0.0 110.223 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -75.64 -19.79 78.86 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.817 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -97.37 140.88 31.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.81 -57.79 1.38 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.232 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.519 ' HA ' ' H ' ' B' ' 220' ' ' ILE . . . -132.5 138.61 47.61 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.23 -20.34 0.78 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.254 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.86 -169.25 1.63 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -136.03 -40.14 0.68 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.756 0.312 . . . . 0.0 110.368 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -77.18 -29.27 54.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.424 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.418 ' NH1' HD12 ' B' ' 220' ' ' ILE . 26.7 mtm105 -80.81 -18.12 48.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.427 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.592 ' HG2' HG23 ' B' ' 220' ' ' ILE . 17.4 mtm180 -64.24 163.92 11.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 111.292 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.778 ' HG ' ' HA ' ' A' ' 168' ' ' SER . 4.5 mp -81.2 145.66 30.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.193 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.79 -15.61 14.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.448 0.642 . . . . 0.0 109.723 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.68 -47.13 2.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.173 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' A' ' 161' ' ' LEU . . . 95.47 26.6 11.77 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.955 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -78.04 -66.11 0.89 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.238 0.542 . . . . 0.0 110.144 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -165.12 -58.9 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.34 114.22 3.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.075 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.778 ' HA ' ' HG ' ' A' ' 161' ' ' LEU . 3.5 m -87.12 -37.91 16.94 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.341 0.591 . . . . 0.0 109.743 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.437 HG21 ' HE2' ' B' ' 216' ' ' MET . 18.2 m -111.74 164.42 7.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.663 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.353 -179.901 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 121.345 0.593 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 8.2 mt -132.8 86.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.889 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.404 ' HD3' ' HG3' ' A' ' 84' ' ' GLU . 64.9 mmtt -64.75 -33.79 76.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.357 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -53.21 -55.26 25.72 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 66.2 mt -65.68 -47.43 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.362 . . . . 0.0 110.956 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 85' ' ' LEU . . . -56.85 -45.3 82.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.524 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' ARG . . . . . 0.6 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 18.3 ttp-105 -62.04 -36.86 82.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' HIS . . . . . 0.41 ' O ' HG22 ' B' ' 212' ' ' VAL . 38.4 t-80 -60.9 -56.1 25.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.304 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.739 HD13 ' HE2' ' A' ' 101' ' ' PHE . 1.5 pp -65.74 -34.85 79.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.487 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -69.88 -43.01 72.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.092 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' B' ' 207' ' ' ARG . 0.7 OUTLIER -65.34 -49.06 70.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.798 -178.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' B' ' 216' ' ' MET . 26.0 m -62.99 -44.27 99.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.409 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.44 -38.62 87.04 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.394 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.8 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 4.0 t0 -67.01 -50.52 61.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.835 0.35 . . . . 0.0 111.335 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 2.7 m -69.72 -49.01 57.33 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' MET . . . . . 0.853 ' HG2' ' HD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -60.18 -37.82 81.37 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.27 -34.05 61.3 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.442 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER -75.22 73.33 2.33 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.278 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 7.8 m 65.93 178.13 0.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.563 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.592 HG23 ' HG2' ' A' ' 160' ' ' ARG . 7.1 tp . . . . . 0 C--N 1.316 -0.889 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.764 0.316 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 m -87.32 113.05 52.11 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.738 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.28 132.59 19.61 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.358 2.039 . . . . 0.0 112.009 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.96 139.52 32.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.118 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.53 116.91 25.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.108 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.77 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -86.24 -60.03 0.28 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.487 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 23.1 Cg_exo -65.7 138.6 54.51 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.057 1.838 . . . . 0.0 112.122 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.14 156.93 28.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.9 m -58.11 -41.13 82.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.946 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -69.95 -27.44 64.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 110.566 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.24 75.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.467 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.43 -40.27 77.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.682 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t -63.13 -47.03 94.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.968 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.95 -38.43 82.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.031 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.94 -43.23 83.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.545 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -65.06 -48.59 73.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -62.43 -45.23 99.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.342 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.75 -41.03 99.56 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.517 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -61.84 -43.09 99.55 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 21.5 mmmt -59.93 -45.26 93.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.049 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.445 HD12 ' HE3' ' A' ' 24' ' ' LYS . 55.2 tp -65.95 -40.45 91.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.706 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 84.6 mtm-85 -73.37 -30.13 63.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.829 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -64.46 -30.17 71.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HE3' HD12 ' A' ' 21' ' ' LEU . 10.0 pttp -92.88 -0.19 57.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.913 0.387 . . . . 0.0 110.938 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.5 -60.36 0.32 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.112 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -154.14 105.26 2.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.97 113.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.162 0.506 . . . . 0.0 110.712 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.8 t -127.79 127.34 43.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.043 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.01 -135.69 5.24 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.844 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.19 158.57 43.89 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.22 111.8 4.03 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.88 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.68 76.14 4.69 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.037 2.492 . . . . 0.0 111.99 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.22 -84.81 0.79 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.569 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -119.18 127.94 53.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.022 0.439 . . . . 0.0 110.115 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.29 91.7 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.441 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.75 110.5 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.83 2.353 . . . . 0.0 112.064 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.2 150.46 21.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.857 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.469 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -70.4 -26.27 63.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.846 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -101.51 104.8 36.51 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.421 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 74.4 Cg_endo -92.29 -3.41 3.84 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.801 2.334 . . . . 0.0 111.566 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.66 -41.33 96.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.731 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -59.62 -38.86 82.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.865 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -80.71 -37.28 30.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.94 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.69 98.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.897 0.38 . . . . 0.0 110.378 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.1 ttt -62.8 -39.65 94.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.856 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -65.96 -48.85 69.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.642 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.16 79.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.62 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.25 62.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.824 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.99 19.49 13.66 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.255 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -132.46 -47.67 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.622 0.249 . . . . 0.0 111.404 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.53 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 6.2 mm-40 -62.46 -30.54 71.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.626 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.574 ' O ' ' HB2' ' A' ' 56' ' ' PHE . 67.0 t80 -59.57 -32.34 70.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.033 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 59' ' ' THR . 4.6 tp10 -87.14 -26.74 23.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.815 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.9 m -54.27 -47.96 71.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.099 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.53 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 23.1 mtm-85 -102.02 12.4 36.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.846 0.355 . . . . 0.0 111.562 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.574 ' HB2' ' O ' ' A' ' 52' ' ' PHE . 3.2 t80 -97.77 -96.74 0.21 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 56' ' ' PHE . 42.4 ttm180 170.48 -68.43 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.8 ' HA ' ' HE ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -154.21 79.36 1.11 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.126 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.458 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 61.6 m -57.17 -44.61 83.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.745 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -74.31 1.14 12.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.856 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . 4.8 m -124.04 -54.93 1.7 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -79.27 -57.23 3.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 66' ' ' GLN . 14.6 tp -58.78 -42.86 90.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.018 0.437 . . . . 0.0 110.904 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.51 -17.5 64.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.664 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.15 -46.73 6.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.519 0.2 . . . . 0.0 111.212 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.509 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 8.4 pt20 -64.06 -33.55 76.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.394 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.476 ' HA ' HD13 ' A' ' 67' ' ' LEU . 2.0 mm? -82.49 -11.21 58.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.063 0.459 . . . . 0.0 110.329 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -91.46 -11.83 36.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.798 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.3 t -66.17 -41.81 90.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -74.44 127.32 87.74 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.62 105.7 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.777 2.318 . . . . 0.0 112.098 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.81 -128.09 3.29 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.146 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.706 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 2.9 m -156.78 -148.3 0.21 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.99 -156.62 0.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.504 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -51.38 -35.06 37.04 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.34 0.4 . . . . 0.0 111.914 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -55.55 -42.96 75.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.11 0.481 . . . . 0.0 110.365 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.706 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 11.1 tpp180 -68.01 -43.0 79.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.393 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.507 ' O ' HG12 ' A' ' 81' ' ' VAL . 48.3 m-85 -62.67 -37.06 84.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.985 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.2 m -65.9 -49.92 66.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.609 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -70.22 -33.78 72.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.273 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.528 ' HA ' HD13 ' B' ' 202' ' ' ILE . 1.4 p -67.06 -31.57 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 0.0 110.498 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.9 m -77.32 -44.05 30.93 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.67 -35.98 79.52 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.613 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -53.7 -60.34 3.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.805 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.629 ' HB2' ' HB1' ' B' ' 206' ' ' ALA . 0.2 OUTLIER -78.67 -16.25 57.53 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.517 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -65.63 -34.73 78.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -90.71 11.2 23.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.202 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.6 25.64 5.02 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.83 83.56 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -83.86 59.24 6.11 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.759 2.306 . . . . 0.0 112.227 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.514 ' HB3' ' OD2' ' B' ' 214' ' ' ASP . 60.2 t30 -76.32 171.8 13.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.818 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.688 ' CD1' HD22 ' A' ' 149' ' ' LEU . 2.4 m0 -52.61 -49.48 64.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.767 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.765 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -65.47 -33.15 85.63 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.465 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -42.67 99.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.663 0.268 . . . . 0.0 110.597 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.404 HD23 ' HD1' ' A' ' 146' ' ' PHE . 29.3 tp -64.32 -42.49 96.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.325 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.76 -47.28 86.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.357 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.644 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -62.21 -40.43 96.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.37 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -59.59 -39.17 83.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.746 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -76.69 -48.83 17.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.193 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 97' ' ' ALA . 7.2 p -63.18 -32.04 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.526 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -60.77 -54.57 43.64 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.987 0.423 . . . . 0.0 110.46 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.03 -43.3 99.05 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.949 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.93 99.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.617 0.246 . . . . 0.0 111.185 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.21 -43.77 97.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.268 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 105' ' ' LEU . 2.1 mm? -68.78 -39.62 80.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.8 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.417 ' O ' HG23 ' A' ' 110' ' ' VAL . 50.4 m -66.12 -46.13 78.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.309 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.5 87.38 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.94 0.4 . . . . 0.0 110.515 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -45.29 91.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.268 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.6 m -65.81 -38.43 88.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.967 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 106' ' ' CYS . 49.9 t -63.16 -41.31 92.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.045 0.45 . . . . 0.0 109.807 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -70.3 -9.56 56.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.369 0.605 . . . . 0.0 110.533 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -105.21 6.4 32.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.008 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 62.66 32.47 16.24 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.198 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.444 ' SD ' ' HB ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -106.57 64.07 0.65 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.646 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -65.56 -21.99 66.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.818 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.444 ' HB ' ' SD ' ' A' ' 114' ' ' MET . 97.4 t -58.83 -56.36 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.758 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 121' ' ' VAL . 28.7 tp -66.95 -37.47 84.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.681 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.5 t -59.28 -48.48 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.44 -38.62 93.76 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.14 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -68.43 -50.45 52.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.747 0.308 . . . . 0.0 110.506 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 117' ' ' LEU . 71.9 t -58.24 -44.02 87.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.107 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -45.59 86.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.245 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.82 -45.16 87.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.729 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -55.91 -44.6 78.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.999 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 89.9 mtp -67.69 -50.08 59.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.392 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.14 -47.05 93.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.262 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.98 93.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.05 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -62.11 -38.48 89.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.874 0.368 . . . . 0.0 110.612 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.829 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 35.7 mt -66.92 -20.93 65.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.282 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.54 -13.72 15.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.3 m -94.96 -64.04 1.11 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -101.81 -32.12 10.42 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.829 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 73.4 mt -90.65 13.19 16.7 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.29 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.23 -53.55 53.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 110.598 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -63.94 -37.23 86.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.589 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.456 ' CD1' ' HA ' ' A' ' 133' ' ' LEU . 91.3 m95 -60.21 -56.5 20.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.681 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.659 HG23 ' HA2' ' A' ' 142' ' ' GLY . 45.9 mm -60.03 -36.14 65.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.009 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -63.61 -48.23 78.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.655 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.5 m -70.74 -32.2 69.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.584 0.23 . . . . 0.0 111.616 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.4 m -82.67 -6.41 59.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.796 0.331 . . . . 0.0 111.074 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.08 41.17 95.22 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.98 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.659 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 73.44 -103.2 1.38 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -118.37 16.08 13.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.59 -51.93 65.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.938 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -83.33 -15.96 48.02 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.625 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 89.0 t80 -61.7 -44.02 97.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.78 0.324 . . . . 0.0 110.5 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -24.67 66.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.129 0.49 . . . . 0.0 110.773 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.86 25.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.375 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.688 HD22 ' CD1' ' A' ' 92' ' ' TRP . 32.4 mt -61.39 -50.55 72.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 110.871 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -90.69 9.24 30.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.638 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.21 -10.61 84.55 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -136.27 159.12 42.71 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.93 93.79 1.27 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.398 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -140.0 20.64 2.46 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.565 0.221 . . . . 0.0 111.223 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.1 tt -159.21 121.88 3.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.771 0.32 . . . . 0.0 111.159 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -124.59 117.93 25.41 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -59.84 -36.87 77.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.709 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -77.21 20.02 0.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -149.14 -34.07 0.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.475 0.179 . . . . 0.0 111.404 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 17.1 mmm180 -58.28 -65.59 0.62 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.777 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 82.8 mt -98.37 -11.46 22.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.931 0.396 . . . . 0.0 111.114 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -113.26 95.23 5.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.063 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.46 -72.83 0.67 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.978 0.418 . . . . 0.0 110.16 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 177.52 -54.92 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.287 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -173.37 -29.2 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -75.31 -73.04 0.27 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -120.65 90.2 3.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.976 0.417 . . . . 0.0 110.8 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.9 m -82.43 -12.34 57.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.38 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.5 m -116.31 41.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.2 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 170' ' ' ARG . 10.2 ptp180 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.651 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . 0.443 HG22 HG13 ' B' ' 202' ' ' ILE . 43.3 mt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.979 0.418 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' A' ' 81' ' ' VAL . 0.8 OUTLIER -150.46 49.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.905 179.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' B' ' 207' ' ' ARG . 42.2 mttp -57.15 -33.71 67.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.632 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -59.78 -50.71 72.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 23.0 mt -70.35 -39.95 77.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.94 0.4 . . . . 0.0 110.026 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . 0.629 ' HB1' ' HB2' ' A' ' 85' ' ' LEU . . . -60.18 -46.09 90.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.215 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' B' ' 203' ' ' LYS . 0.4 OUTLIER -62.25 -36.81 83.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.489 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -58.75 -55.7 31.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.266 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.5 pp -68.76 -36.43 78.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 111.098 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.49 -51.95 63.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.756 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -59.76 -45.5 92.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.595 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' B' ' 216' ' ' MET . 85.4 t -62.75 -55.17 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.604 0.24 . . . . 0.0 111.229 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.71 -45.63 87.99 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 121.182 -0.532 . . . . 0.0 114.385 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.765 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 11.0 t70 -56.06 -47.29 78.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.94 0.4 . . . . 0.0 111.576 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.7 m -75.48 -41.16 56.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.257 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' B' ' 212' ' ' VAL . 5.0 tpt -54.46 -50.01 68.71 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.6 -34.48 74.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.865 0.364 . . . . 0.0 111.402 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . 0.521 HH21 ' HA2' ' A' ' 93' ' ' GLY . 0.1 OUTLIER -76.94 105.14 7.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.352 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 51.0 m 67.12 -177.6 0.2 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.261 0.553 . . . . 0.0 112.337 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.456 ' HB ' ' HG2' ' A' ' 55' ' ' ARG . 17.8 tt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.317 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.76 0.314 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -134.46 102.18 11.77 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.221 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.4 114.21 3.39 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.565 2.177 . . . . 0.0 112.147 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.65 118.48 16.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.504 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -83.27 108.93 16.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.351 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -83.96 -52.14 0.58 Allowed Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.021 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 23.8 Cg_exo -65.05 129.17 22.36 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.941 1.761 . . . . 0.0 112.345 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -78.76 154.36 30.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.227 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -55.82 -38.92 70.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.215 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -69.95 -34.07 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.81 0.338 . . . . 0.0 110.645 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.23 -33.48 76.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.159 0.505 . . . . 0.0 109.878 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.2 tp -70.95 -40.53 71.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.815 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 9' ' ' THR . 87.9 t -62.67 -45.99 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.286 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.04 -36.35 74.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.093 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.68 -51.6 66.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.458 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -63.01 -44.19 96.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.098 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.8 t -61.53 -47.59 92.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 120.846 0.355 . . . . 0.0 110.274 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.31 -36.41 92.71 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.509 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.536 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 30.2 t80 -64.65 -49.64 70.19 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -57.94 -40.28 80.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.238 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.561 HD13 HG12 ' A' ' 110' ' ' VAL . 36.1 tp -65.91 -33.12 75.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.787 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -81.83 -22.24 37.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.498 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 15.6 mm100 -61.68 -26.4 68.0 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -94.95 3.28 55.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.668 0.271 . . . . 0.0 111.394 -179.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -126.91 -60.29 0.14 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.564 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -157.03 104.36 2.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.4 t -65.76 120.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.517 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.2 t -128.79 99.3 5.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.219 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.98 -134.22 1.73 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.894 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.92 174.05 10.89 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.15 83.56 0.35 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.4 99.09 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.824 2.35 . . . . 0.0 111.96 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.64 -52.15 0.82 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.539 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -137.49 91.07 2.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.044 0.45 . . . . 0.0 110.325 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.75 105.32 0.24 Allowed Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.702 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.1 111.95 1.01 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.783 2.322 . . . . 0.0 111.821 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.38 139.96 39.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.431 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.72 -35.26 67.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.527 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 41' ' ' LEU . 4.4 t70 -96.1 112.69 60.39 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.729 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -94.47 -1.5 2.8 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.684 2.256 . . . . 0.0 112.655 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.433 ' HB2' ' OD1' ' A' ' 39' ' ' ASP . 24.9 mt -64.31 -44.64 90.97 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -62.22 -32.19 72.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.386 . . . . 0.0 110.818 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -79.79 -44.17 21.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.129 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.66 ' HB1' ' HE2' ' A' ' 146' ' ' PHE . . . -61.89 -42.96 99.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.743 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.567 ' HG3' ' HE2' ' A' ' 99' ' ' PHE . 13.8 ttt -61.57 -36.64 81.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.247 0.546 . . . . 0.0 110.202 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -73.67 -42.4 61.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.313 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.9 90.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.627 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -55.11 -25.79 33.89 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.86 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.434 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -123.76 39.85 2.09 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.227 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -162.82 -42.59 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.577 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 23.4 mm-40 -54.3 -60.33 3.48 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.434 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 11.5 p90 -57.46 -27.81 62.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.584 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 4.6 tp10 -72.9 -46.43 52.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.754 0.312 . . . . 0.0 110.947 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 m -64.95 -24.32 67.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.109 0.48 . . . . 0.0 110.738 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.577 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 9.6 mtm-85 -87.28 -25.18 24.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.202 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -97.52 -92.27 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.994 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 179.92 -64.23 0.01 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.921 0.391 . . . . 0.0 110.418 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.837 ' HA ' ' HE ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -148.26 54.7 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.209 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.38 -30.41 71.55 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -59.74 -39.04 83.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.937 0.399 . . . . 0.0 110.287 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.424 ' OG ' ' HD3' ' A' ' 58' ' ' ARG . 1.6 m -86.59 -38.42 17.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.389 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 24.0 t70 -60.66 -41.53 95.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.0 tp -59.56 -39.86 85.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.408 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.22 -43.37 61.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.026 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.52 85.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.74 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 10.9 pt20 -66.3 -34.11 77.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 0.0 110.677 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.31 -24.87 63.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.091 0.472 . . . . 0.0 110.366 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -79.66 -13.22 59.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.554 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.4 t -76.25 -29.74 19.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 p -94.03 161.08 30.87 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.366 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.98 70.04 2.98 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.0 2.467 . . . . 0.0 112.034 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.84 -163.79 30.5 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.58 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -152.57 -132.06 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -99.69 -159.08 0.72 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.608 0.242 . . . . 0.0 110.886 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -51.32 -43.39 61.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.279 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -54.49 -44.52 72.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 0.0 111.192 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -71.76 -37.74 70.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.613 ' O ' HG12 ' A' ' 81' ' ' VAL . 15.5 m-85 -65.54 -45.95 81.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.593 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 m -69.38 -38.45 78.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.893 0.378 . . . . 0.0 110.854 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HA ' ' OD1' ' A' ' 83' ' ' ASP . 5.9 tp60 -65.92 -32.22 73.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.682 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 78' ' ' PHE . 1.9 p -75.37 -11.67 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.083 0.468 . . . . 0.0 110.982 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.0 m -86.95 -45.92 10.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.195 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.53 ' OD1' ' HA ' ' A' ' 80' ' ' GLN . 5.1 p-10 -80.7 -12.59 59.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.245 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.99 -41.56 96.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.919 0.39 . . . . 0.0 110.975 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.606 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -97.73 -11.86 22.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.126 -179.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 95' ' ' LEU . 18.4 t80 -68.43 -25.65 65.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.902 0.382 . . . . 0.0 110.732 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -69.18 -9.72 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.657 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.97 -8.88 71.81 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.21 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.87 134.14 3.3 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.786 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.05 69.54 7.88 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.829 2.352 . . . . 0.0 111.945 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.623 ' HB3' ' HB2' ' A' ' 94' ' ' ARG . 21.5 t30 -68.87 171.86 7.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.849 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.613 ' HH2' ' HB3' ' A' ' 158' ' ' ALA . 1.9 m-90 -46.43 -71.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 1.02 ' HA3' ' HA ' ' B' ' 214' ' ' ASP . . . -79.43 -15.98 78.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.555 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.623 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -61.97 -45.29 94.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.494 ' HA ' ' HE1' ' A' ' 86' ' ' PHE . 37.2 tp -68.65 -37.45 79.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.558 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 48' ' ' ALA . 74.7 t -62.01 -53.02 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.697 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.424 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -60.32 -43.82 96.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.509 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -62.19 -41.94 98.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 0.0 110.849 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.567 ' HE2' ' HG3' ' A' ' 45' ' ' MET . 10.9 t80 -71.02 -47.67 57.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.649 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 97' ' ' ALA . 9.8 p -68.12 -31.27 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.464 ' HE2' HD22 ' B' ' 209' ' ' LEU . 0.8 OUTLIER -57.47 -54.42 47.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.895 0.378 . . . . 0.0 110.181 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.81 -43.49 96.08 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.094 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.05 95.53 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.68 -46.2 76.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.704 0.288 . . . . 0.0 111.043 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 41.4 m -64.36 -46.29 84.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.459 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.03 75.26 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.014 0.435 . . . . 0.0 110.16 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.17 -44.12 84.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.735 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.596 ' HB2' HG22 ' A' ' 118' ' ' VAL . 6.3 m -66.66 -36.5 82.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.487 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.561 HG12 HD13 ' A' ' 21' ' ' LEU . 43.4 t -63.56 -43.97 98.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.05 0.453 . . . . 0.0 110.2 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -68.49 -23.09 64.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.793 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -94.7 13.5 24.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.448 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 60.06 45.22 12.21 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.66 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.568 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -124.79 56.8 1.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.18 0.514 . . . . 0.0 109.811 178.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.09 -29.35 68.52 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.837 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 t -56.32 -51.63 61.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.119 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.33 -35.68 76.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.805 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 109' ' ' SER . 55.3 t -59.25 -45.11 93.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 0.0 110.593 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.75 -38.04 94.04 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.786 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -63.21 -48.86 76.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 110.384 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.94 -43.86 96.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.469 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -44.4 97.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.659 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.86 -47.49 84.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.485 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -62.54 -44.88 95.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.912 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.5 ttt -60.3 -52.47 65.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.548 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.409 ' HA ' HD12 ' A' ' 129' ' ' LEU . 91.7 t -62.45 -44.4 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.93 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.89 94.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.445 ' OH ' ' HD3' ' A' ' 132' ' ' ARG . 44.7 t80 -59.59 -38.84 82.29 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.579 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 21.3 mt -63.6 -32.46 73.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.879 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -95.89 -0.85 50.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.422 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.6 m -105.19 -64.13 1.16 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.445 ' HD3' ' OH ' ' A' ' 128' ' ' TYR . 25.1 ttt180 -102.84 -22.52 13.86 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 69.1 mt -101.37 15.12 29.84 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.517 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.1 -50.54 72.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.296 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.07 -41.03 87.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.493 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 89.8 m95 -57.91 -51.59 69.01 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.41 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.515 HG23 ' HA2' ' A' ' 142' ' ' GLY . 26.0 mm -62.73 -37.99 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.353 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -65.47 -36.15 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.916 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.3 m -73.46 -33.61 64.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.162 0.506 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.1 m -85.42 -5.2 59.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.98 42.07 96.99 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.515 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 75.93 -100.33 1.34 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -120.23 14.23 12.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.153 0.501 . . . . 0.0 109.769 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.97 93.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.245 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.527 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -77.62 -17.93 57.28 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.05 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.66 ' HE2' ' HB1' ' A' ' 44' ' ' ALA . 28.3 t80 -63.29 -32.65 74.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.902 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -38.14 68.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.001 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.3 -28.02 23.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.595 ' HB3' ' HA ' ' A' ' 92' ' ' TRP . 62.7 mt -56.02 -53.87 51.67 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.059 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -100.47 10.79 40.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.239 0.542 . . . . 0.0 110.477 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -91.82 23.16 27.41 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.052 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -152.92 -178.96 7.24 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 162.86 -36.85 0.34 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -101.66 -34.45 9.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.728 0.299 . . . . 0.0 111.181 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 18.4 tp -80.42 -28.19 37.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.072 0.463 . . . . 0.0 109.854 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -65.28 144.57 57.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.855 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -149.39 40.66 0.86 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.599 0.714 . . . . 0.0 110.651 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.613 ' HB3' ' HH2' ' A' ' 92' ' ' TRP . . . -93.17 -32.64 14.33 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.446 ' CG ' ' HZ3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -151.03 9.92 0.59 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.694 178.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.47 ' HD2' HG13 ' B' ' 220' ' ' ILE . 2.8 tmm_? -59.21 -70.33 0.16 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.65 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.473 HD12 HD11 ' B' ' 220' ' ' ILE . 14.9 tp -90.36 49.39 1.68 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.234 0.54 . . . . 0.0 109.766 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -116.09 110.86 19.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.976 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.24 158.5 17.41 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.771 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 142.47 -47.63 0.81 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -152.45 121.12 6.46 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -115.17 -33.77 5.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.884 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -114.43 -62.0 1.66 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.5 p -173.95 -63.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.285 0.564 . . . . 0.0 109.749 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.6 m -89.51 -4.01 10.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.999 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.947 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . 0.44 ' HB ' ' H ' ' B' ' 202' ' ' ILE . 4.9 pt . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.706 0.288 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.44 ' H ' ' HB ' ' B' ' 201' ' ' ILE . 24.0 mt -68.98 106.84 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.603 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -62.53 -32.78 73.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.979 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -51.09 -42.73 60.81 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.156 0.285 . . . . 0.0 111.519 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' B' ' 208' ' ' HIS . 21.8 mt -68.39 -42.6 84.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.86 0.362 . . . . 0.0 110.334 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . 0.573 ' HB1' ' HB2' ' A' ' 85' ' ' LEU . . . -61.34 -45.86 92.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.527 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' ARG . . . . . 0.606 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 42.1 ttp85 -64.53 -35.36 80.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.819 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' B' ' 205' ' ' ILE . 3.8 t60 -57.37 -51.03 71.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.925 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.4 pp -74.48 -36.18 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.351 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -62.28 -47.27 85.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.025 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.29 -39.92 93.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.731 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.59 -52.22 60.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.508 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.85 -40.2 98.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.828 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 1.02 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 1.3 t0 -64.4 -55.77 18.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.018 0.437 . . . . 0.0 111.479 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.6 m -66.57 -33.83 76.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' MET . . . . . . . . . . . . . 20.7 tpp -73.38 -48.74 31.63 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.91 -41.5 95.52 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.849 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . 0.47 ' HD3' ' HA ' ' B' ' 218' ' ' ARG . 0.0 OUTLIER -75.28 -21.9 58.17 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.979 179.185 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . 0.427 ' OG ' ' HD2' ' A' ' 55' ' ' ARG . 57.6 m 57.85 -164.58 0.18 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.973 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 161' ' ' LEU . 12.1 tt . . . . . 0 C--O 1.246 0.897 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.176 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.87 0.367 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.4 111.05 15.16 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.747 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.23 134.23 24.51 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.716 2.277 . . . . 0.0 111.485 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.29 115.17 28.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.652 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 m -70.61 120.6 16.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.194 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.605 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -88.54 -51.82 0.38 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.557 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 31.5 Cg_exo -62.58 136.72 60.12 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.078 1.852 . . . . 0.0 112.108 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.99 154.62 40.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.557 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m -63.47 -34.53 77.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.782 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 10' ' ' ARG . 2.0 mtm180 -72.64 -26.8 61.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.811 0.338 . . . . 0.0 110.157 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.99 89.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.156 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.64 -44.18 96.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.556 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.3 t -63.17 -44.72 99.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.114 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.8 -37.12 85.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -68.65 -42.66 77.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.172 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -62.59 -51.61 66.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.393 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.63 -45.41 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.327 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.66 -42.78 99.81 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.778 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.643 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 1.8 t80 -63.71 -45.21 91.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -60.39 -34.82 74.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.593 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.1 tp -70.73 -25.22 62.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.26 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.4 mtm-85 -85.92 -35.56 20.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.56 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.672 ' HA ' HG22 ' A' ' 27' ' ' VAL . 10.1 mm100 -64.12 -25.59 68.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.476 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -84.43 -3.88 58.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.815 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -132.65 -88.54 0.39 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.722 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -113.56 97.52 6.5 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.672 HG22 ' HA ' ' A' ' 23' ' ' GLN . 75.0 t -62.72 115.72 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.057 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.89 97.87 5.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.527 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.462 ' HA3' ' OH ' ' A' ' 19' ' ' TYR . . . -176.82 165.13 35.08 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.82 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.93 123.98 46.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.735 0.302 . . . . 0.0 110.432 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.402 ' HA2' ' HD3' ' A' ' 32' ' ' PRO . . . -72.31 121.09 8.05 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.609 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.402 ' HD3' ' HA2' ' A' ' 31' ' ' GLY . 11.4 Cg_endo -89.08 106.13 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.419 2.746 . . . . 0.0 111.383 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.44 -70.11 0.9 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.015 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -120.46 64.73 0.84 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.277 0.56 . . . . 0.0 110.316 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.02 99.61 0.24 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.116 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.3 109.15 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.845 2.363 . . . . 0.0 112.183 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.72 139.08 34.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.421 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -72.45 -24.32 61.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.681 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -94.16 106.84 24.86 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.974 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 90.6 Cg_endo -95.85 -6.48 1.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.825 2.35 . . . . 0.0 111.74 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.8 mt -65.66 -50.95 63.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.878 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -64.46 -37.88 89.09 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.952 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -69.3 -41.67 76.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.67 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.09 90.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.8 ttt -63.26 -43.24 98.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.714 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -62.48 -46.41 88.59 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.41 87.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.5 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.68 -38.19 69.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.953 0.406 . . . . 0.0 111.812 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.65 27.69 12.94 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.501 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -143.11 -51.9 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.708 ' HA ' HG22 ' A' ' 54' ' ' THR . 41.3 mm-40 -64.11 -35.57 81.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.777 0.322 . . . . 0.0 110.46 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -66.75 -10.96 52.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.783 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.647 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 7.3 tp10 -107.45 -49.94 3.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.667 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.708 HG22 ' HA ' ' A' ' 51' ' ' GLU . 2.0 t -64.67 -31.48 72.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.761 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 55' ' ' ARG . 22.1 mtm180 -94.36 9.83 36.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.081 0.467 . . . . 0.0 110.39 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.959 ' HA ' ' HG2' ' B' ' 216' ' ' MET . 49.7 t80 -107.28 -82.89 0.54 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.642 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 58' ' ' ARG . 5.1 mtm105 167.3 -65.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.808 ' HA ' ' HE ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -153.35 72.2 0.92 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.924 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.647 ' OG1' ' HA ' ' A' ' 53' ' ' GLU . 2.5 m -62.81 -41.58 99.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.024 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.26 20.87 1.52 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.348 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.616 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . 51.9 m -153.2 -77.03 0.12 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -56.72 -44.17 81.36 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 38.4 tp -62.89 -43.49 98.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.859 0.361 . . . . 0.0 110.343 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -66.55 -34.9 78.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.597 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.29 -44.05 72.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.515 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -74.36 -25.74 59.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.867 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -83.82 -17.92 39.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.122 0.487 . . . . 0.0 110.133 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 3.2 t-80 -76.45 -14.14 60.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.39 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.88 -32.88 56.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.305 0.574 . . . . 0.0 109.545 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.58 140.28 55.39 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.881 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.14 99.29 0.16 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.865 2.377 . . . . 0.0 112.257 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.7 -149.49 15.1 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.282 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.837 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 49.0 m -158.22 -157.73 0.66 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.3 -156.92 0.1 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.019 0.438 . . . . 0.0 111.561 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.552 ' HG3' HD21 ' A' ' 117' ' ' LEU . 4.4 mm-40 -56.8 -30.11 63.38 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -66.04 -22.85 66.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.691 0.282 . . . . 0.0 111.434 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.837 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 21.4 tpp85 -85.1 -36.68 20.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.713 0.292 . . . . 0.0 110.444 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -69.9 -31.25 68.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.512 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.96 -20.48 57.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.711 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -111.48 5.37 19.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.718 0.295 . . . . 0.0 111.656 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.8 p -100.59 -14.36 7.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.384 0.611 . . . . 0.0 110.322 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.689 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -85.36 -41.52 15.4 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.535 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.36 -13.96 57.75 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.389 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' B' ' 206' ' ' ALA . 3.6 tp10 -54.96 -41.73 71.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.886 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.5 HD23 ' HB3' ' B' ' 206' ' ' ALA . 0.3 OUTLIER -106.42 32.76 4.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.134 0.492 . . . . 0.0 110.495 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -121.27 -36.02 3.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.528 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -62.42 -31.05 71.68 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.223 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.74 1.48 86.02 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.7 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.78 117.51 1.58 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.678 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.09 164.56 24.66 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.879 2.386 . . . . 0.0 112.037 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.459 ' HB3' ' HB2' ' A' ' 94' ' ' ARG . 24.1 t30 -148.25 169.0 21.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.627 ' HA ' HD22 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -50.04 -61.56 2.08 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.808 0.692 . . . . 0.0 112.213 -178.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.94 -4.83 84.28 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.063 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.459 ' HB2' ' HB3' ' A' ' 91' ' ' ASN . 4.2 tpp85 -65.29 -45.77 83.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.726 0.298 . . . . 0.0 110.558 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.4 tp -67.62 -37.8 83.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.135 0.493 . . . . 0.0 110.058 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.504 HG22 ' HE1' ' A' ' 146' ' ' PHE . 3.1 t -65.92 -41.36 89.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.358 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.637 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -62.21 -39.46 92.83 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.057 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.689 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 66.1 t80 -61.61 -37.08 82.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.167 0.508 . . . . 0.0 110.302 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -79.69 -46.89 16.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.345 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.637 HG12 ' HA ' ' A' ' 97' ' ' ALA . 4.4 p -61.7 -34.02 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.41 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -64.35 -50.93 65.79 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.909 0.385 . . . . 0.0 110.006 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.98 98.59 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.881 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.05 83.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.614 0.245 . . . . 0.0 111.484 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.28 79.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.656 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.464 ' HB3' ' NE2' ' A' ' 75' ' ' GLN . 3.6 mm? -62.71 -38.78 91.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.361 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.7 m -72.66 -43.53 63.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.569 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.1 -37.65 77.67 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.101 0.477 . . . . 0.0 110.424 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.64 -43.68 88.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.787 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 114' ' ' MET . 21.5 m -68.43 -43.87 76.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.251 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.418 HG23 HG21 ' A' ' 118' ' ' VAL . 53.0 t -59.4 -37.37 69.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.017 0.437 . . . . 0.0 110.403 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -63.61 -29.15 70.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.839 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.9 mtpt -99.04 17.14 20.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.099 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 59.8 34.76 21.94 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.546 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.479 ' HB3' ' HB3' ' A' ' 109' ' ' SER . 0.0 OUTLIER -100.47 66.6 1.26 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.953 0.406 . . . . 0.0 110.169 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.07 -28.78 67.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.943 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.519 HG12 HE21 ' A' ' 120' ' ' GLN . 22.3 t -58.39 -51.14 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.003 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.552 HD21 ' HG3' ' A' ' 75' ' ' GLN . 14.1 tp -68.34 -39.69 81.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.984 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 114' ' ' MET . 87.7 t -59.49 -43.9 91.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.86 99.25 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.745 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.519 HE21 HG12 ' A' ' 116' ' ' VAL . 70.0 mt-30 -63.21 -50.9 68.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.624 0.25 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.28 -48.12 88.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.298 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -45.81 91.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.745 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -62.02 -42.8 99.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.246 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -60.62 -46.46 90.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.806 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 88.8 mtp -59.0 -50.94 72.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.975 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.48 -41.27 87.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.936 0.398 . . . . 0.0 110.907 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.3 -51.83 61.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.574 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.41 -42.56 87.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.215 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.666 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 36.7 mt -61.8 -26.34 68.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.102 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -107.89 3.71 24.59 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.675 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.0 m -107.41 -50.56 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -122.05 -18.7 6.85 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.893 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.678 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 83.8 mt -101.69 3.9 40.14 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.631 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.64 87.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.947 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.66 -39.7 81.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.209 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.678 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 91.8 m95 -68.09 -54.43 18.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.372 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.488 HG23 ' HA2' ' A' ' 142' ' ' GLY . 42.0 mm -56.73 -37.38 52.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.301 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -59.5 -45.11 92.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.237 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.4 m -77.51 -33.29 54.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.425 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 67.0 m -74.98 -3.24 31.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.67 39.66 96.91 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.488 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 72.04 -94.17 0.61 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -120.68 17.53 11.96 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.57 -51.56 66.86 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.54 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.622 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 4.2 pt-20 -78.21 -20.97 50.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.915 0.388 . . . . 0.0 110.5 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.504 ' HE1' HG22 ' A' ' 96' ' ' VAL . 91.5 t80 -61.25 -40.96 96.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.222 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.531 ' HA ' ' CE1' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -60.33 -33.45 72.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 110.831 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.23 -34.58 42.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.549 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.627 HD22 ' HA ' ' A' ' 92' ' ' TRP . 81.3 mt -57.38 -50.34 73.3 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.05 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.531 ' CE1' ' HA ' ' A' ' 147' ' ' THR . 5.6 p90 -86.15 -6.49 58.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.089 0.471 . . . . 0.0 110.229 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.65 -25.37 60.79 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -117.2 84.63 2.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.169 0.509 . . . . 0.0 109.844 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.29 23.75 1.88 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.208 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -116.61 65.04 0.71 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.156 0.503 . . . . 0.0 110.5 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 80.1 mt -80.71 -78.55 0.17 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.734 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.623 ' HB3' HH21 ' A' ' 159' ' ' ARG . 0.3 OUTLIER -109.62 89.91 3.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.373 0.606 . . . . 0.0 110.264 179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -110.91 16.9 21.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.719 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -94.84 -56.47 2.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.648 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.623 HH21 ' HB3' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -98.77 12.99 33.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 111.07 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.04 142.23 47.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.245 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 16.1 tp -63.34 116.51 5.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.185 0.517 . . . . 0.0 111.975 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -99.58 -38.56 8.7 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.03 177.08 8.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.079 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -127.29 168.6 19.34 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.073 -1.06 . . . . 0.0 113.417 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -111.94 140.42 46.62 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -103.08 -64.76 1.05 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.834 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -145.05 25.22 1.42 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.869 0.366 . . . . 0.0 111.828 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.5 m -96.53 159.29 15.02 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.47 62.65 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.422 0.63 . . . . 0.0 110.617 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.568 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . 0.558 HG22 HG13 ' B' ' 202' ' ' ILE . 52.0 mt . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.859 0.361 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.558 HG13 HG22 ' B' ' 201' ' ' ILE . 44.9 mt -144.01 111.17 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -64.73 -34.26 77.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.332 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -53.91 -48.11 70.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 38.1 mt -62.6 -48.43 88.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.677 0.275 . . . . 0.0 110.97 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . 0.5 ' HB3' HD23 ' A' ' 85' ' ' LEU . . . -62.28 -43.15 99.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.626 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -35.86 75.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.121 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.99 -55.18 35.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.864 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' B' ' 206' ' ' ALA . 1.3 pp -68.65 -38.03 80.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.643 0.259 . . . . 0.0 111.642 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -65.66 -51.36 60.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -59.12 -52.09 67.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' B' ' 216' ' ' MET . 57.2 t -64.29 -47.85 87.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.683 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.97 -50.66 56.88 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.92 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' B' ' 210' ' ' ALA . 0.9 OUTLIER -61.33 -46.99 87.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 15.9 m -67.18 -34.98 78.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.728 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' MET . . . . . 0.959 ' HG2' ' HA ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -68.83 -46.89 67.4 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.707 -179.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.66 -34.15 77.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.996 0.427 . . . . 0.0 110.503 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.58 -9.84 58.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.165 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 6.3 m 63.95 59.25 1.12 Allowed 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.602 0.563 . . . . 0.0 110.85 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.826 -0.607 . . . . 0.0 110.231 179.575 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.753 0.311 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.8 m -109.66 108.3 59.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.004 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.34 114.61 3.78 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.279 1.986 . . . . 0.0 111.567 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.41 130.32 42.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.528 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 m -88.13 120.7 29.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.638 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -84.4 -53.68 0.5 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 21.5 Cg_exo -66.13 125.72 14.57 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.119 1.879 . . . . 0.0 113.156 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.79 159.74 30.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.25 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -41.46 82.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.771 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 10' ' ' ARG . 0.6 OUTLIER -69.73 -32.6 71.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.713 0.292 . . . . 0.0 110.87 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.72 -40.65 92.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.34 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.8 -40.87 92.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.027 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.0 t -64.59 -42.53 95.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.261 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.55 -42.96 89.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.512 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.26 -37.85 86.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.0 -48.08 69.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.74 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.93 -43.39 97.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.166 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.71 98.35 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.402 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 23.3 t80 -62.81 -42.83 99.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -60.01 -36.22 76.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 0.0 110.432 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.2 tp -72.69 -28.32 62.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.232 0.539 . . . . 0.0 110.216 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 73.8 mtm-85 -80.77 -26.97 36.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.892 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 16.0 mm100 -64.35 -28.26 69.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.327 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -92.37 6.64 46.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.937 0.398 . . . . 0.0 110.789 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.83 -93.92 0.46 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -119.7 108.69 14.75 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.66 113.99 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.962 0.411 . . . . 0.0 110.396 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t -124.2 99.24 6.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.369 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.98 -132.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.538 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.7 149.64 27.72 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.96 112.33 3.43 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.036 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 88.85 1.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.55 2.167 . . . . 0.0 111.877 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.72 -129.22 5.58 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -85.09 68.73 10.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.066 0.46 . . . . 0.0 110.861 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.13 103.74 0.44 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.078 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.12 116.87 3.48 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.95 2.433 . . . . 0.0 112.383 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.52 152.64 18.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.077 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.63 -31.07 32.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.215 0.531 . . . . 0.0 109.981 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -107.92 126.0 30.8 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.196 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 39' ' ' ASP . 57.6 Cg_endo -97.2 4.63 1.58 Allowed 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.074 2.516 . . . . 0.0 111.089 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.9 mt -71.15 -46.87 60.63 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.132 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -61.39 -32.91 72.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.212 0.53 . . . . 0.0 110.084 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -78.69 -38.54 39.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.569 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.503 ' HB1' ' HE2' ' A' ' 146' ' ' PHE . . . -64.24 -41.7 96.87 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.499 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.9 ttt -63.32 -38.36 90.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.943 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -68.24 -48.78 64.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.264 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.59 -43.71 84.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.447 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.46 -42.34 64.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.39 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.6 40.18 2.64 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.614 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -155.62 -42.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 41.5 mm-40 -58.78 -78.41 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 4.5 p90 -64.15 -21.9 66.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.703 0.287 . . . . 0.0 110.668 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 32.1 tp10 -63.55 -52.98 58.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.547 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 m -74.92 -29.56 61.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.584 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.412 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 15.9 mtm-85 -71.22 -17.2 62.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.478 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -102.96 -74.79 0.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.232 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ttm105 177.36 -69.38 0.01 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.999 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.94 58.75 0.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.917 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.698 HG22 HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -57.11 -25.67 59.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.245 -178.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -53.95 -31.11 49.46 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 111.007 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.01 -29.62 5.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 18.0 t70 -69.04 -30.23 68.55 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.698 HD13 HG22 ' A' ' 59' ' ' THR . 5.5 tp -55.65 -38.07 69.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 111.218 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.93 -11.75 56.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.0 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.27 -47.08 8.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.995 0.426 . . . . 0.0 110.618 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 8.3 pt20 -66.98 -30.62 70.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.106 0.479 . . . . 0.0 110.142 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.479 HD22 ' HG3' ' A' ' 66' ' ' GLN . 1.1 mm? -96.73 14.7 24.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.211 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.73 -9.53 58.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.054 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.71 -36.07 75.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.96 129.69 35.0 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.359 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.67 117.02 3.39 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.826 2.35 . . . . 0.0 112.325 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.43 -159.04 21.99 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.159 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.0 m -143.18 -130.64 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -99.05 -153.99 0.45 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.341 0.115 . . . . 0.0 110.719 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.605 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 2.4 mm-40 -56.51 -33.16 65.75 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.422 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.463 ' HG3' ' CZ3' ' A' ' 124' ' ' TRP . 22.9 mp0 -56.58 -28.47 60.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.617 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -83.13 -9.66 59.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.043 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.522 ' O ' HG12 ' A' ' 81' ' ' VAL . 30.8 m-85 -108.59 -43.24 4.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.714 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.25 -30.17 68.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.76 0.314 . . . . 0.0 111.785 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.503 ' HB3' HD11 ' B' ' 201' ' ' ILE . 6.7 tp60 -100.95 12.13 38.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.959 0.409 . . . . 0.0 111.314 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 78' ' ' PHE . 2.1 p -109.27 -14.07 10.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.286 0.565 . . . . 0.0 110.288 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.627 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -81.26 -36.99 29.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.81 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -77.65 -20.28 54.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -53.81 -42.89 68.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.703 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.744 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -95.02 5.92 50.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.26 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -100.86 -36.52 9.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.423 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -52.32 -39.24 60.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.591 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.76 34.2 5.11 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.498 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.523 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . 175.94 83.34 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.837 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.47 ' HG3' ' CZ3' ' A' ' 136' ' ' TRP . 4.8 Cg_exo -79.85 53.01 4.54 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.223 2.615 . . . . 0.0 111.688 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -71.68 164.9 25.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.617 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.847 ' HD1' HD22 ' A' ' 149' ' ' LEU . 2.2 m-90 -53.89 -58.02 8.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.755 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.65 -14.13 79.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.26 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 6.7 tpp85 -66.79 -47.78 71.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.748 0.309 . . . . 0.0 110.586 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.405 HD23 ' CD1' ' A' ' 146' ' ' PHE . 26.3 tp -64.86 -36.06 83.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.741 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.7 t -62.97 -50.93 77.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.264 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -60.2 -42.49 95.22 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.458 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.627 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 52.5 t80 -62.69 -45.21 93.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.081 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -72.11 -42.53 65.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.912 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 97' ' ' ALA . 3.9 p -70.46 -27.98 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.634 ' HE2' HD13 ' B' ' 209' ' ' LEU . 0.2 OUTLIER -57.53 -50.69 72.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 110.444 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.1 -43.26 97.48 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.862 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -46.77 88.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.467 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.15 -43.53 98.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.268 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.605 ' HB3' ' NE2' ' A' ' 75' ' ' GLN . 2.0 mm? -68.17 -39.34 82.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.984 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.2 m -67.2 -39.65 86.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.243 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.72 89.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.946 0.403 . . . . 0.0 110.291 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -41.24 82.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.855 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -67.55 -46.39 72.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.204 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.16 -40.3 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.894 0.378 . . . . 0.0 110.422 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -64.1 -26.8 68.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.415 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -96.03 9.87 39.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.148 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 68.73 15.88 8.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.197 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.459 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -88.58 67.23 8.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.182 0.515 . . . . 0.0 110.481 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -71.53 -28.76 64.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.704 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -56.87 -46.61 83.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.578 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.4 HD21 ' HG3' ' A' ' 75' ' ' GLN . 25.6 tp -67.94 -43.62 78.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.923 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 114' ' ' MET . 64.0 t -56.98 -46.67 84.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.641 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.04 -35.12 82.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.726 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -77.25 -47.15 20.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.622 0.248 . . . . 0.0 110.572 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.47 -45.79 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.784 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.404 ' NE2' ' HA ' ' A' ' 122' ' ' GLN . 1.3 tp60 -61.36 -44.42 97.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.677 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -63.69 -40.04 95.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.165 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.463 ' CZ3' ' HG3' ' A' ' 76' ' ' GLN . 13.1 m0 -59.93 -44.52 94.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.635 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 85.1 mtp -60.65 -51.91 67.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.175 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.68 -44.55 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.77 0.319 . . . . 0.0 111.263 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.26 -44.97 96.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -60.85 -42.88 98.7 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.626 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.505 HD23 HD12 ' A' ' 133' ' ' LEU . 68.8 mt -62.84 -31.81 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.4 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -92.46 11.4 26.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 111.629 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.0 m -122.92 -70.0 0.8 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.606 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -85.35 -33.89 21.93 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.505 HD12 HD23 ' A' ' 129' ' ' LEU . 48.0 mt -102.47 16.58 25.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.268 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.12 -48.5 79.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.0 110.733 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.61 -36.83 84.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.321 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.47 ' CZ3' ' HG3' ' A' ' 90' ' ' PRO . 11.3 m95 -61.02 -55.37 33.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.392 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.414 HG23 ' HA2' ' A' ' 142' ' ' GLY . 46.7 mm -59.55 -39.9 80.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.685 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -63.37 -41.64 98.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.159 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.5 m -71.54 -37.73 71.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.375 . . . . 0.0 111.173 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.608 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 65.4 m -81.19 -6.3 58.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.812 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.46 43.32 96.86 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.004 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.414 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 78.95 -113.62 3.71 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.327 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -110.49 17.97 20.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.997 0.427 . . . . 0.0 110.379 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.66 -60.37 3.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.432 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.608 ' HG2' ' HB3' ' A' ' 140' ' ' SER . 5.9 pt-20 -68.5 -27.49 66.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 110.643 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.616 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 73.7 t80 -61.88 -35.79 79.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.049 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.776 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 27.7 m -62.8 -24.82 67.93 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.569 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.98 -24.0 22.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.122 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.847 HD22 ' HD1' ' A' ' 92' ' ' TRP . 29.8 mt -62.58 -47.64 82.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 110.819 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.776 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 11.1 p90 -96.29 12.67 30.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.301 0.572 . . . . 0.0 110.096 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.88 -23.73 63.47 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.11 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -117.51 173.46 6.7 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -131.61 79.92 0.35 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.947 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.1 132.09 50.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.75 0.309 . . . . 0.0 110.764 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.16 96.39 8.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.482 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.54 112.85 21.95 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.437 ' HA ' ' HG3' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -110.05 28.51 8.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.338 -178.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -104.76 -67.91 0.88 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.777 0.322 . . . . 0.0 111.285 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.596 HH22 ' HA ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -87.69 42.11 1.03 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.562 ' HD2' ' OXT' ' B' ' 220' ' ' ILE . 8.5 mtm180 -76.21 -175.64 3.25 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.847 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 72.5 mt -70.8 85.42 0.67 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.375 0.607 . . . . 0.0 111.831 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 160' ' ' ARG . 1.2 mpp_? -127.24 39.06 3.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.538 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -106.95 169.65 8.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.81 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.99 18.02 0.1 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.734 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -71.25 126.03 28.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.717 0.294 . . . . 0.0 110.646 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -150.97 -68.43 0.18 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -114.18 -125.02 0.28 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.832 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.1 -40.65 90.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.943 0.402 . . . . 0.0 110.882 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.2 m -95.63 154.26 3.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.781 0.324 . . . . 0.0 110.745 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.542 ' NH1' ' HB2' ' A' ' 170' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.894 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.226 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . 0.503 HD11 ' HB3' ' A' ' 80' ' ' GLN . 26.1 mt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.718 0.294 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 96.3 mt -143.1 114.81 2.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -61.38 -38.0 85.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.231 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -57.53 -44.38 85.06 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 111.665 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.65 -52.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.083 0.468 . . . . 0.0 110.493 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . 0.457 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -60.21 -40.72 91.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.078 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' ARG . . . . . 0.744 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 28.8 ttp-105 -63.47 -37.2 86.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.055 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -63.68 -49.64 72.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.209 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.634 HD13 ' HE2' ' A' ' 101' ' ' PHE . 1.5 pp -67.63 -37.91 83.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.738 0.304 . . . . 0.0 110.918 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -67.32 -44.47 79.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.081 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -59.67 -47.27 86.3 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 123.272 0.358 . . . . 0.0 111.008 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.38 -53.45 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.25 0.343 . . . . 0.0 111.349 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -43.55 98.14 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.149 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.52 -40.07 85.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.005 0.431 . . . . 0.0 111.751 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.432 ' HB3' HH11 ' A' ' 159' ' ' ARG . 51.0 m -75.34 -46.01 35.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -34.18 77.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . 34.5 t70 -75.16 -33.35 61.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.576 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' B' ' 218' ' ' ARG . 0.0 OUTLIER -75.67 45.83 0.34 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 7.8 m 57.13 88.24 0.05 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.445 0.64 . . . . 0.0 111.884 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.596 ' HA ' HH22 ' A' ' 159' ' ' ARG . 15.5 tt . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.279 -0.867 . . . . 0.0 109.83 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.781 0.324 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 m -124.17 113.6 27.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.51 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.0 128.27 20.33 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.777 2.318 . . . . 0.0 111.834 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.83 122.4 45.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.69 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.7 m -96.85 112.47 24.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.935 0.398 . . . . 0.0 110.619 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.561 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.8 -50.06 5.81 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.605 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 31.3 Cg_exo -60.85 126.54 19.92 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.103 1.869 . . . . 0.0 112.256 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.42 155.29 39.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.74 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -55.9 -38.33 70.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.962 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -68.7 -23.92 64.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 111.006 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.66 -37.22 65.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -68.88 -38.82 79.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.771 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' THR . 82.8 t -60.96 -43.71 96.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.673 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.76 -27.4 67.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.623 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 35.7 t70 -69.94 -44.0 70.46 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -68.5 -45.97 70.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.41 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.49 -46.82 95.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.965 0.412 . . . . 0.0 110.162 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.06 97.31 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.435 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.679 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 6.7 t80 -60.83 -47.68 85.27 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 19.8 mmmt -57.43 -39.27 75.87 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.642 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.491 HD12 ' HE3' ' A' ' 24' ' ' LYS . 24.3 tp -66.92 -32.97 74.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.449 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.3 mtm-85 -81.22 -29.38 34.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.188 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.679 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 12.8 mm100 -64.32 -26.82 68.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.63 0.252 . . . . 0.0 111.293 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HE3' HD12 ' A' ' 21' ' ' LEU . 6.7 pttp -97.61 13.26 30.76 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.899 0.38 . . . . 0.0 111.372 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.15 -75.4 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -142.46 106.3 4.7 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.38 109.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.922 0.391 . . . . 0.0 110.796 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 37.8 m -110.31 122.93 48.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.048 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.43 -133.4 4.57 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.862 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.451 ' O ' ' HD3' ' A' ' 32' ' ' PRO . . . -150.64 174.93 12.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.604 0.24 . . . . 0.0 110.638 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.87 99.19 1.41 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.792 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 30' ' ' ALA . 4.9 Cg_exo -76.7 89.97 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.816 2.344 . . . . 0.0 112.103 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.19 -74.53 0.95 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.471 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.92 108.23 19.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.956 0.408 . . . . 0.0 110.069 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.54 95.8 0.11 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.576 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.97 112.14 1.43 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.931 2.42 . . . . 0.0 112.109 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.29 153.16 17.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.212 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.21 -28.62 48.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.031 0.443 . . . . 0.0 110.013 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.31 110.18 59.13 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.88 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -103.91 10.72 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.557 2.838 . . . . 0.0 112.199 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' A' ' 143' ' ' TRP . 59.3 mt -72.11 -45.59 60.0 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -66.09 -38.47 88.33 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -67.73 -39.37 84.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.259 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.6 98.45 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.253 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 46.3 mtt -62.87 -44.68 95.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.162 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.544 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 6.7 tmm_? -65.06 -43.98 90.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.143 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.72 79.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.286 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.67 89.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.058 0.456 . . . . 0.0 110.328 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.07 22.66 30.66 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.773 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 3.2 t0 -126.8 -61.06 1.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.555 0.217 . . . . 0.0 110.967 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.785 ' HA ' HG22 ' A' ' 54' ' ' THR . 76.0 mm-40 -63.0 -41.81 99.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.032 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.484 ' HA ' ' OD1' ' B' ' 217' ' ' ASP . 51.3 t80 -58.73 -29.28 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.972 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -91.24 -40.89 11.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.398 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.785 HG22 ' HA ' ' A' ' 51' ' ' GLU . 12.6 t -70.02 -32.42 70.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 51' ' ' GLU . 21.8 mtm180 -85.07 -22.19 29.05 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 110.514 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.6 ' HA ' ' HG2' ' B' ' 216' ' ' MET . 36.3 t80 -80.08 -82.47 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 56' ' ' PHE . 9.8 ttm105 165.82 -68.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 O-C-N 123.993 0.808 . . . . 0.0 109.264 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.462 ' HD3' ' OG ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -159.42 72.45 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.056 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 m -56.47 -34.77 67.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.478 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -65.24 -15.5 62.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.584 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.462 ' OG ' ' HD3' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -118.88 -53.96 2.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.733 0.302 . . . . 0.0 111.792 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.7 -68.79 0.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.176 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.572 ' HA ' ' HG2' ' A' ' 66' ' ' GLN . 9.7 tp -57.88 -42.65 85.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.564 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 68' ' ' HIS . . . -61.53 -29.79 70.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.046 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.74 -44.44 10.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.572 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 8.1 pt20 -65.37 -31.79 73.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.758 0.313 . . . . 0.0 111.27 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.773 ' HG ' ' HB3' ' B' ' 209' ' ' LEU . 2.2 mm? -87.87 -4.62 58.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.959 0.409 . . . . 0.0 110.757 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.525 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 4.7 t-80 -88.0 -10.94 48.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.778 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.1 t -75.17 -33.93 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.522 0.677 . . . . 0.0 109.595 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -74.46 148.42 85.74 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.185 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 70' ' ' THR . 23.4 Cg_exo -63.83 94.98 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.577 2.185 . . . . 0.0 112.213 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.43 -147.42 14.61 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.306 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.682 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 66.4 m -162.31 -159.7 0.61 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.461 0.304 . . . . 0.0 110.217 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.04 -160.7 0.25 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.679 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.838 ' HG3' HD21 ' A' ' 117' ' ' LEU . 11.8 mm-40 -58.28 -27.51 64.11 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -63.58 -25.3 68.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.842 0.353 . . . . 0.0 110.592 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.682 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 13.1 tpp85 -88.95 -34.95 16.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.071 0.462 . . . . 0.0 109.937 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -67.74 -32.65 73.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.546 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 p -81.47 7.36 12.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.83 0.348 . . . . 0.0 111.502 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -127.09 -41.31 1.79 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.157 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.483 HG23 HG21 ' B' ' 202' ' ' ILE . 9.9 p -55.56 -29.22 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.473 ' HB2' ' HD1' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -74.22 -46.15 43.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.109 0.481 . . . . 0.0 110.974 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.01 -33.74 75.19 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.207 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' B' ' 202' ' ' ILE . 8.2 mm-40 -53.88 -31.77 50.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.369 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.702 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.2 OUTLIER -103.37 -14.52 16.24 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.813 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -70.53 -43.27 69.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.134 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.427 HE22 ' HD3' ' A' ' 132' ' ' ARG . 61.0 mt-30 -77.28 -2.16 33.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.176 0.513 . . . . 0.0 110.741 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -106.33 16.18 41.9 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.475 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . 148.23 85.95 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HG3' ' HZ3' ' A' ' 136' ' ' TRP . 3.8 Cg_exo -74.64 70.81 4.92 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 123.059 2.506 . . . . 0.0 112.746 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -82.61 173.15 12.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.38 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.559 ' CD1' HD22 ' A' ' 149' ' ' LEU . 35.3 m0 -51.32 -62.63 1.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.556 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.25 -18.81 75.33 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.155 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 3.5 tpp85 -63.91 -46.46 84.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.417 HD23 ' CD1' ' A' ' 146' ' ' PHE . 39.3 tp -69.66 -35.33 75.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.089 0.471 . . . . 0.0 109.817 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 92' ' ' TRP . 84.6 t -63.35 -44.98 99.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.022 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.665 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -63.2 -38.8 92.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.597 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.473 ' HD1' ' HB2' ' A' ' 82' ' ' SER . 89.1 t80 -60.92 -40.83 94.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.419 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -76.26 -47.42 23.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.43 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.665 HG12 ' HA ' ' A' ' 97' ' ' ALA . 5.5 p -65.05 -30.52 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.534 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 1.2 t80 -61.08 -54.61 42.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.849 0.357 . . . . 0.0 110.231 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.62 -40.7 96.09 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.042 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.75 95.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.557 0.217 . . . . 0.0 111.459 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.31 75.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.112 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.506 ' HB3' HE22 ' A' ' 75' ' ' GLN . 1.7 mm? -61.58 -41.36 97.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.508 ' O ' HG23 ' A' ' 110' ' ' VAL . 30.2 m -66.44 -45.9 78.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.663 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.71 86.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.02 -42.66 99.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.993 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.2 m -67.04 -37.51 84.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.327 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 106' ' ' CYS . 76.7 t -62.89 -38.61 82.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.2 0.524 . . . . 0.0 110.095 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -73.08 -12.95 61.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.801 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -106.47 13.14 28.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.365 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 56.7 48.96 15.32 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.329 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.454 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.02 61.27 0.9 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.105 0.478 . . . . 0.0 110.509 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -60.36 -30.48 69.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.034 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.8 t -59.24 -45.18 93.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.402 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.838 HD21 ' HG3' ' A' ' 75' ' ' GLN . 48.5 tp -72.04 -41.52 67.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.667 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 114' ' ' MET . 83.1 t -60.42 -48.91 86.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.235 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.84 -40.08 96.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.239 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -66.66 -47.54 72.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.525 0.203 . . . . 0.0 110.671 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.42 ' O ' ' HG3' ' A' ' 125' ' ' MET . 64.6 t -59.46 -45.96 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.726 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.2 -45.4 93.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -63.28 -42.3 99.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -61.31 -38.34 86.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 121' ' ' VAL . 95.7 mtp -66.81 -48.67 68.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.258 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.06 -42.52 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.53 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.22 -43.67 83.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 132' ' ' ARG . 0.2 OUTLIER -62.88 -41.84 99.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.414 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.651 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 91.3 mt -65.56 -31.39 72.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.657 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.27 -3.71 55.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.0 m -115.41 -88.93 0.57 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.49 ' HB3' ' CE1' ' A' ' 128' ' ' TYR . 64.2 ttt180 -72.47 -36.27 68.41 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.651 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 97.5 mt -89.71 14.66 11.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.727 0.298 . . . . 0.0 111.372 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.32 -55.27 29.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.844 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.97 -34.68 78.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.775 0.322 . . . . 0.0 110.87 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.41 ' HZ3' ' HG3' ' A' ' 90' ' ' PRO . 60.9 m95 -59.37 -57.93 10.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.46 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.408 HG23 ' HA2' ' A' ' 142' ' ' GLY . 47.3 mm -61.69 -37.27 77.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.913 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -63.49 -42.0 98.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.461 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.8 m -76.71 -27.88 55.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.728 0.299 . . . . 0.0 111.279 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 70.3 m -85.04 -11.95 54.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.583 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.17 44.82 85.79 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.408 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 70.53 -100.84 0.85 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.59 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.532 ' HB2' HD22 ' A' ' 41' ' ' LEU . 84.2 m95 -116.78 15.15 15.36 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.65 -60.24 3.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.592 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.527 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 3.7 pt-20 -66.76 -28.23 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 110.579 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.504 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 74.0 t80 -62.07 -30.57 71.08 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.638 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 5.6 m -61.83 -28.34 69.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.216 0.531 . . . . 0.0 110.569 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.27 -26.64 18.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.773 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.559 HD22 ' CD1' ' A' ' 92' ' ' TRP . 24.4 mt -62.69 -53.85 48.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.15 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.638 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 1.5 p90 -84.3 17.8 2.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.951 0.405 . . . . 0.0 111.141 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.03 -31.09 62.24 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.862 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.83 168.58 17.83 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.575 -0.367 . . . . 0.0 110.463 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.95 18.57 0.4 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.121 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -122.62 -162.05 0.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.574 HD23 ' HB ' ' B' ' 220' ' ' ILE . 6.0 mp -77.4 86.35 3.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.94 0.4 . . . . 0.0 110.817 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.763 ' HB3' ' HG3' ' B' ' 218' ' ' ARG . 0.8 OUTLIER -77.0 124.48 27.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.174 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.584 ' HG2' ' HD3' ' A' ' 160' ' ' ARG . 20.7 mt-10 -120.64 18.7 11.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.227 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.59 ' HA ' ' HB3' ' A' ' 162' ' ' ARG . . . -62.65 -57.01 12.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.906 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.431 ' HG3' ' OE2' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -83.09 -5.06 58.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.252 0.548 . . . . 0.0 110.408 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.584 ' HD3' ' HG2' ' A' ' 157' ' ' GLU . 8.3 ttt85 -87.64 -54.05 4.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.564 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 10.9 tp -159.19 43.06 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.239 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.59 ' HB3' ' HA ' ' A' ' 158' ' ' ALA . 0.2 OUTLIER -153.12 44.51 0.64 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.976 0.417 . . . . 0.0 111.076 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -79.92 -24.33 41.15 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.94 -152.87 39.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.163 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -101.31 142.4 32.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.763 0.316 . . . . 0.0 110.335 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -118.73 -41.84 2.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.909 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -147.8 -155.26 0.61 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.467 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -32.66 53.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.884 0.374 . . . . 0.0 110.819 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.9 m -71.08 -47.28 62.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.858 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.012 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . 0.541 HG13 HG12 ' B' ' 202' ' ' ILE . 13.9 pt . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.541 HG12 HG13 ' B' ' 201' ' ' ILE . 44.5 mm -104.09 114.7 44.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.861 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.3 -43.84 2.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.28 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -64.1 -54.81 28.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 0.0 111.135 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . 0.559 HG23 HD12 ' A' ' 67' ' ' LEU . 94.1 mt -63.15 -40.56 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.231 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . 0.464 ' HB1' ' HB2' ' A' ' 85' ' ' LEU . . . -61.64 -47.42 85.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.905 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' ARG . . . . . 0.702 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 74.3 ttt180 -65.94 -35.07 79.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.902 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' HIS . . . . . 0.746 ' HB3' HD11 ' A' ' 67' ' ' LEU . 3.3 t-80 -58.25 -51.92 67.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.762 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.773 ' HB3' ' HG ' ' A' ' 67' ' ' LEU . 1.2 pp -74.92 -38.44 61.81 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.733 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . 0.456 ' HB1' ' HD3' ' A' ' 94' ' ' ARG . . . -68.81 -48.26 64.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -69.41 -48.66 60.36 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 43.0 t -57.18 -43.76 82.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.812 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.74 -50.62 29.28 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.088 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 25.4 t0 -57.26 -44.58 84.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.449 0.3 . . . . 0.0 111.785 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 12.8 m -68.18 -36.22 79.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.714 0.292 . . . . 0.0 111.758 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' MET . . . . . 0.6 ' HG2' ' HA ' ' A' ' 56' ' ' PHE . 23.6 ttm -74.59 -40.81 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.76 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . 0.484 ' OD1' ' HA ' ' A' ' 52' ' ' PHE . 37.8 t70 -65.53 -34.27 77.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.455 0.645 . . . . 0.0 109.417 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . 0.763 ' HG3' ' HB3' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -75.16 -6.3 48.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.693 179.2 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 11.1 m 68.85 4.81 4.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.202 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.574 ' HB ' HD23 ' A' ' 155' ' ' LEU . 9.9 tp . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.61 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.87 0.366 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.7 m -127.86 106.11 20.48 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.122 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.85 122.54 9.91 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.885 2.39 . . . . 0.0 112.11 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.6 119.09 24.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.742 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.1 m -74.98 108.17 7.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.359 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.57 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -74.08 -51.93 4.57 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 25.8 Cg_exo -63.84 140.3 72.81 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.868 1.712 . . . . 0.0 113.007 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 10' ' ' ARG . 22.2 t70 -81.4 151.83 27.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.377 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -58.61 -36.89 74.75 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.445 ' HB2' ' OD2' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -73.19 -37.96 66.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.879 0.371 . . . . 0.0 110.55 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.22 -33.4 75.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.166 0.508 . . . . 0.0 109.919 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 41' ' ' LEU . 20.3 tp -64.32 -42.03 96.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.047 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' THR . 48.7 t -69.92 -40.17 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.963 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 -37.17 77.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.784 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.67 -37.3 86.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.346 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -67.87 -49.87 59.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.185 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.6 t -62.84 -44.73 99.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.107 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.13 -38.09 95.02 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.619 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.586 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 9.2 t80 -66.63 -43.09 85.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -61.44 -37.1 82.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.317 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.618 HD12 ' HE3' ' A' ' 24' ' ' LYS . 15.8 tp -65.63 -33.01 74.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.733 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.7 mtm-85 -79.42 -34.4 41.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.684 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 13.7 mm100 -61.19 -39.05 88.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.354 . . . . 0.0 111.181 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.618 ' HE3' HD12 ' A' ' 21' ' ' LEU . 11.6 pttp -84.77 2.57 41.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.177 0.513 . . . . 0.0 110.823 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.25 -108.33 1.07 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.441 ' HD1' ' SG ' ' A' ' 28' ' ' CYS . 17.3 t80 -101.67 105.19 16.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 23' ' ' GLN . 98.2 t -65.17 107.46 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.171 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.441 ' SG ' ' HD1' ' A' ' 26' ' ' TYR . 8.2 m -113.82 118.77 35.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.87 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.57 178.74 25.72 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.058 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.31 155.91 23.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.612 0.244 . . . . 0.0 110.609 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.55 106.86 3.27 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.774 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.95 109.13 1.04 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.932 2.422 . . . . 0.0 112.438 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.78 -118.27 2.57 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.876 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -85.66 66.8 9.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.274 0.559 . . . . 0.0 109.688 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.18 98.79 0.24 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.484 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.27 112.88 1.25 Allowed 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.9 2.4 . . . . 0.0 111.613 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.69 151.48 22.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.266 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.88 -34.03 51.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.927 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.65 120.47 46.18 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.002 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -102.33 16.79 0.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.602 2.868 . . . . 0.0 112.498 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.64 ' HB3' HD21 ' A' ' 12' ' ' LEU . 79.6 mt -68.76 -46.26 69.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.714 0.292 . . . . 0.0 111.494 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -70.0 -37.69 75.76 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -65.43 -39.66 92.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.379 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.21 86.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.627 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 36.5 mtt -64.93 -38.2 90.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.416 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -69.02 -30.02 68.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.753 179.272 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.82 -35.42 38.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.809 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.61 -41.82 67.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 111.024 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.89 37.41 3.44 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.056 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.07 -43.22 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 54' ' ' THR . 56.4 mm-40 -54.13 -63.99 0.97 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.555 ' O ' ' HB2' ' A' ' 56' ' ' PHE . 1.2 p90 -64.94 -21.14 66.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.451 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 53' ' ' GLU . 5.0 tp10 -80.93 -40.7 24.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 111.589 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 51' ' ' GLU . 4.0 t -70.62 -13.75 62.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.732 0.301 . . . . 0.0 111.385 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.507 ' O ' ' HG3' ' B' ' 216' ' ' MET . 81.1 mtm-85 -113.93 6.79 16.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.752 0.31 . . . . 0.0 111.148 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 52' ' ' PHE . 2.1 t80 -116.16 -88.89 0.58 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.574 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 mtm105 -174.75 -83.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.174 0.511 . . . . 0.0 109.672 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.709 ' HA ' ' HE ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -148.87 49.99 0.99 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.758 HG22 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -53.72 -28.66 35.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.985 -178.083 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -52.85 -31.06 37.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 110.99 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.92 -37.47 3.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.648 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 15.5 t70 -61.7 -39.14 90.43 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.444 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.758 ' HB2' HG22 ' A' ' 59' ' ' THR . 14.7 tp -61.83 -34.79 76.58 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.164 0.506 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.68 -32.6 41.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.315 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.54 -44.28 62.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.538 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 9.7 pt20 -65.34 -32.36 73.96 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.885 0.374 . . . . 0.0 110.64 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.71 -8.8 59.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.284 0.564 . . . . 0.0 110.109 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -12.97 46.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.02 -37.73 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.966 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -86.5 160.53 50.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.067 178.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.966 ' HD2' HG22 ' A' ' 70' ' ' THR . 10.9 Cg_endo -55.08 115.78 2.68 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.394 2.063 . . . . 0.0 112.146 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.42 -164.53 11.0 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.41 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 50.3 m -152.36 -155.28 0.6 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.87 -159.18 0.1 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.855 0.36 . . . . 0.0 111.617 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.59 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 1.9 mm-40 -50.27 -34.77 24.42 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.719 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -56.04 -36.43 67.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.356 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 22.4 tpp85 -72.7 -34.27 67.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.702 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.59 ' HD2' ' HA ' ' A' ' 75' ' ' GLN . 90.6 m-85 -69.15 -40.46 78.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.125 0.488 . . . . 0.0 110.328 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -68.54 -36.16 78.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.284 0.564 . . . . 0.0 110.172 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.85 ' HG2' HD12 ' B' ' 201' ' ' ILE . 22.5 tp60 -71.53 -42.55 67.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.941 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 78' ' ' PHE . 3.4 p -61.22 -20.72 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.039 0.447 . . . . 0.0 111.342 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -87.67 -46.63 9.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.959 0.409 . . . . 0.0 110.445 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -35.8 80.47 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.352 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.624 ' HG3' ' HG2' ' B' ' 203' ' ' LYS . 6.3 tp10 -49.42 -39.4 32.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.246 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.701 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.5 OUTLIER -105.54 3.41 29.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.813 0.34 . . . . 0.0 111.469 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.501 ' HE1' ' HA ' ' A' ' 95' ' ' LEU . 28.7 t80 -84.15 -37.48 21.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.53 -21.46 66.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.654 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.85 8.39 69.91 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.515 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.455 ' HA2' ' HD3' ' A' ' 90' ' ' PRO . . . 130.33 116.57 1.85 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.464 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.455 ' HD3' ' HA2' ' A' ' 89' ' ' GLY . 5.6 Cg_exo -75.35 65.2 6.37 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.375 2.716 . . . . 0.0 111.321 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -68.13 178.02 2.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.72 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.665 ' H ' ' HE3' ' A' ' 92' ' ' TRP . 1.4 m-90 -45.0 -72.47 0.06 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.529 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.46 68.35 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.197 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.5 tpp85 -66.65 -51.23 58.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.612 0.244 . . . . 0.0 110.62 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.501 ' HA ' ' HE1' ' A' ' 86' ' ' PHE . 25.3 tp -67.03 -36.08 81.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.966 0.412 . . . . 0.0 110.505 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.462 HG22 ' HE1' ' A' ' 146' ' ' PHE . 60.9 t -65.83 -54.33 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.821 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.751 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -61.03 -41.74 97.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.021 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -54.6 -36.56 64.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.535 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -90.86 -46.56 8.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.818 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 97' ' ' ALA . 5.6 p -65.15 -37.15 79.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.455 ' HD1' ' HA ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -65.7 -45.4 82.91 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.105 -179.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.03 -45.6 95.76 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.61 98.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.215 . . . . 0.0 111.015 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.47 97.31 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.807 0.337 . . . . 0.0 111.208 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 105' ' ' LEU . 2.0 mm? -73.74 -39.69 64.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.29 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.431 ' O ' HG23 ' A' ' 110' ' ' VAL . 52.1 m -64.57 -42.18 95.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.391 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.35 -42.53 87.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.875 0.369 . . . . 0.0 110.348 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -42.65 98.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.476 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m -65.34 -37.1 86.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.545 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 106' ' ' CYS . 42.5 t -62.51 -44.85 99.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.274 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -66.01 -24.8 66.83 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.416 0.627 . . . . 0.0 110.177 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -89.54 5.24 46.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.101 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 66.98 18.57 10.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.696 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.46 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -92.25 60.33 3.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.219 0.533 . . . . 0.0 109.584 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.78 -24.63 66.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.341 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.7 t -62.63 -47.31 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.024 0.44 . . . . 0.0 109.914 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.73 -38.96 87.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.217 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 114' ' ' MET . 87.7 t -58.23 -52.05 63.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.532 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.74 93.18 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.041 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -62.13 -53.83 49.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.709 0.29 . . . . 0.0 110.88 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.68 -44.43 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.25 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -45.46 88.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.548 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.52 -46.07 91.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.268 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -60.02 -43.51 95.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.003 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 96.8 mtp -64.31 -52.4 58.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 72.1 t -60.57 -42.56 92.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.296 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.06 -48.41 73.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.818 0.342 . . . . 0.0 110.679 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -59.7 -39.54 84.94 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.55 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.6 mt -59.17 -29.96 67.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.409 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -106.01 11.41 31.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.702 0.287 . . . . 0.0 110.966 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 78.4 m -108.29 -65.61 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.495 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -108.24 -22.03 12.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.788 0.328 . . . . 0.0 111.396 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.775 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 61.0 mt -101.15 11.97 38.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.646 0.26 . . . . 0.0 111.024 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.52 -49.0 77.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.27 -43.72 92.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.716 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.775 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 83.0 m95 -60.11 -49.43 77.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.579 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 133' ' ' LEU . 46.0 mm -63.45 -39.37 85.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.512 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.15 -49.83 72.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.923 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.3 m -63.78 -47.77 79.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.325 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 50.7 m -70.17 -16.75 63.12 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.78 41.19 50.65 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.877 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.89 -100.95 0.67 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.125 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -111.77 13.78 21.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.782 0.325 . . . . 0.0 110.548 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.23 -50.91 71.4 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.822 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.617 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 11.0 pt-20 -86.26 -22.37 26.87 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.587 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.462 ' HE1' HG22 ' A' ' 96' ' ' VAL . 90.0 t80 -59.38 -41.05 88.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.947 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.566 ' HA ' ' CE2' ' A' ' 150' ' ' TYR . 0.4 OUTLIER -64.81 -26.16 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.218 0.532 . . . . 0.0 111.046 -179.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.79 -26.27 24.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.948 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 84.7 mt -60.76 -60.54 3.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.893 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 147' ' ' THR . 34.0 p90 -74.87 -10.54 59.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.984 0.421 . . . . 0.0 110.591 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.34 -19.1 77.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.559 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -123.32 -65.39 1.09 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 63.23 23.97 66.83 Favored Glycine 0 C--O 1.228 -0.251 0 CA-C-N 115.722 -0.672 . . . . 0.0 114.409 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -125.29 -41.67 2.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.455 0.627 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 33.9 mt -81.79 77.98 8.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.061 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -142.07 110.13 5.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.744 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -112.92 41.68 2.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.622 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -93.01 -50.27 5.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.659 0.266 . . . . 0.0 110.902 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.512 HH21 ' HG2' ' B' ' 218' ' ' ARG . 0.3 OUTLIER -105.55 9.5 33.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.908 0.385 . . . . 0.0 111.278 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' B' ' 220' ' ' ILE . 6.3 mtm180 -90.92 81.21 5.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.486 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 19.0 tp -85.03 133.62 34.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.118 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -102.69 94.63 5.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.715 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.48 176.5 5.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.591 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.56 115.58 0.63 Allowed Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -90.45 72.97 6.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.253 0.549 . . . . 0.0 109.988 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -171.26 -65.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.605 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -127.03 152.24 47.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.064 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.9 m -83.73 -8.18 59.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.011 0.434 . . . . 0.0 110.317 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.3 t -69.35 126.27 29.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.406 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.931 -0.556 . . . . 0.0 109.604 -179.849 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . 0.85 HD12 ' HG2' ' A' ' 80' ' ' GLN . 25.6 mt . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.676 0.274 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.647 HG12 HG12 ' B' ' 205' ' ' ILE . 10.0 tt -162.3 100.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.639 0.733 . . . . 0.0 110.743 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.624 ' HG2' ' HG3' ' A' ' 84' ' ' GLU . 48.5 mttm -77.63 -32.41 53.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.92 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -45.93 -61.09 1.89 Allowed 'General case' 0 C--O 1.24 0.575 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . 0.647 HG12 HG12 ' B' ' 202' ' ' ILE . 45.3 pt -69.46 -34.38 61.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.69 0.281 . . . . 0.0 111.283 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . 0.447 ' HA ' HG22 ' A' ' 81' ' ' VAL . . . -62.54 -37.51 86.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.203 0.525 . . . . 0.0 110.365 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' ARG . . . . . 0.701 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 38.0 ttp180 -62.85 -44.42 96.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.317 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' HIS . . . . . 0.402 ' O ' HG22 ' B' ' 212' ' ' VAL . 84.5 t60 -63.65 -40.09 95.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.27 -52.45 65.63 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.29 0.567 . . . . 0.0 110.507 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -68.56 -34.98 76.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.731 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -56.6 -56.03 26.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.79 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 208' ' ' HIS . 13.0 m -63.1 -43.41 98.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.535 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.08 -42.2 98.2 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.76 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.513 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 0.6 OUTLIER -70.33 -47.62 60.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.654 0.264 . . . . 0.0 111.574 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.439 ' OG ' ' HD3' ' A' ' 159' ' ' ARG . 12.2 m -68.34 -42.74 78.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 55' ' ' ARG . 6.5 tpt -66.05 -48.16 71.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.01 -35.03 79.89 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.067 0.461 . . . . 0.0 110.548 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' B' ' 214' ' ' ASP . 0.0 OUTLIER -73.0 -15.59 61.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 15.3 m 70.36 -57.67 0.57 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.215 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.41 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 2.8 mt . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.554 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.0 m -141.19 88.52 10.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.848 0.356 . . . . 0.0 110.508 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.23 129.78 19.97 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.473 2.115 . . . . 0.0 112.074 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.09 167.66 12.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.285 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.6 m -104.88 125.7 51.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.829 0.347 . . . . 0.0 110.58 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.656 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -84.59 -53.0 0.51 Allowed Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.224 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 10.9 Cg_exo -71.09 133.95 24.18 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.91 1.74 . . . . 0.0 111.788 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.0 149.91 47.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.935 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.91 -40.91 67.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.325 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -73.59 -27.09 61.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 0.0 110.945 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.01 94.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 mp -64.17 -42.54 96.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.289 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.99 -45.89 95.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.149 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.5 80.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.565 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.0 -42.05 85.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.215 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -63.22 -46.08 88.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.31 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.18 -47.38 93.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.073 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.46 99.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.692 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.655 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 18.3 t80 -60.78 -48.89 79.73 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -60.03 -38.86 83.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.597 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 21' ' ' LEU . 8.3 tp -67.77 -25.79 65.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.074 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -89.44 -29.59 18.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 19' ' ' TYR . 15.6 mm100 -60.87 -28.61 68.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.017 0.436 . . . . 0.0 111.347 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -88.48 16.04 7.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.582 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.87 -62.75 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.845 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -145.3 102.53 3.74 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.82 107.41 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.252 0.549 . . . . 0.0 110.885 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.8 t -110.11 127.39 54.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.996 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.83 -124.07 2.18 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.018 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.27 172.27 16.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.764 0.316 . . . . 0.0 110.653 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.09 108.64 2.87 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.1 110.24 2.58 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.936 2.424 . . . . 0.0 111.851 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.63 -104.31 2.46 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.894 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -90.15 109.72 20.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.284 0.564 . . . . 0.0 110.24 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.98 90.71 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -48.0 108.56 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.331 2.687 . . . . 0.0 112.863 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.11 141.14 38.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.68 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.67 79.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.007 0.432 . . . . 0.0 110.152 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.87 126.33 32.13 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.21 0.529 . . . . 0.0 110.436 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -96.59 1.65 1.91 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.826 2.351 . . . . 0.0 110.716 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.594 HD23 ' HB2' ' A' ' 143' ' ' TRP . 12.2 mt -67.18 -50.23 61.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.661 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -62.13 -34.11 75.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.07 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -80.84 -38.58 28.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.465 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HB1' ' HD2' ' A' ' 146' ' ' PHE . . . -60.87 -43.97 97.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.706 0.288 . . . . 0.0 111.011 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 54.9 mtt -63.8 -38.41 90.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.032 0.444 . . . . 0.0 110.535 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 4.9 tmm_? -70.42 -42.53 71.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.224 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.38 -32.6 71.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.875 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.93 -50.52 57.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.045 0.45 . . . . 0.0 110.609 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.421 ' HA2' ' HE1' ' A' ' 52' ' ' PHE . . . -98.6 42.71 2.0 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.329 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 2.8 t0 -148.34 -46.48 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.586 0.231 . . . . 0.0 111.26 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.496 ' O ' HG22 ' A' ' 54' ' ' THR . 71.0 mm-40 -57.19 -55.53 33.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.801 0.334 . . . . 0.0 111.9 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.421 ' HE1' ' HA2' ' A' ' 49' ' ' GLY . 2.1 p90 -68.35 -26.48 65.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.687 0.28 . . . . 0.0 111.248 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -77.23 -42.79 35.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.172 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 51' ' ' GLU . 6.5 t -65.22 -26.02 67.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.154 0.502 . . . . 0.0 110.219 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' A' ' 51' ' ' GLU . 37.3 mtm-85 -93.2 -1.07 56.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.895 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.601 ' HD2' ' HG2' ' B' ' 216' ' ' MET . 42.9 t80 -111.87 -92.47 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.283 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.0 ttp85 175.11 -66.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.718 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.794 ' HA ' ' HE ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -154.3 56.55 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.268 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -30.6 71.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.995 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -52.12 -38.63 58.04 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 123.455 0.472 . . . . 0.0 110.981 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.04 -41.2 6.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.258 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -59.45 -46.44 88.75 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.629 HD11 ' HA ' ' B' ' 209' ' ' LEU . 7.4 tp -62.81 -37.47 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 110.499 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.69 -30.7 63.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.295 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.04 -49.09 54.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.799 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -66.49 -31.5 72.27 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.941 0.4 . . . . 0.0 110.128 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.797 ' HG ' ' HZ ' ' A' ' 101' ' ' PHE . 0.5 OUTLIER -69.32 -22.27 63.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 178.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -83.18 -22.49 33.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.935 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.31 -49.04 34.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.551 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -72.53 141.36 82.71 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.697 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.551 ' HD2' HG22 ' A' ' 70' ' ' THR . 77.8 Cg_exo -50.92 104.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.77 2.314 . . . . 0.0 112.63 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -127.59 -158.77 9.87 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.954 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.606 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 7.4 m -142.84 -148.44 0.24 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.03 -158.19 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.976 0.417 . . . . 0.0 111.423 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.622 ' HA ' ' HD2' ' A' ' 78' ' ' PHE . 3.7 mm-40 -53.04 -38.13 62.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.576 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -56.82 -40.03 75.29 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.944 0.402 . . . . 0.0 110.842 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.606 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 14.0 tpp85 -64.94 -37.94 89.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.975 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.622 ' HD2' ' HA ' ' A' ' 75' ' ' GLN . 40.9 m-85 -69.16 -37.32 78.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.526 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 m -69.04 -46.7 67.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.084 0.469 . . . . 0.0 110.632 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.81 -32.62 69.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.866 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 78' ' ' PHE . 2.5 p -69.25 -19.17 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.164 0.507 . . . . 0.0 110.774 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.506 ' HB3' ' HA ' ' A' ' 98' ' ' PHE . 38.4 m -82.48 -43.65 16.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.117 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.89 -24.12 55.63 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.063 0.459 . . . . 0.0 109.976 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.795 ' HG3' ' HD3' ' B' ' 203' ' ' LYS . 2.9 tp10 -51.33 -48.01 62.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.44 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.569 HD21 ' HG2' ' B' ' 207' ' ' ARG . 0.1 OUTLIER -90.1 -5.77 56.17 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.924 -0.311 . . . . 0.0 111.658 -178.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.2 -27.95 57.05 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -65.47 -23.58 66.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.297 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.19 3.3 86.38 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.908 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 90' ' ' PRO . . . 131.33 133.16 3.45 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.547 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 89' ' ' GLY . 6.3 Cg_exo -78.53 65.83 8.57 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.141 2.561 . . . . 0.0 111.618 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -70.9 169.76 14.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.277 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.529 ' H ' ' HE3' ' A' ' 92' ' ' TRP . 5.1 m-90 -52.24 -63.17 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.865 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.32 -11.28 75.72 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.182 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -67.0 -49.99 63.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.732 0.301 . . . . 0.0 110.307 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.9 tp -67.29 -33.92 76.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.266 0.555 . . . . 0.0 109.736 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.14 -54.13 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.472 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.576 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -61.91 -43.17 99.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.574 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.506 ' HA ' ' HB3' ' A' ' 82' ' ' SER . 79.3 t80 -57.91 -42.89 85.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.039 0.447 . . . . 0.0 111.53 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -75.86 -46.78 28.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.709 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 97' ' ' ALA . 9.8 p -66.93 -34.0 67.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.797 ' HZ ' ' HG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -60.8 -50.31 73.95 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 110.43 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.4 -43.23 95.28 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.918 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.11 87.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.46 97.71 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.3 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.16 -43.33 71.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.044 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.454 ' O ' HG23 ' A' ' 110' ' ' VAL . 34.7 m -61.94 -44.15 97.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.416 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.58 82.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.908 0.385 . . . . 0.0 110.488 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -68.31 -40.51 81.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.164 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.476 ' HB2' HG22 ' A' ' 118' ' ' VAL . 17.2 m -63.99 -37.81 88.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.812 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 106' ' ' CYS . 99.5 t -67.65 -33.42 61.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.122 0.487 . . . . 0.0 109.764 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.08 -13.23 61.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.248 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -106.94 7.92 30.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.121 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 62.61 34.31 15.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.48 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.541 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -106.73 62.79 0.63 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.008 0.432 . . . . 0.0 110.117 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -64.96 -27.6 68.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.678 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.9 t -59.08 -48.36 86.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.304 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 tp -70.37 -39.17 74.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.353 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 114' ' ' MET . 99.4 t -59.2 -49.51 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.837 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.56 84.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.384 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -69.02 -51.25 41.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.71 0.291 . . . . 0.0 110.664 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.84 -43.48 97.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.759 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -43.24 94.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.989 0.423 . . . . 0.0 110.099 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.28 -42.47 88.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.36 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -60.5 -41.45 94.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 93.1 mtp -59.35 -52.22 66.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.456 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.1 t -65.18 -42.31 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.586 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.02 -47.21 81.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -63.22 -40.41 97.38 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.992 0.425 . . . . 0.0 110.119 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.721 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 24.3 mt -63.08 -35.36 79.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.145 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -90.95 6.51 44.39 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.2 m -121.37 -61.52 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -101.44 -26.6 13.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.721 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 97.3 mt -98.77 10.03 42.1 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.324 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.14 -48.07 77.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.767 0.317 . . . . 0.0 111.17 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.85 -52.09 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.621 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -61.42 -50.6 72.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.475 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.574 HG23 ' HA2' ' A' ' 142' ' ' GLY . 17.5 mm -58.92 -40.2 79.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.694 0.283 . . . . 0.0 110.938 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -61.37 -43.67 98.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.962 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.4 m -69.94 -41.01 75.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.752 0.311 . . . . 0.0 111.119 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.0 m -75.09 -2.06 25.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.594 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.0 42.02 98.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.08 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.574 ' HA2' HG23 ' A' ' 137' ' ' ILE . . . 72.95 -102.12 1.19 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.393 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.594 ' HB2' HD23 ' A' ' 41' ' ' LEU . 82.0 m95 -112.49 9.33 19.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.668 0.271 . . . . 0.0 110.365 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.16 -55.88 28.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.988 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.601 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 43.8 tt0 -59.9 -39.3 84.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.124 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.44 ' HA ' ' HG ' ' A' ' 149' ' ' LEU . 48.9 t80 -57.97 -34.84 70.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.626 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.456 ' HA ' ' CE2' ' A' ' 150' ' ' TYR . 2.1 m -60.46 -37.35 80.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.04 0.448 . . . . 0.0 110.778 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.81 -27.54 30.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.505 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 26.3 mt -57.23 -52.39 65.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.261 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.456 ' CE2' ' HA ' ' A' ' 147' ' ' THR . 30.3 p90 -87.08 8.26 24.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.838 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -62.72 -34.91 91.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.969 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -154.71 125.28 6.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.64 0.257 . . . . 0.0 110.382 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.6 30.07 2.72 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.692 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -145.85 -25.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.1 mp -102.12 -40.51 6.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.335 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.96 128.26 35.05 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.2 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.58 ' OE2' ' HB3' ' A' ' 160' ' ' ARG . 0.2 OUTLIER -117.05 31.64 6.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.762 0.315 . . . . 0.0 111.379 -179.057 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -97.46 -26.06 14.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -148.36 41.39 0.97 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.299 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.59 ' HA ' ' HG3' ' B' ' 218' ' ' ARG . 27.3 ttp180 -108.76 -81.6 0.57 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.172 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.727 ' HA ' HD12 ' B' ' 220' ' ' ILE . 22.5 mt -79.92 88.52 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.362 . . . . 0.0 111.122 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.406 ' HD3' ' HA ' ' A' ' 162' ' ' ARG . 66.2 mmt-85 -122.56 -93.71 0.51 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.919 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -153.6 157.35 39.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.148 0.499 . . . . 0.0 111.632 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.57 151.94 7.42 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -60.86 -38.65 86.28 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 117.196 0.498 . . . . 0.0 111.441 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.496 ' CZ3' ' HB3' ' B' ' 211' ' ' GLN . 31.7 m-90 -95.21 1.38 54.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.981 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.49 ' HB1' HG12 ' B' ' 220' ' ' ILE . . . -69.64 113.5 6.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.772 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.9 m -104.73 -32.48 8.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.982 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.2 t -81.6 107.05 13.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.261 0.553 . . . . 0.0 110.15 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 170' ' ' ARG . 9.6 ptp180 . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.254 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 43.7 mt . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 120.739 0.304 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -147.22 79.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.239 0.542 . . . . 0.0 110.363 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.795 ' HD3' ' HG3' ' A' ' 84' ' ' GLU . 39.2 mmtm -58.92 -36.07 74.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.13 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -62.49 -43.52 98.62 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.155 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 38.7 mt -64.99 -41.68 92.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.111 0.481 . . . . 0.0 109.707 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . 0.462 ' HB3' HD23 ' A' ' 85' ' ' LEU . . . -62.45 -42.59 99.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.631 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' ARG . . . . . 0.569 ' HG2' HD21 ' A' ' 85' ' ' LEU . 15.2 mtp180 -61.35 -34.61 75.58 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.114 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -58.69 7.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.569 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.629 ' HA ' HD11 ' A' ' 63' ' ' LEU . 1.2 pp -67.72 -42.25 82.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' B' ' 214' ' ' ASP . . . -64.92 -47.18 78.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' GLN . . . . . 0.496 ' HB3' ' CZ3' ' A' ' 166' ' ' TRP . 6.3 tp60 -65.69 -37.91 87.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 16.5 t -58.19 -55.09 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.656 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.29 -38.45 91.56 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.468 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' B' ' 218' ' ' ARG . 2.3 t0 -63.83 -49.77 71.53 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.7 m -68.42 -40.24 81.31 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' MET . . . . . 0.601 ' HG2' ' HD2' ' A' ' 56' ' ' PHE . 5.6 tpt -64.64 -42.68 95.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.744 0.306 . . . . 0.0 111.094 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.34 -33.34 69.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.318 0.58 . . . . 0.0 110.047 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . 0.59 ' HG3' ' HA ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -73.51 -9.96 59.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.887 179.234 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 14.4 m 64.99 37.66 6.73 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 123.604 0.565 . . . . 0.0 111.216 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.727 HD12 ' HA ' ' A' ' 161' ' ' LEU . 11.0 tt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.148 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.715 0.293 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 m -133.62 117.19 14.11 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.513 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.16 144.05 99.5 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.645 2.23 . . . . 0.0 112.15 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.62 114.86 29.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.815 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -69.72 115.88 9.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.989 0.423 . . . . 0.0 110.647 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.548 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -86.32 -49.93 0.5 Allowed Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.327 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 32.7 Cg_exo -61.3 131.87 38.48 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.05 1.833 . . . . 0.0 113.042 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -75.62 149.08 38.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.378 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 m -57.22 -36.94 71.51 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -69.66 -31.38 69.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.668 0.271 . . . . 0.0 110.617 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.45 78.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.237 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 mp -69.15 -41.7 76.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.744 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.64 -42.99 98.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.995 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.32 87.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.667 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.42 -46.89 81.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -61.05 -48.86 79.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.974 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.13 -46.66 95.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.51 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.71 98.95 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.794 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -61.95 -46.14 90.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.724 0.297 . . . . 0.0 110.272 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 20' ' ' LYS . 11.8 mmmt -61.65 -35.91 79.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.936 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.11 -26.24 59.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.683 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -84.26 -36.99 22.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.379 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -56.97 -35.4 69.11 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 24.18 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.932 0.396 . . . . 0.0 111.382 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.04 -54.95 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.683 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -154.52 111.83 3.39 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.93 120.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.148 0.499 . . . . 0.0 110.812 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.8 m -132.37 108.56 9.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.397 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.5 -134.87 3.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.843 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.09 146.77 26.38 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.94 114.84 4.08 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.653 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.59 83.7 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.064 2.509 . . . . 0.0 112.2 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.63 -103.65 1.24 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.234 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -103.15 105.74 16.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.046 0.45 . . . . 0.0 109.798 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.45 85.73 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.577 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -57.22 119.17 6.25 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.069 2.512 . . . . 0.0 112.252 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.49 164.19 13.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.485 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.435 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . -85.45 -15.98 41.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.133 0.492 . . . . 0.0 110.294 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -105.87 102.52 39.38 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.844 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 41.0 Cg_endo -96.77 5.28 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.224 2.616 . . . . 0.0 111.57 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.0 mt -64.27 -45.95 85.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.155 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -63.78 -43.07 97.45 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.74 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -65.49 -43.54 89.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.934 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.17 -39.0 93.39 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.834 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.1 ttt -73.55 -34.98 65.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.091 0.472 . . . . 0.0 110.602 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -68.81 -40.87 79.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.84 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 50' ' ' ASP . . . -95.01 5.14 52.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.739 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.54 58.31 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.189 0.518 . . . . 0.0 110.801 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -96.67 29.2 10.8 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.43 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -124.77 -31.2 3.21 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.358 -0.137 . . . . 0.0 111.215 -179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -56.99 -71.89 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.116 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.511 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 54.2 p90 -58.95 -25.76 63.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.113 0.482 . . . . 0.0 110.545 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 4.0 tp10 -66.29 -38.06 86.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.489 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -61.16 -36.9 81.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.29 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.604 ' HB2' ' HG3' ' B' ' 216' ' ' MET . 0.0 OUTLIER -86.65 -17.42 33.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.343 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.695 ' HB2' ' HG2' ' B' ' 216' ' ' MET . 41.8 t80 -97.05 -93.62 0.22 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.295 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 57' ' ' ARG . 26.1 ttm105 -175.39 -81.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.416 0.627 . . . . 0.0 109.534 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.404 ' HA ' ' HE ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -153.03 67.26 0.79 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.385 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -53.22 -32.89 50.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.496 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.62 -36.58 64.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 110.619 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -99.23 -32.95 10.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.093 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 10.6 t70 -63.18 -38.21 90.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.92 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.2 tp -57.27 -43.71 83.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.49 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.72 -35.99 79.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.052 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.1 -47.6 35.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.747 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 9.5 pt20 -66.23 -33.04 74.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.602 0.239 . . . . 0.0 111.118 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.87 -0.75 40.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.737 0.303 . . . . 0.0 111.006 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -94.3 -29.35 15.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.6 t -62.57 -46.8 95.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.56 0.695 . . . . 0.0 109.3 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.582 HG22 ' HD2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -92.9 145.18 29.69 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.495 178.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.582 ' HD2' HG22 ' A' ' 70' ' ' THR . 69.0 Cg_exo -52.35 107.65 0.2 Allowed 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.708 2.272 . . . . 0.0 112.597 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.57 -166.11 28.45 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.094 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.657 ' HB2' ' HB2' ' A' ' 77' ' ' ARG . 73.2 m -157.21 -150.43 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.898 -0.177 . . . . 0.0 110.717 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.35 -168.19 0.92 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.676 0.275 . . . . 0.0 111.192 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.44 HE22 HG11 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -56.69 -34.15 67.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -55.42 -27.8 50.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.373 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.657 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 15.4 tpp85 -75.61 -13.04 60.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.51 ' O ' HG12 ' A' ' 81' ' ' VAL . 80.1 m-85 -104.3 -40.78 5.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.41 HG21 HG13 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -65.99 -36.46 83.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 111.71 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -95.22 3.96 54.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 111.722 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -97.32 -23.73 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.259 0.552 . . . . 0.0 109.681 179.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.12 -42.45 19.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.592 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -21.64 58.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.026 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 3.4 tp10 -55.1 -41.89 72.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.193 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.749 ' HG ' ' HA ' ' B' ' 207' ' ' ARG . 0.3 OUTLIER -97.76 10.03 41.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.99 0.424 . . . . 0.0 110.718 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -99.17 -29.35 12.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -56.1 -45.59 79.37 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.982 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -106.07 15.46 43.71 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.294 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.1 78.35 0.15 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.734 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.89 54.22 5.03 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 123.221 2.614 . . . . 0.0 111.641 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -74.93 162.37 28.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.093 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.473 ' HZ3' ' HD2' ' B' ' 218' ' ' ARG . 0.3 OUTLIER -58.41 -51.64 68.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.655 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.69 -28.48 73.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.099 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.9 tpp85 -65.83 -44.69 84.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.77 -42.21 95.27 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 71.6 t -61.48 -44.84 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.948 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.52 ' HA ' HG12 ' A' ' 100' ' ' VAL . . . -62.01 -45.02 95.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.933 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.22 -40.21 93.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.152 0.501 . . . . 0.0 110.668 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -71.11 -47.05 60.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.29 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 97' ' ' ALA . 6.7 p -70.23 -29.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.476 ' CZ ' HD13 ' B' ' 209' ' ' LEU . 0.5 OUTLIER -59.14 -52.01 67.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.088 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.91 -42.01 95.13 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.629 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.98 -49.78 76.07 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.35 -46.24 84.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.572 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.472 ' HA ' HD13 ' A' ' 105' ' ' LEU . 1.6 mm? -64.12 -39.26 93.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.048 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.31 -39.73 71.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.65 91.37 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.867 0.365 . . . . 0.0 110.259 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.36 -42.82 98.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.818 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.7 m -66.11 -44.22 84.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.031 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.458 HG23 HG21 ' A' ' 118' ' ' VAL . 51.6 t -60.35 -43.01 92.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 121.171 0.51 . . . . 0.0 109.833 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -65.56 -25.08 67.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.554 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -93.6 10.86 30.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.669 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 66.58 25.52 9.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.041 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.63 75.86 1.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.005 0.431 . . . . 0.0 110.213 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -76.14 -27.24 56.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.0 t -55.0 -50.57 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.424 HD21 ' HG3' ' A' ' 75' ' ' GLN . 57.3 tp -63.08 -44.25 96.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.334 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.458 HG21 HG23 ' A' ' 110' ' ' VAL . 87.3 t -57.43 -49.1 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.195 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.18 -42.03 87.26 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.555 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -69.33 -49.48 55.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.507 0.194 . . . . 0.0 110.648 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.44 HG11 HE22 ' A' ' 75' ' ' GLN . 77.2 t -57.83 -46.85 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.182 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -40.34 96.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.763 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.26 -38.91 91.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 0.0 110.437 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -66.6 -42.22 87.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.131 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 87.0 mtp -63.22 -48.6 77.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.438 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.67 -42.71 89.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.551 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.14 74.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.371 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -57.74 -41.46 81.92 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.367 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.519 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 79.3 mt -63.5 -31.78 73.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.615 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.28 9.96 42.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.638 0.256 . . . . 0.0 111.372 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.4 m -119.1 -80.15 0.61 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.448 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -81.67 -35.6 29.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.865 0.364 . . . . 0.0 111.659 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.593 ' HA ' ' HD1' ' A' ' 136' ' ' TRP . 35.4 mt -91.63 5.8 48.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.814 0.34 . . . . 0.0 110.978 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.18 81.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.854 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.98 -45.66 70.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.922 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.593 ' HD1' ' HA ' ' A' ' 133' ' ' LEU . 87.9 m95 -59.28 -51.69 68.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.411 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 133' ' ' LEU . 51.6 mm -61.58 -30.92 49.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.053 0.454 . . . . 0.0 111.011 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -72.3 -45.77 58.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.089 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.6 m -70.9 -30.12 66.38 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.554 ' HB3' ' HG2' ' A' ' 145' ' ' GLU . 67.5 m -89.31 1.93 55.07 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.11 41.05 96.38 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.441 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.99 -98.84 0.9 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -115.15 11.22 16.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -54.07 -51.05 65.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.778 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.652 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 3.2 pt-20 -85.65 -24.0 27.26 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.423 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -59.88 -42.22 93.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.228 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.473 ' HA ' ' HE1' ' A' ' 150' ' ' TYR . 1.2 p -72.68 -5.49 37.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.976 0.417 . . . . 0.0 111.258 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.85 -17.52 15.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.245 0.545 . . . . 0.0 110.323 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 145' ' ' GLU . 41.3 mt -76.34 -57.14 4.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.945 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.473 ' HE1' ' HA ' ' A' ' 147' ' ' THR . 4.8 p90 -74.59 -10.37 59.48 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.386 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.84 -22.74 78.87 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.818 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -121.43 80.76 1.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 0.0 110.271 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.79 31.23 8.91 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.083 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -132.79 83.11 2.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.907 0.384 . . . . 0.0 110.263 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.422 ' H ' ' HG ' ' A' ' 155' ' ' LEU . 0.7 OUTLIER -70.13 -25.61 63.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.598 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.27 132.77 8.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.202 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -122.36 44.62 2.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.905 0.383 . . . . 0.0 110.553 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -110.63 -55.75 2.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.913 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.69 -6.0 4.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.678 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 160' ' ' ARG . 25.7 ttp85 -63.38 142.96 58.2 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.212 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.92 149.34 49.81 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -67.64 90.48 0.27 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.039 0.447 . . . . 0.0 111.221 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.449 ' OE1' ' HD3' ' A' ' 55' ' ' ARG . 9.7 mm-40 -148.77 -177.28 5.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.998 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.18 -161.46 31.57 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.201 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -136.09 122.79 21.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -164.93 172.46 12.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.901 0.381 . . . . 0.0 110.632 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.47 -13.11 60.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.031 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.0 p -76.03 176.58 7.81 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.297 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.7 t -92.78 115.89 32.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.993 0.425 . . . . 0.0 109.941 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.147 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . 0.638 HG22 HG13 ' B' ' 202' ' ' ILE . 50.2 mt . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.419 0.152 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.638 HG13 HG22 ' B' ' 201' ' ' ILE . 29.0 mt -145.83 119.18 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.382 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -72.96 -34.58 66.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -57.4 -57.48 12.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.834 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' A' ' 70' ' ' THR . 33.2 mm -62.28 -39.22 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.437 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . 0.434 ' HA ' HG22 ' A' ' 81' ' ' VAL . . . -60.45 -46.89 88.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.997 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' ARG . . . . . 0.749 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 2.1 ttp-105 -58.91 -37.78 77.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.66 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' HIS . . . . . 0.508 ' O ' HG23 ' B' ' 212' ' ' VAL . 9.1 t-80 -58.68 -60.59 3.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.105 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.476 HD13 ' CZ ' ' A' ' 101' ' ' PHE . 0.8 OUTLIER -66.17 -41.88 89.69 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -60.75 -44.65 96.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.433 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -67.36 -35.08 78.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.371 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 208' ' ' HIS . 32.8 t -56.36 -54.61 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 123.084 0.24 . . . . 0.0 110.826 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.09 -44.94 43.29 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.244 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -61.39 -56.54 19.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.6 m -62.97 -34.19 77.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.352 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' MET . . . . . 0.695 ' HG2' ' HB2' ' A' ' 56' ' ' PHE . 4.0 tpt -65.85 -44.74 84.58 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.433 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . 0.52 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 30.1 t70 -61.65 -33.94 74.83 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.038 0.447 . . . . 0.0 110.071 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . 0.473 ' HD2' ' HZ3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -66.94 -9.06 34.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.066 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 5.5 m 67.82 -170.43 0.19 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.179 0.592 . . . . 0.0 111.755 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 1.9 pt . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.446 -179.698 . . . . . . . . 0 0 . 1 stop_ save_